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ABSTRACT 
The upregulation of alpha 7 nicotinic acetylcholine receptors ( a7 nAChRs) are putatively 
reported to play a role in in vivo cortical spreading depression-elicited neuroprotection. In 
this study, a reliable in vitro spreading depression model was created for studying this 
phenomenon. In contradiction to previous studies, it was, however, shown that functional 
a7 nAChRs are down-regulated upon chronic depolarisation with KCl, although the 
activity of this receptor subtype remained essential for the preconditioning mechanism. 
Evidence was provided for a differential mechanism underlying protection against 
NMDA-mediated and hypotonic-shock induced cell loss. Non-pharmacological 
upregulation of the a7 nAChRs in pure neuronal cortical cultures by means of a 
recombinant adenovirus led to the increased cell death subsequent to an excitotoxic 
glutamate insult. In addition, in order to study the relationship between a7 nAChRs and 
its function-dependent regulator Ric3, a novel anti-Ric3 antibody and a recombinant 
adenovirus expressing the ric3 gene were created. Ric3 was found to be expressed in 
many important brain structures, including hippocampus, perhinal cortex, thalamic and 
hypothalamic paraventricular nucleus, structures implicated in both cognitive and 
emotional behaviours. Interestingly, Ric3 was also expressed in the choroid plexus, a 
non-neuronal cell type not known to a7 nAChRs, indicating additional roles for this 
protein. The recombinant constructs expressing ric3, a7 nAChRs and dual ric3/ a7 
nAChRs were all validated in vitro. 
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CHAPTER 1: Literature Review and Aims 
1.1.1.1. Cortical Spreading Depression 
Spreading depression (SD) is a transient suppression of neuronal activity, resulting from 
a temporary disruption of local brain ionic homeostasis by a propagating wave of 
neuronal hyperexcitability over the cerebral cortex and was first identified by Leao ( 1944) 
in the cerebral cortex of rabbits (Lauritzen, 1994). Cortical spreading depression (CSD) 
has been hypothesized to form the basis of the aura and spreading neurovascular events 
associated with migraines (Young and Van Vliet, 1992; Lauritzen, 1994; Lauritzen, 
2001), as well as being associated with the cerebral pathology following ischaemia 
(Nedergaard, 1988; Nedergaard and Hansen, 1993; Obrenovitch and Zilkha, 1995) or 
trauma (Oka et al., 1977; Sunami et al., 1989; Strong et al., 2002; Fabricius et al., 2006). 
In an in vivo environment, it is generally thought that the propagating wave of neuronal 
hyperexcitability is merely triggered by the application of high concentrations of 
potassium ions (K+) but is sustained by the efflux of intracellular K+, which diffuses to 
the surrounding tissue to promote further cell firing and depolarisation (Gardner-Medwin, 
1981; Obrenovitch and Zilkha, 1995; Koroleva and Bures, 1996). Experimentally, SD 
can be reliably achieved in vivo by increasing the extracellular K+ concentration, which 
has long been known to reach levels of 50 mM or more during normal SD (Szerb, 1991; 
Herreras and Somjen1993; Martins-Ferreira et al. 2000). Numerous attempts to produce 
CSD using different stimuli have been attempted: chemical stimuli (Van Harreveld, 1959; 
Aquino-Cias et al., 1967; Obrenovitch and Zilkha, 1995, Menna et al., 2000), mechanical 
stimuli e.g. puncture of the cortex (Nellgard and Wieloch, 1992; Lambert et al., 1999; 
Ebersberger et al., 2001) and electrical stimuli e.g. cathodal stimulation (Koroleva and 
Bure, 1980; Reid et al., 1987; Golanov and Reis, 1999). Despite this, only endothelin 
(ET)-1 has been found to reflect the potency and reliability achieved with KCl-induced 
CSD in vivo (Dreier et al., 2002; Petzold et al., 2003; Somjen 2001). It should, however, 
be noted that endothelin-1 induced CSD may take place through a mechanism distinct 
from that ofKCl (Kleeberg et al., 2004). 
The CSD phenomenon is restricted to the brain and appears to involve both neuronal and 
glial cell populations (Smith et al., 2006). CSD is not associated with neuronal injury in 
the normal brain (Nedergaard and Hansen, 1988; Nedergaard and Hansen, 1993). This 
differs from ex vivo experiments, such as in isolated tissue slices, where continuous K+-
depolarisation was associated with neuronal injury, indicating that the mechanism or the 
characteristics associated with the processes and environments might differ (Jing et al., 
1991). This also emphasizes the effect of vascular clearance on the concentration 
gradients ofKCl in intact tissue (Gardner-Medwin et al., 1981; Gardner-Medwin, 1983). 
1.1.1.2. Cortical Spreading Depression and Preconditioning 
Application of high concentrations of K+ -triggered spreading depression or a minor non-
injurious ischemic event accompanied by the associated CSD can also induce tolerance to 
a subsequent sustained ischemic insult in vivo, a phenomenon known as preconditioning 
(Kawahara et al., 1995; Kobayashi et al., 1995; Matsushima et al., 1996; Kawahara et al., 
1997; Taga et al., 1997). The first documented case of in vivo preconditioning was 
performed by Dahl and Balfour in 1964 where it was discovered that brief anoxia leads to 
an acute increase in the capacity of the rat brain for anaerobic glycolysis with an 
increased survival time of the animal subsequent to prolonged anoxic exposure (Dahl and 
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Balfour, 1964). Preconditioning, or ischemic tolerance, is a latent cerebroprotective 
phenotype that has been evolutionarily conserved as a form of cerebral plasticity that 
occurs in invertebrates and vertebrates (Gidday, 2006). 
Preconditioning triggers one of two adaptive cytoprotective responses: acute and chronic 
phase protection. Acute phase protection is the short-lasting tolerance gained to an insult 
only a few minutes subsequent to preconditioning, whereas with chronic phase protection 
the insult can be applied days after the preconditioning event and has a longer window of 
protection than exists with the acute phase preconditioning. The acute phase, or rapid 
preconditioning as it is more commonly referred to, is mostly due to changes in the ion 
channel permeability, protein phosphorylation and other post-translational modifications 
(Perez-Pinzon eta/., 1997; Perez-Pinz6n and Born, 1999; Stagliano eta/., 1999; Lu eta/., 
2005). Chronic phase preconditioning, the classical and more attractive model, requires 
time for pro-survival gene activation with de novo protein synthesis, and the suppression 
of strenuous metabolic pathways and pro-apoptotic/ necrotic genes to generate resistance 
to the delayed ischemic insult (Shimazaki et a/., 1994; Shimizu et a/. 2001; 
Trendelenburg eta/., 2002; Stenzel-Poore eta/., 2003; Wu eta/., 2003). Kitagawa eta/. 
(1990) was the first to illustrate that the disturbance of cellular metabolism caused by the 
preconditioning event, requires time for transcriptional regulation and cellular adaptation 
to occur. This reprogramming of the cell's genomic response to an ischemic insult can be 
produced by various stimuli activating a wide array of cellular mechanisms with different 
degrees of successful protection spanning different windows of opportunity e.g. hypoxia 
(Perez-Pinz6n et a/., 1996; Emerson et a/., 1999; Gidday et a/., 1999; Centeno et a/., 
1999), seizures (Plamondon eta/., 1999; Borges eta/., 2007), hyperthermia (Chopp eta/., 
1989; Kitagawa et al., 1991), adenosine (Heurteaux eta/., 1995; Perez-Pinz6n and Born, 
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1999; Blondeau et al., 2000), and oxidative phosphorylation inhibitors (Riepe et al., 1997; 
Riepe and Ludolph, 1997; Christophe and Nicolas, 2006). Although the triggering and 
propagation of CSD might have been attributed to K+ ions, it is highly probable that there 
are other biological processes that are necessary or, at the very least, contribute to the 
elicitation and propagation of CSD and its subsequent neuroprotective effect. 
The number of consecutive recurrent CSD induced in vivo is the main determinant as to 
whether or not tolerance to an ischemic event will be induced and is subject to the 
environmental conditions that affect the metabolic rate of the subject during the 
preconditioning period. Horiguchi et al. (2005) illustrated that the application of 0.5 M 
KCl for a period of 120 minutes on the intact brain dura mater overlaying the occipital 
cortex of a rat treated with 1% halothane elicited approximately 12 CSD, effectively 
inducing tolerance to an ischemic insult four days later. Tolerance was not induced under 
the same conditions, however, when the rats were anaesthetised with either 0.5% or 2% 
halothane. The animals experienced enhanced metabolic stress under 0.5% halothane 
with an average of 27 CSD being elicited in the two hour period. Contrary to this, 2% 
halothane reduced the metabolic rate with an average of only 6 CSD being induced; 
supporting previous findings that CSD-induced tolerance can be abrogated by the 
reduction in metabolic rate by means of e.g. halothane or hypothermia (Saito et al., 1995; 
Wada et al., 1997; Horiguchi et al., 2005). It is possible to induce tolerance in animals 
with a lowered metabolic rate by utilizing a higher concentration of KCl for a shorter 
time period, e.g. 1 M KCl for 90 minutes and 3 M KCl for 30 minutes both produce 10 
consecutive CSD in the presence of 2% anaesthetic (Taga et al., 1997; Chazot et al., 
2002). The chronic window of protection generated by this treatment spans from between 
24 hours up to seven days (Obrenovitch and Chazot, personal communication). 
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1.1.1.3. The Molecular Mechanism of Cortical Spreading Depression 
The fundamental molecular mechanisms of CSD-induced ischemic tolerance have yet to 
be fully unravelled. During an ischemic event, spontaneous, recurrent CSD can be found in 
the penumbra region - the area surrounding the ischaemic core with blood flow below what 
is needed to sustain electrical activity, but above that which is required to preserve cellular 
ionic gradients (Obrenovitch and Zilkha, 1995). The presence of CSD in this region may 
promote lesion progression and worsen the outcome in stroke models (Back et al., 1996; 
Busch eta!., 1996; Hossmann, 1996; Back et al., 2004) despite high potassium-induced 
CSD not being associated with irreversible damage under normal circumstances 
(Nedergaard and Hansen, 1988, Nedergaard and Hansen, 1993). The number of naturally 
occurring CSD during focal ischaemia correlates directly with or, in the case of 
superimposing K+-induced CSD on middle cerebral artery occlusion (MCAO), worsens the 
extent of damage observed (Alexis et al., 1996; Back eta!., 1996; Tatlisumak et al., 1998; 
Tatlisumak et al., 2000). It is also possible to reduce the infarct size of the ischemic lesion 
by the application of CSD blockers, such as the N-methyl-D-aspartate (NMDA) channel 
antagonist MK801 (Gillet al., 1992; Iijima et al., 1992) or magnesium ions (van den Bergh 
et al., 2002). 
Due to this association between ischaemia and CSD, it was thought that the preconditioning 
models had similar mechanisms of activation and tolerance. In a seminal paper by 
Heurteaux et al. (1995) it was shown that the first period of ischemic preconditioning 
releases adenosine and the resultant activation of adenosine A 1 receptors then activates 
the ATP-sensitive K+ (KATP) channels, leading to the generation of ischemic tolerance. 
Ischemia-generated tolerance can be fully blocked by the application of adenosine A 1 
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antagonists and partial protection is gained by the application of adenosine AI receptor 
agonists (Heurteaux et al., I995). The partial protection indicates that although activation 
of the KATP channels is necessary, it is not the only prerequisite for the full complement 
of the cell's survival-promoting mechanisms. This, however, is not the case for CSD 
preconditioning where the inhibition of either KATP channels or adenosine AI receptors 
had no effect on the development of CSD-induced tolerance to ischaemia (Horiguchi et 
al., 2005). In the same preconditioning model, W-nitro-L-arginine methyl ester (L-
NAME), an inhibitor of nitric oxide synthase (NOS), effectively blocked CSD-induced 
tolerance to an ischemic insult (Horiguchi eta!., 2005b ). 
The neurotransmitter glutamate, with enhanced NMDA-receptor activation and a 
subsequent Ca2+ influx (Rosen et al., I994; Iida eta!., 200I), has been proposed to play 
an active role in CSD preconditioning. During CSD, a marked transient increase in 
extracellular glutamate has been detected (Fabricius et a!., I993; Zilkha et al., 1995; 
Basarsky et a!., 1999) and it has been found that CSD (McLachlan, 1992; Nellgard and 
Wieloch, 1992) and its tolerance to an ischemic insult (Kitagawa et a!., 1990; Kitagawa 
et al., 1991; Kato eta!., 1992; Taga eta!., 1997) can be blocked by various NMDA-
receptor antagonists. 
Of note for the reduction of the cells' Ca2+ permeability and subsequent metabotropic 
demands, are the changes to the cell surface receptors associated with the acquisition of 
an ischaemia-tolerant phenotype. There seems to exist a relative shift between excitatory 
glutamate receptors and inhibitory y-aminobutyric acid (GABA)A receptors post-
ischaemia which may contribute to endogenous neuroprotection with the glutamate 
receptors being largely, but not exclusively, downregulated and the GABAA receptors 
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being upregulated (Sommer eta!., 2002). For example, with regard to glutamate receptor 
expression: a decrease, or no change, of the NMDA receptor subunits NR2A, NR2B and 
NR1 (Shamloo and Wieloch, 1999; Chazot et al., 2002), a decrease in Alpha-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMP A) receptor subunit expression GluR 
1 and GluR 2 (Chazot et al., 2002 Sommer and Kiessling, 2002) or upregulation of GluR 
4 (Ying et al., 1997); a decrease in metabotropic glutamate receptors (mGluRs) subtypes 
1 b and 5 of group I but not subtypes 2 and 3 of group II mGluRs (Sommer et al., 2000), a 
down-regulation of the glial glutamate transporter isoforms EAAT2 and EAAT1 on glial 
cells (Douen et al., 2000). The balance between excitatory and inhibitory receptors is, 
therefore, not clearly defined. 
Of more importance to this study is the observation by Chazot et al. (2002) of a 12-15-
fold increase in a7 nicotinic acetylcholine receptor (nAChR) following CSD in the mouse 
cerebral cortex. This is a selective upregulation as can be seen from the unaltered 
expression of a4 nAChR subunit (Chazot et al., 2002). This change might contribute to 
the increased tolerance to ischaemia. The concept that a7 nAChR is a key contributor to 
adaptive neuroprotection is also supported by data obtained from the literature and is the 
focal point ofthis study. 
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1.1.2.1. Alpha 7 Nicotinic Acetylcholine Receptors 
Neuronal nicotinic acetylcholine receptors (nAChRs) mediate synaptic transmission in 
many parts of the vertebrate central nervous system, as well as in autonomic ganglia, 
retinal and adrenal medulla, and may play a role in perception, cognition and emotion 
(Zhao et a!., 2003). These membrane-bound receptors belong to the ligand-gated ion 
channel superfamily (Patrick et al., 1987; Vijayaraghavan et al., 1992; Alkondon and 
Albuquerque, 2004). There are at least 17 different nAChR subunits that can be divided 
into two categories: muscle type (a1, ~1, 8, y and E) and neuronal type (a2- a10 and ~2-
~4) subunits (Lukas et al., 1999). The neuronal nAChR channel is composed of five 
subunits, which can be subdivided into two groups: subunits carrying the principal 
acetylcholine binding site component (a2 - alO) and subunits carrying the 
complementary component of the acetylcholine binding site (non-a or ~2 - ~4) (Cooper 
et al., 1991; Galzi et al., 1991; Lukas and Bencherif, 1992). The channels formed by 
these subunits can be either homomeric, consisting of five subunits comprising the same 
type ( a7 - a9), or heteromeric, where the pen tam eric channel consists of two or more 
different subunits. It was first discovered in 1973 by Salvaterra and Moore that the 
curaremimetic neurotoxin a-bungarotoxin ( abtx), a component of the venom of the 
Formosan krait, Bungurus multicinctus, bound selectively to a subset of nAChRs in the 
brain (Salvaterra and Moore, 1973; Eterovi6 and Bennett, 1974; McQuarrie et al., 1976; 
Oswald and Freeman, 1981; Elgoyhen et al., 2001). It was only much later that it was 
shown that this subgroup is actually the homo-oligomeric receptors, pentameric channels 
consisting of either a7, a8 or a9 subunits. The abtx-binding subgroup of nAChRs has a 
lower affinity for binding nicotine, in contrast to the heteromeric nAChRs, consisting of 
both a and ~ subunits, which bind nicotine with a high affinity and abtx with low affinity 
8 
(Marks et al., 1986; Wonnacott, 1986; Goldman et al., 1987; Schoepfer et al., 1990; 
Amar et al., 1993; Zhang et al., 1994). Although it is possible for a7 subunits to combine 
in vitro with P-subunits to form heteromeric a7-containing channels with significant 
pharmacological differences, such heteromeric receptors have not been unequivocally 
proven to exist in vivo (Palma et al., 1999; Khiroug et al., 2002). 
Alpha 7 nicotinic acetylcholine receptors are the only homomeric nicotinic receptors 
expressed in the human brain and is one of the two most abundantly expressed nicotinic 
receptor subtypes in the brain, the other being the heterodimer consisting of a4 and P2 
subunits (Clarke et al., 1985; Gault et al., 1998; Belluardo et al. 2000; Alkondon and 
Albuquerque, 2004). The a8 nAChR is exclusively found in the brain of chickens 
(Schoepfer et a!., 1990), whereas a9 homomeric channel formations can be found in the 
cochlear hair cells and the pituitary, and also in non-neuronal tissues such as tonsil, 
immortalized B-cells, cultured T-cells and peripheral blood lymphocytes (Elgoyhen eta!., 
1994; Lustig et al., 2001). The distribution pattern and expression levels of a7 nAChRs in 
the brain differ greatly depending on the detection technique employed and the species 
investigated. Low levels of a7 nAChRs expression can be detected in most nuclei 
throughout the human brain. High density a7 nAChR can be found in the nucleus 
reticularis, the lateral and medial geniculate bodies, pontine nucleus, the horizontal limb 
of the diagonal band of Broca, the nucleus basalis of Meynert, and the inferior olivary 
nucleus. Moderate density a7 nAChRs can be located in the hippocampus, the 
hypothalamus, pons, and the medulla, with low density expression in the cortex and the 
cerebellum (Rubboli eta!., 1994; Breese et al., 1997; Spurden eta!., 1997; Summarized 
in Paterson and Nordberg, 2000). 
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1.1.2.2. Function of Alpha 7 Nicotinic Acetylcholine Receptors 
The release of acetylcholine (ACh) and several other neurotransmitters throughout the 
CNS is modulated by presynaptic and preterminal nAChRs. Stimulation of a nAChR 
induces the influx of Ca2+ through the nAChR channels or through the opening of 
voltage-gated calcium channel, which results in the release of neurotransmitters. The 
synaptic release of each neurotransmitter is regulated by a specific nAChR depending on 
its location in the CNS. The a7 nAChR regulates the release of GABA in the 
hippocampus and the spinal cord, as well as the regulation of glutamatergic 
neurotransmission throughout the brain (Wonnacott, 1997; Sher et al., 2004). 
Homopentameric nAChR complexes have greater relative Ca2+ permeabilities and faster 
desensitization rates than their heteromeric counterparts (Jensen et al., 2005). a7 nAChRs 
are selectively permeable to high levels of Ca2+ and have an even greater relative Ca2+ 
permeability than the other nAChRs (Vijayaraghavan et al., 1992). This permeability is 
even greater than that of the NMDA subtype of glutamate receptors, which is known to 
be potentially excitotoxic (Choi et al. 1987; Seguela et al. 1993; Rothman and Olney, 
1995). However, the a7 nAChR is much more rapidly desensitized in the presence of an 
agonist than NMDA receptors and may in this way be able to self-limit intracellular Ca2+. 
The mutated, non-desensitizing form of a7 nAChRs was found to reduce cell viability, 
apparently due to intracellular calcium-overload (Treinin and Chalfie, 1995). The mode 
of entry and levels of intracellular Ca2+ achieved appears to be decisive to the outcome of 
intracellular signalling. An influx of Ca2+ through a7 nAChRs may play a role in 
activating beneficial downstream calcium-dependent mechanisms (Seguela et al. 1993, 
Donnely-Roberts et al. 1996). 
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The receptor has been implicated in diverse functions, such as stabilizing synapse 
formation during development, learning and memory, and neuronal survival (Gotti and 
Clementi, 2004). It is purported that a7 nAChRs might play a role in a range of diseases 
including epilepsy, schizophrenia, Alzheimer's disease and anxiety disorders (Kern, 2000; 
Picciotto et al., 2001; Martin and Freedman, 2007; Morissette et al., 2007). To further 
elucidate the role of a7 nAChR in the brain, knock-out mice with no detectable abtx-
binding sites were created (Orr-Urtreger et al., 1997). Taking into account the a7 nAChR 
subunit's prevalence in the brain, it came as a surprise that a plethora of behavioural tests 
yielded no significant deviations when compared with wildtype animals. Subsequent to 
this, a knock-in mouse model was created expressing hypersensitive mutated Leu250Thr 
a7 nAChRs (Orr-Urtreger et a/., 2000). Transgenic mice homozygous for this trait died 
within hours of birth - the increased Ca2+ influx through the non-desensitizing a7 mutant 
receptors lead to substantial neuronal apoptosis in the somatosensory cortex. Heteromeric 
a7 nAChRs containing Leu250Thr mutated and wildtype a7 subunits desensitize more 
slowly when exposed to an agonist, although the heterozygous knock-in mice expressing 
this mixed population of a7 nAChR subunits once again showed no apparent behavioural 
dysfunction (Orr-Urtreger eta/., 2000). 
1.1.2.3. Structure of the Alpha 7 Nicotinic Acetylcholine Receptor Gene 
The human a7 neuronal nicotinic acetylcholine receptor eDNA consists of 1509 bp, 
including the ATG start and the T AA stop codons, and is translated into a 502 amino acid 
protein (Peng eta/., 1994). There exists a high level of amino acid conservation for the 
a7 subunit between species with 94% amino acid identity between human and rat 
sequences, and 92% homology between humans and chickens (Schoepfer et a/., 1990; 
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Seguela et al. 1993; Peng et al., 1994.) This serves to indicate the importance of the 
amino acid sequence for correct formation of functional a7 receptors. The human gene 
itself spans a minimum of 75 kb in the chromosome 15q13 region and contains of 10 
exons (Gault et al., 1998). The splice junctions, as presented in Table 1, have locations 
identical to those in the chick a7 gene (Matter- Sadzinski et al., 1992, Gault et al., 1998). 
Table 1 Exon-Intron Splice Junctions of the Human a7 nAChR 
Exon No. lEx on size eDNA Peptide size in Intron No. Intron size 
(bp) position amino acids (kb) 
1 55 1-55 18.3 1 0.3 
2 140 56-195 46.7 2 >25 
3 45 196-240 15 3 9.0 
4 110 241-350 36.7 4 >25 
5 80 351-430 26.7 5 4.0 
6 168 431-598 56 6 0.6 
7 195 599-793 65 7 1.0 
8 87 794-880 29 8 3.5 
9 110 881-990 36.7 9 5.0 
10 519 991-1509 173 
*Created from data provided in Gault et al., 1998. 
Of note is the possibility for the human a7 nAChR gene to undergo alternative splicing, 
yielding an array of mostly non-functional a7-like proteins (Gault et al., 1998; Garcia-
Guzman et al., 1995). Also, a duplication of exons 5 - 10 of the a7 nAChR gene can be 
found within 1 Mb and centromeric to the full-length a7 gene on chromosome 15 of the 
human genome. This duplicated region differs from the a7 gene by either an adenosine 
substitution at base position 690 or a 2-bp (TG) deletion at position 497-498 of exon 6. 
Four novel non-a7 exons, 5'-a7D, a7C, a7B, and a7A-3', have also been discovered that 
bind to the duplicated a7 exons. Variation is also generated by the alternative splicing of 
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the non-a7 sequence, a7B, in some of the transcripts. These transcripts, however, miss 
the a7 signal peptide that normally occur in exons 1 and 2 of the a7 nAChR gene, which 
is necessary for assembly and surface presentation of functional receptors (Gault et al., 
1998). The function of these alternatively spliced and duplicate transcripts has yet to be 
elucidated although the duplicated region with its 4 novel N-terminal exons and the 
possibility for alternative splicing might account, in part, for the non-specificity of 
primary antibodies directed at a7 nAChRs (Jones and Wonnacott, 2005; Moser et al., 
2007). This problem becomes apparent in transgenic animals in which the a7 nAChR 
gene has been deleted. Despite the absence of this gene, antibodies specifically targeted 
at amino acid sequences from within the a7 nAChR polypeptide still produce 
immunoreactivity indicating the non-specificity of the antibodies (Herber et al., 2004; 
Moser et al., 2007; Jones and Wonnacott, 2005). 
1.1.2.4. Transcription of the Alpha 7 N~cotinic Acetylcholine Receptor Gene 
High levels of the a7 nAChR gene expression is driven by a cell-specific 178-base pair 
promoter in rat neurons. This sequence has a high GC-content with no CAAT- or TAT A-
boxes and is located upstream between -275 and -97 relative to the translation start 
codon. A negative regulatory element is present at position -172. Several transcription 
factors interact in close proximity to control the expression of the a7 nAChR gene. 
Upstream stimulatory factor- I (USFl) positively regulates a7 expression as a homodimer 
by binding to an E-box at position -116. SPl and/ or SP3 binding occurs downstream to 
or overlapping an early growth response- I (Egr-1) binding site, which is located directly 
next to theE-box (Nagavarapu et al. 2001). 
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Sp 1 is a ubiquitous mammalian transcription factor that frequently initiates 
transcriptional activation in housekeeping genes that lack the TAT A and the CAA T 
boxes (Boisclair eta/. 1993). The interaction between Sp 1 and Egr-1 transcription factors 
has been studied for the rat phenylethanolamine N-methyltransferase (PNMT) gene 
promoter where both these factors bind specifically to overlapping elements. It was 
determined that the binding is mutually exclusive in a concentration-dependent fashion 
and also depends on the binding affinity of each factor for the site (Ebert and Wong, 
1995). 
The presence of the USF1 binding may stabilise Egr-1 binding to the a7-promoter in the 
rat model since the removal of the USF1 binding site results in no Egr-1 binding but 
binding of Sp 1 and Sp3 (Nagavarapu et al. 2001; Carrasco-Serrano et a/. 1998). It has 
been shown repeatedly that Egr-1 stimulation and binding increase the a7-promoter 
activity by up to 14-fold (Carrasco-Serrano et al. 2000; Carrasco-Serrano et al. 1998; 
Carrasco-Serrano and Criado 2004). However, Nagavarapu et al. (2001) found that when 
treating pheochromocytoma (PC12) cells with nerve growth factor (NGF), egr-1 RNA 
increased many fold while a7 RNA levels decreased. However, the evidence is stacked 
against the Nagavarapu et al. (2001) paper. Egr-1 (also known as Krox-24, NGFI-A, 
Zif268, Tis8 and Zenk) is an immediate early gene (lEG) whose activity does not require 
new protein synthesis and is activated within minutes. Diverse biological processes 
modulate the expression of the Egr-1 gene. These include cell growth, differentiation and 
following cellular depolarization. The promoter region of Egr-1 is complex and can be 
activated through many possible mechanisms depending on the stimulant and the cell 
type. The 5' upstream promoter region contains four (human) or five (mouse) serum 
response elements (SREs), an SPl-like motif, one Krox response element (KRE), one 
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calcium response element (CRE)-like, one AP-1-like motif and AP-2-like binding 
sequences and two CCAATT sequences (Tsai-Morris et al. 1988). Egr-1 can autoregulate 
its own transcription by binding with high affinity to the KRE or GSG box in its own 
promoter (Cao et al. 1993). However, the focus here will remain on activation through a 
potassium-induced depolarization mechanism. The activation of Egr-1 corresponds with 
the increased expression of a7 nAChR. Egr-1 mRNA levels increase dramatically 
following membrane depolarization both in vitro and in vivo (Sukhatme et a!. 1988; 
Enslen and Soderling 1994) and transient focal ischaemia induced by middle cerebral 
artery occlusion led to increased egr-1 mRNA expression in the cerebral cortex (Abe et 
a!., 1991). Application of 1 M KCl to rat cortical surfaces induced cortical spreading 
depression where Egr-1 was expressed in all cortical layers but with different intensities 
of immunoreactivity (Herdegen et al. 1993). Egr-1 showed a prominent expression in 
layers II, IV, and VI. It was also found that Egr-1 proteins were expressed in neurons but 
not in glial cell populations (Herdegen et al. 1993). Most importantly, however, 
Utsugisawa et a!. (1999) found that the relative amount of a7 subunit mRNA compared 
with that before transient hypoxia of PC12 cells decreased to 84% immediately after 
hypoxia, but then began to increase at 6 h after hypoxia, reaching 171% at 12 h. 
The human a7 nAChR gene promoter region also contains an Egr-1 transcription factor 
binding site (Gault et al. 1998). This might be indicative of a conserved mechanism for 
the activation of a7 expression. It does not appear that any of the other known a-subunit 
nicotinic receptor promoter regions contain an Egr-1 binding site (a2, Bessis eta!. 1993; 
a2, Milton et al. 199S; a3, Yang et al. 199S; a3, Liu eta!. 1999; a3 and aS, Duet al. 
1998; aS, Campos-Caro eta!. 2001; a6, Ebihara et al. 2002; a9, Valor et al. 2003; a9, 
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Lustig and Peng 2002; alO, Lustig et al. 2001). No information concerning the promoter 
region of the a4 subunit gene is currently available. 
Consequent to an increase in cytosolic Ca+2, multiple pathways may be recruited to 
promote cell survival, which can differ in the pattern of intracellular signalling between 
different types of neurons. The signal transduction machinery of cortical neurons differs 
from other neuron populations in a number of significant ways. For example: it has been 
shown that the survival of retinal ganglion cells promoted by brain-derived neurotrophic 
factor (BDNF) is dependent on cAMP. Yet in cortical neurons it was shown that cAMP 
attenuates the ability of BDNF to rescue the cells from serum deprivation (Poser et al. 
2003). Further investigation is still required. 
1.1.2.5. Structure of the Alpha 7 Nicotinic Acetylcholine Receptor 
Upon completing translation of the a7 nAChR polypeptide, the first 22 amino acids of the 
mature protein, as coded for by exon 1 and the start of exon 2 and which forms the signal 
peptide, is removed by cleavage between Q22 and G23 (Seguela et a!. 1993; 
Avramopoulou eta!., 2004). The remaining 480 amino acids become a large membrane 
bound protein, which form part of a homopentameric a7 nAChR channel. TheN-terminal 
208 amino acids form an extracellular region that contains all the loops necessary for the 
binding of agonists and competitive antagonists (Arias, 1997). The rest of the peptide 
meanders between the extracellular and the cells' cytoplasmic environments by crossing 
the hydrophobic membrane four times; peptide areas referred to as membrane spanning 
regions (MSR) I- IV (Seguela eta!. 1993; Gault eta!., 1998). The assembly of these two 
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regions of the five separate a7 subunits into a functional a7 nAChR creates the N-
terminal domain (NTD) and the ion channel domain (ICD) of the pentameric complex. 
Attempts at obtaining x-ray crystallographic images of the structure of any AChR have 
met with little success (Avramopoulou et al., 2004). The recent uncovering of the crystal 
structure of a mollusk Lymnaea stagnalis acetylcholine binding protein (AChBP) has 
shed more light on the structure of the N-terminal domain of a7 nAChR (Brejc et al., 
2001; Celie et al., 2004; Celie et al., 2005). The mature free-floating AChBP acts as a 
buffer to cholinergic neurotransmission by binding to acetylcholine (Smit et al., 2001 ). 
The 210 amino acid long AChBP shows a significant 24% homology with the 
extracellular N-terminal 208 amino acids of a7 nAChR, as well as having all the 
structural hallmarks that can be found in the a7 extracellular domain (Smit et al., 2003). 
In concordance with these structural similarities AChBP is able to form a homopentamer 
that actively binds abtx and other a7 nAChR cholinergic ligands with comparable 
affinities, making it a suitable structural model for the a7 nAChR (Smit et a! 2001; Brejc 
et al., 2001; Smit eta!., 2003). 
The acetylcholine binding protein monomer has a short a-helix at the N-terminus, 
followed by two short 310 helices and ten ~-strands, termed ~ 1 - ~ 10 (Brejc et a!., 2001 ). 
The protein conforms to a modified immunoglobulin (Ig) topology in which an inner ~­
sheet (composed of ~1, ~2, ~3, ~5, ~6 and ~8) is linked to an outer ~-sheet (composed of 
~4, ~7, ~9 and ~10) by means of a "Cys-loop" disulfide bridge between Cys123 and 
Cys136 and organized in a curled ~-sandwich (Brejc eta!., 2001; Smit eta!., 2003). The 
Cys-loop is a feature of the N-terminal of the acetylcholine ion channels superfamily 
(other members being GABAA and glycine receptors), and can be found between Cys128 
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and Cys142 of a7 nAChR (Galzi eta/., 1991; Seguela eta/. 1993; Avramopoulou eta/., 
2004 ). The only contacts between subunits of a pentamer are the two dimer interfaces of 
each protomer. There are five orthosteric nAChR ligand-binding sites, which can be 
located at these five protomer interfaces, close to the outside surface of the pentameric 
AChBP ring. The residues forming the orthosteric binding pockets are highly conserved 
between LGIC superfamily members, contradicting the low homology of the residues 
lining the interface between two protomers (Brejc et a/., 2001; Smit et a/., 2003). In 
addition, the a7 nAChR subunit contains three potential sites ofN-linked glycosylation at 
N22, N68 and Nlll within the extracellular domain, although, due to their distance from 
the ligand-binding sites, the absence of glycosylation does not appear to affect ligand 
binding (Marinou et a/., 2003). The binding of either an agonist or antagonist to the 
orthosteric binding pockets in the NTD cause changes in the molecular structure of the 
receptor, which gets translated down to the lCD resulting in the opening or closing of the 
ion channel. 
The ion channel domain of a7 nAChR is composed of four putative a-helix membrane 
spanning regions consisting of 19 - 24 amino acids (MSR I - 24 aa, II - 19 aa, III - 20 aa, 
and IV- 19 aa) (Seguela et al. 1993; Gault et al., 1998). There exists a short cytoplasmic 
region between MSR I and II (7 aa), and a short extracellular region between MSR II and 
III (15 aa). A large intracellular domain exists, however, between MSR III and IV. This 
hydrophilic 154 amino acid domain contains multiple putative sites for the 
phosphorylation at S343 by cAMP-dependent protein kinase, at T393 and S405 by casein 
kinase II, and at Y420 by tyrosine kinase (Kemp and Pearson, 1990). No predicted site 
for protein kinase C was detected in the MSR III and IV cytoplasmic domain. After MSR 
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IV, the remaining 14 amino acid hydrophilic C-terminal of the peptide exits on the 
extracellular side of the membrane (Seguela eta!. 1993; Gault eta!., 1998). 
Seminal work by Unwin and co-workers on the AChR at the neuromuscular junction of 
the electric ray Torpedo californica [(a1)2~1yo] serves as model for the ion channel 
domain of a7 nAChR (Unwin eta!., 1988; Unwin, 1993; Unwin, 1995; Unwin, 1996). 
When the five a7 nAChR subunits come together to form a homopentameric ion channel, 
the central ion channel is mostly composed of the five a-helix-folded MSR II regions 
arranged symmetrically around an axis perpendicular to the membrane. The MSR II 
central core is supported by the other three MSR's in what appears to be a configuration 
resembling a 'starfish' (Bertrand et a!., 1993; Karlin, 1993; Unwin, 1993; Ortells and 
Lunt, 1996). In keeping with the 'starfish' analogy, the MSR IV a-helix forms the outside 
tip of a single pointed arm; the adjoining a-helix-tum-~-sheet MSR III and the ~-sheet 
MSR I from the same peptide form the base of each arm surrounding the MSR II core 
channel (Unwin, 1993; Gome-Tschelnokow eta!., 1994; Ortells and Lunt, 1996). There 
exists minimal contact between the MSR II ion pore and the surrounding MSR I and III 
helical regions, with these two regions forming a scaffolding around the MSR II channel 
and sequestering it from the surrounding membrane. This water-filled cavity provides the 
space needed for the agonist-induced conformational changes in the ion channel which 
allows the influx of Ca2+ and cellular signalling (Unwin, 1995). 
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Diagram of the human a7 neuronal nicotinic receptor subunit (Gault eta!., 1998). 
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1.1.3. Ric3 
Halevi et al. (2002) created a dominant mutation in the pore-forming transmembrane 
domain ofDEG-3 acetylcholine receptor subunit ofCaenorhabditis elegans (C. elegans) in 
a search for genes required for receptor activity. When assembled, this specific mutation 
in the DEG-3 subunit form a non-desensitizing channel in the receptor, ultimately leading 
to degeneration and necrosis of the neuron in which it is being expressed (Treinin and 
Chalfie, 1995; Treinin et al., 1998) This experiment led to the identification of ric3 
(resistant to inhibitors of cholinesterase), miss-folding of which suppressed the DEG-3 
mutational effect, providing the first indication that it was required for receptor 
functionality (Halevi et a/., 2002). Further investigation revealed that ric-3 activity is 
required for the functional expression of multiple acetylcholine-specific ligand-gated ion 
channels, including the alpha 7 acetylcholine receptor, in both neuronal and muscle cells 
but is not necessary for the function of GABAA, glycine and glutamate receptors in the 
same cells. A possible link between a7 nAChRs and Ric3 was first observed by 
Dominguez del Toro eta/. (1994) who described how regions with high levels of ric3 
transcript expression correlate with a7 expression in the mouse brain, thus indicating an 
interaction between the two proteins. 
Receptor subunits are folded and assembled into pentamers in the Endoplasmic Reticulum 
(ER) before being exported through the Golgi apparatus to the plasma membrane (Keller et 
al., 2001). Coimmunoprecipitation experiments have provided evidence that ER-localised 
Ric3 associates with the unassembled acetylcholine receptor subunits - whether for correct 
folding or assembly is not known (Lansdell eta/., 2005; Williams eta/., 2005). The absence 
of Ric3 expression prevents the transportation of receptors from their assembly point in the 
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ER to the cell surface. Cell surface expression of the a-7 acetylcholine receptor has always 
been thought to be cell type specific (Cooper and Millar, 1997; Sweileh et al., 2000). The 
heterologous expression of Ric3 greatly enhanced the rat a7 acetylcholine receptor activity 
in Xenopus laevis oocytes (Halevi et al., 2003). 
Ric3 is the only protein to date that has been described as specific to the maturation pathway 
of acetylcholine receptor processing pathway. Other non-specific proteins that have been 
implicated in acetylcholine receptor biogenesis are BiP, calnexin and 14-3-311 (Blount and 
Merlie, 1991; Chang et al., 1997; Jeanclos et al., 2001). Ric3's ability to specifically 
recognize and individually process different receptors is thought to provide an additional 
regulatory mechanism to distinguish between different groups of receptors for cell surface 
expressiOn. 
Sequence homology alignments indicate that ric3 is a member of a conserved gene family 
with representatives in both vertebrates and invertebrates. Like its C. elegans homolog, the 
human ric3 homolog (hric3) can also be heterologously expressed in Xenopus laevis oocytes 
leading to enhanced whole-cell current amplitudes when co-expressing a7 nAChR. The 
same enhanced amplitudes can be attained when co-expressing hric3 with either rat a7 
nAChR or C. elegans DEG-3/DES-2 receptor in Xenopus oocytes. This implies an 
evolutionary conservation of the interactive regions of ric3 and respective receptor 
partners. It should be noted, however, that this conservation does not extend to all the 
members of the nAChR family. Contrary to the results attained with other members of the 
nAChR family, the co-expression of hric3 with a4~2 and a3~4 receptors in the oocytes lead 
to a decrease in the whole-cell current amplitude (Halevi et al., 2003). This, however, is not 
the case where expression of hric3 with a4~2 and a3~ receptors occurs in homologous 
22 
mammalian cells. Ric3 significantly enhances the functional expression levels of these 
receptors, as well as those ofheteromeric receptors a3~2 and a4~4 in mammalian cells. This 
phenomenon seems to indicate that the effect of Ric3 upon the functional expression of 
nAChRs can be influenced by other host cell factors (Lansdell et a/., 2005). Of the 
homomeric nAChRs, only a7 and closely the related a8 had enhanced levels of receptor 
formation in the presence of Ric3 in otherwise nonpermissive mammalian cells (Lansdell et 
al., 2005; Williams et al., 2005). 
Multiple transcripts for the hric-3 resulting from editing, alternative splicing, and alternative 
promoters are differentially expressed in a variety of tissues, including non-excitable ones. 
The purpose for this complexity is unknown at this stage although three possible options 
remain: 1) functional proteins that differentially affect the maturation machinery are 
produced; 2) functional proteins are produced whose function is unrelated to nAChR 
maturation; or 3) the shorter isoforms are non-functional (Halevi et al., 2003). 
Initial analyses of the Ric3 amino acid interspecies sequences indicated that all of the 
proteins consist of two transmembrane domains, separated by a proline-rich spacer and 
followed by extensive coiled-coil domains (Halevi et al., 2002 and 2003). Using more 
recent databases, Cheng et al., (2005) concluded that only a single transmembrane region 
can be detected in the Ric3 amino acid sequence and that the first transmembrane region 
described by Halevi et al. (2002) is in reality a signal sequence. Both the N - and C-
terminus coiled-coil are predicted to be cytosolic, implying that Ric3 acts as an adapter 
protein - bringing together receptors and proteins in a multi protein maturation complex. It 
is possible that the proline-rich spacer between the two transmembrane domains serve as a 
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structural scaffold on which interacting partners can be anchored. The transmembrane 
domain may also serve a similar function. 
1.1.4. Alpha 7 Nicotinic Acetylcholine Receptor Upregulation and Neuroprotection 
The generally accepted paradigm for receptor regulation is for receptors to be down 
regulated when over exposed to an agonist and upregulated after overexposure to an 
antagonist. It appears, however, that a7 nicotinic acetylcholine receptors (nAChRs) and 
nicotinic receptors in general, contradict this convention. This phenomenon becomes 
apparent in postmortem binding studies using eH] nicotine and eH] acetylcholine when 
comparing the brains of smokers and non-smokers, with a positive correlation existing 
between the amount of cigarettes smoked and an increase in the number of binding sites 
(Benwell et al., 1988; Breese et al., 1997; Nyback et al., 1989). The number of binding 
sites was, however, lower in ex-smokers than in non-smokers. In rodents, chronic 
treatment in vivo with nicotine also results in a comparable increase in the number of 
high affinity binding to eH] nicotine and e251] a bungarotoxin (abtx) - an effect that 
reflects an increase in the number of high affinity nAChRs with no increase in the 
receptor's affinity (Romanelli et aL, 1988; Wonnacott, 1990; Flores et al., 1992; 
Barrantes et al., 1995; Rowell and Li, 1997; Gopalakrishnan et al., 1997). (-)-Nicotine, 
the prototypical agonist for neuronal nAChR, non-selectively activates nAChRs but binds 
with a higher affinity to a4~2 nAChRs than to the a7 nAChR. High affinity binding to 
eH] nicotine is associated with a4~2 nAChRs (Flores et al., 1992; Zoli et al., 1998) 
whereas the increased binding to [1251] abtx reflects an increase in a7 nAChRs (Seguela 
et al., 1993; Barrantes et al., 1995; Orr-Urtreger et al., 1997). It should be noted though 
that the increase in [1251] abtx binding is weaker than that of high affinity binding to [3H] 
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nicotine, and can only be achieved in vivo with much higher concentrations of chronic 
nicotine treatment - concentrations that might not be relevant to human smokers 
(Wonnacott, 1990; Pauly et al., 1991). Despite this, chronic nicotine treatment is still able 
to increase [1251] abtx in various cell types in vitro e.g. primary hippocampal cultures and 
SH-SY5Y cells (Barrantes et al., 1995; Peng et al., 1997), as well as a7 nAChR-
transfected cell lines such as GH4Cl rat pituitary clonal line and HEK 293 cells (Quik et 
al., 1996; Molinari et al., 1998). 
The reason for the receptor upregulation remains unclear although it has been speculated 
that the receptor's rapid desensitization property and inactivation upon chronic exposure 
to an agonist leads to a deficit in cholinergic function that is counteracted by an increase 
in receptor number (Schwartz and Kellar, 1985). This is supported by the fact that 
chronic nicotine exposure of oocytes expressing a7 nAChRs results in the irreversible 
inactivation of the majority of a7 receptors, indicating multiple states of recovery from 
desensitization (Olale et al., 1997; Reitstetter et al., 1999). Desensitization and recovery 
or eventual inactivation and subsequent upregulation seem to be dependent on the nature 
of the agonist and the length of exposure to the particular agonist (Olale et al., 1997; 
Rowell and Duggan, 1998; Reitstetter et a!., 1999). The chronic exposure of human a7 
nAChR expressed in HEK 293 cells to agonists like epibatidine, anabaseine and 1,1-
dimethyl-4-phenylpiperaziniurn (DMPP) resulted in an increase of [1251] abtx sites, an 
effect that was observed to be concentration dependent (Molinari et al., 1998). Treatment 
of these cells with 100 11M nicotine resulted in a 2.5 fold increase of [ 1251] abtx sites in a 
concentration dependent manner. 
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The structural changes wrought by the chronic binding of an agonist leading to the 
irreversible inactivation of the receptor, is also thought to prevent the receptor from being 
removed from the cell surface (Peng et al., 1994). The reduced turnover yet constant 
cellular production of receptors accounts for the observed increase in cell surface 
nicotinic acetylcholine receptors. This view is supported by the observations that no 
corresponding m.RNA upregulation can be found during chronic nicotine treatment with 
the nAChR upregulation, thus implicating the involvement of a posttranscriptional 
mechanism (Marks et al., 1992~ Peng et al., 1994; Bencherif et al., 1995; Zhang et al., 
1995). Activity of certain nAChRs seems to be dependent on phosphorylation by protein 
kinase C (PKC). Inhibition of PKC by protein kinase A (PKA) leads to deactivation of 
the receptors by dephosphorylation of the PKC sites of the receptor protein (Madhok et 
al., 1995~ Gopalakrishnan et al., 1997; Hsu et al., 1997; Eilers et al., 1997). It is thought 
that reactivation of the receptors require phosphorylation at these same PKC sites. This 
mechanism applies to a4 nAChRs but not a7 nAChRs, as the latter lacks a PKC 
phosphorylation site (Gault et al., 1998). 
As stated before, Chazot et al. (2002) reported a 12-15-fold increase in a7 nAChR 
protein following KCI-induced cortical spreading depression in the mouse cerebral cortex, 
with an unaltered expression of a4 nAChR subunit protein (Chazot et al., 2002). Further 
in vivo support comes from epidemiological and clinical studies that have revealed that 
the amount of a7 subunit mRNA was significantly higher in the putamen of patients with 
multiple small infarcts (status lacunaris) compared with controls (Utsugisawa et al., 
1999). This is in contrast to findings on a4 and ~2 subunit mRNA expression, which 
were lower in the putamen of patients with status lacunaris compared with controls 
(Tohgi et al., 1998). The mechanism by which this upregulation occurs seems to differ 
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from that mediating agonist-induced a7 nAChR upregulation (De Koninck and Cooper, 
1995; Ridley et al., 2001). Contrary to the above mentioned mechanism, the upregulation 
of a7 nAChRs upon chronic KCl depolarization is accompanied by a corresponding 
increase of a7 nAChR mRNA (De Koninck and Cooper, 1995; Utsugisawa et al., 1999; 
Ridley et al., 2001; Chazot et al., 2002). This upregulation is specific to the a7 subset of 
receptors, with a3, a4, a5, ~2 and ~4 subunit mRNA and protein expression levels 
remaining mostly unaffected (De Koninck and Cooper, 1995; Tohgi et al., 1998; 
Utsugisawa et al., 1999; Chazot et al., 2002). Upregulation of a7 nAChR mRNA is 
thought to result from an influx of Ca2+ through L-type Ca2+ channels and activation of a 
Ca2+-calmodulin dependent kinase (CaM-kinase II) pathway in a PKA/ PKC-independent 
manner (De Koninck and Cooper, 1995; Ridley et al., 2001). KN-62, a CaM-kinase II 
inhibitor, not only blocks the upregulation of a7 nAChR mRNA upon KCl stimulation, 
but also the transcription of Egr-1, further lending evidence to the argument that Egr-1 is 
responsible for transcriptional activation of the a7 gene (De Koninck and Cooper, 1995; 
Enslen and Soderling, 1994). 
Alpha 7 nicotinic acetylcholine receptors play an important role in neuroprotection. Co-
incubating cells with nicotine has been demonstrated to be neuroprotective against 
various lethal insults: cultured striatal neurons against an excitotoxic NMDA insult 
(Marin et al., 1994); mixed cortical neuronal and glial cultures against a glutamate insult 
(Donnelly-Roberts et a/1996); cultured hippocampal neurons against kainic acid-induced 
neurotoxicity (Semba et al., 1996); pure hippocampal neuronal cultures against a NMDA 
stimulus (Dajas-Bailador et al., 2000); PC12 cells against hypoxia (Tohgi et al., 2000); 
and the protection of pure neuronal primary cortical cultures against a hypoxic insult 
(Hejmadi et al., 2003). Alpa-bungarotoxin was able to block nicotine's neuroprotective 
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effect in each of these studies, clearly indicating that although nicotine has a higher 
affinity for a4~2 nAChRs, the neuroprotective effect of nicotine is mediated by 
homomeric a7 nAChRs through an as yet unknown Ca+2 dependent mechanism 
(Donnelly-Roberts et al., 1996; Dajas-Bailador et al., 2000; Tohgi et al., 2000). In the 
Hejmadi et al. (2003) study, activation by nicotine of both the a7 nAChR and the a4~2 
nAChR was required for protection against the hypoxic insult. Unfortunately, the role 
played by a4~2 nAChR was not investigated in the other studies, making it impossible to 
say whether or not a7 nAChR alone was responsible for mediating the nicotine-induced 
neuroprotection (Donnelly-Roberts et al., 1996; Dajas-Bailador et al., 2000; Tohgi et al., 
2000). 
Chronic exposure ofPC12 cells to nicotine is not only neuroprotective, but this treatment 
is also known to upregulate a7 nAChR subunit expression (Jonnala and Buccafusco 
2001). Jonnala and Buccafusco (2001) analysed the neuroprotective profiles of different 
a7 nAChR agonists. The agonists' rank order of potencies (EC50) for activating u7 
receptors correlated well with their rank order of binding affinities (K;) for the a7 
receptor but lacked correlation with the agonists' ability to elicit a neuroprotective 
mechanism for cell survival. This is indicative of a mechanism involved in u7 mediated 
neuroprotection that requires more than simply activating u7 receptors and might be a 
balance between the acute agonist action and the protracted antagonist/ agonist 
desensitization action characteristic to each chemical (Meyer et al. 1998; Briggs and 
McKenna, 1998). The research group managed to link the attained level of 
neuroprotection to the level of u7 nAChRs upregulation, after drug treatment, on the cell 
surface in PC12 cells. More importantly, Jonnala and Buccafusco (2001) found that by 
increasing the amount of u7 nAChRs on the cell surface, they were able to increase 
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nicotine's attained level of neuroprotection. It is, however, important to note that 
treatment of cells with the a7-prefering antagonist methyllycaconitine (MLA) increases 
the population of functional a7 nAChRs but is not neuroprotective (Jonnala and 
Buccafusco 2001; Molinari eta/., 1998). 
It is also possible to precondition cells in vitro with nicotine against a subsequent lethal 
insult. Akaike et a/. (1994) preconditioned mixed cortical neurons and glial cells by the 
addition of 10 11M nicotine for two hours against an acute ten minute 1 mM glutamate 
insult. The nicotine treatment was also able to ameliorate NMDA insults but no 
protection was generated against AMP A or kainate exposure. It is unlikely that that a 
direct action of nicotine on the NMDA receptor-ion channel complex was the cause of 
the nicotine-induced neuroprotection since concomitant incubation of nicotine with the 
insult proved to be ineffectual. The short extent of the nicotine incubation makes it 
doubtful that the generated protection was due to de novo protein synthesis, although 
enough time was required for either cell signalling or receptor inactivation given that a 
thirty minute preconditioning period proved to be unsuccessful. Kaneko et a/. (1997) also 
preconditioned mixed cortical neurons and glial cells with 1 0 11M nicotine but for 24 
hours, not two hours as in the Akaike et a/. (1994) study, before the acute glutamate 
insult. Concomitant treatment with either a7 nAChR agonist abtx or a4~2 nAChR 
agonist dihydro-~-erythroidine (DH~E), resulted in a reduction but not the abolishment of 
the amount of protection generated by preconditioning with nicotine against the 
glutamatergic insult. This indicates that the preconditioning effect is due to the additive 
actions of a7 and a4~2 nAChRs (Kaneko et al., 1997). The researchers in this study 
could not rule out the possibility that the observed protection was largely due to the 
inactivation of the nAChR following the long-term exposure to nicotine. 
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Controversial in vivo studies have shown that nicotine could be protective against 
neurodegeneration induced by 1-methyl-4-phenyl-1 ,2,3,6-tetrahydropyridine (MPTP) 
(Maggio eta/., 1998), as well as quinolinic acid evoked neuronal death (O'Neill eta/., 
1998) and systemic kainic acid toxicity (Borlongan et a/., 1995). 
Ll.S. Alpha 7 Nicotinic Acetylcholine Receptor and Anxiety 
Anxiety can be defined as a future-oriented state involving perceived uncontrollability 
and unpredictability over dangerous events or the individual's emotional response to 
those events (Barlow, 2002). There exists a well documented connection between anxiety 
disorders and cigarette smoking (Russel, 1970; Lasser et a/., 2000). Patients with an 
anxiety disorder without depression were found to be twice as likely to smoke as 
individuals without any psychiatric disorders (Breslau et a/., 1991). Individuals with 
generalized anxiety disorder were more likely to become lifetime smokers and found it 
harder to stop smoking, than individuals without this disorder (Covey et a/., 1993). 
Patients with a past history of major depression disorders and with a high anxiety 
sensitivity score have a higher tendency of relapsing within the first seven days of 
smoking cessation (Brown et a/., 2001 ). Anxiety is commonly implicated by smokers as a 
risk factor for the relapse to smoking (Shiffman, 1982; Brandon et a/., 1990). Patients 
with agoraphobia have a higher rate of smoking (Black et a!., 1999). Patients with panic 
disorders where the illness started after the usual age of onset have a higher rate of 
smoking but patients with a preadolescent onset of the illness essentially did not smoke 
(Pohl et a/., 1992). However, no correlation could be found between panic disorders and 
smoking cessation. Interesting enough, it has been found that daily smoking increases the 
risk for the first occurrence of panic attack and disorder, with the risk higher in active 
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than in past smokers (Breslau and Klein, 1999). It should also be noted that there exist 
conflicting reports concerning the relative anxiety levels experienced post smoking 
cessation. Some findings conclude that withdrawal can be anxiolytic, with higher levels 
of anxiety experienced pre-cessation, whereas other reports state it is anxiogenic in that 
the levels of anxiety experienced were the anxiety levels experienced were lower before 
the subjects stopped smoking (Gross and Stitzer, 1989; Hughes et al., 1994; West and 
Hajek, 1997). 
Nicotine was shown to be the active anxiolytic ingredient in smoking in experiments 
where subjects received varying yields or no nicotine in cigarettes before being subjected 
to a shock and their anxiety levels measured (Silverstein et al., 1982; Pomerleau et al., 
1984; Kassel and Unrod, 2000; Juliano and Brandon, 2002). Nicotine and some, but not 
all, nicotinic receptor agonists have an anxiolytic effect in animal models as well as in 
humans (Pomerleau, 1986; Brioni et al., 1993; Decker et al., 1995; Potter et al., 1999). 
Also, of note is the fact that although low doses of nicotine have been shown to be 
anxiolytic, the administration of higher doses in rats can be anxiogenic (File et al., 1998). 
The differential behavioural profiles induced by the various nicotinic receptor agonists, as 
well as the concentration dependent manner in which nicotine affects behaviour, indicate 
that specific subtypes of nAChR configurations play a role in anxiety and the anxiolytic 
effect of nicotine. 
The pivotal role of the a4 nAChR subunit in nicotine binding and anxiety has been well 
established. The a4 subunit in combination with the ~2 subunit form the heteromeric 
a4~2 nAChR which has a greater affinity for nicotine than the homomeric a7 nAChR. 
The anxiolytic effect of a low dose of nicotine in the dorsal Raphe nucleus, the crucial 
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structure in mediating the anxiolytic effect of nicotine, can be blocked by the a4~2 high 
affinity antagonist dihydro-~-erythroidine (DH~E) (Cheeta et al., 2001a; Cheeta et al., 
2001 b). The a4-subunit knockout mice model show apparent increased basal levels of 
anxiety during the elevated plus-maze assay. In this test, the application of nicotine had 
little effect on the anxiety levels of the animals except in the later stages of the assay with 
unhabituated mutant animals (Ross et al., 2000). 
Contrary to a4~2 nAChR's role in mediating nicotine's anxiolytic effect, the a7 nAChR 
seems to be involved in mediating nicotine's anxiogenic behavioural effect. Alpha 7 
nAChR subunit knockout mice showed an increase in the time spend in the centre of an 
open field platform, indicating a reduction in anxiety levels (Paylor et al., 1998). From 
studies performed by File and colleagues, it would seem that a7 nAChRs and the binding · 
of nicotine to this receptor subtype are involved with increased anxiety levels (File et al., 
1998; File et al., 2000a; File et al., 2000b; Tucci et al., 2003). This receptor is highly 
expressed in the dorsal hippocampus (Fabian-Fine et al., 2001), a region that has been 
shown to mediate nicotine's anxiogenic effect (File et al., 1998; File et al., 2000a; File et 
al., 2000b ). The co-administration of nicotine with methyllycaconitine, an antagonist at 
a7 and a3 nAChR subunits, to the dorsal hippocampal region blocked any anxiogenic 
effect the application of a high concentration of nicotine would have had, although co-
administration with DH~E (an antagonist of a4~2 and a3~2 receptors) had no effect on 
nicotine's anxiogenicity (Tucci et al., 2003). Alpha3 nAChRs have not been detected in 
the dorsal hippocampus and only low levels of mRNA, further eliminating the role that 
this subunit may play in nicotine's anxiogenic effect (Wada et al., 1989; Whiteaker et al., 
2002). The anxiogenic effect of nicotine has been shown to be facilitated by the release of 
5-hydroxytryptamine (5-HT) in the dorsal hippocampus which then binds to the 5-HT1A 
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receptors (Kenny et al., 2000; Cheeta et al., 2000a; Cheeta et al., 2000b; Cheeta et al., 
2001a). In nicotine-treated hippocampal slices methyllycaconitine succeeded in blocking 
the release of 5-HT, whereas DH~E failed, indicating that a7 nAChRs are responsible for 
the release of 5-HT (Tucci et al., 2003). 
It can be concluded that a possible explanation for the bimodal effect of nicotine in 
anxiety is that low concentrations of the drug first binds to the high-affinity a4~2 receptor 
thus leading to the observed anxiolytic behaviour but with higher concentrations and 
possible a4~2 receptor saturation, binding to the lower affinity a7 nAChRs occur more 
frequently leading to the observed anxiogenic behaviour. 
33 
1.2. Aims of the Investigation 
1. Creation of a functional and reliable in vitro model for studying spreading depression 
preconditioning. 
2. Determination whether u7 nicotinic acetylcholine receptor upregulation (nAChR) 
induced by preconditioning contributes effectively to the subsequent increase in the brain 
tolerance to ischaemia. 
3. The generation of an anti-Ric3 antibody to study the relationship between Ric-3 and u7 
nAChRs. 
4. To determine whether increased expressiOn of u7 nAChRs by itself, without 
pharmacological intervention, is sufficient to increase the brain tolerance to ischaemia to 
a level similar to that achieved with CSD preconditioning. 
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CHAPTER 2: Generation of an In Vitro Preconditioning Model and Analysing the 
Role Played by Alpha 7 Nicotinic Acetylcholine Receptors. 
2.1. Introduction 
Neuronal tissue culture have been important experimental models for the study of the 
cellular and molecular mechanisms underlying excitotoxicity leading to direct 
applications for the study of neurodegenerative processes in vivo (Choi et a/., 1987; 
Akaike et a/., 1994; Doble, 1999). The first aim of this study was to establish an in vitro 
model for the study of spreading depression-induced preconditioning that could protect 
against an excitotoxic insult. Such a model is not only of scientific importance but would 
also provide advantageous at various practical levels, e.g. the reduction of labour, time 
and cost; repeatability; ease of drug application. There is also the ethical impact that 
should also be considered, i.e. the reduction in animal use. In an in vivo experiment, a 
single animal leads to a single increase in n-numbers, whereas in an in vitro experiment a 
single animal could potentially lead to as many as three hundred n-numbers. 
As has been clearly illustrated by the in vivo models, preconditioning is a fine balance 
between a minor insult that would be ineffectual, an excessive insult which would result 
in cellular death, or the appropriate insult that would engage the innate survival 
mechanisms (Horiguchi et al., 2005). To date, little success has been attained in the 
creation of an in vitro model for KCl-dependant preconditioning. Grabb et al. (1999, 
2002) produced a mixed neuronal and glial cortical culture that relied upon a 15 minute 
preconditioning period with 45 mM KCl protecting against a 10 minute 1 mM glutamate 
insult - 24 hours subsequent to the preconditioning event. Hester et a/. (2007) 
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preconditioned the DRG/neuroblastoma hybrid cell line F-11 and cerebellar granule 
neurons isolated from 7- to 9- day-old mice for 90 minutes with 50 mM KCl, washed the 
cultures and then acutely applied the 3 hour 1 mM potassium cyanide insult; with 
viability being measured 24 hours later. The short KCl treatment period and the acute 
delivery of the insult in this latter study, makes this an acute phase preconditioning event 
where the observed protection is likely due to changes in the ion channel permeability, 
protein phosphorylation and other post-translational modifications (Perez-Pinzon et al., 
1997; Perez-Pinz6n and Born, 1999; Stagliano et al., 1999; Lu et al., 2005). 
The creation of an in vitro preconditioning model is merely the first step in analyzing the 
importance of the Chazot et al. (2002) observation that an increase in a.7 nAChRs might 
play an important role in in vivo cortical spreading depression-induced preconditioning. 
As discussed earlier, this receptor has been shown to play an important role in 
neuroprotection, possibly in conjunction with a.4P2 nAChRs (Donnelly-Roberts et al., 
1996; Dajas-Bailador et al., 2000; Tohgi et al., 2000; Hejmadi et al., 2003). Whether or 
not a simple change in activity of the a.7 nAChRs is required without any need for an 
increase in receptor numbers remains unknown. Both nicotine and potassium chloride 
~reatments have been shown to upregulate a.7 nAChRs, albeit through different 
mechanisms (Olale et al., 1997; Rowell and Duggan, 1998; Reitstetter et al., 1999; De 
Koninck and Cooper, 1995; Utsugisawa et al., 1999; Ridley et al., 2001; Chazot et al., 
2002). This is another factor to be addressed within this chapter. 
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2.2. Materials and Methods 
2.2.1. Neuronal Cortical Culture 
Rat cortical regions were removed from day 17 embryonic Sprague Dawley rats (Charles 
River) and maintained at 4 °C in Hanks Balanced Salt Solution (HBSS) without Ca2+ and 
5 mM Glucose; 5 mM HEPES; 1 mM Sodium Pyruvate). Cortical neurons were dispersed 
by triturating (lOx) with a fire-polished Pasteur pipette in 1 ml of the maintenance 
solution. 2x HBSS containing Ca2+ and Mg2+ (5 mM KCI; 0.4 mM KH2P04; 137 mM 
NaCl; 4 mM NaHC03; 0.3 mM Na2HP04; 1.25 mM CaC}z; 0.5 mM MgClz; 0.85 mM 
MgS04; 5 mM Glucose; 5 mM HEPES; 1 mM Sodium Pyruvate) was added to the 
neuronal suspension. Non-dispersed tissue settled within 90 seconds and was removed 
before the solution was centrifuged for 1 minute at 300 rpm. The supernatant was 
removed and the cells were gently resuspended in 5 ml cold HBSS containing Ca2+ and 
M 2+ g . 
The surface of Iwaki 24 well tissue culture treated microplates were coated with poly-D-
Lysine (0.05 g/ 1) for 1 hour before being washed with water and allowed to air-dry. For 
the mixed glial and neuronal cortical cultures, a cell suspension of 105 cells/ cm2 was 
created in culture medium consisting of 80 % Eagle's Minimum Essential Medium 
(MEM), 10 % heat-inactivated fetal bovine seium (FBS), 10 % heat-inactivated horse 
serum, 25 mM glucose, 2 mM L-glutamine, 20 units/ ml penicillin and 20 Jlg/ ml 
streptomycin before plating them in 500 111 medium on poly-D-Lysine coated 24 well 
plates. The cultures were incubated at 37 oc in 5 % C02. The mixed culture population 
containing both neurons and glial cells were treated on day in vitro (DIV) 4 with 15 Jlg/ 
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ml 5-fluoro-2'-deoxyuridine and 35 Jlg/ ml uridine to minimize glial growth. One half of 
the medium was replaced on DIV 6 with growth medium consisting of 90 % MEM and 
10 % heat-inactivated horse serum. 
Pure neuronal cortical cultures were created by seeding the plates with a concentration of 
1500 cell/ mm2 (unless otherwise stated) in 500 J.!l culture medium consisting of 
Neurobasal, 2 % B27 supplement, 20 units/ ml penicillin, 20 Jlg/ ml streptomycin, 2.5 
J.!M L-glutamate and 0.5 mM Glutamax-1. The cultures were incubated at 37 oc in 5 % 
C02. On DIV 3 and DIV 7, 200 J.!l of the culture medium was removed and the cultures 
were fed with 300 J.!l feeding medium (Neurobasal, 2 % B27 supplement, 20 units/ ml 
penicillin, 20 Jlg/ ml streptomycin, 0.5 mM Glutamax-1). 
2.2.2. Mixed Glial and Neuronal Cortical Culture Treatments 
On DIV 14 culture medium was removed and the cultures were exposed to either 1 J.!M 
MK 801 for 30 minutes, 10 J.!M nicotine for 1 hour or 45 rnM KCl for 15 minutes, all 
dissolved in Exposure Buffer Saline (EBS) (137 mM NaCl, 5 mM KCl, 2.5 mM CaC}z, 
0.3 mM Na2HP04, 0.3 mM KH2P04, 4 mM NaHC03, 5.6 mM Glucose, 0.01 mM 
Glycine, 10 mM HEPES, pH 7.4). The EBS in which the KCl was dissolved only 
contained 97 mM NaCl to maintain osmotic pressure. Controls were exposed to drug-free 
EBS solution and received all the washing steps in conjunction with the treatments. This 
was followed by removal of the drug and three wash steps with EBS before the culture 
medium was reapplied and cultures incubated for either a 24 or a 48 hour time period. 
The lethal insult, consisting of the indicated concentration of N-Methyl-D-aspartic acid 
(NMDA) dissolved in EBS, was applied for a specific time after the medium was 
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removed once agam. A subsequent three further washes with EBS preceded the 
reapplication of the culture medium (fresh MEM containing only 20 units/ ml penicillin 
and 20 11g/ ml streptomycin for LDH purposes), followed by a further 24 hours 
incubation period. 
2.2.3. Pure Neuronal Cortical Treatments 
On DIY 14 (unless stated otherwise) culture medium was removed and the cultures were 
exposed for the allotted time to 500 111 Exposure Buffer Saline (EBS) (13 7 mM NaCl, 5 
mM KCl, 2.5 mM CaCh, 0.3 mM Na2HP04, 0.3 mM KH2P04, 4 mM NaHC03, 5.6 mM 
Glucose, 0.01 mM Glycine, 10 mM HEPES, pH 7.4) containing the indicated doses of 
preconditioning drugs, or blank EBS solution for the controls, which were processed in 
parallel. For 24 hour incubation treatments, the drug was dissolved in culture medium. 
Dissolving the chemical KN-62 required the solvent dimethyl sulfoxide (final 
concentration 0.1 %), which was also added to control cells in this experiment. Treatment 
was followed by removal of the drug and three wash steps with EBS before the culture 
medium was reapplied and cultures incubated for the required time period. The lethal 
insult, consisting of either of 1 hour incubation with 1 mM or 200 11M NMDA, or 10 
minutes with I mM glutamate dissolved in EBS, was applied after the medium was 
removed once again. A subsequent three wash steps with EBS preceded the reapplication 
of the used culture medium, followed by a further 24 hours incubation period and MTT 
cell viability assessment 
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2.2.4. Oxygen Glucose Deprivation 
On DIV 8 pure neuronal cortical cultures were preconditioned as above. Twenty-four 
hours later the medium was removed inside of an Anaerobic Workstation (Whitley 
Scientific) where the atmosphere consisted of 5% C02, 10% H, 85% N. Cultures were 
washed twice with a balanced salt solution lacking any glucose or oxygen (0.8 mM 
MgS04, 1 mM KH2P04, 26 mM NaHC03, 1.8 mM CaCh, 117 mM NaCl, 4.5 mM KCl, 
10 mM HEPES, 0.01 mM Glycine). Subsequent to this, cultures were incubated in the 
chamber for the necessary amount of time before being removed, the normal culture 
medium reapplied, and incubated at 3 7 oc in 5 % C02. Control cultures received the 
same treatments although the balanced salt solution contained 5.6 mM glucose and were 
conducted in an aerobic environment. In addition to this, the control cultures were 
incubated in an aerobic environment for the same amount of time as the cultures in the 
Anaerobic Workstation. The MTT cell viable assay was performed 24 hours later. 
2.2.5. Lactate Dehydrogenase Assay 
Neuronal injury and death was assessed by the measurement of lactate dehydrogenase 
(LDH) efflux into fresh MEM 24 h after every lethal insult using a CytoTox 96® Non-
Radioactive Cytotoxicity Assay (Promega). In brief; an equal volume of the culture 
MEM supernatant was incubated with reconstituted Substrate Mix for 30 minutes in the 
dark before and equal volume of Stop Solution was added. Absorbance was read at 490 
nm. Normalization of the plates were achieved by freeze-thawing the cells in MEM after 
the removal of the initial MEM for LDH assay and calculating the percentage of the 
initial LDH release over the total LDH for every well. 
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2.2.6. MTT Assay 
MTT (1-(4, 5-Dimethylthiazol-2-yl)-3,5-diphenylformazan) is a measure of cell viability 
by mitochondrial dehydrogenase. 50 !Jl Phosphate Buffered Saline (PBS) (136.9 mM 
NaCl, 2.68 mM KCl, 4.3 mM NazHP04, 1.4 mM KHzP04, pH 7.4) containing 5 mg/ ml 
MTT was added to the cultures and incubated at 37 oc for 2.5 hours. The MTT-
containing medium was removed, the surface of the wells were rinsed with 300 Ill PBS 
before the application of 250 !Jl isopropanol. After the crystals dissolved, the optical 
density of 100 !Jl sample was spectrophotometrically read at 595 nm. 
2.2.7. Chloroform/ methanol protein precipitation 
Tissue or harvested cell cultures were homogenized in phosphate buffered saline (PBS) 
containing Protease Inhibitor Cocktail Set III (Calbiochem), 1/100 dilution. Protein 
samples for SDS-PAGE analyses were precipitated by the Chloroform/ methanol method 
(Wessel and Fliigge, 1984). Four volumes of methanol was added to the protein samples 
(25- 50 !Jg) followed by vortexing and 1 minute centrifugation at 12 000 rpm at room 
temperature. This was followed by the addition of one volume chloroform, vortexing and 
1 minute centrifugation at 13000 rpm at room temperature. Three volumes of water were 
added to the mixtures before commencing with a repeat of the vortexing and 
centrifugation steps. Subsequent to the centrifugation step, the upper layer was removed 
and discarded without disturbing the intermediate phase containing the protein fraction. 
One volume of methanol was added to the remaining suspension, vortexed and 
centrifuged for 4 minutes. The supernatant was removed and the protein samples air-
dried before the samples were resuspended in the correct amount of sample buffer. The 
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protein samples were resuspended in 6 Ill HzO before adding equal volumes of 2 x 
protein sample buffer (PSB) 0.125 M Tris-HCl pH 6.8, 4 % SDS, 20 % glycerol, 10 % 2-
mercaptoethanol) and 1.5 Ill 100 mM dithiothreitol (DTT). The samples were then 
denatured for 3 minutes at 95 °C and incubated for 1 min on ice before analysis by SDS-
PAGE. 
2.2.8. SDS-Polyacrylamide Gel Electrophoresis 
A 6 % SDS-PAGE gels were made as described by Laemmli (1970). The separating gels 
consisted of 0.375 M Tris-HCl pH 8.8, 0.1 % SDS, 12 % acrylamide and 0.32 % 
bisacrylamide. Polymerisation of the gels occurred by the addition of 0.008 % (v/v) tetra-
methyl-ethylene-diamine (TEMED) and 0.08 % (w/v) ammonium peroxysulfate. The 
stacking gel contained the same except for 0.125 M Tris-HCl pH 6.8 and 0.1 % SDS. 
TGS buffer (0.025 M Tris-HCl pH 8.3, 0.192 M glycine, 0.1 % SDS) was used for the 
protein electrophoresis which occurred using a Hoefer Mighty small II Vertical Slab Gel 
SE 250 unit (Hoefer Scientific Instruments). Electrophoresis was carried out for 
approximately 2 hours at 15 rnA. 
2.2.9 Western Bnot Protein Analysis 
The proteins were transferred from the SDS-PAGE gel (section 2.2.8) to a Hybond™-
ECL™ Nitrocellulose membrane in a Hoefer TE series Transphor Tank (Hoefer 
Scientific Instruments) using transfer buffer consisting of 25 mM Iris, 192 mM glycine, 
pH 8.4, and 20 % (v/v) methanol. 50 volts was constantly passed through the tank for a 
period of2.5 hours. 
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Following the protein transfer, the nitrocellulose membrane was briefly rinsed in Tris 
Buffer Saline (TBS) (50 mM Tris-HCl, 9 % w/v NaCl, pH 7.4) before being incubated 
for 1 hour at room temperature in blocking buffer consisting of 5% (w/v) dried milk and 
0.02 % (v/v) Tween-20 dissolved in TBS. After this blocking step, the appropriate 
primary antibody was added in an incubation solution consisting of 2.5 % (w/v) dried 
milk powder dissolved in TBS and incubated for 12 hours at 4 oc with gentle shaking. 
Subsequent to the incubation with the primary antibody, the nitrocellulose membrane 
underwent four 10 minute washes with wash buffer containing TBS with 2.5 % (w/v) 
dried milk and 0.2 % (v/v) Tween-20. Depending on the host the primary antibody was 
raised in, the nitrocellulose membrane was incubated with either mouse, rabbit or goat 
horseradish peroxidase (HRP) labelled secondary antibody (1 :2000) for 1 hour at room 
temperature with gentle shaking. The membrane underwent four more washes as before 
the 1 hour incubation step before being briefly rinsed in TBS. For the visualization of the 
chemiluminescent bands, the nitrocellulose membrane had to be incubated for 1 minute at 
room temperature with a development solution containing 68 mM p-couramic acid (1 00 
J.tl), 1.25 mM luminol (10 ml) and 30% H20 2 (6 Jll). The fluorescent bands were exposed 
to Hyperfilm ™ for various times and the film was developed in Kodak D-19 Developer 
before being fixed in Kodak Unifix for 5 minutes at room temperature. Band intensities 
were quantified with SigmaGel™ software from the autoradiographic records. 
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2.2.10. Alpha Bungarotoxin Chemiluminescence 
Pure neuronal cortical cultures grown on glass coverslips coated with poly-D-Lysine 
(0.05 g/ I) were subjected to various treatments before undergoing staining with u-
Bungarotoxin-FITC to detect functional levels of u7 nAChRs (Method is based on 
personal communication from Prof. Wonnocott, University of Bath). Medium was 
removed and cells on the coverslips were washed with PBS before being fixed in 2 % 
formaldehyde/ PBS solution for 30 minutes at room temperature in. This was followed by 
three 5 minute PBS washes and 20 minute incubation with 0.3 M glycine dissolved in 
PBS. Cells were washed twice for 5 minutes with PBS and incubated in 0.5% Triton X-
I 00 (Sigma)/ PBS solution for twenty minutes. This was followed by another double 5 
minute wash with PBS before blocking with 0.5 % Bovine Serum Albumin (BSA) 
(Sigma)/ PBS solution for 30 minutes at room temperature. u-Bungarotoxin-FITC (Sigma) 
was made up to a final concentration of 10 nM in 0.5% BSA and incubated with the cells 
for 30 minutes at room temperature before washing twice for 5 minutes with 0.5 % BSA/ 
PBS solution. For the negative control, cells were incubated first with 1 mM nicotine for 
30 minutes before- and during the 30 minute incubation with a-Bungarotoxin-FITC. 
Cells were washed a fmal time for 5 minutes with PBS and coverslips were permanently 
fixed on a glass slide with Citifluor AFI (Agar Scietific). Five pictures were taken with a 
Nikon digital camera DXM 1200 on a Nikon Eclipse E400 microscope at lOX 
magnification of every coverslip in an X configuration - a photograph at each point and 
one in the centre. The images were submitted to independent blind counting of the 
fluorescent signal. 
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2.2.11. Alpha 7 Nicotinic Acetylcholine Receptor Expression in Preconditioned Pure 
Neuronal Cortical Cultures 
Pure neuronal cortical culture (sections 2.2.1 and 2.2.3) were seeded at 1500 cells/ mm2 
on poly-D-Lysine-coated 35 mm Iwaki tissue culture treated dishes and treated for 24 
hours on DIV 14 with either 11.25 mM KCl dissolved in medium or just plain medium 
for the control group. Cells were harvested either acutely or chronically (3 wash steps and 
24 hours after subsequent incubation) in 500 111 phosphate buffered saline (PBS) 
containing 1 in 100 dilution of Protease Inhibitor Cocktail Set III. The samples were 
sonicated four times for 30 seconds in a sonication bath with a 1 minute incubation 
period on ice in between every sonication pulse. 100 111 of the sample was chloroform/ 
methanol precipitated (section 2.2.7) before being applied to a 6% SDS-polyacrylamide 
gel (section 2.2.8) and subjected to a Western blot analysis (section 2.2.9). 
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2.3. Results 
2.3.1. Preconditioning of mixed cortical neuron and glial cell cultures 
Tremblay et al. (2000) described a preconditioning model in which the application of the 
N-methyl-D-aspartate (NMDA) antagonist (1)-5-methyl-10, 11-dihydro-5H-dibenzo [a, d] 
cyclohepten-5, 10-imine maleate (MK801) was used to protect mixed cortical neurons 
and glial cells against a subsequent NMDA insult. A brief 30 min exposure to 0.1 !lM 
MK80 1 was able to protect primary cortical neurons against a lethal insult applied up to 
96 hours after the removal of the preconditioning agent (Tremblay et al., 2000). This 
culture model was replicated and preconditioned with either MK801 (Tremblay et a!., 
2000), 15 minute 45 mM KCl (Grabb et al., 1999), or 1 hour with 1 !lM nicotine (loosely 
based on the Akaike et al., 1994 paper), with the 5 minute 50 !lM NMDA insult 24 hours 
after preconditioning (Fig. 2.1). Due to the 'masking' effect generated by the presence of 
numerous glial cells, a viability test, such as the use of MTT, is insufficient to detect any 
changes caused by the NMDA insult. Tremblay and co-workers resorted to the time-
consuming method of blind counting, whereas in this study the efflux of lactate 
dehydrogenase (LDH) from injured or lysed cells were used to determine the extent of 
the neuroprotection generated by the various chemicals (Tremblay et al., 2000). 
In this present study, a differential degree of preconditioning was achieved. It would 
appear that KCl has the greatest neuroprotective effect twenty-four hours after 
preconditioning, with only 25 % of the expected cell death actually occurring equating to 
75 % obtained protection (Fig. 2.1A). Approximately sixty percent of the potentially 
lysed cells are protected by treatment with MK80 1 but only about fifteen percent could 
be protected by the one hour treatment with 1 J.LM nicotine. 
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Highly significant protection is achieved by both MK80 1 and KCl preconditioning when 
the 5 minute 50 JlM NMDA insult is delayed until 48 hours after the preconditioning 
event (Fig. 2.1B). The neuroprotection offered by MK801 seems to increase with a longer 
time period between the sublethal and the lethal insult, whereas KCl's neuroprotection 
decreased over the same time period. Preconditioning was also attempted using 1 J.1M and 
1 0 JlM nicotine but no significant protection was achieved. There does, however, exist a 
definite trend towards protection with the cell death being reduced by 30 - 40 %. MK 
801 seems to elicit the strongest protection with approximately only 20 % of the cells 
being damaged (80 % protection). Potassium chloride treatment achieves less 
neuroprotection with approximately 55 % of the cells protected. These different levels of 
protection, and the time period elapsed before maximum protection post-preconditioning 
are achieved, indicate separate molecular pathways activated by each treatment. 
An investigation was initiated to optimize the efficacy of the NMDA insult by applying 
either 50 JlM NMDA or 200 JlM NMDA for 1 hour to the 48-hour post-preconditioned 
cultures (Fig. 2.2). It should be noted that plate normalization was not applied in this set 
of experiments and the results might be skewed as a result. Approximately 20 % fewer 
cells were killed with the lower dose of NMDA for each of the two preconditioning 
strategies employed in this study. The neuroprotection offered by the preconditioning 
agents were unable to combat the overwhelming cell loss caused by the higher 
concentration NMDA insult (Similar findings to other studies in the laboratory, Errington 
eta/., unpublished). 
Of importance is the fact that the results for this section can be split into two groups: 
successful and unsuccessful protection. The 24 hour preconditioning experiments (Fig. 
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2.2) were performed in four sets of which 2 sets gave no significant protection (Data not 
shown). The data compiled for Figure 2.1 arose from 8 separate data sets (individual 
cultures). It should, however, be mentioned that an additional 7 data sets in support of 
this specific data compilation was attempted yet gave inconsistent results (Data not 
shown). The inconsistency of these cultures become apparent during the parallel 
processing of two identical culture plates - from the initial seeding of the neurons to the 
final LDH analysis- that yielded contradicting results. Attempts were made to stabilise 
and homogenise the cultures i.e. substituting glutamine with the more stable form of 
glutamax-1; reducing the unequal heat distribution and evaporation rates normally 
associated with 24-well tissue culture plates by the addition of preheated sterile water 
between the wells. Unfortunately all these additional attempts failed to improve the 
reliability of this tissue culture method. Visual inspection of mixed cortical neuronal and 
glial cell cultures on DIV 14 (Fig. 2.3A) show a mixture of the two cell types occurring 
in concentrated clusters throughout the sample. Pure neuronal cell cultures, discussed in 
the section 2.3.2, show evenly dispersed neuronal cells without any contaminating glial 
cells (Fig. 2.3B). 
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Figure 2.1. Comparison of treatments of mixed glial and cortical neuronal cultures 
treated with preconditioning agents (A) 24 hours and (B) 48 hours before the insult. The 
lethal insult consisted out oftreatinent for 5 minutes with 50 ~M NMDA. LDH readings 
were taken 24 hours after the insults and values represent the mean LDH release/ 
absorbance± S.E.M. Control cultures, which did not receive any insults, were subtracted 
from all the values before the values were expressed as a percentage of the lethal insult 
control [NMDA (A) n = 35; (B) n = 41]. MK+NMDA indicates 30 minutes of 1 ~M 
MK801 treatment [(A) n = 12; (B) n = 35]; KCl is the 15 minute 45 mM KCl treatment 
[(A) n = 12; (B) n = 29]; and N1 +NMDA is the treatment with 1 ~M nicotine for 1 hour 
[(A) n = 8; (B) n = 6] and N10+NMDA represent treatment with 10 ~M nicotine for 1 
hour (n = 12) ** P < 0.01 , *** P < 0.001. 
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Figure 2.2. Comparison between lethal insults on mixed glial and cortical neuronal 
cultures that were preconditioned with either with 1 11M MK801 (MK) for 30 minutes or 
45 mM KCl for 15 minutes, 48 hours before the insult. The lethal insult consisted out of 
either the application of 50 11M NMDA (50) for 1 hour or 200 11M NMDA (200) for 1 
hour. LDH readings were taken 24 hours after the insult. Control cultures that did not 
receive any insults were subtracted from all the values before the values were divided by 
CL- the control that did received the insult. n = 12 ** P < 0.01. 
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Figure 2.3. Visual comparison between DIV 14 mixed neuronal and glial cortical cell 
cultures (A), and DIV 14 pure neuronal cortical cell cultures from section 2.3.2 (B). The 
mixed neuronal and glial cortical cell cultures have clusters of glial cells (indicated by the 
red arrow), whereas in the pure neuronal cortical cell cultures, the cells are evenly spread 
without any clusters. Scale bar = 20 Jlm 
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2.3.2. Pure Neuronal Cortical Cultures 
2.3.2.1. Excitotoxicity 
The first step in the process of establishing a reliable in vitro preconditioning model was 
to determine the concentrations and optimal time periods required for the excitotoxic 
chemical which was to serve as lethal insult. Glutamate is thought to play an important 
role in the neurodegeneration subsequent to hypoxic-ischemic brain injury (Choi, 1988; 
Meldrum and Garthwaite, 1990). All subtypes of glutamate receptors can initiate 
excitotoxic processes (Leist and Nicotera, 1998) where an over stimulation of the 
receptors lead to an excessive increase in the intracellular Ca2+, leading to impaired 
energy metabolism, mitochondrial dysfunction and oxidative stress, and fmally neuronal 
cell death (Meldrum and Garthwaite, 1990; Leist and Nicotera, 1998). In cortical neurons 
it is generally accepted that the NMDA subtype of glutamate receptors play a crucial role 
in the glutamate-induced cytotoxicity since this effect can consistently be blocked by 
NMDA receptor antagonists (Meldrum and Garthwaite, 1990; Stuiver et al., 1996). It was 
thought that NMDA would yield the maximum cell death when applied to the pure 
neuronal cortical cultures and would serve as the lethal insult. The initial insult level 
caused by the application of NMDA to the cultures was analysed by removing the 
medium, applying the different concentrations of NMDA for 1 hour to the cultures, 
followed by three washes with EBS, subsequent reapplication of the culture medium and 
incubation for 24 hours at 37 °C, after which cell viability was assayed with MTT. It 
seems that an NMDA insult of70 ~M and higher attain the maximum kill (approximately 
twenty percent of the cells) possible in these cultures (Fig. 2.4). The IC50 of 15 +/- 5 ~M 
NMDA is consistent with the published affmity for NMDA (Erreger et al., 2007). This 
homogeneous resistance to various high concentrations of NMDA could possibly be the 
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result of the neuron-selective pressure that took place at the creation of the cultures, 
especially the 2.5J.1M L-glutamate that was added at the start to the medium of the pure 
neuronal cortical cultures. To test this theory, cells were incubated with a single 
concentration of NMDA (200 J.tM) but for various times before receiving three EBS 
washes, a 24 hour incubation period, and being assayed with MTT (Fig. 2.5). Once again 
homogeneous resistance against the NMDA insult was observed, even when the cells 
were incubated for 24 hours with the 200 J.!M NMDA insult. Incubation for one or two 
hours with 200 J.!M NMDA killed approximately 10 % of the cultures whereas 24 hour 
incubation resulted in only a further cell loss of approximately 13 %. 
In the Kaneko et al. (1997) study a more robust insult (1 mM glutamate for 10 minutes) 
was applied to mixed glial and cortical neurons. The insult was repeated on our pure 
neuronal cortical cultures (Fig. 2.6). Both 10 minute and 1 hour incubations with the 
excitotoxic glutamate resulted in an approximate 10 % loss in culture viability. The 
glutamate insults seemed to follow a similar trend as that of the NMDA insults, the only 
difference being that the 24 hours of incubation with glutamate resulted in a higher 
percentage cellular death(~ 27 %). 
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Figure 2.4. NMDA neurotoxicity optimization in pure neuronal cortical cultures to 
determine the most appropriate concentration of NMDA for optimum neuronal kill. DIV 
14 cultures were treated with various concentrations ofNMDA (Control, 10 JlM, 40 !J.M, 
70 11M, 100 !J.M, and 1 mM) for 1 hour. The control received no insult but blank EBS 
treatment with the same washes. After 24 hours of incubation; cell viability was assayed 
with MTT. The values represent the mean MTT produced/ absorbance. Data are 
expressed as percentage of controls with the bars representing the mean ± S.E.M. A non-
parametric one-way ANOV A statistical analyses was done with significance indicated by 
* P < 0.05; ** P < 0.01; *** P < 0.001. n = 8. 
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Figure 2.5. NMDA-mediated cytotoxicity optimization in pure neuronal cortical cultures 
to determine the ideal length of time for the lethal insult. DIV 14 cultures were treated 
with 200 J.l.M NMDA for various periods of time. The control received no insult but blank 
EBS treatment with the same washes. After 24 hours of incubation; cell viability was 
assayed with MTT. The 24 hour glutamate treatment did not receive the subsequent 24 
hour incubation but was rather assayed directly. The values represent the mean MTT 
produced/ absorbance and data are expressed as percentage of controls with the bars 
representing the mean ± S.E.M from at least two independent culture experiments. A 
non-parametric one-way ANOVA statistical analyses was done with significance 
indicated by*** P < 0.001. n = 18. 
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Figure 2.6. Glutamate cytotoxicity optimization in pure neuronal cortical cultures to 
determine the optimum length of time for the lethal insult. DIV 14 cultures were treated 
with 1 mM glutamate for various periods of time. The control received no insult but 
blank EBS treatment with the same washes. After 24 hours of incubation; cell viability 
was assayed with MTT. The 24 hour glutamate treatment did not receive the subsequent 
24 hour incubation but was rather assayed directly. The values represent the mean MTT 
produced/ absorbance and data are expressed as percentage of controls with the bars 
representing the mean ± S.E.M from at least two independent culture experiments. A 
non-parametric one-way ANOVA statistical analyses was done with significance 
indicated by* P < 0.05; ** P < 0.01; *** P < 0.001. n = 12. 
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2.3.2.2. Nicotine Neuroprotection 
The role of (-)-nicotine in neuroprotection is a well documented phenomenon in vitro 
(Marin eta!., 1994; Donnelly-Roberts et a/1996; Dajas-Bailador eta!., 2000; Tohgi eta!., 
2000). Dajas-Bailador and co-workers (2000) reported neuroprotection where the co-
incubation of 10 11M nicotine with 200 11M NMDA resulted in complete protection of the 
cells against the NMDA insult. This research group employed a high density pure 
hippocampal cell tissue culture model with less than 5 % glial cells present. This 
neuroprotective strategy was attempted in the pure neuronal cortical cultures but met with 
no success (Fig. 2.7A). Neither 10 11M nor 20 11M nicotine offered any protection when 
co-incubated for 1 hour with 200 11M NMDA. A refinement to the protocol was 
introduced by seeding the cells at a lower defined concentration of 105 cells per well and 
applying the lethal insult on DIV 9 - an attempt to see if the age and density of the 
neurons might have an effect on their survival. Neuroprotection by co-incubation with 10 
11M nicotine was once again attempted but yielded no improvements in the achieved level 
of protection (Fig. 2. 7B). 
Of interest is the fmding that the DIV 9 cells seem to be more sensitive to a one hour 200 
11M NMDA insult than cells that were incubated longer until DIV 14, with DIV 14 cells 
having approximately 30 % and DIV 9 cells have approximately 60 % neuronal death 
(Fig. 2.7B). The younger age of the cells is probably the cause for this doubling in the 
neuronal death, although as noted before, the different seeding density might also have 
had an influence. 
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Figure 2.7. Nicotine's neuroprotective properties against an NMDA insult was tested on 
(A) DIV 14 and (B) DIV 9 pure cortical cultures. The DIV 9 cultures were seeded at the 
lower defmed concentration of 105 cells per well on a 24 well plate.1 0 f.lM nicotine (Nl 0) 
was incubated for one hour without a lethal NMDA insult to test whether the nicotine 
treatment affected the cells. A NMDA insult consisting of 200 J.!M NMDA was applied 
for one hour to cultures containing no nicotine (NMDA). Either 10 J.!M nicotine 
(NIO+NMDA; n = 12) or 20 J.!M nicotine (N20+NMDA) were co-applied with 200 J.!M 
NMDA for 1 hour before being removed, the cultures washed and subsequent incubation 
for 24 hours. MIT readings were taken 24 hours later and values represent the mean 
MIT produced/ absorbance. Data are expressed as percentage of controls and bars 
represents the mean± S.E.M from at least two independent culture experiments. A non-
parametric one-way ANOVA statistical analyses was done with significance indicated by 
** p < 0.01 ; *** p < 0.001. 
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2.3.2.3. Nicotinic Preconditioning 
Following upon the partial success of nicotine preconditioning in the mixed cortical 
neuron and glial cell cultures and despite the failure of this agonist to lend protection 
when co-incubated with NMDA, an attempt was made to precondition with nicotine in 
the pure neuronal cortical cultures. Pure neuronal cortical cultures were preconditioned 
for one hour with 10 1-1M nicotine (NlO) 24 hours before receiving the 1 mM NMDA 
insult (Fig. 2.8). Both the nicotine pre-treated and the control NMDA-insult group had 
cell death of approximately thirty percent when compared to the control that did not 
receive any insult. No significant difference was observed between the nicotine 
preconditioned group and the control group, which received only EBS treatment before 
the NMDA insult (denoted as NMDA). 
In accordance with the Kaneko et al. (1997) study, prolonged exposure to the 
preconditioning agent was attempted and the cultures were incubated for 24 hours with 
101-!M nicotine (Fig. 2.9). Prolonged exposure to the agent did not have any effect on the 
elicitation of a protective mechanism against the subsequent 1 hour lmM NMDA (Fig. 
2.9A), the chronic 10 minute 1 mM glutamate (Fig. 2.9B) or the acute 10 minute 1 mM 
glutamate (Fig. 2.9C) excitotoxic insults. Cell viability was reduced by twenty percent 
when the glutamate insult was applied directly after the 24 hours nicotine treatment (Fig. 
2.9C), whereas a reduction of thirty percent was observed when the insult was applied 24 
hours after the prolonged nicotine treatment (Fig. 2.9B). It is fair to assume that the cell 
densities were approximately the same since these two culture sets were produced at the 
same time from the same batch of dissociated neurons. This could possibly reflect the 
vulnerability of the cells to an NMDA insult directly after having been washed. Washes 
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with physiological saline are associated with a variety of brief insults, including osmotic, 
gluconic, thermal and ischemic insults (Stackpole et al., 2007). Exposure of cultures to 
24 hours of nicotine treatment did not have a detrimental effect on the cells; on the 
contrary, there seems to be an indication that the nicotinic treatment protected cells 
against the insults experienced during the wash steps. In both experiments where the cells 
were exposed for 24 hours without lethal insults to either fresh medium or nicotine-
containing medium (Fig. 2.9B and C), the nicotinic groups yielded approximately five 
percent higher cell survival than their control counterparts. 
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Figure 2.8. Pure neuronal cultures preconditioned on DIV 14 for one hour with 10 ~-tM 
nicotine. Cultures were washed and incubated for 24 hours before receiving and insult 
consisting of 1 mM NMDA treatment for 1 hour. MTT readings were taken 24 hours 
after the insult and values represent the mean MTT produced/ absorbance. Control 
cultures did not receive a NMDA insult and data are expressed as percentage of controls; 
the bars represent the mean ± S.E.M from at least two independent culture experiments. 
A non-parametric one-way ANOVA statistical analyses was done with significance 
indicated by*** P < 0.001. Control n = 12, NMDA and Nic+NMDA n = 16. 
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Figure 2.9. Prolonged exposure to 10 J.LM nicotine on D IV 14 was attempted by 
incubating pure neuronal cultures for 24 hours. Cultures were washed and incubated for 
24 hours before receiving an insult consisting of (A) 1 mM NMDA treatment for 1 hour 
or (B) 1 mM glutamate (10 minutes). (C) 1 mM glutamate insult (10 minutes) but the 
insult was acutely i.e. directly after the 24 hour nicotine preconditioning, MIT readings 
were taken 24 hours after the insults and values represent the mean MIT produced/ 
absorbance. Control cultures in Figures (A), (B) and (C) and nicotine control cultures in 
Figures (B) and (C) did not receive an insult. The data are expressed as percentage of 
controls; the bars represent the mean ± S.E.M from at least two independent culture 
experiments in the case of (B) and (C), whereas a single culture experiment was 
performed in the case of (A). A non-parametric one-way ANOV A statistical analyses was 
done with significance indicated by* P < 0.05; *** P < 0.001. (A) n = 6; (B) and (C) n = 
12. 
61 
2.3.2.4. Potassium Chloride Preconditioning 
2.3.2.4.1. Potassium Chloride preconditioning of DIV 8 pure neuronal cultures 
Pure neuronal cortical cultures, utilizing the exact same production methodology, were 
preconditioned by Kapinya and co-workers with the volatile anaesthetic isoflurane 
(Kapinya et al., 2002). They achieved approximately 25 percent protection on DIV 8 
cultures against an insult consisting of three hours of oxygen glucose deprivation (OGD). 
Notably, this experiment was successfully repeated and expanded upon in our lab using 
sevoflurane (Errington, van Rensburg, manuscript in preparation), indicating that 
preconditioning is indeed possible in the current tissue culture regime despite the failure 
of the nicotine preconditioning and neuroprotection experiments. 
Building upon the success of the volatile anaesthetic experiments (results not shown), 
DIV 8 pure neuronal cortical cultures were preconditioned with 45 mM KCl for either 15 
min (Fig. 2.10B and C) or 1 hour (Fig. 2.10A). Irrespective of the incubation time, the 
KCl treatment did not protect the cultures against the lethal insult (either 200 JlM NMDA 
for 1 hour [(A) and (B)] or 50 JlM NMDA for 5 min (C)), that was applied 24 hours later. 
The 1 hour NMDA insult resulted in a decrease in cell viability of approximately 35 - 45 
percent. The less intensive 5 minute 50 JlM NMDA insult, as used in the mixed cortical 
and glial cell cultures and utilised by Tremblay et al. (2000), killed less than ten percent 
of the cells, indicating that any preconditioning effect was not diminished by the 
magnitude of the lethal insult. 
The Kapinya eta/. (2002) experiments relied upon the application of an oxygen glucose 
deprivation (OGD) insult. This type of insult was also utilized in our replication of the 
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isoflurane preconditioning experiments. To dismiss the possibility that potassium 
chloride preconditioning was only effective against a certain type of insult in pure 
neuronal cortical cultures, DIV 8 neurons were preconditioned with 45 mM KCl for 1 
hour 24 hours before receiving an OGD insult. Both a 4 hour and a 5.5 hour OGD insult 
was delivered to cells incubated in the OGD solution (Fig. 2.11 ). Both these insults 
reduced neuronal viability by approximately 45 percent, but with no apparent potassium 
chloride-induced protective effect induced. 
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Figure 2.10. Pure neuronal cultures preconditioned on DIV 8 for either one hour (A) or 
fifteen minutes [(B) and (C)] with 45 mM KCl. Cultures were washed and incubated for 
24 hours before receiving an insult consisting of200 J..i.M NMDA treatment for 1 hour [(A) 
and (B)] or 50 J..i.M NMDA for 5 minutes (C). MTI readings were taken 24 hours after 
the insults and values represent the mean MTI produced/ absorbance. Neither the control 
nor the KCl group cultures received an insult. The data are expressed as percentage of 
controls; the bars represent the mean ± S.E.M. A non-parametric one-way ANOV A 
statistical analyses was done with significance indicated by* P < 0.05; ** P < 0.01 ; *** 
P < 0.001. n = 8. 
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Figure 2.11. Pure neuronal cultures preconditioned on DIV 8 for 1 hour with 45 mM KCl. 
Cultures were washed and incubated for 24 hours before receiving an OGD insult for 
either 4 hours (A) or 5 hours 30 minutes (B). MTT readings were taken 24 hours after the 
insults and values represent the mean MIT produced/ absorbance. Neither the control nor 
the KCl group cultures received an insult. The data are expressed as percentage of 
controls; the bars represent the mean ± S.E.M. A non-parametric one-way ANOV A 
statistical analyses was done with significance indicated by** P < 0.01; *** P < 0.001. n 
= 12. 
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2.3.2.4.2. Acute Potassium Chloride Treatment of DIV 14 Pure Neuronal Cultures 
The failure of potassium chloride to precondition pure neuronal cortical cultures after 
eight days in vitro led to a study on DIV 14. The study of potassium chloride on DIV 14 
pure neuronal cultures began by preconditioning the cultures with 45 mM KCl for 15 
minutes, 24 hours before either a one hour 200 !J.M NMDA insult or an insult with 1 mM 
glutamate for 10 minutes (Fig. 2.12). Both these insults reduced cellular viability by 
approximately twenty percent, with no effect resulting from the potassium chloride 
treatment with or without the lethal insults. Following upon this, cultures were treated for 
one hour with various concentrations of potassium chloride 24 hours before receiving a 
10 minute 1 mM glutamate insult (Fig. 2.13). Once. again no protective effect against the 
excitotoxic glutamate insult was detected. Of note is the indication that 11.25 mM KCl 
treatment protects the cells against the insults associated with the washing of the cultures 
- as noted following the 24 hour nicotine treatment. The effect is modest ( + 4 % more 
viable cells) but consistent, and no such effect was detected with the 22.5 mM KCl 
treatment, while the 45 mM KCl treatment actually reduced neuronal viability by 
approximately 4 %. To delve further into this potential preconditioning effect elicited by 
11.25 mM KCl, it was decided to look at the consequences of prolonged exposure to 
potassium chloride. 
2.3.2.4.3. Chronic Potassium Chloride Treatment of DIV 14 Pure Neuronal Cultures 
Subsequent to the observation in the previous section that 45 mM potassium chloride 
treatment reduced cell viability by approximately 4% after only one hour of exposure, an 
assay was performed to establish the lowest concentration of KCl treatment that would 
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not reduce cell viability during 24 hours of incubation. Prolonged treatment with 45 mM 
KCl resulted in approximately a quarter of the cells dying, whereas 22.5 mM KCl 
reduced cell viability by approximately 13% over the twenty four hour period (Fig. 2.14). 
In contrast, a minimal insignificant amount of neuronal death was caused by the twenty-
four hour treatment with 11.25 mM KCl. 
To fully investigate any potential preconditioning effect produced by the prolonged 
treatment with KCl, a 10 minute 1 mM glutamate insult was either delivered directly after 
the treatment (acute glutamate insult) or twenty-four hours after the treatment (chronic 
glutamate insult) (Fig. 2.15). Clear protection was achieved against either the acute 
(approximately 47 % protection) or the chronic (approximately 44 % protection) 
glutamate insult subsequent to prolonged KCl treatment. To further investigate this 
phenomenon cultures were created with a range of different cellular densities (Fig. 2.16). 
Glutamate insult efficacy seem to be dependent on the density of the cultures - the 
tendency being that denser cultures result in a higher cell death subsequent to the same 
insult probably due to the formation of a chain reaction where dead cells release their 
own glutamate and cytotoxins, exacerbating the effect (consistent with other findings in 
the laboratory). The preconditioning effect over the first three densities (1000 cells/ mm2, 
1500 cells/ mm2, and 2000 cells/ mm2) remained constant and approximately 6 - 7 % 
more viable cells. The highest seeded density (3000 cells/ mm2) resulted in a doubling of 
the protected cells, approximately 12 % more viable cells (approximately 40 % 
protection). 
The effect of prolonged potassium chloride exposure on the viability of the pure neuronal 
cultures and their resistance to an excitotoxic insult was investigated by treating DIV 14 
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cultures for 24 hours with 11.25 mM KCl but staggering the lethal glutamate insults (Fig. 
2.17). After 48 hours cell death had increased from approximately 5 % at 24 hours post 
treatment, to approximately 11 %. At 72 hours post treatment, KCl-induced cell death 
rose to approximately 19 %where it stabilised and remained beyond 96 hours post KCl 
treatment. A lesser neuroprotective effect was observed in the KCl treated cells that also 
received the glutamate insult. Forty-eight hours after the potassium chloride treatment, an 
insignificant amount of cells (approximately 2 %) were still protected against the 
glutamate insult, whereas at time points 72 hours and 96 hours, the viability dropped 
below the untreated glutamate-insulted cells, by approximately three percent. 
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Figure 2.12. Pure neuronal cultures preconditioned on DIV 14 for fifteen minutes with 
45 mM KCL Cultures were washed three times and incubated for 24 hours before 
receiving an insult consisting of 200 11M NMDA treatment for 1 hour (A) or 1 mM 
glutamate for ten minutes (B). MIT readings were taken 24 hours after the insult and 
values represent the mean MTT produced/ absorbance. Neither the control nor the KCl 
group cultures received an insult. Data is expressed as percentage of controls; the bars 
represent the mean± S.E.M from two independent culture experiments. A non-parametric 
one-way ANOVA statistical analyses was done with significance indicated by ** P < 
0.01; *** P < 0.001. n = 12. 
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Figure 2.13. Pure neuronal cultures preconditioned on DIV 14 for one hour with either 
11.25 mM KCI (A), 22.5 mM KCl (B), or 45 mM KCl (C). Cultures were washed thrice 
and incubated for 24 hours before receiving and insult consisting of 1 mM glutamate for 
ten minutes. MTT readings were taken 24 hours after the insult and values represent the 
mean MTT produced/ absorbance. Neither the control nor the KCl group cultures 
received an insult. Data are expressed as percentage of controls; the bars represent the 
mean ± S.E.M from two independent culture experiments. A non-parametric one-way 
ANOV A statistical analyses was done with significance indicated by ** P < 0.01; *** P 
< 0.001. n = 12. 
70 
Control 11.25mM KCI 22.5mM KCI 45mM KCI 
Figure 2.14. Pure neuronal cultures preconditioned on DIV 14 for 24 hours with either 
11.25 mM, 22.5 mM, or 45 mM KCl. These cultures did not receive any excitotoxic 
insults. Cultures were washed thrice and incubated for 24 hours before MTT readings 
were taken. The values represent the mean MIT produced/ absorbance and the data is 
expressed as percentage of controls; the bars represent the mean ± S.E.M from at least 
two independent culture experiments. A non-parametric one-way ANOVA statistical 
analyses was done with significance indicated by** P < 0.01; *** P < 0.001. n = 18. 
71 
Cont+Giu KCI+Giu Cont+Giu KCI+Giu 
Acute Chronic 
Figure 2.15. DIV 14 pure neuronal cortical cultures were treated for 24 hours by the 
addition of 11.25 mM KCl to the cell medium. Following the incubation period, cells 
were washed three times with EBS before, in the case of the acute study, receiving a 10 
minute lmM glutamate insult, three more EBS washes and a 24 hour incubation period 
before MIT analyses. For the chronic study, the KCl treated cells were washed with EBS 
and incubated in medium for an additional 24 hours before receiving the 1 0 minute 1 mM 
glutamate lethal insult, three more EBS washes and the 24 hour post-insult incubation 
before MTT analyses. In order the demonstrate the preconditioning effect, the lethal 
insult group is expressed as a percentage of the control whereas the KCl group that 
received a lethal insult is expressed as a percentage of the respective KCl treated cells 
that did not receive the glutamate insult. At-test was used to compare the two resulting 
groups with the bars representing the mean ± S.E.M from two independent culture 
experiments. Significance indicated by** P < 0.01; *** P < 0.001. n = 12. 
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Figure 2.16. DIV 14 pure neuronal cortical cultures that were seeded at various cellular 
densities were treated for 24 hours by the addition of 11.25 mM KCl to the cell medium. 
Following the incubation period, cells were washed three times with EBS and incubated 
in medium for an additional 24 hours before receiving the 10 minute 1 mM glutamate 
lethal insult, three more EBS washes and the 24 hour post-insult incubation before MTT 
analyses. In order to demonstrate the preconditioning effect, the lethal insult group is 
expressed as a percentage of the control whereas the KCl group that received a lethal 
insult is expressed as a percentage of the respective KCl treated cells that did not receive 
the glutamate insult. A t-test was used to compare the two resulting groups with the bars 
representing the mean ± S.E.M from two independent culture experiments. Significance 
indicated by** P < 0.01; *** P < 0.001. n = 12. 
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Figure 2.17. DIV 14 pure neuronal cortical cultures were treated for 24 hours by the 
addition of 11.25 mM KCl to the cell medium. Following the incubation period, cells 
were washed three times with EBS before but the 10 minute 1 mM glutamate excitotoxic 
insult was applied after incubating the cells for either 48 hours (A), 72 hours (B), or 96 
hours (C). The cultures were incubated a further 24 hours before the MIT analyses. 
Neither the control nor the KCl group cultures received an insult. Data are expressed as 
percentage of controls; the bars represent the mean ± S.E.M from two independent 
culture experiments. A non-parametric one-way ANOV A statistical analyses was done 
with significance indicated by** P < 0.01; *** P < 0.001. n = 12. 
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2.3.2.4.4. Confirmation of Spreading Depression Preconditioning Mechanism 
Potassium chloride-induced cortical spreading depression in vivo can be blocked by the 
application of the N-methyl-D-aspartate (NMDA) channel antagonist MK801 (Kitagawa et 
al., 1990; Kitagawa et al., 1991; Kato et al., 1992; Taga et al., 1997). In order to confirm 
that the in vitro model relies upon a similar mechanism of activation despite the initial 
neuronal loss, experiments were preformed applying MK801 30 minutes before the 
initiation of the 24 hour KCl treatment of the pure neuronal cortical cultures (Fig. 2.18B). 
MK80 1 was also applied to cultures without the addition of any KCl to see if it is capable of 
preconditioning the pure neuronal cultures against an excitotoxic insult by MK80 1 itself as 
was done with the mixed glial and neuronal cell cultures in section 2.3.1 (Fig. 2.18A). 
Prolonged exposure of pure neuronal cortical cultures to MK80 1 resulted in the loss of the 
KCl-induced preconditioning effect with no significant increase of neuronal viability 
observed. The absence of any protection against the 1 mM glutamate insult showed that 
as with in vivo CSD, the preconditioning effect of potassium chloride is mediated by 
NMDA receptors. Chronic exposure to MK801 by itself was also ineffective in producing 
any protection against a 10 minute 1 mM glutamate insult. 
However, as with prolonged nicotine exposure in Figure 2.9, MK801 is able to elicit a 
neuroprotective effect against wash-related insults. Chronic exposure of cells to MK80 1 or 
MK80 1 co-incubated with KCl led to approximately 8 - 13 % overall increase in cell 
viability when compared to the control which also only received washes and no glutamate 
insult (Fig. 2.18). 
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Figure 2.18. DIV 14 pure neuronal cortical cultures were treated for 24 h with either 1 
f..LM MK801 alone (A) or 11.25 mM KCl and 1 f..LM MK801 with the MK801 being added 
to the culture 30 min before the KCl (B). Following the incubation period, cells were 
washed three times with EBS and incubated for 24 hours at 3 7 °C and 5 % C02 before 
the 10 minute 1 mM glutamate excitotoxic insult was applied. The cultures were 
incubated a further 24 hours before the MTT analyses. Control cultures did not receive an 
excitotoxic glutamate insult, nor did the KCI and the KCl!MK801 group. Data is 
expressed as percentage of controls; the bars represent the mean ± S.E.M from two 
independent experiments. A non-parametric one-way ANOV A statistical analyses was 
done with significance indicated by* P < 0.05; ** P < 0.01; *** P < 0.001. n = 12. 
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2.3.2.4.5. The Role of Alpha 7 Nicotinic Acetylcholine Receptors in Potassium 
Chloride Mediated Preconditioning. 
With the successful establishment of a reliable in vitro KCl-dependent preconditioning 
model which reflects the in vivo cortical spreading depression mechanism, the role, if any, 
played by a7 nAChRs was investigated. Two strategies were employed; the first strategy 
blocked the potential upregulation of a7 nAChR expression during KCl preconditioning 
whereas the second strategy cancelled any potential protective effects provided by a7 
nAChR against the glutamate insult subsequent to KCl preconditioning using a selective 
antagonist 
KN-62, a Ca2+-calmodulin dependent kinase II inhibitor (CaM-kinase II), has been shown 
to block the upregulation of a7 nAChR mRNA (De Koninck and Cooper, 1995). This 
inhibitor was applied to DIV 14 pure neuronal cortical cultures 30 minutes before the 
application of the 11.25 mM KCl and co-incubated for 24 hours before being removed. 
The application of the 10 minute glutamate insult followed 24 hours later in the absence 
of either KCl or KN-62. The second strategy relied upon the blocking of any functional 
homomeric a7 nAChRs by a-bungarotoxin (abtx). Here, the DIV 14 neuronal cultures 
were preconditioned for 24 hours with 11.25 mM KCl alone. Directly after the removal 
of KCl and washing, the 200 nM abtx was added to the medium and the cells incubated 
for 24 hours. The medium was removed and the lethal insult, consisting of a 10 minute 
exposure to 10 mM glutamate, was applied directly. 
As can be seen in Figure 2.19, both the strategies effectively blocked the neuroprotective 
effect generated by prolonged preconditioning with KCl. An approximate 90 % reduction 
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of the KCl neuroprotective effect was observed when KN-62 was co-incubated during the 
preconditioning period. The possibility that both CaM-kinase II and Egr-I could lead to 
the activation of other neuroprotective genes, not necessarily a7 nAChR, necessitated the 
use of abtx, an a7 nAChR-specific antagonist. The application of abtx before the 
glutamate insult reduced the KCl-induced preconditioning effect by approximately 95 %, 
suggesting that this small protective effect is dependent upon the presence of functional 
a7 nAChRs. 
In Figure 2.20, the preconditioning effect of either KN-62 or abtx alone is analysed. 
Neither one elicited significant protection against the 10 minute 1 mM glutamate insult, 
although both treatments increased cell survival by approximately 3 %. KN-62 also did 
not have any effect on the survival of the cells against the wash-related insult with only a 
1.3 % increase in viability being observed, whereas the abtx treatment led to a significant 
increase of approximately 6 %. A summarised analysis of neuroprotection elicited by 24 
hour treatment with various chemicals against the wash-related insult is represented in 
Figure 2.21. As can be seen, MK80 1 provides the highest amount of protection 
(approximately 13 % more viable cells), whereas nicotine and abtx both also provide 
significant protection of approximately 6 % more viable cells. KN-62 is the only 
chemical which did not yield any significant protection against the wash related insult. 
An analysis with a-Bungarotoxin-FITC of the functional expression of a7 nAChR after 
prolonged treatment with either potassium chloride or nicotine indicates a trend towards 
down-regulation of the receptor (Fig. 2.22). Nicotine treatment elicited minimal effects 
upon a-Bungarotoxin-FITC binding to a7 nAChRs, whereas depolarization with KCl 
decreased binding by approximately 18.82 %. Neither one of these treatments yielded a 
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statistically significant difference although a definite tendency for a7 nAChR down 
regulation upon KCl treatment was indicated. The negative control for the 
immunocytochemistry procedure used nicotine, which effectively blocked a-
Bungarotoxin-FITC binding to a7 nAChRs. Confirmation by means of Western blot 
analyses was not possible. Experiments with the polyclonal anti-rabbit a7 nAChR from 
Santa Cruz Biotechnology directed at the C-terminal of the protein were too variable to 
make any conclusions (Results not shown). No results were attained with the anti-rabbit 
a7 nAChR from Abeam (ab23832) (1.5 j.!g/ ml), which is directed against a region within 
the first hundred amino acids of theN-terminal of the receptor (Results not shown). 
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Figure 2.19. DIV 14 pure neuronal cortical cultures were treated for 24 hours with 11.25 
mM KCl alone (A) or with 10 J.tM KN-62 (B), the KN-62 being added to the culture 30 
min before the KCl. Following the incubation period, cells were washed three times with 
EBS and incubated for 24 hours before the 10 minute 1 mM glutamate excitotoxic insult 
was applied. Alternatively, cells were treated with 200 nM abtx for 24 h, directly before 
the glutamate insult subsequent to the removal and washes of the KCl preconditioned 
cultures (C). Following the glutamate insult and three EBS washes, cultures were 
incubated a further 24 hours before the MTI analyses. Control, KCl or KC1/MK801 
control cultures did not receive an excitotoxic glutamate insult. Data are expressed as 
percentage of controls; the bars represent the mean ± S.E.M from two independent 
culture experiments. At-test statistical analyses was done with significance indicated by 
** P < 0.01. n = 12. 
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Figure 2.20. DIV 14 pure neuronal cortical cultures were treated for 24 hours with either 
10 J.!M KN-62 24 hours before the glutamate insult (A) or 200 nM abtx directly before 
the glutamate insult (B). Following the glutamate insult and three EBS washes, cultures 
were incubated a further 24 hours before the MIT analyses. Control, KN-62 or abtx 
control cultures did not receive an excitotox.ic glutamate insult. Data are expressed as 
percentage of controls; the bars represent the mean ± S.E.M from two independent 
culture experiments. A non-parametric one-way ANOV A statistical analyses was 
preformed with significance indicated by* P < 0.05; ** P < 0.01; *** P < 0.001. n = 12 . 
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Figure 2.21. A summary of the neuroprotection generated against the wash insult by the 
treatment of pure neuronal cultures on DIV 14 for 24 hours with various chemicals. 
Either 1 J.!M MK801 (A), 10 J.!M KN-62 (B), 200 nM abtx (C), or 10 J.!M nicotine (D) 
was incubated for 24 hours with the cells during the various preconditioning experiments. 
Data is expressed as percentage of controls; the bars represent the mean± S.E.M from 
two independent cultures. A t-test statistical analyses was done on the MIT generated 
results and significance indicated by* P < 0.05; ** P < 0.01 ; *** P < 0.001. n = 12. 
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Figure 2.22. DIV 14 pure neuronal cortical cultures grown on glass coverslips were 
treated for 24 hours by the addition of medium containing either 11.25 mM KCl, 10 ~M 
nicotine, or nothing in the case ofthe control. Following the incubation period, cells were 
washed with PBS before being labelled with a-Bungarotoxin-FITC. Five digital images 
were taken of each coverslip and submitted to independent blind counting. The average 
was calculated for each coverslip, each average representing a single n-number. Data are 
expressed as percentage of controls; the bars represent the mean ± S.E.M from two 
independent culture experiments. A non-parametric one-way ANOVA statistical analyses 
was done with n = 12. 
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Figure 2.23. Visual representation of A) the a-Bungarotoxin-FITC bound to functional 
a7 nAChR subsequent to prolonged treatment with either potassium chloride or nicotine. 
B) A representation of the negative control which was incubated with 1 mM nicotine 
before-and during a-Bungarotoxin-FITC incubation to illustrate the non-specific staining 
with FITC. The white scale bar represents 10 J.lM. 
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2.4. Discussion 
The aim of this chapter was to establish an in vitro model for the study of spreading 
depression ( depolarisation)-induced preconditioning and to assess the role of a7 nAChRs 
in this neuroprotective mechanism. Taking into consideration that the CSD phenomenon 
is restricted to the brain and appears to involve both neuronal and glial cell populations 
(Smith et al., 2006), it was thought that the creation of a mixed neuronal and glial cell 
culture would be less artificial and truer to an in vivo environment. Preconditioning with 
both MK801 (as reported by Tremblay et al., 2000) and KCl (Grabb et al., 1999; Grabb 
et al., 2002), and to a lesser extend nicotine (Akaike et al., 1994), was attainable in our 
model. The results also suggest that different molecular pathways are followed by 
MK80 1 and KCl treatments. The protection generated by MK80 1 seems to reach its 
maximum level after 48 hours incubation, whereas potassium chloride's maximum 
generated protection is reached much earlier, after only 24 hours and is already 
decreasing at 48 hours. Preconditioning remained sporadic and inconsistent, with 
repeated attempts at increasing the consistency being thwarted. Visual analysis of mixed 
glial and neuronal cell cultures revealed that the glial cells form clusters with an uneven 
cellular distribution and subsequent unequal treatment exposure. The failures, and the 
high variance levels attained during the 'successful' preconditioning experiments, are 
reported to illustrate the poor reliability of this particular tissue culture technique possibly 
owing to the variable presence of the clustered glial cells. 
Pure neuronal cortical cultures were created in an attempt to overcome the shortcomings 
of the mixed neuronal glial cell cultures. The neurons in these cultures are evenly 
dispersed with a minimal, if any, presence of glial cells. This new culture technique led to 
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cultures with high reproducibility and low vanance. There does, however, exist 
discrepancies between the glutamate and NMDA-induced cell death from cultures 
prepared on various dates due to variations in the respective cell densities. Tissue culture 
plates were consistently seeded at a density 1500 cells/ mm2 or 300 000 cells per well, 
unless stated otherwise. The inconsistencies in cell densities are probably due to 
differences in the quality of the culture preparation i.e. the initial amount of 
haemorrhaging of the foetal brains; dissection time and precision; as well as the total 
duration of the culture preparation. As the a7 nAChR is one of the main focus points of 
this study, pure neuronal cultures has the additional advantage of possessing higher a7 
nAChR expression than mixed neuronal and glial cell cultures. Jensen eta!. (1997) found 
that the presence of glia in cortical cultures or the addition of glial-conditioned media to 
cultures, led to the reduced formation of functional a-bungarotoxin-binding a7 nAChRs 
in the neuronal population. 
Taking into consideration the role of glutamatergic receptors, especially the NMDA receptor 
subtypes, in hypoxic-ischemic brain injury (Choi, 1988; Meldrum and Garthwaite, 1990; 
Stuiver et al., 1996; Leist and Nicotera, 1998), an initial investigation was launched into 
the reduction in neuronal viability ofDIV 14 pure neuronal cultures upon exposure to either 
glutamate or NMDA insults. A plateau of cellular death level was achieved, despite efforts 
to increase the cell death by either raising the concentration or extending the exposure time 
to the excitotoxic treatments. This is possibly due to the putative desensitization of the 
NMDA receptors by the prolonged exposure or the high concentrations of the agonists 
(Skolnick et al., 1992; Shi et al., 2001). In later experiments where pure neuronal cultures 
were exposed earlier at either DIV 8 or 9 to NMDA, preconditioning experiments with KCl 
and nicotine respectively, a greater reduction in cellular viability was achieved. This is in 
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contradiction to other studies where it was shown that susceptibility to glutamate or 
NMDA-induced cell death increases over time in cultured neurons from rats (Peterson et 
a!., 1989; Cheng et a!., 1999; Frandsen and Schousboe, 1990; Xia et a!., 1995) and mice 
(Frandsen and Schousboe, 1990; Mizuta eta!., 1998; Schubert and Piasecki, 2001). Fogal 
et a!. (2005), comparing DIV 10 and DIV 14 neurons, ascribed the observed increased 
susceptibility of DIV 14 cells to the increased secondary release of glutamate from 
stimulated or depolarized cells; not from a difference in NMDA receptor expression or 
function. A possible explanation for the observed differences in this study is that at an 
early age of the culture a number of 'fragile' cells are still present in the culture, with 
only the more resilient neurons surviving in the older cultures. The presence of such 
'fragile' cells would have the dual consequence of increasing the cell number with a 
subsequent higher glutamate release; and increasing the difference between the control 
group with its surviving 'fragile' cells and the insulted group that have lost the 'fragile' 
cells in addition to the loss of the cells normally associated with an NMDA excitotoxic 
insult. A simpler explanation might be that the increased cell death is due to cultures 
being seeded at a very high density which would yield an increased cell death, although 
this seems unlikely. As noted before, there are many factors involved in the early stages 
when creating a culture set that would affect cell density, although the variation seems to 
be limited between culture sessions and cell death of the magnitude observed in DIV 8 or 
DIV 9 cultures were never observed in DIV 14 cultures. 
Nicotine neuroprotection, a well documented phenomenon in neuronal cultures (Marin et 
a!., 1994; Donnelly-Roberts et a/1996; Dajas-Bailador eta!., 2000; Tohgi et al., 2000), 
remained elusive in the pure neuronal cortical cultures. The reason why nicotine 
succeeded to protect pure hippocampal neurons in the Dajas-Bailador eta!. (2000) study 
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yet failed to protect the pure neuronal mixed cortical culture against the concurrent 
NMDA insult might be due to the differences in cell type between the two culture 
systems. In experiments of where neurons were deprived of oxygen, it was shown that the 
neuronal death depended not only on the magnitude of exposure (Banasiak et al., 2000; 
Luhmann and Kral, 1997) but also on the CNS region affected (Jiang and Haddad, 1992; 
Nieber, 1999). This might be a similar case for the response of neurons to various stimuli, 
in that the response would depend on the neurons' region of origin. It could also be due to 
the differences in the culture regime that might generate different levels of 
neuroprotective proteins and cell surface receptor expression at various times. 
Preconditioning with nicotine also failed; independent of the nicotine concentration, the 
exposure length or the day in vitro upon which the cells were preconditioned. A 
conclusive reason for the failure of nicotine to elicit a neuroprotective effect was not 
reached, although it could probably, once again, be ascribed to the culture system. 
Achieving neuroprotective preconditioning in pure neuronal cortical cultures seem to be 
more difficult than in mixed glial and neuronal cortical cultures, possibly owing to the 
stringent chemical selection necessary to achieve the pure neuronal culture quality. As 
stated, Kapinya and co-workers where able to precondition DIV 8 pure neuronal cortical 
cultures created in exactly the same way as employed in this study, with the volatile 
anaesthetic isoflurane against a subsequent insult consisting of oxygen glucose 
deprivation (OGD) (Kapinya et al., 2002). Following successful replication of these 
experiments with isoflurane, an attempt was made to precondition DIV 8 pure neuronal 
cortical cultures with potassium chloride against either OGD or a NMDA insult. In the 
Grabb et al. (1999) study, 45 mM KCl treatment was used to precondition mixed 
neuronal and glial cells against a subsequent excitotoxic NMDA insult. These 
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experiments were also repeated with significant but irregular success, also using mixed 
cortical neuronal and glial cultures. A follow-up study by the same group once again 
successfully used potassium chloride induced depolarisation to precondition mixed 
neuronal and glial cells against an OGD insult (Grabb et al., 2002). In pure neuronal 
cultures, KCl did not induce any neuroprotective mechanisms against various magnitudes 
of either NMDA or OGD insults. 
Subsequent to the experiments on DIV 8 pure neuronal cortical cultures, it was decided to 
return to attempting KCl-induced preconditioning in more mature DIV 14 cultures. As 
stated above, Fogal et al. (2005) observed that DIV 14 cells have increased secondary 
release of glutamate from depolarized cells. It has been shown that in vivo cortical 
spreading depression is dependent on such a release, as indicated by the ability of an 
NMDA receptor antagonist MK80 1 to block the neuroprotective effect of CSD (Gill et al., 
1992; Iijima et al., 1992; Obrenovitch et al., 2002). Initial short term exposure of DIV 14 
pure neuronal cortical cultures to various concentration of KCl for either 15 minutes or 1 
hour proved to be ineffective against a subsequent NMDA or glutamate lethal insult. 
Chronic or prolonged exposure (24 hours) of the cultures to various concentrations of 
KCl led to a significant reduction in cell viability, except for the lowest concentration 
employed i.e. 11.25 mM KCI. This is due to the glutamate release associated with 
depolarization, as mentioned above (Fogal et al., 2005). Similar damage is observed in ex 
vivo experiments, such as in isolated tissue slices, where continuous K+- depolarisation 
was associated with neuronal injury (Jing et al., 1991). During cortical spreading 
depression in vivo, a similar marked transient increase in extracellular glutamate has been 
detected (Fabricius et al., 1993; Zilkha et al., 1995; Basarsky et al., 1999), although this 
release is not associated with neuronal injury in the normal brain (Nedergaard and 
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Hansen, 1988; Nedergaard and Hansen, 1993). The brain is able to accommodate the 
glutamate release by either re-uptake or carrying the glutamate away, emphasizing the 
effect of vascular clearance (Gardner-Medwin et al., 1981; Gardner-Medwin, 1983). The 
release of glutamate within the confines of a tissue culture microplate well has a cumulative 
effect, leading to the reduced viability observed with chronic treatment of KCl. 
Importantly, prolonged exposure of the pure neuronal cultures to 11.25 mM potassium 
chloride resulted in significant protection of the cells against a subsequent glutamate 
insult, reducing the kill by approximately 45 %. The preconditioning effect also seemed 
to increase with an increase in cellular density. The marked apparent increase in cell 
viability at a density of 3000 cells/ mm2 is, however, an artefact of the statistical analysis. 
The cell death due to the prolonged KCl treatment in the KCl treated control group is 
approximately double that experienced by the other densities (±8 % versus ±4 %) and 
division by this lowered viability score resulted in an increased product. Attempts to 
accurately judge how long the elicited neuroprotective effect lasts were hampered by 
potassium chloride induced cell death. The decrease in the neuroprotection induced by 
the preconditioning with KCl between the acute and chronic glutamate insults could 
possibly be due to the decline in the cells neuroprotective response or simply a reduced 
viability of the cells due to the prolonged treatment with KCI. It can, however, be 
assumed that the preconditioning effect is not due to a lowered metabolic state of 
damaged cells since the MTT scores are subject to mitochondrial activity- an indicator a 
cell's metabolic status. The attainment of KCl-induced neuroprotection with prolonged 
treatment and not with acute treatment may reflect the number of depolarisations induced 
in the set period of time. As observed by Horiguchi et al., (2005) and discussed in the 
literature review, achieving CSD-induced tolerance in vivo requires the correct number of 
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waves of spreading depression., This depends on the metabolic rate of the animal at the 
time of treatment, with a high metabolic rate leading to too many CSDs and no 
neuroprotection, whereas a low, metabolic rate has too few CSDs, once again leading to 
no generation of tolerance. Factors including the concentration of the potassium chloride 
and the duration of KCl application can also be manipulated to achieve the correct 
number of cortical spreading , depressions. Inducing depolarization in vitro has the 
additional complication of balancing the attained level of tolerance while limiting the 
damage from the KCl-induced glutamate release. It was confirmed that the induction of 
neuroprotection in the in vitro model follows a similar mechanism to that seen in vivo, 
with tolerance generation being dependent upon NMDA receptor function; blocking of 
the tolerance generation being: possible with the NMDA receptor antagonist MK801 
(Kitagawa eta/., 1990; Kitagawa eta/., 1991; Kato eta/., 1992; Taga eta/., 1997) 
Chazot eta/. (2002) noted a 12-15-fold increase in a7 nicotinic acetylcholine receptor 
(nAChR) protein following KCl-induced CSD in the mouse cerebral cortex, 
hypothesizing that this increase might contribute to the increased tolerance to ischaemia. 
The role of a7 nAChRs in the KCl-induced neuroprotective effect associated with CSD 
was analysed in vitro, first by inhibiting the activation of Ca2+ -calmodulin dependent 
kinase II with KN-62, and secon.d by directly blocking any action of a7 nAChR with the 
receptor-specific antagonist a~bungarotoxin. KN-62 has been shown to block the 
upregulation of a7 nAChR messenger RNA, possibly by blocking its transcriptional 
activation by the Egr-1 protein (De Koninck and Cooper, 1995; Enslen and Soderling, 
1994). In pure neuronal cortical cultures, KN-62 was able to negate the KCl-induced 
neuroprotective effect. This does not, however, imply that specifically a7 nAChRs are 
involved in obtaining the KCli-induced neuroprotective effect, since Ca2+-calmodulin 
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dependent kinase II as well as Egr-1 lead to the activation of various genes with 
potentially neuroprotective functions. A more specific experiment was performed using 
a-bungarotoxin, a homomeric a7 nAChR-specific antagonist. Subsequent to 
preconditioning in vitro with K!Cl, the pure neuronal cortical cultures were treated with 
this antagonist, which effectively cancelled the activity of a7 nAChRs during the 
glutamate excitotoxic insult. This cancellation of a7 nAChR activity led to the loss of the 
KCl-induced neuroprotective efiect, strongly supporting the contention that a7 nAChR 
activity is required for KCl-indvced protection. In an attempt to quantify the change- if 
any- in a7 nAChR expression', KCl preconditioned and nicotine treated cultures were 
stained with a-Bungarotoxin-FIITC. Prolonged treatment with nicotine (24 hours) had no 
effect upon the expression and formation of functional a7 nAChRs. Contrary to the 
findings of Chazot et al. (20021) and other various studies in which KCl treatment was 
shown to increase a7 nAChR. protein expression (De Koninck and Cooper, 1995; 
Utsugisawa et al., 1997; Ridley et al., 2001), here it was found that there was no such 
change; if anything there is a &end towards a decrease in the formation of functional 
homomeric a7 nAChRs. The statistical non-significance can be attributed to the high 
variance due to the independent blind counting methodology employed, as well as the 
fact that the cultures were created on poly-D-Lysine coated glass coverslips to which the 
cells attach poorly. 
Attempts at verifying the a-bungarotoxin-FITC binding result with a Western blot protein 
analysis was unsuccessful due 1to the anti-a7 nAChR antibodies employed. The Santa 
Cruz Biotechnology rabbit polyclonal antibody (sc-5544) gave inconsistent results. This 
antibody was raised against a recombinant protein corresponding to amino acids 367 -
502 mapping at the carboxy terrilinus of human a7 nAChR subunit. As mentioned in the 
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introduction, the a7 nAChR gene undergoes alternative splicing resulting in an array of 
mostly non-functional a7-like proteins being formed. In addition to this, a duplication of 
exons 5 - 10 of the a7 nAChR gene, corresponding to amino acids 386 - 502, can be 
found within 1 Mb and centromeric to the full-length a7 nAChR gene on chromosome 15 
of the human genome proteins (Gault et al., 1998; Garcia-Guzman et al., 1995). 
Antibodies and genetic probes oirected at the a7 nAChR subunit are notorious for their 
unreliability (Herber et al., 2004; Jones and Wonnacott, 2005; Moser et al., 2007). 
Attempts to probe the preconditioned samples with an anti-rabbit a7 nAChR antibody 
from Abeam (ab23832), directed against a region within the first hundred amino acids of 
theN-terminal of the receptor yielded no signal. 
Taking into account the unreliafuility of the antibody probes for the a7 nAChR subunit, a 
closer look was taken at the critical studies in which a7 nAChR upregulation subsequent 
to exposure to KCl was reported. The Utsugisawa et al. (1999) study only looked at the a7 
nAChRs on an mRNA level, using reverse transcription polymerase chain reaction (RT-
1 
PCR) primers amplifying nucle.otides 684 - 1055, corresponding to amino acids 228 -
352 i.e. the duplicated genome I region. Chazot et al. (2002) utilized two mouse anti-a7 
antibodies, Mab306 and Mab319 (Cambridge Bioscience). Mab306 is a monoclonal 
mouse anti-a? antibody that recognizes amino acids 380 - 400, whereas Mab 319 is 
another monoclonal anti-a? antibody that recognizes amino acids 365 - 384. Both of 
these antibodies are targeted at regions in the C-terminus of the a7 nAChR subunit. The 
validity of studies on a7 nAChRs relying on either antibodies or genetic mRNA probes 
without looking at any functiqnal changes by means of a-bungarotoxin binding are 
questionable (Herber et al., 200;4; Jones and Wonnacott, 2005; Moser et al., 2007). It is, 
however, accepted that this current study does not absolutely refute these previous studies 
92 
since there exist large differences between the strategies and methodologies employed to 
study the a7 nAChR phenomemm. 
Both the De Koninck and Cooper (1995) and the Ridley et a/. (200 1) studies relied upon 
the use of a-bungarotoxin binding to confirm their results that chronic depolarisation of 
neurons with KCllead to an increase in a-bungarotoxin binding. De Koninck and Cooper 
(1995) applied 40 mM KCl to' DIV 5 neonatal rat sympathetic neurons for two days, 
resulting in the detection of a! three- to fivefold increase in a-bungarotoxin binding. 
Ridley eta!. (2001) applied 20 imM KCl to DIV 3 rat primary hippocampal cultures for 
four days before analysing the functional a7 nAChR expression level, detecting an 
approximate 72 % increase in a1-bungarotoxin binding. Neither of these studies looked at 
the preconditioning effect of KCl, which would have proved difficult taking into 
consideration the findings in the present study indicating the loss of neurons due to 
secondary glutamate release over prolonged periods of time. Of interest is the Barrantes 
et al. (1995) study in which it was shown that primary hippocampal cultures on average 
express five times as much functional a-bungarotoxin binding a7 nAChRs than primary 
cortical cultures, which might account for some of the differences observed between the 
present study and the literature. Utilizing similar cultures treatment methodology as the 
Ridley et al. (2001) study, it was also shown in the Barrantes et al. (1995) study that 24 
hour treatment with 10 11M nicotine does not increase a7 nAChRs in hippocampal 
cultures. Only after four days of: nicotinic treatment was an approximate 10 % increase in 
a-bungarotoxin binding detected. 
In conclusion, this chapter has discussed the creation, optimization and the validation of a 
reliable in vitro KCI-induced preconditioning system using pure neuronal cortical 
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cultures. This chapter provided evidence that the model follows a similar mechanism as 
cortical spreading depression in vivo, despite the lack of glia. In contradiction to the 
prediction made in the Chazot et al. (2002) paper which served as basis for the current 
study, it was shown that functional a7 nAChRs are not upregulated upon chronic 
depolarisation with KCl, although the activity of this receptor subtype remained essential 
for the preconditioning mechanism. In addition, preliminary studies by Dr. G. Jackson have 
indicated that the same samples used in the Chazot et al. (2002) study do not have an 
increase in functional a-bungarotbxin binding to a7 nAChRs, further lending support for the 
present study and illustrating that any potential a7 nAChR protein expression changes 
previously reported does not extrapolate to increase in functional expression, but may in fact 
reflect a loss of function. 
The next chapter is concerned with studying the putative obligatory a7 nAChRs trafficking 
protein, Ric3 and its potential role in controlling the functional expression of a7 nAChRs in 
vitro. This next stage required the development, characterisation and use of the first anti-
mouse Ric3 selective antibody. 
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CHAPTER 3: Molecular Oharacterisation of the Putative Alpha 7 nAChR 
Trafficking Protein, Ric3 
3.1. Introduction 
The regulation of functional exwession of the a7 nAChR has significant implications for 
this study. Ric3 has recently been identified as an obligatory trafficking protein for the a7 
I 
nAChR in heterologous expression studies in vitro (Halevi et al., 2002) - a link that 
remains to be confirmed in vivo: In addition to this, Ric3 has been shown to have diverse 
effects on other ligand-gated ion channel expression, i.e. hric-3 decreases the whole-cell 
current amplitude when co-expressed with a4P2 and a3p4 receptors in oocytes (Halevi et 
al., 2003) but leads to an increase in these receptors when expression occurs in homologous 
mammalian cells (Lansdell et al., 2005). Halevi et al. (2003) reported mRNA transcription 
of ric3 gene isoforms as detected by Northern blot analyses in various tissues, including 
brain, heart, kidney, lung, liver, ;muscle, and pancreatic tissue. The functions and targets 
of all these isoforms are still upknown, although the diverse effects of this protein on 
ligand-gated ion channel expression and the varied tissue expression pattern necessitates 
I 
a detailed in vivo Ric3 distributi0n analysis. 
In an attempt to analyze the distribution of ric3 expression within the mouse brain, 
I 
Halevi et al. (2003) performed .an in situ analysis using an mRNA probe based on the 
sequence of the second membl:ane domain and the coiled-coil domain of the partial 
mouse sequence to which they1 had access at the time. Taking into consideration the 
I 
varied isoforms of the mRNA de:tected with their Northern blot analysis of various tissues, 
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it would be a leap to conclude that they all translate into protein - not to mention 
functional protein. To address this problem, we will attempt to design a specific anti-
mouse Ric3 antibody to identify Ric3 protein expression in the mouse brain. 
Within this chapter, the methods are described for structurally analysing the mouse Ric3 
protein for the design of the antifuody peptide, preparing the peptides for immunization, 
the immunization procedure, antibody purification and the experiments performed to 
analyse the antibody's specificity. 
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3.2. Materials and Methods 
3.2.1. Sequence Homology Analyses and Secondary Structure Prediction 
Nucleotide and amino acid sequences of the human and mouse ric3 were aligned and 
compared using the CLUSTAL X (1.81) program (Higgins and Sharp, 1988; Higgins et 
a/., 1996). Secondary structure consensus prediction was performed using the Network 
Protein Sequence Analysis program (NPS@) (Combet et a!., 2000), which relied on the 
average of the following predictive methods: 
SOPMA (Geourjon and Deleage, 1995) 
HNN (Guermeur, 1997) 
MLRC (Guermeur et al., 1999) 
DPM (Deleage and Roux, 1987) 
GOR III (Gibrat et al., 1987) 
GOR IV (Garnier et al., 1996) 
PHD (Rost and Sander, 1993) 
SIMP A96 (Levin, 1997) 
SOPM (Geourjon and Deleage, 1994) parameters: Window width = 17; Similarity 
threshold= 8; Number of states = 4. 
GOR I (Garnier et al., 1978) parameters: Decision constant for: helix= -100; sheet= -88; 
tum= 0; coil = 0. 
PREDATOR (Frishman and Argos, 1996) parameters: Secondary structure data= dssp 
Each one of these secondary structure predictive methods is loosely based on the 
principal that the parameters used for the prediction were determined from a subset of x-
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amount of proteins with known three dimensional structures to form an algorithm (using 
the theory of information) with conditional probabilities being calculated. 
The prediction of transmembranous regions is based on hydrophobicity analyses and the 
positive inside rule that indicates that the cytoplasmic side of a membrane is rather 
positively charged whereas the external side tends to be more negatively charged. This 
was preformed using Von Heijne (1992) transmembrane predictive method of the 
ANTHEPROT package (Geourjon et al., 1991; Geourjon and Deleage, 1995). 
The NetNGlyc 1.0 Server (Gupta et al., 2004) predicts N-glycosylation sites in human 
proteins using artificial neural networks that examine the sequence context for the 
presence of an Asn-Xaa-Ser/Thr motif, where X stands for any amino acid. A consensus 
prediction for the presence of possible phosphorylation sites was derived from 
KinasePhos (Huang et al., 2005a; Huang et al., 2005b) and NetPhosK 1.0 Server (Blom 
et al., 2004). 
3.2.2. Peptide Design and Creation 
The ANTHEPROT package utilizing the Hopp and Woods predictive method (Hopp and 
Woods, 1981; Hopp and Woods, 1983) were used to calculate the hydropathy plot of the 
mouse Ric3 protein. The same package used the antigenicity predictive method as 
described by Parker et al. (1986) for identifying the strongest antibody generating regions 
within the Ric3 protein. The choice of the peptide sequence relied upon these two factors 
as well as the potential peptide's position relative to the carboxyl terminal. Another 
important factor is how unique the chosen peptide sequence is within the genome of the 
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organism for which the sequence was compared to all known protein sequences in 
National Centre for Biotechnology Information (NCBI) records system .. 
A cysteine residue was added to the carboxyl-terminal of the sequence enabling the 
peptide to be coupled to the thyroglobulin carrier protein and to the sepharose beads for 
the antibody purification (see below). The peptide itself was produced by Cambridge 
Research Biochemicals Ltd. (UK). 
3.2.3. Coupling of the Peptide to the Carrier Protein 
The 15 amino acid peptide is too small to stimulate an immune response and has to be 
coupled to a large immunogenic carrier protein. The 3-maleimimdobenzoic acid N-
hydroxysuccinimide ester (MBS) method, as described by Duggan et al. (1991), was used 
to conjugate the peptide to the thyroglobulin carrier protein by means of a cysteine residue 
that was incorporated at the carboxyl-terminal of the peptide 
Thyroglobulin was dissolved to a final concentration of 20 mg/ ml in a buffer (1 0 mM 
KH2P04, 10 mM Na2HP04, pH 7 .2) before being dialysed against 500 ml of the same 
buffer for 12 hours at 4 °C. 4 mg (200 Ill) of the dialysed carrier protein was further 
diluted by the addition of 50 111 of the buffer prior to the activation of the carrier protein 
by dropwise addition of 85 111 stock MBS (3 mg/ ml MBS inN, N-dimethylformamide). 
The solution was incubated at room temperature for 30 minutes with shaking. The 
activated thyroglobulin was separated from free MBS by dialysis against 1 litre of a 
second buffer consisting of 50 mM KH2P04, 50 mM Na2HP04, pH 6.0, for 2 hours at 
room temperature with 2 x 1 litre solution changes. 4 mg of peptide was dissolved in 1 ml 
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of 10 mM KH2P04, 10 mM Na2HP04, pH 7.2 before being added to the dialysed activated 
carrier protein and incubated for 12 hours at room temperature with gentle mixing. The 
peptide-carrier protein conjugate was separated from the uncoupled peptide by dialysis 
against phosphate buffered saline (PBS) for a total of 4 hours at 4 °C, with 4 x 500 ml 
solution changes. The dialysed peptide protein conjugate was made up to a final 
concentration of 1 mg/ ml with PBS and stored in 100 Jll aliquots at -20 °C. 
3.2.4. Inoculation procedure 
A 100 J.!l (1 00 Jlg) of freshly thawed peptide-carrier protein conjugate was mixed with 
200 Jll sterile PBS and emulsified with an equal volume of complete Freund's Adjuvant. 
This preparation was injected intramuscularly into both hind legs of a Dutch rabbit. 
Secondary immunisations at 1 month intervals were prepared using incomplete Freund's 
Adjuvant. 10 - 15 ml of blood was collected from the marginal ear vein of the animal, 7 -
10 days subsequent to every secondary or booster injection. The blood sample was 
allowed to stand at room temperature for 2 hours, and then clot contraction was allowed 
to occur over 16 hours at 4 °C. The serum was collected by centrifugation at 12000g for 
10 minutes at 4 °C, and was stored in 1ml aliquots at -20 °C. All procedures were 
performed in accordance with the Animals (Scientific Procedures) Act 1986 (PPL 
602/657). 
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3.2.5. Coupling of Peptides to Sepharose Beads via Sulphydryl Groups 
For the purification of anti-peptide polyclonal antibodies, the antigen peptide had to be 
coupled to thiol-sepharose beads via the peptides C-terminal cysteine residue. The 
coupling of the peptide to the activated sepharose beads was carried out according to the 
method described by Stephenson and Duggan (1989). 
0.35 g of activated thiol-sepharose was allowed to swell in 100 ml ddH20 at room 
temperature for 15 minutes. The swollen sepharose was added to a 15 ml column with a 
scintered filter at the bottom and the water allowed to flow through the column under 
gravity flow. The swollen sepharose was washed with a 100 ml of a Solution A consisting 
of 0.1 M Tris-HCl, 0.3 M NaCl and 1 mM EDTA, pH 8.0. 1 ml of Solution A containing 
5 mg of the dissolved peptide was added to the sepharose. Subsequent to a one hour 
incubation period, the reaction was terminated by washing the sepharose with 25 ml of 
Solution A, followed by a second wash consisting of 10 ml of Solution B consisting of 
100 mM citric acid at pH 4.5. Any remaining unbound thiol groups were blocked by 
incubating the sepharose with 3 ml of 1 mM ~-mercaptoethanol dissolved in Solution B 
for 45 minutes at room temperature, with shaking. The blocking reaction was terminated 
by washing the sepharose with 25 ml of Solution B. The sepharose was equilibrated with 
25 ml PBS before being stored in 10 ml PBS containing 0.02% (w/v) sodium azide, and 
the column at 4 oc until use. 
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3.2.6. Peptide Mfmity Purification of Antibodies 
The sepharose column linked to the appropriate peptide (section 3.2.5) was equilibrated 
by passing a 100 ml of PBS through the column. Five millilitres of the immune serum 
(section 3.2.4) was added to the sepharose and incubated for twelve hours at 4 °C with 
gentle shaking. The unbound immune serum was allowed to pass through the column 
under gravity flow before the column was washed with 100 ml PBS. The bound antibody 
was released from the sepharose and eluted drop-wise from the column by the application 
of 10 ml of 50 mM glycine/ HCl, pH 2.3. 10 x 1 ml fractions were sequentially collected 
in eppendorftubes before being equilibrated by the addition of20 ~1 of 1M Tris to give a 
final pH 7.4. The optical density (O.D.) readings of the antibody fractions were taken at A 
= 280 nm before the concentration of the antibodies was calculated using the Beer 
Lambert law, 
C = A 
EL 
Where 'C' represents the concentration of antibody, 'A' is the absorbance of the antibody 
at A = 280 nm, 'E' is the molar extinction coefficient, and 'L' is the path length. The 
fractions with concentrations above 0.1 mg/ ml protein were pooled and dialysed against 
500 ml TBS for 12 hours at 4 °C. Subsequent to dialysis, the antibody was again 
subjected to spectral analyses at A = 280 nm and the concentration recalculated. The 
purified antibody was then stored with the addition of 250 ~M sodium azide at 4 oc until 
use. 
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The sepharose affinity column was regenerated with the application of 100 ml PBS and, 
once again, stored with 10 ml of PBS containing 250 JlM sodium azide at 4 oc until later 
use. 
3.2. 7. Immunoblotting of Various Tissues 
Brain, kidney, and lung tissue were harvested from adult CD1 mice (25 - 30 g; Charles 
River UK) and homogenized in phosphate buffered saline (PBS) containing 1 in 100 
dilution of Protease Inhibitor Cocktail Set III with a dounce glass/glass homogenizer at a 
concentration of approximately 50 mg/ mi. In chapter two the methods are described for 
SDS page gel analyses (section 2.2.8), and Western blot protein analyses (section 2.2.9). 
Adult male C57BL/6 mice (25-30 g; Harlan UK) were preconditioned by the elicitation 
of 10 full consecutive recurrent cortical spreading depressions (CSD) by the epidural 
application of 1 M KCl to the right occipital cortex, applying physiological saline to the 
sham-operated controls, as described by Godukhin and Obrenovitch (200 1 ). The brains 
were extracted at various times post-preconditioning (24, 72, and 168 hours) and frozen 
in liquid N2 before being stored at -20 °C. They were a kind gift from Dr. G. Jackson and 
Prof. T. P. Obrenovitch. Whole brain samples were homogenized, as above, at fmal 
concentration of 2 mg/ mi. 
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3.2.8. Ric3 Expression in Preconditioned Pure Neuronal Cortical Cultures 
Pure neuronal cortical culture (sections 2.2.1 and 2.2.3) were seeded at 1500 cells/ mm2 
on poly-D-Lysine-coated 35 mm Iwaki tissue culture treated dishes and treated for 24 
hours on DIV 14 with either 11.25 mM KCl dissolved in medium or just plain medium 
for the control group. Cells were harvested either acutely or chronically (3 wash steps and 
24 hours after subsequent incubation) in 500 Ill phosphate buffered saline (PBS) 
containing 1 in 100 dilution of Protease Inhibitor Cocktail Set III. The samples were 
sonicated four times for 30 seconds in a sonication bath with a 1 minute incubation 
period on ice in between every sonication pulse. 100 Ill of the sample was chloroform/ 
methanol precipitated (section 2.2.7) before being run on a 6% SDS-polyacrylamide gel 
(section 2.2.8) and a Western blot analysis (section 2.2.9). 
3.2.9. Immunohistochemistry 
Murine brain samples subjected to cortical spreading depression or sham treatment by Dr. 
G. Jackson and Prof. T. P. Obrenovitch were harvested at various times (24 h, 72 h, and 
168 h) and subjected to immunohistochemical analyses. 25 11m coronal cryostat sections 
of the unfixed brains were collected onto Po lysine ™ glass slides (Agar Scientific, Ltd.) 
coated glass slides before being air dried and stored at -20 oc until use. The samples were 
fixed in 2% (v/v) formaldehyde in Tris Buffer Saline (TBS) and incubated at 37 oc for 
20 minutes followed by 30 minutes incubation in 2 % (v/v) formaldehyde but at room 
temperature. Samples were washed thrice for 5 minutes with TBS before incubating in a 
solution consisting of 10% (v/v) methanol and 3 % (v/v) hydrogen peroxide dissolved in 
TBS for 10 minutes. This was followed by a 15 minute incubation with 0.2 % (w/v) 
104 
glycine and 0.2% (v/v) Tween 20 in TBS and a subsequent incubation with 0.2% (v/v) 
Triton-X-100 in TBS for 15 minutes. Samples were next incubated in 50 mM sodium 
citrate, pH 8.4 first at room temperature for 30 minutes then at 80 oc for another 30 
minutes. This was followed by a 15 minute incubation in 0.2 % (v/v) Triton-X-100 in 
TBS followed by the application of the blocking solution consisting of 2 % (v/v) fetal 
calf serum (FCS) and 0.2 % (v/v) Tween 20 in TBS forl hour. The anti-mRic3 primary 
antibody (2 1-1g/ ml) was diluted in 1 % (v/v) FCS-containing TBS and applied to the 
tissue for 12 hours at 4 °C. For the peptide block experiment, the antibody was incubated 
with the original antigenic peptide (500 1-1g/ ml; Cambridge Research Biochemicals Ltd., 
UK) for a period of 12 hours before use in the immunohistochemistry procedure 
The Vectastain ABC kit (Vector Laboratories, Inc.), a biotin-avidin-peroxidase system, 
was used to detect the bound primary antibody. The samples were washed thrice for two 
minutes with 2.5 % (w/v) dried milk in TBS before the application of 1 % (v/v) FCS 
containing a 1 in 100 dilution of the biotinylated secondary antibody for 20 minutes. 
Samples were washed again (3 x 2 minutes) with 2.5 % (w/v) dried milk in TBS before 
the 5 minute application of Vector ABC diluted in TBS (1 in 50). Samples were washed 
five times for 2 minutes in TBS and developed in DAB (3, 3 '-diaminobenzidine) ( 10 ml 
TBS, 1 DAB tablet, 6 1-11 H20 2) for 20 minutes in the dark. Samples were washed a final 
time with water before being mounted with DPX Mountant for histology (Fluka). Images 
were taken with a COOLPIX 950 Digital Camera on a Nikon Eclipse E400 microscope at 
1 OX magnification. The composite picture in Figure 3.9 was created by taking sequential 
photographs of the region of interest and aligning them in Microsoft® Word 2002. 
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3.3. Results 
3.3.1. Ric3 Gene and Protein Sequence Analysis 
At the time that Halevi and co-workers conducted their interspecies ric3 sequence 
homology study (Halevi et al., 2003), the complete mouse ric3 gene (mric3) sequence 
was unavailable for comparison and they relied upon an extrapolation from the human 
ric3 gene (hric3) sequence (NCBI accession number A Y326435) to complete the mouse 
sequence. Subsequent to the Ric3 protein species alignment (Halevi et al., 2003), several 
mric3 isoforms cDNAs were submitted to NCBI, and the one with the highest homology 
was used in the following experiments (RIKEN Genome Exploration Research Group 
Phase II Team and the FANTOM Consortium; NCBI accession number AK053760). 
Other mric3 isoforms (NCBI accession number NM_178780 and AK082275) consisting 
of equal or less nucleotides than the AK053760 isoform yet with lower homology, were 
also detected in the NCBI submission (results not shown). As can be seen from the 
sequence homology analysis using ClustalX version 1.81 in Figure 3.1, the 3' region of 
the mouse gene coding for the C-terminal of the Ric3 protein is distinctly different and 
considerably shorter ( 413 base pairs) than its human counterpart. The mric3 consists of 
687 base pairs (bp) coding for 228 amino acids (aa), whereas the human counterpart 
consists out of 1100 bp coding for a 369 aa protein. Only 87 bp of the 687 bp mouse ric3 
gene differ from the human gene, resulting in 87.33 %homology within this first stretch 
of DNA, although taking into account the much longer human gene results in the 
reduction of the homology to approximately 54.55 %. 
A comparison between the predicted secondary structure of the human and mouse Ric3 
proteins was also performed and is shown in Figure 3.2. There exists high homology 
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between the secondary structures with five common large alpha-helix motifs found at 
approximate amino acid positions 4- 30, 66- 81, 109- 118, 143- 168, and 181 -201. 
Similarly, two common random coil regions or coil-coil regions are found at approximate 
amino acid positions 30 - 66 and 81 - 95, although only one of the three extended 
regions found in the human form of Ric3 is also located in the mouse version of the 
protein at approximate amino acid position 97 - 1 02. The extended regions in the first 
228 aa of the human Ric3 protein accounts for 4.82% of the structure, whereas only 2.19 
% of the mouse homolog. The function of these regions in the Ric3 protein remain to be 
identified although the transmembrane predictive comparison in Figure 3.3 indicates that 
the first extended region at approximate 97 - 102 aa, which is common to both the human 
and mouse version, is in fact necessary for crossing the cell membrane (aa 99- 112) from 
the extracellular domain to the cytoplasmic region. The transmembrane prediction also 
indicates an earlier crossing event at approximate aa position 11 - 22 which corresponds 
to an area within one of the large alpha-helix regions. 
The ammo acid sequence of both mouse and human Ric3 were analysed for N-
glycosylation and phosphorylation sites. The NetNGlyc 1.0 Server detected no motifs in 
either the human or mouse versions of the Ric3 protein which would indicate the 
presence of a glycosylation site. The consensus phosphorylation prediction derived from 
the KinasePhos and NetPhosK 1.0 Server prediction programs revealed the presence of a 
putative protein kinase C (PKC) phosphorylation site at amino acid 178 of the human 
homolog, a protein kinase CK2 (previously known as casein kinase II) site at amino acid 
positions 180 and 334, and finally a potential phosphorylation site for either protein 
kinase CK1 or CK2 at amino acid position 273. The mouse Ric3 protein contains a single 
potential protein kinase CK2 phosphorylation site at aa position 179. 
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The mouse ric3 gene sequence was further analysed using the ANTHEPROT package in 
an attempt to identify a possible region for the antibody generation. A hydrophilic region 
is required for the antigenic peptide since these are the regions most likely to be exposed 
on the surface of the mature folded protein and a short hydrophobic peptide might lead to 
aggregation. A hydropathy plot was drawn using the Hopp and Woods predictive method 
(Fig. 3.2 A), which depends on the hydrophilic character of each amino acid. This is 
based on the property of the amino acid's side chain to be more soluble in water than in 
an apolar solvent. As can be seen in Figure 3.2 A, Ric3 is an overall hydrophilic molecule 
with 49.1 %hydrophilic aa, 12.3 %ambivalent aa, and 38.6 hydrophobic aa, with a net 
hydropathy value of+ 38. 6. It was decided that the peptide region from aa 208 to aa 222 
with a net hydrophilic character of+ 61 was ideally located close to the C-terminus. An 
antigenicity plot according to the predictive method described by Parker et al. (1986) was 
calculated and it was found that the region from aa 208 to aa 222 also has a high 
antigenic value (Fig. 3.2 B). In addition to the hydrophilicity character of the amino acids, 
the antigenicity predictive profile is based on the atomic flexibility and experimental 
HPLC retention times of synthetic peptides. A cysteine residue was attached the C-
terminus to yield a final peptide with a sequence of H-Cys-Glu-Lys-Glu-Ala-Glu-Glu-
Ala-Pro-Tyr-Met-Glu-Asp-Trp-Glu-Gly-NH2• 
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ATGGCGTACTCCACGGTGCAGAGAGTGGCGCTGGCCTCGGGGCTCGTCCTGGCCGTGTCG 
M A Y S T V Q R V A L A S G L V L A V S 
ATGGCGTACTCCACAGTGCAGAGAGTCGCTCTGGCTTCTGGGCTTGTCCTGGCTCTGTCG 
M A Y S T V Q R V A L A S G L V L A L S 
************** *********** ** ***** ** ***** ******** ***** 
CTGCTGCTGCCCAAGGCCTTCTTGTCTCGCGGGAAGCGACCGGAGCCGCCGCCGGGCCCG 
L L L P K A F L S R G K R P E P P P G P 
CTGCTGCTGCCCAAGGCCTTCCTGTCCCGCGGGAAGCGGCAGGAGCCGCCGCCGACACCT 
L L L P K A F L S R G K R Q E P P P T P 
********************* **** *********** * ************* ** 
GAAGGAAAATTGGACCGATTTCCACCTATGATGCATCACCACTCGGCACCCTCAGATGGT 
E G K L D R F P P M M H H H S A P S D G 
GAAGGAAAATTGGGCCGATTTCCACCTATGATGCATCATCACCAGGCACCCTCAGATGGC 
E G K L G R F P P M M H H H Q A P S D G 
************* ************************ *** *************** 
CAGACACCAGGGGCTCGTTTCCAGAGGTCTCACCTTGCAGAGGCCTTTGCAAAGGCCAAG 
Q T P G A R F Q R S H L A E A F A K A K 
CAGACTCCTGGGGCTCGTTTCCARAGGTCTCACCTTGCCGAGGCATTTGCAAAGGCCAAA 
Q T P G A R F Q R S H L A E A F A K A K 
***** ** ************** ************** ***** ************** 
GGAGCAGGTGGAGGTGCTGGAGGAGGGGGTAGTGGAAGAGGACTGATGGGCCAGATCATT 
G A G G G A G G G G S G R G L M G Q I I 
GGATCAGGTGGAGGTGCTGGAGGAGGAGGTAGTGGAAGAGGTCTGATGGGGCAGATTATT 
G S G G G A G G G G S G R G L M G Q I I 
*** ********************** ************** ******** ***** *** 
CCAATCTATGGCTTTGGGATCTTTTTGTACATACTGTACATTTTGTTTAAGCTTTCAAAG 
P I Y G F G I F L Y I L Y I L F K L S K 
CCAATCTACGGTTTTGGGATTTTTTTATATATACTGTACATTCTATTTAAGCTCTCAAAG 
P I Y G F G I F L Y I L Y I L F K L S K 
******** ** ******** ***** ** ************ * ******** ****** 
GGGAAAACT---GCAGAGGATCGGAACTGCTCCACTGCCCCACCTGGAAACGCCCACAGG 
G K T A E D R N C S T A P P G N A H R 
GGGAAAACAACTGCAGAGGATGGGAAATGCTATACTGCCATGCCTGGAAACACCCACAGG 
G K T T A E D G K C Y T A M P G N T H R 
DNA Hornol ******** ********* **** **** ****** ********* ******** 
M ric3 
M Ric3 
H ric3 
H Ric3 
AAGATTACCAACTTTGAGCTTGTTCAACTACAAGAAAAACTAAAAGAGACAGAAGAAGCC 
K I T N F E L V Q L Q E K L K E T E E A 
AAAATTACCAGTTTTGAGCTTGCTCAACTGCAAGAAAAACTGAAGGAGACAGAAGCAGCC 
K I T S F E L A Q L Q E K L K E T E A A 
DNA Hornol ** ******* ********** ****** *********** ** ********** **** 
M ric3 
M Ric3 
H ric3 
H Ric3 
DNA Hornol 
M ric3 
M Ric3 
H ric3 
H Ric3 
DNA Hornol 
M ric3 
ATGGAAAAATTAATCAACAGAGTTGGACCTAATGGTGAGAGCAGAGCACAGGCTGTGACT 
M E K L I N R V G P N G E S R A Q A V T 
ATGGAAAAATTAATCAACAGAGTGGGACCTAATGGTGAGAGCAGAGCACAGACTGTGACT 
M E K L I N R V G P N G E S R A Q T V T 
*********************** *************************** ******** 
TCTGACCAAGAGAAACGATTACTGCATCAGCTCCGAGAAATCACCAGGGTCATGAAAGAA 
S D Q E K R L L H Q L R E I T R V M K E 
TCTGACCAAGAGAAACGGTTGCTACATCAGCTCCGAGAAATCACCAGGGTCATGAAAGAA 
S D Q E K R L L H Q L R E I T R V M K E 
***************** ** ** ************************************ 
GGCAAGTTCATCGACACA---TCTCCAGAGAAGGAAGCTGAGGAAGCCCCATACATGGAG 
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M Ric3 
H ric3 
H Ric3 
G K F I D T S P E K E A E E A P Y M E 
GGAAAATTCATTGACAGATTTTCTCCAGAGAAAGAAGCTGAGGAGGCCCCTTACATGGAG 
G K F I D R F S P E K E A E E A P Y M E 
DNA Homol ** ** ***** **** * *********** *********** ***** ********* 
M ric3 
M Ric3 
H ric3 
H Ric3 
DNA Homol 
M ric3 
M Ric3 
H ric3 
H Ric3 
DNA Homol 
M ric3 
M Ric3 
H ric3 
H Ric3 
DNA Homol 
M ric3 
M Ric3 
H ric3 
H Ric3 
DNA Homol 
M ric3 
M Ric3 
H ric3 
H Ric3 
DNA Homol 
M ric3 
M Ric3 
H ric3 
H Ric3 
DNA Homol 
M ric3 
M Ric3 
H ric3 
H Ric3 
DNA Homol 
M ric3 
M Ric3 
H ric3 
H Ric3 
DNA Homol 
GACTGGGAAGGTAAA-----ATGCCCCTTCCTTGTTAG----------------------
0 W E G K - M P L P C Stop 
GACTGGGAAGGTTACCCTGAAGAGACTTACCCAATTTATGACCTTTCAGACTGTATCAAG 
D W E G Y P E E T Y P I Y D L S D C I K 
************ * * * * ** ** 
CGTAGGCAAGAAACAATCTTGGTGGATTACCCTGACCCAAAAGAACTTTCTGCTGAAGAA 
R R Q E T I L V D Y P D P K E L S A E E 
ATAGCTGAAAGAATGGGAATGATAGAAGAGGAAGAATCAGATCATTTGGGTTGGGAAAGT 
I A E R M G M I E E E E S D H L G W E S 
CTGCCCACTGACCCCAGAGCCCAGGAAGATAATTCTGTTACCTCGTGTGATCCAAAGCCA 
L P T D P R A Q E D N S V T S C D P K P 
GAAACATGTTCCTGCTGTTTTCATGAAGACGAGGATCCTGCTGTCTTGGCAGAGAATGCT 
E T C S C C F H E D E D P A V L A E N A 
GGATTCAGTGCAGATAGCTACCCTGAGCAAGAGGAAACCACCAAAGAAGAGTGGTCCCAA 
G F S A D S Y P E Q E E T T K E E W S Q 
GACTTTAAAGATGAAGGGTTGGGCATCAGCACCGATAAAGCATATACAGGCAGCATGCTG 
D F K D E G L G I S T D K A Y T G S M L 
AGGAAGCGTAACCCCCAGGGTTTAGAGTGA 
R K R N P Q G L E Stop 
Figure 3.1. CLUSTAL X (1.81) multiple sequence homology alignment between the 
mouse (NCBI accession number AK053760) and human ric3 (NCB! accession number 
AY326435) genes, accompanied by their respective amino acid sequences. DNA 
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homology is indicated by * whereas amino acid differences are highlighted in red in the 
human. The 15 blue amino acids represent the peptide chosen for antibody generation. 
Human Ric3 Secondary Structure Prediction 
1 11 21 31 41 51 61 71 81 91 101111 121131 141151161 171181191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 
Amino Acid Position 
Mouse Ric3 Secondary Structure Prediction 
1 11 21 31 41 51 61 71 81 91 101111 121131 141151161 171181 191 201 211 221 
Amino Acid Position 
Secondary Structure Comparison 
Motif Mouse Human First 228 aa Full Length Human 
Alpha helix 106 is 46.49% 109 is 47.81% 165 is 44.72% 
310 helix 0 is 0.00% 0 is 0.00% 0 is 0.00% 
Pi helix 0 is 0.00% 0 is 0.00% 0 is 0.00% 
Beta bridge 0 is 0.00% 0 is 0.00% 0 is 0.00% 
Extended strand Sis 2.19% 11 is 4.82% 16 is 4.34% 
Beta turn 0 is 0.00% 0 is 0.00% 0 is 0.00% 
Bend region 0 is 0.00% 0 is 0.00% 0 is 0.00% 
Random coil 103 is 45.18% 96 is 42.11% 161 is 43.63% 
Other states 0 is 0.00% 0 is 0.00% 0 is 0.00% 
Figure 3.2. The secondary structure prediction of the mouse and human Ric3 proteins 
accompanied by a table containing an analysis of each motifs occurrence. 
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1.5 
-1 
Extracellular Cytoplasmic 
Region 
1 21 41 61 81 101 121 141 161 181 201 221 241 261 281 301 321 341 361 
Amino Acid Position 
Figure 3.3. A prediction of the transmembrane regions indicates that both the mouse 
(blue) and the human (red) Ric3 proteins cross the membrane (green) twice as is depicted 
by the two peaks rising above the green line. + indicates the end of the mouse Ric3 
protein. 
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A Peptide 
Hydrophilicity 0 
Value 
-5 
-~ L_ __________________________________________ ~---
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161171 181 191 201 211 221 
Amino Acid Position 
B Peptide 
Antigenicity 60 +------- -
Value 
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 
Amino Acid Position 
Figure 3.4. Hydrophilicity Plots of mouse Ric3 according to the Hopp and Woods 
Predictive method (Hopp and Woods, 1981; Hopp and Woods, 1983.) (A), and the 
antigenicity plot according to the predictive method described by Parker et al. (1986) (B). 
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3.3.2. Peptide Mfinity Purification and Concentration Determination 
The polyclonal antibody raised against the mRic3 protein is intermingled in the serum 
with animal's natural antibodies as well as antibodies against the thyroglobulin carrier 
protein. To remove the impurities that could possibly cause non-specific binding, the pure 
peptide was coupled to activated sepharose beads using a similar coupling strategy as that 
between the peptide and the carrier protein. The serum was then incubated with the 
peptide affinity column which bound the anti-mRic3 antibodies. Subsequent to washing, 
the purified anti-mRic3 antibody was eluted in 1 ml fractions and the absorbance of each 
fraction was measured spectrophotometrically at 280 nm. The fractions from each bleed 
with an optical density (O.D.) of approximately 0.1 or higher were grouped (Fig. 3.5). 
The first six fractions from the first bleed fulfilled this requirement and were grouped to 
yield a final absorbance of 0.103 which, according to the Beer Lambert law, equates to 
0.0769 mgl ml of anti-mRic3 antibody. The antibody concentrations from the second 
bleed were too low to be used but the concentrations from the third bleed yielded two 
groups with high enough concentrations: fractions 2- 3 (O.D. = 0.146, thus 0.108 mg/ 
ml) and fractions 4- 10 = 0.177, thus 0.132 mg/ mi. The first three fractions from the 
final terminal bleed were grouped to yield a final O.D. of0.134, which equates to 0.1 mg/ 
ml anti-mRic3 antibody. 
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3.3.3. Immunoblotting Analysis of the Anti-mRic3 Antibody 
HEK 293 cells were infected with adenovirus expressmg either enhanced green 
fluorescent protein, the a7 nAChR subunit, the 25 kDa isoform of Ric3, or both the a7 
nAChR subunit and the 25 kDa Ric3 protein (See Chapter 4). Samples were analysed on 
a Western blot with 2 j.!g/ ml of the new anti-mRic3 antibody. The antibody only 
identified a single band at approximately 25 kDa in cells infected with an adenovirus 
expressing Ric3. In the absence of a7 nAChR subunits, an additional band was observed 
at approximately 37 kDa. 
Various quantities of mouse brain (50 mg/ ml), kidney (75 mg/ ml) and lung (45 mg/ ml) 
samples were analyzed with 2 j.!g/ ml of the new anti-mRic3 antibody (Fig. 3.7). A range 
of immunoreactive bands were identified in all three tissue types with a major Mr ~ 
56,000 species being identified in the mouse brain samples, which is absent or modestly 
expressed in lung and kidney samples, respectively. This species corresponds with the 
human size Ric3 protein (theoretical size 41 kDa) as observed by Halevi eta!. (2003) and 
not with the mouse Ric3 protein, which has a theoretical molecular weight of 
approximately 25 kDa - at this size only a very faint band can be identified (indicated 
with an arrow in Figure 3.7). The 25 kDa species also seem to appear in the kidney tissue 
at a higher concentration than in the brain but is absent in mouse lung tissue. A range of 
bands are closely clustered around the Mr ~ 56 kDa species, indications of possible 
isoforms or various post-translational states. Both the mouse lung and kidney samples 
share a prominent species of Mr ~ 80 kDa - low levels of which is present in the brain 
samples. In addition to this, a species of lower prominence can be detected in the kidney 
samples at Mr ~ 40 kDa and a distinct species in the lung samples at Mr ~ 35 kDa. A 
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band of Mr ~ 180 kDa is found in both the brain and kidney samples at approximate 
equal intensity - the only band between the brain and any of the other two samples 
corresponding in both size and concentration. 
The effect of prolonged exposure to potassium chloride on the levels of the Ric3 protein 
expression was investigated by exposing rat pure neuronal cortical cultures to 11.25 mM 
KCl for 24 hours (Fig. 3.8). Samples were either harvested acutely post-exposure or 
chronically, following a 24 hour treatment-free recovery period. Two main species of 
protein were detected by the anti-mRic3 antibody at Mr ~ 50 kDa and Mr ~ 25 kDa. The 
Mr ~ 25 kDa corresponds with the expected size of the mouse protein upon which the 
antibody was based whereas the Mr ~ 50 kDa species seems, once again, to correspond to 
the human size Ric3 protein as observed by Halevi et al. (2003). Normalization with~­
actin revealed that the expression of the Ric3 protein remains unaltered subsequent to 
prolonged treatment with KCl, irrespective of when the samples were harvested. Another 
possible isoform of the Ric3 protein is visible marginally above the position of the Mr ~ 
50 kDa species. 
Murine brain samples harvested at 24 hours, 72 hours, or 168 hours subsequent to in vivo 
cortical spreading depression or sham treatment, were analysed with the new anti-mRic3 
antibody (Fig. 3.9). CSD induced an approximate doubling in the amount ofRic3 species 
expressed at approximately 50 kDa for the 24 hour and 72 hour harvested samples. No 
increase in this species was detected in samples harvested 168 hours after the CSD event. 
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0.14 
0.12 
0.1 
Absorbance A = 280 nm 0.08 
0.06 
0.04 
0.02 
0 
2 3 4 5 6 7 8 9 10 
Bleed 1 Fractions 
0.1 
0.08 
Absorbance A = 280 nm 0.06 
0.04 
0.02 
0 
2 3 4 5 6 7 8 9 10 
Bleed 2 Fractions 
0.2 
0.15 
Absorbance A = 280 nm 0.1 
0.05 
0 
2 3 4 5 6 7 8 9 10 
Bleed 3 Fractions 
0.16 
0.14 
0.12 
0.1 
Absorbance A = 280 nm 0.08 
0.06 
0.04 
0.02 
0 
2 3 4 5 6 7 8 9 10 
Tenninal Bleed Fractions 
Figure 3.5. The optical density (O.D.) readings of the eluted antibody fractions for each 
bleed were taken at A. = 280 nm. Fractions that had readings of approximately 0.1 were 
grouped and are represented by blue bars, or blue and red bars for the two groups in 
Bleed 3. The black bars in the graphs represent fractions that were too low to be used. 
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kDa 
174.6 
115.6 
93.1 
65.1 
56.8 
35.8 
31.2 Ric3 
M C SG SR SI S7 SR+S7 
Figure 3.6. A copy of Figure 4.4A illustrating the effectiveness and specificity of the 
Ric3-antibody in identifying Ric3 transgene expression in recombinant adenoviral 
infected HEK 293 cells. 50 J.Ll of the 1 m1 harvested cell suspension was analysed on a 6 
% SDS-PAGE gel. M represents the molecular weight marker used (Precision Plus 
Protein ™ Standards, Bio-Rad), C the control uninfected HEK 293 cells, SG the SG-AdV 
infected cells expressing green fluorescent protein (GFP), SR the SR-AdV infected cells 
expressing Ric3, SI the bicystronic adenovirus SI-AdV infected cells expressing o.7 
nAChR subunit and Ric3, S7 the 87-AdV infected HEK cells expressing o.7 nAChRs, and 
SR+S7 the HEK cells infected with both SR-AdV and S7-AdV simultaneously. The 
Ric3-antibody was used at a concentration of 2J.Lg/ ml in combination with an anti-rabbit 
horseradish peroxidase linked secondary antibody (1 in 2000 dilution; ECL ™). To 
normalize the protein expression, monoclonal anti-P-actin antibody (Sigma Aldrich) at a 
1 in 2000 dilution was used with an anti-mouse horseradish peroxidase linked secondary 
antibody (ECL ™) also at a 1 in 2000 dilution (inserted at the bottom). 
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174.6 
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93.1 
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... ... ... ... ... ... 
Brain Kidney Lung 
Figure 3.7. Various quantities of mouse brain (50 mgl ml), kidney (75 mgl ml) and lung 
( 45 mgl ml) samples were analyzed on a 6 % SDS polyacrylamide gel and 
immunostained with the new anti-mRic-3 antibody (2 flgl ml) in conjugation with the 
anti-rabbit horseradish peroxidase linked secondary antibody (1 in 2000 dilution; ECL ™). 
This was followed by immunostaining with a monoclonal anti-~-actin antibody (Sigma 
Aldrich) at a 1 in 2000 dilution in combination with an anti-mouse horseradish 
peroxidase linked secondary antibody (ECL ™) to normalize the amounts of protein 
loaded unto the gel. M represents the molecular weight marker used (Precision Plus 
Protein™ Standards, Bio-Rad). The arrowhead indicates a faint 25 kDa band. 
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250 " .t 
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75 
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37 
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Acute Chronic 
Figure 3.8. Rat pure neuronal cortical cultures were treated for 24 hours on DIV 14 with 
plain medium (C) or with 11.25 mM KCl (K) dissolved in medium. The acute group was 
harvested directly after the 24 hours treatment whereas the chronic group was washed 
thrice with EBS and incubated for another 24 hours in plain medium before being 
harvested. Samples were analysed on a 6 % SDS polyacrylamide gel and immunostained 
with the new anti-mRic-3 antibody (2 llgl ml) in conjugation with the anti-rabbit 
secondary antibody (1 in 2000 dilution). This was followed by immunostaining with a 
monoclonal anti-~-actin antibody (1 in 2000 dilution) in combination with an anti-mouse 
secondary antibody to normalize the amounts of protein loaded unto the gel. M represents 
the molecular weight marker used (Precision Plus Protein™ Standards, Bio-Rad). 
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Figure 3.9. Mouse brains samples were harvested at 24 h, 72 h, or 168 h subsequent to in 
vivo cortical spreading depression (CSD) or sham treatment (C). 15 Jlg of murine whole 
brain samples were analysed on a 7.5 % SDS polyacrylamide gel and immunostained 
with the new anti-mRic-3 antibody (2 Jlg/ ml) in conjugation with the anti-rabbit 
secondary antibody (1 in 2000 dilution). This was followed by immunostaining with a 
monoclonal anti-P-actin antibody (1 in 2000 dilution) in combination with an anti-mouse 
secondary antibody to normalize the amounts of protein loaded unto the gel. M represents 
the molecular weight marker used (Precision Plus Protein ™ Standards, Bio-Rad). 
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3.3.4. Immunohistochemistry 
To identify the distribution of the Ric3 protein within the mouse brain, brain sections 
were subjected to immunohistochemical analyses using the new anti-mRic3 antibody. In 
addition, to confirm the results from the in vitro preconditioning experiment, the brains 
from mice subjected to 10 consecutive cortical spreading depressions were harvested at 
24 hours, 72 hours, or 168 hours post-preconditioning. These samples were analysed with 
their respective sham-operated controls. 
Figure 3.10 represent the images taken from a sham treated animal that was harvested 24 
hours post treatment. Low levels of Ric3 protein expression was detected in most regions 
ofthe brain. A high expression signal was detected in the CAl (Fig. 3.10B) and CA3 (Fig. 
3.10D) regions of the hippocampus, whereas lower levels were detected in the CA2 (Fig. 
3.10C) and CA4 (Fig. 3.10E) regions. High expression levels were also detected in the 
dentate gyrus (Fig. 3.10F), and the thalamic paraventricular nucleus (PVN) (Fig. 3.10H), 
Lower levels of Ric3 protein expression was detected in the cortex (Fig. 3.1 OJ) but with 
an increase in the perirhinal cortex (Fig. 3.10K) stretching down to the piriform cortex 
region. The hypothalamic PVN (Fig. 3.101) and surrounding areas also had higher levels 
of Ric3 protein expression. Of note is the high expression of Ric3 that was detected in the 
dorsal third ventricle ((Fig. 3.10G) and the other ventricles containing cells of the choroid 
plexus (results not shown). 
No obvious changes in gene expression were detected in the potassium chloride treated 
animals, no matter at which time point the samples were harvested (results not shown). 
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A) Composite figure spanning the hippocampal, dorsal third ventrical and thalamic 
paraventricular nucleus regions. Scale bar = 1 mm. 
·. 
B) CAl C)CA2 
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D)CA3 E)CA4 
F) Dentate Gyrus G) Dorsal Third Ventricle 
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H) Thalamic Paraventricular Nucleus I) Hypothalamic Paraventricular Nucleus 
J) Cortex K) Perirhinal Cortex 
Figure 3.10. Immunohistochemistry of a 25 J.lm coronal mouse brain sections, which was 
harvest 24 hours after sham treatment. 2 J.lg/ ml of the anti-mRic2 antibody was used in 
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conjugation with a 1 in 100 dilution of the biotinylated secondary antibody from the 
Vectastain ABC kit. Scale bar = 1 mm. 
I" 
A) Lamina IT Cortex B) Lamina II Cortex with peptide block 
Figure 3.11. Immunohistochemistry of a 25 J..lm coronal mouse brain sections, which was 
harvest 24 hours after sham treatment. 2 J..lg/ ml of the anti-mRic2 antibody was used in 
conjugation with a 1 in I 00 dilution of the biotinylated secondary antibody from the 
Vectastain ABC kit (A) and also in combination 500 J..lg/ ml peptide. Scale bar= 10 J..lm. 
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Brain Area Immunoreactivity Intensity 
Hippocampus 
CAl +++ 
CA2 ++ 
CA3 +++ 
CA4 ++ 
Dentate gyrus ++ 
Cerebral cortex 
Lamina I -
Lamina II ++ 
Lamina III (+) 
Lamina IV (+) 
Lamina V (+) 
Lamina VI (+) 
Perirhinal cortex ++ 
Piriform cortex ++ 
Thalamic paraventricular nucleus ++ 
Hypothalamic paraventricular nucleus ++ 
Ventricles 
Dorsal third ventricle +++ 
Lateral ventricle +++ 
Table 3.1. Distribution of the Ric3 protein in adult mouse brain where no staining is 
indicated by -; (+) indicates light diffuse or scattered staining; and +, ++, and +++ 
indicates increasing stained profiles. 
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3.3. Discussion 
The aim of this chapter was to develop a novel antibody for the identification of the 
mouse Ric3 protein. Ric3 has been shown to be involved in the regulation of functional 
expression of a7 nAChR and belongs to an evolutionary conserved gene family (Halevi 
et al., 2003). At least four isoforms of this protein has been detected for the human 
homolog. An NCBI homology search resulted in the detection of three complete mouse 
eDNA sequences, all much shorter than the human version but exhibiting a high sequence 
identity when compared with this homolog. 
Structural analyses of the human and the mouse homolog with the highest identity 
revealed two very similar proteins. Both proteins are predicted to contain two 
transmembrane regions although it is highly probable that the first crossing event at aa 
position 11 - 22 is a signal peptide and not a transmembrane region. The structural and 
transmembrane predictive methods portray a protein which has its first hundred amino 
acids outside the cell with the rest of the protein present within the cytoplasm. This 
agrees with other known receptor regulatory proteins e.g. the prototypical stargazin 
protein y-2, a transmembrane AMPA receptor regulatory protein (TARP) (Chen eta/., 
2000). This four-pass transmembrane protein is essential for the surface trafficking and 
synaptic targeting of AMP A receptors by binding directly to AMP A receptors - the first 
extracellular loop of stargazin associates with the glutamate-binding module in AMP A 
receptors (Tomita et a/., 2007). Similarly, engagement of the a7 nAChR by the Ric3 
protein is necessary for the functional expression of the receptor in vitro. Of great 
importance to this study is the recent paper by Ben-Ami eta/. (2005) where it was shown 
that the effects of Ric3 on the functional expression and on receptor properties, like 
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T ARPs, are mediated by the two transmembrane domains - the variable length random 
coil domain or coiled-coil domain of the C-terminal is not required. A truncated version 
of the human Ric3 protein consisting only of the two transmembrane regions was able to 
upregulate the functional expression of the Caenorhabditis elegans DEG-3/DES-2 
nAChR in oocytes. Coincidentally, it was also observed in this study that Ric3 may 
preferentially promote maturation of DEG-3-rich receptors, leading to alterations to the 
kinetics and agonist affinity of the DEG-3/DES-2 nAChR in C. elegans (Ben-Ami et al., 
2005). 
Like stargazin where phosphorylation regulate AMP A receptors in synaptic plasticity 
(Tomita et al., 2005), analyses of the Ric3 homologs revealed a single phosphorylation 
site in the mouse homolog and four phosphorylation sites in the human homolog. The 
cytoplasmic region of the mouse homolog is much shorter than that of its human 
counterpart resulting in two of the human Ric3 phosphorylation sites at aa position 273 
and 334 to fall outside the range of the mouse Ric3 protein. In addition to these two sites, 
the human Ric3 protein contains a PKC phosphorylation site at aa 178 and a protein 
kinase CK2 site at aa positions 180. The mouse Ric3 protein contains a single potential 
protein kinase CK2 phosphorylation site at aa position 179. 
Subsequent to the structural, as well as hydrophilicity and antigenicity analyses of the 
chosen mouse Ric3 protein isoforrn's sequence, a peptide was chosen for the generation 
of a polyclonal anti-rnRic3 antibody. Affinity column purification of the serum from the 
first, third and terminal bleeds resulted in modest concentrations of antibody being 
recovered. The reason for the recovery of low concentration of anti-rnRic3 antibody from 
the second bleed is unknown. Subsequent inoculations resulted in the higher generation 
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of purified anti-Ric3 antibody, as can be seen from the concentrations ofthe third and the 
terminal bleed (Chazot et al., 1992). 
The next stage of this study was to demonstrate the specificity and the sensitivity of the 
newly generated anti-mRic3 antibody. HEK 293 cells were infected with recombinant 
adenoviruses expressing transgenes (Fig. 3.6, Also see Chapter 4). Ric3 protein was 
detected in HEK 293 cells infected with SR-AdV and SI-AdV at 25 kDa. An additional 
band was detected in cells infected with SR-AdV in the absence of any u7 nAChR 
protein expression. This protein species of approximately 37 kDa is too small to indicate 
a Rid dimer but might indicate the interaction of Ric3 with another endogenous protein. 
Various concentrations of mouse brain, kidney and lung tissues were analyzed under 
reducing/ denaturing conditions. All three tissue types yielded a range of anti-mRic3 
immunoreactive species. A single prominent band was detected in the mouse brain 
sample at Mr ~56 kDa, corresponding to the band detected in Halevi et al. (2003) study, 
although the predicted size of the human Ric3 protein is only 41 kDa. The shorter mouse 
homolog has a predicted size of 25 kDa. It is possible that the prominent band in the 
mouse brain sample is a dimer, as it is known that under the reducing/ denaturing 
conditions employed it is possible for structures to retain dimeric formations e.g. 
transthyretin and many G-protein-coupled receptors (Blake et al., 1978; Kent et al., 2007). 
This is, however, improbable considering that the human isoform of Ric3 is known for it 
various isoforms; the very low levels of the monomer at 25 kDa; and taking into account 
the range of bands surrounding the ~ 56 kDa species which may indicate possible 
posttranslational modifications of the major species. Comparing the hric3 gene with the 
mouse genome identified a region on chromosome 7 that has 85 % identity with the 
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region spanning 669 bp to 1110 bp of the C-terminal of the hric3 gene. This would 
indicate that although only the eDNA for the shorter isoform of Ric3 has been cloned, it 
is possible for the longer 56 kDa isoform to be transcribed from the mouse genome. Also, 
it is possible for receptor regulatory proteins to have isoforms that differ greatly in size as 
is observed with TARPs where at least eight isoforms of various sizes have been 
identified. It has been suggested that a role for these auxiliary subunits may lie in 
dictating the unique properties of receptors in specific brain regions (Kato et a!., 2007). 
Taking into account the presence of anti-mRic3 immunoreactivity in non-a7 nAChR 
expressing tissues, it is highly probable that the possible Ric3 isoforms regulate the 
expression of other proteins e.g. 5-HT3 (Cheng eta!., 2005; Castillo eta!., 2005; Castillo 
et al., 2006). Various barely detectable bands are also visible throughout the blot but 
despite these additional and seemingly non-specific bands, the newly created anti-mRic3 
antibody is a far more informative probe when compared to the Northern blot performed 
by Halevi et al. (2003). 
An investigation was launched into the effect of cortical spreading depression on the 
expression of the Ric3 protein. Brain samples, subjected to either cortical spreading 
depression or sham treatment, were harvested at various time points post treatment: 24 h, 
72 h and 168 h. A prominent protein species was detected at approximately 50 kDa, 
taken to be a larger isoform of Ric3. Subjecting the mouse to CSD resulted in an 
approximate doubling of the Ric3 protein expression up to 72 hours subsequent to the 
CSD event. Expression levels returned to normal at 168 hours after CSD. This 
upregulation suggests that Ric3 might be required, either to directly facilitate 
cytoprotection or with the formation of proteins that do have a direct function on the 
protective mechanism. A Western blot analyses of day in vitro 14 rat pure neuronal 
131 
primary cortical cultures detected two prominent bands at Mr ~50 kDa and at Mr ~ 25 
kDa. The ~ 50 kDa species correlates with prominent band observed in the treated mouse 
brain samples of~ 50 kDa. The second species of Mr ~ 25 kDa compares favourably with 
the mouse isoform upon which the antibody is based. The prominence of this smaller 
band could be due to a number of reasons: i) this isoform is more highly expressed in rat 
than in mouse brain; ii) the artificial tissue culture environment induced the upregulation 
of this protein; or iii) the isoform has a higher expression level in primary neurons than in 
the adult brain. Treatment of the pure neuronal cells for 24 hours with potassium chloride 
had no apparent effect on the expression level of the either one of the Ric3 isoforms. This 
contradicts the in vivo results where an upregulation in protein expression was detected. 
The apparent lack of Ric3 to be upregulated in the culture system might, once again, be 
due to a number of reasons: i) there is an upregulation but it was too small to detect; ii) 
Ric3 is not only upregulated in the neuronal brain tissue but also other cells such as glia 
or other cell types that are not represented in the in vitro model; or iii) the 
preconditioning model does not elicit the same molecular changes in rat primary neurons 
as CSD does in the adult mouse brain. 
In order to identify the distribution of Ric3 within the mouse brain and to confirm the in 
vitro preconditioning results, an immunohistochemical analysis was conducted on in vivo 
sham and preconditioned brains harvested at various times post treatment. Halevi et al. 
(2003) conducted an in situ analyses of the distribution of ric-3 mRNA production in the 
mouse brain using a 0.6 kb mouse ric3 probe, which indicated that low levels of 
transcription is present throughout the brain although stronger signals were detected in 
the CAl - CA3 region in the hippocampus, the deep nuclei and the Purkinje cell layer in 
the cerebellum, and the superior colliculus. The Halevi et al. (2003) study correlates well 
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with the normal distribution of high a7 nAChR expression, the exception being the 
absence of ric3 mRNA production in the dentate gyrus- a region normally associated 
with high a7 nAChR expression (Adams et al., 2001; Gahring et al., 2005). As with the 
in situ analysis, a high level ofRic3 protein expression was detected in the CAl and CA3 
regions of the hippocampus although a clearly lower amount was detected in the CA2 
region. In this study it was observed that Ric-3 protein, in contrast to the mRNA, is 
strongly expressed in the dentate gyrus (granule and molecular layers, with clear 
evidence of interneuron labelling) in agreement with high a7 nAChR expression. This 
discrepancy between the two probing methods can be the result of either a flaw in one of 
the detection systems or the existence of a low but more stable form ric3 mRNA being 
transcribed in the dentate gyrus leading to elevated protein expression, although this latter 
explanation seems less probable. 
Aside from the hippocampal area, the anti-mRic3 antibody also identified high Ric3 
protein expression in the thalamic paraventricular nucleus (PVN) and the hypothalamic 
PVN. In addition to their respective functions as a viscerosensory input to the amygdala 
and the maintainer of homeostasis, both these regions are involved with the adaptation to 
internal or external stressors (Bhatnagar and Dallman, 1999; Spencer et al., 2004; 
Benarroch, 2005). The putative role of a7 nAChR in anxiety has been discussed in the 
introduction. It would be of interest to investigate further the role, if any, that Ric3 might 
play in anxiety. High levels of Ric3 expression was also detected in the perirhinal and 
the piriform cortex, regions where a7 nAChRs are known to play a role in visual memory 
(Hampton, 2005; Hasselmo, 2006). Of interest is the high expression of the Ric3 protein 
in choroid plexus lining of the dorsal third and lateral ventricles. It is known that although 
Ric3 is not required for the functional formation 5-HT3A receptors, it does increase the 
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surface expression of this receptor subtype (Cheng et al., 2005; Castillo et al., 2005; 
Castillo et al., 2006). Despite a7 nAChR expression not occurring in the choroid plexus, 
5-HT3 expression has been detected in this tissue (Johnson and Heinemann, 1995) -
providing a possible function for Ric3 within this tissue type. The presence of Ric3 in the 
choroid plexus might also account for the difference in Ric3 changes observed between 
the in vivo and the in vitro results subsequent to exposure to KCl, since a tissue-specific 
change in the choroid plexus would not be detected in the pure neuronal cortical culture 
system. It has been noted that CSD is capable of changing the expression of choroid 
plexus proteins, as is observed with a more than doubling of transthyretin mRNA 
production, a protein solely expressed in the choroid plexus of the brain (Personal 
communication Obrenovitch and Chazot). 
The second part of the immunohistochemical study attempted to analyse any changes in 
Ric3 distribution associated with the induction of cortical spreading depression in vivo, as 
the expression level of CSD treated brains showed an approximate doubling in expression 
level. Brain tissues harvested at 24, 72 and 168 hours post preconditioning showed no 
apparent difference in the distribution of Ric3 or any obvious changes in expression level, 
although it should be noted that immunohistochemistry is not a quantitative technique. 
In conclusion, we have developed a new anti-mRic-3 polyclonal antibody, which we have 
validated and used to define the anatomy of ric-3 expression in the mammalian brain, as 
well as studying the effect that depolarization has on the level of Ric3 protein synthesis. 
The next chapter will describe the development of a series of novel recombinant 
adenoviral constructs to be used to manipulate the expression of a7 nAChR and Ric-3 
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both in vitro and in vivo to investigate the roles of these proteins in preconditioning and 
brain function. 
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CHAPTER 4: Generation of Recombinant Adenoviruses for the Artificial 
Upregulation of Alpha 7 Nicotinic Acetylcholine Receptors 
4.1. Introduction 
A microarray analysis of mixed cortical neurons and glial cells subjected to potassium 
chloride-mediated membrane depolarisation have indicated the differential expression of 
more than 500 activity-dependent regulated genes (Li et al., 2004). Microarray analyses 
of both nicotine and ischemic treatments have yielded similar results (Zhang et al., 2001; 
Trendelenburg et al., 2001; Stenzel-Poore et al., 2003). Studying the effect that the up-
or down regulation of a specific protein has on the physiology and survival of a cell is 
complicated when using pharmacological means since any effect might be immersed or 
attenuated by the altered regulation of other genes. 
Adenovirus vectors are the viral vectors of choice for gene therapy applications (Nadeau 
and Kamen, 2003). They are naturally benign viruses able to infect a large variety of 
dividing and non-dividing cells, including neurons (Hermens and Verhaagen, 1998). 
Adenoviruses belong to the parvovirideae family and the virion is a small, non-enveloped 
particle with a spiked icosahedral morphology (Trapnell, 1993). The wildtype genome 
consists of a linear double stranded DNA molecule of approximately 36 kb in length, 
which is highly stable and undergoes rearrangement at a very low rate. As the virion is 
restricted in the volume of DNA it can accommodate, the amount of transgenes that can 
be added to the wildtype genome of the adenovirus is approximately 5 % i.e. ~ 2 kb (Bett 
et al., 1993). The first generation of adenoviruses developed for gene delivery have a 
deletion in their E1 (early gene 1) region, restricting their replication to cells naturally 
expressing this gene, e.g. HEK 293 cells. Adenoviruses retain the ability to replicate at 
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high titers in these E 1-complementing cell lines. The E 1 deletion has the added benefit of 
increasing the transgene accommodation size to approximately 5 kb (Graham and Prevec, 
1995). 
Adenoviruses have been used in various neuronal transgene studies in vivo and in vitro 
(Hermens and Verhaagen, 1998), including similar neuroprotective studies as was 
conducted in chapter 2. Tan et al. (2003) created an adenovirus containing the gene 
coding for tissue inhibitors of metalloproteinases under control of a cytomegalovirus 
(CMV) promoter. Primary hippocampal cultures infected 5 to 7 days after plating at a 
multiplicity of infection (MOl) of 100 were significantly protected against a 1 hour 300 
1-lM glutamate insult, 48 hours subsequent to the infection. This experiment was 
independently duplicated by Pi et al. (2004) using DlV 12 primary cortical neuronal 
cultures infected at a MOl of 0. 7 for three days before being submitted to a 24 hour 200 
j.lM glutamate insult. Similar neuroprotective studies were also conducted by various 
other groups, each using the adenoviral vector system as an effective means to upregulate 
their gene of interest (Tsai et al., 2007; Hester et al., 2007). 
The aim of this chapter is to create an E 1-deleted recombinant adenovirus vector 
expressing the a7 nAChR gene in neuronal cells. Any study aiming to look at the effect 
of increasing the functional expression of a protein would have to include the increase of 
any necessary function-dependent regulatory proteins. The formation of functional a7 
nAChRs requires the chaperone protein Ric3 (Halevi et al., 2002; Chapter 3). This 
dependency of functional a7 nAChRs on the presence of Ric3 necessitates the creation of 
an adenovirus for Ric3 protein production. Despite Ric3 being present in neuronal cells, 
the quantity of Ric3 present in these cells might prove to be a limiting factor for the 
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upregulation functional a7 nAChRs. For this reason and to further explore the function 
and nature of Ric3, a recombinant adenovirus expressing this protein will also be created. 
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4.2. Materials and Methods 
4.2.1. Polymerase Chain Reaction 
Polymerase chain reaction (PCR) was used to amplify the regions to be inserted into the 
genome of the adenoviral vector. All of these high fidelity reactions PCR reactions were 
carried out using TaKaRa Ex Taq™ polymerase (Life Technologies) and consisted of 10 
ng template DNA, 100 pmol of each primer (table 4.1 ), 3 !J.l 2.5 mM Deoxynucleotide 
Solution Mix (New England Biolabs), 5 !J.l 10 x TaKaRa Ex Taq™ polymerase buffer 
(250 mM TAPS pH 9.3, 500 mM KCl, 20 mM MgClz, 10 mM 2-mercaptoethanol), 5 
units (U) TaKaRa Ex Taq™ polymerase enzyme and made up to a final volume of 50 !J.l 
with ddH20. A Multi Gene II thermal cycler (Labnet) was used for the PCR reactions. 
The amplification conditions for both the reaction were as follows: 1 cycle at 94 oc for 2 
minutes; 25 cycles 93 oc for 45 seconds, annealing temperature (provided in table 4.1 for 
each reaction) for 1 minute, 72 oc for 2 minutes; 1 final elongation cycle at 72 °C for 10 
minutes. 
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Primer Oligonucleotide Sequence and Restriction Enzymes Tm°C 
Name 
The mouse a.7 nAChR gene was amplified from plasmid pCDNA5 ma.7 for construction 
ofpS7-AdV and pS7IR-AdV. Annealing temperature was set at 61 °C. 
Alpha7-5 5' TAGGTACCATGTGCGGCCGGCGGGG3' 62 
Kpnl Start Codon 
Alpha7-3 5' CTTCTCGAGTTAAGCAAAGTCTTTGGACACAGCC3' 59 
Xhol Stop Codon 
pAA V-IRES-hrGFP was used as template for the amplification of the IRES region for the 
construction ofpS7IR-AdV. Annealing temperature was set at 58 oc 
IRES for 5' AACTCGAGCCCCTCTCCCTCCCC3' 59 
Xhol 
IRES rev 5' TGTGAATTCGGTTGTGGCCATTATCATCGTG3' 57 
EcoRI 
A RIKEN plasmid (AK053760) was used for the amplification of the ric3 gene for the 
construction ofpS7IR-AdV. Annealing temperature was set at 59 °C. 
Ric3for 5' ACAGAATTCATGGCGTACTCCACGGTGCAG3' 59 
EcoRI Start Codon 
Ric3rev2 5' GTGGATCCCTAACAAGGAAGGGGCATTTTACC3 ' 59 
BamHI Stop Codon 
A RIKEN plasmid (AK053760) was used for the amplification of the ric3 gene for the 
construction of pSR-AdV. Annealing temperature was set at 59 °C. Primer Ric3for was 
used as the forward primer. 
Ric3revl 5' GTCTCGAGCTAACAAGGAAGGGGCATTTTACC 3' 59 
Xhol Stop Codon 
Table 4.1. Primer sequences and restriction enzymes employed in the amplification and 
cloning of the genes of interest. 
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4.2.2. Agarose Gel Electrophoresis 
DNA samples were analyzed by the electrophoretic separation (Thermo EC Primo TM 
Horizontal Submarine Gel Systems) of DNA in agarose gels containing 0.5 j.lg/ ml 
ethidium bromide. A 1 % agarose gel was generally used depending on the sizes of the 
fragments to be separated, using 1 % UltraPure Agarose (Invitrogen) melted in TAE 
buffer (40 mM Tris-HCl, 20 mM NaAc, 1 mM EDTA, pH 8). The samples were mixed 
with a loading buffer (1 %bromophenol blue, 1 %xylene cyanol, 1xTAE buffer, 50% 
glycerol) prior to loading on the set gel. DNA bands were separated by electrophoresis by 
placing the gel in T AE buffer and passing 100 m V through the system for approximately 
20 minutes (Electrophoresis Power Supply- EPS301; Amersham Biosciences). Results 
were visualized by UV fluorescence. 
4.2.3. Purification of Amplified DNA Fragments 
DNA fragments of interest were purified after PCR and restriction enzyme digestions via 
the GFX PCR DNA And Gel Band Purification Kit (Amersham Biosciences). 
4.2.4. Restriction Enzyme Digestion 
The restriction endonucleases that were used in the cloning procedure during the 
preparation of DNA fragments or in the characterization and identification of 
recombinant DNA plasmids were used according to the specifications of the 
manufacturers (Roche Diagnostics). 
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4.2.5. Dephosphorylation 
The digested composite expression cassette pXCXSyni-WPRE plasmid as well as the 
pS7-AdV plasmid were dephosphorylated by incubating the linearised DNA in a total 
reaction volume of 20 J ..tl in the presence of 0.5 U of shrimp alkaline phosphatase (Roche 
Diagnostics) and 2 U of 10 x dephosphorylation buffer (0.5 M Tris-HCl, 1 mM EDTA, 
pH 8.5) at 3 7 oc for 20 min. 
4.2.6. Ligation 
Ligations were carried out at 16 °C for 12 h. A 1 0: 1, ratio of insert: vector molecules was 
used in a total volume of 20 ~1, which also contained 2 U of T4 DNA ligase (Roche 
Diagnostics) and 2 U of 10 x ligation buffer (660 mM Tris-HCl, 50 mM MgC12, 10 mM 
dithio-erythritol, 10 mM ATP, pH 7 .5). 
4.2. 7. Preparation of Competent Escherichia Coli Cells 
The standard CaCh method described by Cohen et a/ (1972) was used to prepare the 
Escherichia coli (E. coli) Xll Blue competent (Stratagene) cells used in all plasmid 
transformations. 1 ml of an overnight Xl1 Blue culture was used to inoculate 100 ml 
Terrific Broth medium (47.6 g Terrific Broth and 0.8% glycerol in 1litre ddH20). Cells 
were grown at 37 °C with shaking to logarithmic (log) phase (OD550 = 0.5). The cells 
were collected by centrifugation at 5000 rpm for 5 minutes at 4 °C. The pellet was then 
gently resuspended in 50 ml of freshly made ice-cold 50 mM CaCh, centrifuged again at 
the above-mentioned conditions and resuspended in 5 ml of 50 mM CaCh. The cells 
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were kept on ice for 1 h before sterile 15% (v/v) glycerol was added and the cells frozen 
away at -80 °C. 
4.2.8. Transformation of Competent Cells 
Transformation of competent cells was performed as described by Dagert and Ehrlich 
(1979). The ligation mixture was added to 100 Jll of competent cells and allowed to 
absorb for 30 min on ice. The mixture was then subjected to a 90 second heat shock at 42 
°C and left to cool on ice for 2 min. 900 Jll Terrific Broth medium was added, followed 
by an incubation period of 1 h at 3 7 oc with shaking. Aliquots of 100 Jll were then plated 
out on Terrific Broth agar plates (1.2 %agar in Terrific Broth medium) containing 12.5 
Jlg/ml tetracycline hydrochloride (tet) and 100 Jlg/ml ampicillin (amp). Plates were then 
incubated overnight at 3 7 °C. 
4.2.9. Plasmid DNA Isolation and Purification 
The Bimboim and Doly (1979) alkaline lysis method was used for the isolation of 
plasmid DNA. Selected colonies from the agar plates were inoculated into 5 ml of 
Terrific Broth medium, containing the appropriate antibiotics (amp and tet), and grown 
for 16 h at 3 7 oc with shaking. 3 ml of each culture was harvested by bench top 
centrifugation at 15000 rpm for 1 min after which the pellets were resuspended in 100 Jll 
of solution 1 (50 mM glucose, 10 mM EDTA, 25 mM Tris, pH 8) and incubated at room 
temperature for 5 min. Cell lysis and chromosomal DNA denaturation were achieved by 
adding 200 Jll of freshly prepared alkaline-SDS buffer (0.2 N NaOH, 1 % SDS), followed 
by a 5 min incubation on ice. 150 Jll cold 3M NaAc (pH 4.8) was added resulting in the 
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reannealing of the plasmid DNA and the precipitation of the genomic DNA, proteins and 
high molecular weight RNA. After a 10 min incubation period on ice, the supernatant, 
containing the plasmid DNA, was collected after centrifugation at 15000 rpm for 10 min 
at 4 °C. Two volumes of 96 % ethanol was added to the supernatants and incubated at -
20 °C for 30 min to precipitate the plasmid DNA. This was followed by 10 min 
centrifugation at 15000 rpm and subsequent washing of the DNA pellet with 80 % 
ethanol. The clean DNA pellet was resuspended in UHQ. 
Alternatively, GenElute Plasmid Miniprep kit (Sigma-Aldrich) was used for the 
extraction of small volumes of high quality plasmid DNA or the QIAGE~ Plasmid 
Maxi kit (QIAGEN) for the extraction oflarge volumes of high quality plasmid DNA. 
4.2.10. Nucleotide Sequence Determination 
Nucleotide sequence determination was performed independently by Geneservice Ltd, 
UK. Due to the length of the a7 nAChR gene, three additional internal primers were 
required to enable the full sequence analysis of the cloned product (table 4.2) 
Primer Oligonucleotide Sequence Tm°C 
Name 
A7IntFw 5'ACCTGCGCTCAGCTCCACACTGG3' 62 
Binds at 1100 - 1122 bp and elongates towards the 3' end 
A7IntRev 5'CCTCTATAACAGTGCAGATGAACGC3' 58 
Binds at 339-363 bp and elongates towards the 5' end 
A7IntRev 5'CCAGTGTGGAGCTGAGCGCAGGT3' 62 
Binds at 1100- 1122 bp and elongates towards the 5' end 
Table 4.2. Additional primers required for the full sequencing of the mouse a7 nAChR 
gene insert of the newly created pS7-AdV. 
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4.2.11. Sequence Homology Analyses 
Nucleotide sequences were aligned and compared using the CLUSTAL X (1.81) program 
(Higgins and Sharp, 1988; Higgins et al., 1996). 
4.2.13. Subculturing of HEK 293 Cells 
Low passage ( <40) human embryonic kidney (HEK) 293 cells (Microbix Biosystems Inc., 
Toronto, Canada) were grown at 37 oc in 5 % C02 using 75 cm2 Greiner culture flasks. 
The medium consisted of 80% Dulbeccos's Minimum Eagle's Medium Nutrient Mixture 
F-12 (DMEM/F12), 10 %heat inactivated Fetal Calf Serum (FCS) (Biowest), 0.3 % (w/v) 
NaHC03, 2 % penicillin (500 IU/ ml)/ streptomycin (500 11g/ ml) solution, and 7.7 % 
ddH20, pH 7.6. Approximately every 4 days the cells reached 90% confluence and had 
to be subcultured. The used medium was removed, and the cell monolayer was washed 
with 10 ml PBS before being incubated for one minute in 2 ml trypsin-EDT A (Sigma) at 
3 7 °C. Cells were washed off the flask surface by the addition of 10 ml medium before 
being centrifuged for one minute at 1000 rpm. The cell pellet was resuspended in 12 ml 
medium and 2 ml of this suspension was added to 75 cm2 culture flasks containing 10 ml 
medium, which was then incubated at 37 oc in 5% C02. 
4.2.14. Co-Transfection 
Co-transfections to create the adenoviral particles were performed by Virapur, LLC 
(USA). 
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4.2.15. Overlaying 
Methods for the purification of recombinant adenovirus vectors were adapted from 
(Graham and Prevec, 1995). Falcon 60 mm dishes (BD Biosciences) were coated with 
poly-D-lysine (0.05 g/ l) for 1 hour, washed with sterile ddH20 and air dried. 1 ml of the 
HEK 293 cell suspension from section 4.2.13 was added to 5 ml media in the dishes and 
incubated at 37 oc in 5 % C02 for 24 hours. A 100 Jll of a dilution series of either the 
transfection medium containing the new recombinant viruses (section 4.2.14.) or the 
PBS2+/plaque (section 4.2.16) mixture was added to the cells that had reached 
approximately 80- 90 % confluency. After incubation for an additional 12 hours at 37 
oc in 5 % C02, the virus-containing medium was removed from the dishes. A sterile 37 
oc agarose/ media mixture was prepared beforehand, consisting of 5 ml lOx DMEM, 5 
ml heat inactivated FCS, 0.5 ml penicillin (500 IU/ ml)/ streptomycin (500 Jlg/ ml), 0.5 
ml glutamine (stock= 200mM in ddH20), 11.5 ml ddH20, 2.5 ml 7.5% NaHC03 and 
fmally 25 ml of 1.6% agarose/ ddH20 (SeaPlaque® Agarose, Cambrex). Each dish was 
carefully overlayed with 10 ml of this mixture and the agarose allowed to polymerise at 
room temperature, before being incubated at 3 7 oc in 5 % C02 for seven to ten days. 
Cytolytic viral plaques as observed by eye I microscopy would typically start to appear 
by day 8 post-infection. 
4.2.16. Plaque Purification 
A shortened yellow pipette tip was used to select and remove a plug of agarose 
surrounding an isolated viral plaque. The agarose plug, which contains the plaque-
forming virus, was placed in an eppendorf tube before the addition of 1 ml of sterile 
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PBS2+ (136.9 mM NaCl, 2.68 mM KCl, 4.3 mM Na2HP04, 1.4 mM KH2P04, 0.68 mM 
CaCh.2H20, 0.5 mM MgCh.6H20, pH 7.4). The cells were lysed by freezing the 
suspension in liquid nitrogen and then rapidly thawing at 37 °C in a hot water bath. This 
step was repeated three times, vortexing the solution for 1 minute in between each turn. 
Low passage HEK cells were grown in 60 mm dishes and allowed to reach 80 - 90 % 
confluency. The cells were infected with either 10 Ill of the PBS2+/plaque mixture to be 
overlayed as described in Section 4.2.15 for another round of plaque purification, or 100 
jll of the PBS2+ /plaque mixture and incubated in the 5 ml cell medium at 3 7 °C in C02 
until full cytopathic effect (CPE) was reached. 
4.2.17. Viral DNA Isolation 
DNA was isolated from 100 Ill of the virus-containing CPE medium (section 4.2.16) to 
confirm plaque identity, ensuring that only recombinant adenoviruses carrying the genes 
of interest were used for the next round of plaque purification. ViralXpress™ Nucleic 
Acid Extraction Kit (Chemicon® International) was used to extract recombinant 
adenovirus genomic DNA from the medium-containing virus. 
41.2.18. PCR Analysis of Viral Recombinants 
In order to confirm that the virus obtained was recombinant and contained the correct 
transgene of interest subsequent to every round of plaque purification, PCR analysis was 
performed. Each plaque underwent two PCR screening reactions. The first general PCR 
screening reaction was designed to detect the presence of the WPRE motif, eliminating 
the presence of any wildtype adenovirus plaques that might have formed. The second 
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reaction was specific to the transgene of interest, with genetic primers used for either a7 
nAChR, ric3, IRES (table 4.1) or EGFP (table 4.3). 
A MultiGene II thermal cycler (Labnet) with the appropriate heating/ cooling program 
was used for the PCR reactions which consisted of 1 !J.g of viral recombinant DNA 
(section 4.2.17), 100 pmol of each primer (table 4.1 and 4.3), 3 f.!l 2.5 mM 
Deoxynucleotide Solution Mix, 5 units (U) Taq DNA Polymerase in Storage Buffer A 
(Promega), 5 f.!l lOx Taq reaction buffer (Promega), 3 !J.l 250mM MgCh (Promega), and 
made up to a final volume of 50 !J.l with ddH20. The amplification conditions for both the 
reactions were as follows: 1 cycle at 94 °C for 2 minutes; 25 cycles 93 oc for 45 seconds, 
annealing temperature (provided in table 4.1 and 4.2 for each reaction) for 1 minute, 72 
oc for 2 minutes; 1 final elongation cycle at 72 oc for 10 minutes. Each PCR mix was 
electrophoresed on a 1 % agarose gel to assess the size of band produced (section 4.2.2). 
Primer Oligonucleotide Sequence and Restriction Enzymes Tm°C 
Name 
The adenoviral plaque DNA were tested for the presence of the WPRE sequence. 
Annealing temperature was set at 50 °C. 
WPREFor 5' GGGAGATCCGACTCGTCTGAGG 3' 55 
WPRERev 5'GTGAAAGATTGACTGGTATTC3' 43 
The presence of the EGFP transgene of the SG-AdV plaques were identified with the 
following primers. Annealing temperature was set at 62 oc 
GFPForl 5'CCGCATGGTGAGCAAGGGCGAGGAGC3' 62 
GFPRev 5'CTTCTCGAGCTTTACTTGTACAGCTCGTCCATGCC3' 62 
Table 4.3. Additional primer sequences required for confirming the identity of the 
recombinant adenoviruses and their transgenes. 
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4.2.19. Large Scale Adenovirus Amplification and Purification 
Low passage HEK 293 cells were seeded into a 75 cm2 tissue-culture flask (section 
4.2.13) and allowed to reach 80% confluency at 37 °C, 5 % C02• 500 j.!l of the plaque 
purified PBS2+ /plaque mix supernatant of the recombinant adenovirus that had gone 
through three sequential rounds of plaque purification and confirmation, was used to 
infect the flask. Full CPE was reached in approximately five days. Virus was liberated 
from HEK 293 cells by a freeze I thaw cycle where the cells were rapidly frozen with 
liquid nitrogen and thawed at 37 °C. Five 175 cm2 tissue-culture flasks (Greiner), each 
containing HEK 293 cells at 80 % confluency, was infected with 2 ml virus-containing 
medium from the 75 cm2 tissue-culture flask. Incubation lasted for approximately three 
days, until the cells had a swelled appearance but were not yet virally lysed. The 
supernatant and the cells were harvested and centrifuged at 1500 rpm for 10 minutes. The 
viral-infected cells were resuspended in 20 ml of supernatant before undergoing three 
freeze/ thaw cycles. Both the 150 ml supernatant and the 20 ml cellular released virus 
were used in the subsequent viral purification step utilizing the Vivapure® 
AdenoPACK™ 100 (Vivascience, Sartorius Group, USA). 
4.2.20. Recombinant Adenovirus Titration by Plaque Assay 
HEK 293 cells were grown in 60 mm dishes to approximately 80% confluency before 
being infected with a viral serial dilution (1 0 IJ.l Ad suspension in 990 IJ.l PBS2+) to 1 o-12 
of the original volume. Like a normal plaque overlay, the infection was incubated for 12 
hours in medium before being overlayed with agarose, allowed to set and before, once 
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again, being incubated at 37 °C in C02 (section 4.2.15). Plaques usually started to appear 
at day 7 and were counted by eye or by microscopy over a 6-14 day period. 
4.4.21. Recombinant Adenoviral Gene Expression in HEK 293 Cells 
HEK 293 cells that were grown to approximately 80 % confluency in 60 mm dishes were 
infected with 107 viral particles and incubated at 37 oc in 5% C02 for 48 hours. The cell 
medium was removed and the cells were harvested in 1 ml TBS with inhibitor and 
sonicated four times for 30 seconds in a sonication bath with a 1 minute incubation 
period on ice in between every sonication pulse. 1 00 J..Ll of the sample was chloroform/ 
methanol precipitated before a Western blot analysis was performed on a 6 % SDS-
polyacrylamide gel (section 2.2.7 to section 2.2.9). 
4.4.22. Recombinant Adenoviral Gene Expression in Pure Neuronal Cortical 
Cultures 
Day in vitro (D IV) 14 pure neuronal cortical cultures were prepared as in section 2.2.1. 
Cultures were infected during the DlV 7 medium change at either a multiplicity of 
infection (MOl) of 1 or 100. The MOl of 1 infections were performed on cultures that 
were grown on glass coverslips coated with poly-D-Lysine (0.05 g/ 1). Cultures were also 
prepared in poly-D-Lysine-coated 35 mm lwaki tissue culture treated dishes at the same 
density as the 24 well microplates. These dishes were infected on DlV 7 at a MOl of one 
for Western blot protein analyses (section 2.2.7 to section 2.2.9). 
150 
Pure neuronal cortical cultures grown on glass coverslips and infected on DIV 7 with 
recombinant adenovirus at a MOl of 1 (SR-AdV, SI-AdV, and 87-AdV), were also 
subjected to a-Bungarotoxin-FITC chemiluminescent staining on DIV 14, as described in 
section 2.2.1 0, to analyse the functional expression of a7 nAChR expression. 
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41.3. Results 
An adenovirus expressing the mouse alpha 7 nicotinic acetylcholine receptor ( a7 nAChR) 
(pS7-AdV) was created to study, in isolation, the importance of upregulating this protein 
for the survival of neurons without disturbing the regulation of other proteins. The 
adenovirus was created from the composite expression cassette (pXCXSynl-WPRE) 
received from Dr. James Uney (Glover eta!., 2002). The cassette contains a neuron-
specific 5' human synapsin-1 (Synl) promoter ahead of the multiple cloning site (MCS) 
into which the gene of interest is to be inserted. The expression of any gene cloned into 
the MCS region would also benefit from amplified mRNA translation due to the presence 
of the 3' woodchuck hepatitis virus posttranscriptional regulatory element (WPRE) 
before the poly-A tail. This enhancer motif has been shown to increase protein production 
by a factor of three, without the loss of promoter specificity (Glover et al., 2002). The 
promoter, the MCS, the enhancer element and the poly-A tail are all located between two 
homologous recombination sites, which are necessary for the whole region to be 
transposed into the adenoviral genome after any necessary modifications have been made. 
4.3.1. pS7-AdV 
The a7 nAChR gene was amplified using the pCDNA5 ma7 plasmid as template, a kind 
gift from Professor Lucia Sivilotti (UCL, London) (National Centre for Biotechnology 
Information accession number 790853). The gene consists of 1509 bp and was amplified 
with the primers given in table 4.1 at an annealing temperature of 61 °C. The primers 
(Alpha7-5 and Alpha7-3) were designed to incorporate a Kpnl restriction enzyme site 
directly before the ATG start codon, and a Xhol restriction enzyme site directly following 
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the translational stop codon. The multiple cloning site of pXCXSynl-WPRE was also cut 
with these two enzymes and dephosphorylated before the alpha 7 gene was directionally 
ligated into the plasmid, thereby completing the pS7-AdV vector required for the 
formation of the recombinant S7-AdV adenovirus. Competent E. coli Xll Blue cells were 
transformed with the ligation mixture and the colony forming bacterial cultures were 
screened for the presence of the recombinant plasmid by means of restriction enzyme 
digestion and agarose gel electrophoresis. The newly created plasmid construct was then 
submitted to nucleotide sequenced analysis. As can be seen in appendix A, no point 
mutations were created in the inserted gene. 
4.3.2. pSR-AdV 
The 684 bp mouse ric3 gene was amplified from a plasmid received from the RIKEN 
Genome Exploration Research Group Phase II Team and the FANTOM Consortium 
(NCBI accession number AK053760). The PCR used the Ric3for and the Ric3revl 
primers at an annealing temperature of 59 oc (table 4.1 ). An EcoRI restriction enzyme 
site was included in the forward primer and a Xhol restriction enzyme site in the reverse 
primer. The amplified fragment was digested with these. two enzymes. The composite 
expression cassette pXCXSyni-WPRE was also digested with these two enzymes and 
submitted to a subsequent dephosphorylation reaction before being ligated to the 
processed ric3 gene. The newly created recombinant plasmid, pSR-AdV, underwent the 
same processing and screening as the pS7-AdV, and the homologous sequence 
comparison is reported in appendix B. 
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4.3.3. pSI-AdV 
A bicystronic adenoviral construct was made expressing both the a7 nAChR and the ric3 
genes. This was made possible by the insertion of an internal ribosome entry site (IRES) 
between the two genes, enabling the translation of two genes from a single mRNA 
molecule. The 586 bp internal ribosome entry site (IRES) region was amplified using the 
pAA V-IRES-hrGFP plasmid vector (Stratagene) as template. The PCR utilized the 
IRESfor and the IRESrev primers at an annealing temperature of 58 oc (table 4.1). The 
IRESfor primer bound to start of the IRES motif of the pAA V-IRES-hrGFP plasmid at 
position 1528 and added a Xhoi restriction enzyme site to the 5' end of the IRES 
fragment. The IRES rev primer bound to the end of the IRES motif at position 2114 of the 
plasmid and added an EcoRI restriction enzyme site to its 3' end. A second ric3 gene was 
amplified with primers Ric3for containing the EcoRI site, and Ric3rev2 containing a 
BamHI restriction enzyme in a PCR with an annealing temperature of 59 °C. The two 
fragments were digested with their respective enzymes before being simultaneously 
ligated to the newly created pS7-AdV plasmid vector that was digested with Xhol and 
BamHI before being dephosphorylated. This ligation reaction resulted in a single plasmid 
denoted as pSI-AdV that contained the following sequence of motifs: Synl- a7nAChR-
IRES - ric3 - WPRE. Positive bacterial colonies carrying this full plasmid were selected, 
and the plasmid DNA submitted for nucleotide sequence determination of all three genes 
of interest (Appendix C). 
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4.3.4. pSG-AdV 
Plasmid DNA and the virus for an enhanced green fluorescent protein (EGFP) (pSG-AdV) 
cloned into the pXCXSynl-WPRE plasmid vector were received as a kind gift from Dr. 
James Uney (Glover et al., 2002), the sequence of which is reported in appendix D. 
155 
Homologous Rec Site 
l 
pSG-AdV 
8803bp 
/
oly-A 
/ WPRE element 
\ Homologous Rec Site 
Figure 4.1. Plasmid map of the pXCXSyni-WPRE plasmid vector (Glover eta/., 2002). 
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Figure 4.2. Plasmid map-based diagram depicting the construction of the various plasmid 
vectors using the pXCXSynl-WPRE plasmid vector (Glover eta/. , 2002) as starting point. 
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4.3.5. Adenoviral Creation, Selection and Purification 
Co-transfections to create the adenoviral particles were performed by Virapur, LLC. 
HEK 293 cells were co-transfected with the helper plasmid (pJM17) and either pS7-AdV, 
pS71R-AdV or pSR-AdV DNA. The region between the two homologous recombination 
sites (the Synl promoter, the gene of interest, the WPRE element, and the poly-A tail) 
transposed to homologously recombine with the adenoviral genome contained in the 
JM17 plasmid. The expression of the viral genes form the proteins that encapsulate the 
recombined viral genomic DNA leading to the formation of the recombinant 
adenoviruses (S7-AdV, S7IR-AdV or SR-AdV). 
The three recombinant viruses, as well as the recombinant adenovirus expressing EGFP 
(SG-AdV) were subjected to three rounds of viral plaque identification and purifications 
before a final large scale viral purification was done for each, which yielded viral 
concentrations of approximately 107 infective viral particles per 1-11. Viral DNA were 
screened after the large scale viral purification to confirm the identity of the recombinant 
adenoviruses. 
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Figure 4.3. 1 % Agarose gel electrophoresis of plaque screening and confirmation PCRs. 
All extracted plaque viral DNA was first submitted to a PCR using the WPRE motif 
primers (table 4.3) in a general screening reaction, which resulted in the amplification of 
a 564 bp region (A). The SG-AdV construct's genomic DNA was also used in a further 
screening reaction for the confirmation of the presence of the EGFP gene (B). The 
GFPForl and the GFPRev primers (table 4.3) were used in this reaction to generate a 735 
bp positive band. The S7-AdV, SR-AdV and SI-AdV recombinant adenoviruses were 
screened together using either the Alpha7-5 and Alpha7-3 primers to screen for the 
presence of the 1526 bp o.7 nAChR gene (C), the IRESfor and IRESrev primers to screen 
for the presence of the 603 bp IRES fragment (D), or the Ric3for and Ric3rev2 for the 
amplification of a present 704 bp ric3 gene (E). Lane 1 of all the gels contains the DNA 
Molecular Weight Marker III (Roche Diagnostics). 
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4.3.6. Adenoviral Infection of HEK 293 Cells and Western Blot Analysis 
The human synapsin-1 (Synl) promoter is a neuron-specific promoter, although low 
levels of non-specific expression can be detected in other cell types, e.g. HEK 293 cells. 
This trait was exploited to confirm and study the heterologous expression of both the a7 
nAChR and Ric3 proteins in a non-native environment. HEK 293 cells were infected with 
either SG-AdV, SR-AdV, SI-AdV, S7-AdV, or SR-AdV and S7-AdV simultaneously. 
The cells were harvested 48 hours post-infection, sonicated to homogenize the protein 
suspension and analysed by 6 % SDS-PAGE. Western blots were performed (Fig. 4.4A 
and 4.4B). 
The anti-mRic3 antibody developed in Chapter 3 was used to detect expression of the 
ric3 gene in HEK 293 cells infected with either SR-AdV or SI-AdV (Fig. 4.4A). Ric3 
protein expression was only detected in samples where infections with either the SR-AdV 
or the SI -AdV recombinant adenoviruses. The Ric3 protein consists of 228 amino acids 
and has a theoretical molecular weight of 24.92 kDa. A single band of approximately this 
size can be found in both the SR-AdV and SI-AdV infected HEK cell samples. The 
intensity of the SI-AdV generated band is significantly lower than that of the SR-AdV 
generated band, despite both samples being infected with approximately 107 viral 
particles. Protein quantities loaded unto the gel were also normalized with ~-actin ( ~ 42 
kDa) blotting (Fig. 4.4A). This is explained by the fact that the Ric3 protein production 
from the mRNA of the SI-AdV construct is under the control of the IRES region, which 
generally cause a ten times lower protein production than the first gene on the same 
mRNA strand, in this case the a7 nAChR (AA V Helper-Free System Introduction 
Manual, Stratagene ). 
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The specificity of the anti-mRic3 antibody is very high although three faint non-specific 
bands can be found in the SG-AdV infected HEK cells at approximate sizes of 80, 56 and 
32 kDa. An additional high intensity band of approximately 37 kDa also appears in the 
SR-AdV infected group. This protein species is, however, not present when Ric3 is co-
expressed in the bicystronic IRES-mediated vector (SI-AdV) together with a7 nAChR, or 
in the two groups where a simultaneous co-infection was performed with SR-AdV and 
S7-AdV. 
Primary antibodies targeted at the a7 nAchR protein are well known for their poor 
affinity and specificity (Herber eta/., 2004; Moser eta/., 2007; Jones and Wonnacott, 
2005). Despite this, the anti-human a7 nAChR antibody (Santa Cruz a7 # sc-5544) was 
used in Figure 4.4B for the detection a7 nAChR expression by either the S7-AdV or the 
SI-AdV recombinant constructs. The reliability of the anti-human a7 nAChR primary 
antibody in this study is probably due to the fact that the expression of a7 nAChR or any 
of its alternative splice forms are not native to HEK 293 cells (Williams et a/., 2005). The 
502 amino acid a7 nAChR peptide has a theoretical molecular weight of 56.63 kDa. A 
single protein species of this approximate size was detected in all the lanes containing a 
a7 nAChR-expressing adenovirus. Note, the same nitrocellulose membrane was used as 
in the Figure 4A, and the Ric3 immunoreactive bands can still clearly be seen at 
approximately 25 kDa. 
These two antibody studies clearly showed that the genes of interest are expressed by the 
functional recombinant adenoviral constructs, including the double gene expression by 
the bicystronic adenovirus. 
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Figure 4.4. HEK 293 cells were infected with recombinant adenoviruses. 50 J.ll of the 1 
m1 harvested cell suspension was analysed on a 6 % SDS-PAGE gel. M represents the 
molecular weight marker used (Precision Plus Protein ™ Standards, Bio-Rad), C the 
control uninfected HEK 293 cells, SG the SG-AdV infected cells, SR the SR-AdV 
infected cells, SI the bicystronic adenovirus SI-AdV infected cells, 87 the 87-AdV 
infected HEK cells, and SR+S7 the HEK cells infected with both SR-AdV and 87-AdV 
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simultaneously. The Ric3-antibody from Chapter 3 was used at a concentration of 2J.tg/ 
ml in combination with an anti-rabbit horseradish peroxidase linked secondary antibody 
(1 in 2000 dilution; ECL ™) to generate Figure 4.4A. To normalize the protein expression, 
monoclonal anti-~-actin antibody (Sigma Aldrich) at a 1 in 2000 dilution was used with 
an anti-mouse horseradish peroxidase linked secondary antibody (ECL ™) also at a 1 in 
2000 dilution (inserted at the bottom of the Figure 4.4.A). Figure 4.4B was created by 
using the rabbit polyclonal anti-a7 nAChR antibody (Santa Cruz a7 # sc-5544) (1 in 2000 
dilution) in conjugation with a mouse secondary antibody (1 in 2000 dilution). 
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4.3.7. The Effect of Recombinant Adenoviral Infections on Pure Neuronal Tissue 
Cultures 
Pure neuronal cortical cultures were infected separately with four adenoviruses, SG-AdV, 
S7-AdV, SR-AdV, SI-AdV, to determine whether increased expression of a7 nAChRs by 
itself, without pharmacological intervention, is sufficient to increase the brain's tolerance 
to ischaemia to a level similar to that achieved with potassium chloride preconditioning. 
Initially DIV 7 pure neuronal cultures grown in 35 mm dishes or on coverslips in 24 well 
microplates were infected at a MOl of 1 with the recombinant adenoviruses. The samples 
from the dishes were harvested on DIV 14 and subjected to Western blot analyses. The 
samples were first analysed with the newly developed anti-mRic3 antibody (Fig. 4.5). In 
all the samples, as in chapter 3, a prominent double species was detected at 
approximately 50 kDa and a lesser expressed species at approximately 25 kDa. In 
addition, another lesser expressed protein species was detected at approximately 75 kDa. 
Only in the SR-AdV infected cells was the faint 25 kDa species highly expressed, 
corresponding to the expected adenoviral expression of the Ric3 protein. No increase in 
Ric3 protein expression was, however, detected in the SI-AdV infected cells. The SR-
AdV infected cells also express an additional faint band of approximately 37 kDa that is 
not detected in the control or any of the other infected cells. 
Western blot analysis of infected pure neuronal cultures with the anti-GFP antibody 
resulted in the detection of a 27 kDa protein in the SG-AdV infected cells, corresponding 
to the expected protein production of EGFP (Fig. 4.6). Attempts at detecting a7 nAChR 
expression with the polyclonal anti-rabbit a7 nAChR from Santa Cruz Biotechnology (sc-
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5544) and with the anti-rabbit a7 nAChR from Abeam (ab23832), as in Chapter 2, failed 
(results not shown). Subsequently, pure neuronal cultures grown on coverslips were 
infected on DlV 7 at a MOl of 1 and analysed on DlV 14 with a-Bungarotoxin-FITC. 
Highly variable results were attained due to the use of coverslips and blind counting. An 
approximate 9.7 % increase in a-Bungarotoxin-FITC binding to functional a7 nAChR 
was detected in cells infected with the SR-AdV virus, expressing the Ric3 protein, 
whereas an approximate 13.59 % decrease in binding was detected in Sl-AdV infected 
cells. Pure neuronal cultures infected with S7-AdV had an increase in a-bungarotoxin 
bound to functional a7 nAChRs of approximately 25.7 %. Despite this increase not being 
statistically significant, the trend for the upregulation of functional a7 nAChRs in pure 
neuronal cortical cultures by infection with the S7-AdV recombinant adenovirus was 
confirmed in a subsequent experiment (results not shown). 
Subsequent to confirmation of recombinant adenovirus transgene expression in pure 
neuronal cortical cultures, DlV 7 cultures were infected at either a MOl of 1 or 100 and 
left for an additional 7 days. On DIV 14 the cultures received a 10 minute 1 mM 
glutamate insult, followed by three washes and 24 hour incubation before MTT analyses. 
As can be seen in Figure 4.8A, the one week incubation of pure neuronal cultures with 
any of the viruses at a MOl of 100 led to extensive cell death. Both the control 
recombinant adenovirus 8G-AdV and the a7 nAChR expressing recombinant virus, 87-
AdV, killed approximately 32 % of the cells. Of interest is the significant reduction in 
cell death caused by the recombinant adenoviruses expressing Ric3, SR-AdV and SI-
AdV. SR-AdV, which expresses approximately ten times more Ric3 than SI-AdV, has an 
approximate 11 % increase in cell viability when compared to the control SG-AdV 
infection and the 87-AdV infection, whereas SI-AdV has an approximate 7% increase in 
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cell viability. This could possibly indicate a neuroprotective role of Ric3 against 
adenoviral infection although it is more likely that the cells were infected at a lower MOl 
than intended, due to titration variations. 
The detrimental effect of recombinant viral infections were attenuated at a MOl of one 
with negligible cell death being observed except for the control 8G-AdV infection which 
reduced neuronal viability by approximately 16% (Fig. 4.8B). The 87-AdV recombinant 
showed similar levels of negligible cell death as 8R-AdV, contrary to the earlier proposed 
hypothesis that the Ric3 protein might be neuroprotective against the viral infection. The 
increased cellular lethality caused by 8G-AdV is once again probably due to variations in 
titration between the adenoviruses. 
Infecting pure neuronal cultures with the recombinant adenoviruses expressing the a7 
nAChR and/ or its chaperone protein Ric3 had no neuroprotective effects; on the contrary, 
upregulation of the a7 nAChR seems to increase the susceptibility of the cells to an 
excitotoxic glutamate insult. The 10 minute 1 mM glutamate insult killed approximately 
10 % of the control cells whereas the decrease in viability of MOl of 100 virally infected 
cells ranged from 31 %for the control SG-AdV infection to approximately 37% for the 
87-AdV recombinant adenovirus infection (Fig. 4.9A). At a MOl of 1 the decrease in cell 
viability after the excitotoxic insult of the virally infected cells was insignificant when 
compared to the glutamate-insulted control groups. For all the adenoviral infected cells, 
only a slight decrease in viability was observed, except for the 87-AdV infected group. In 
the latter group a highly significant (approximate 22 %) decrease was observed when 
compared to the glutamate-insulted control group. This decrease is reflected in the MOl 
of 100 virally infected culture set where cells infected with 87-AdV expressing the a7 
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nAChR resulted in an approximate 4 % decrease in cellular viability subsequent to the 
glutamate, when compared to the other virally infected cultures. It should be noted that 
the cultures in Figures 4.8B and 4.9B were prepared on poly-D-Lysine-coated glass 
coverslips - an unsuitable surface for cell attachment which resulted in cell loss during 
the wash steps and a subsequent increase in the standard errors of the experiments. 
169 
kDa ~-....-----,...,....----~~~J'~~-.,. 
250 
150 
100 
75 
50 
37 
25 
M Cl C2 SRI SR2 S71 S72 Sll SI2 SGl SG2 
Figure 4.5. Pure neuronal cortical cultures grown in 35 mm dishes at a density of 1500 
cells/ mm2 were infected on DIV 7 with either no virus (Cl and C2), SR-AdV (SRI and 
SR2), 87-AdV (871 and 872), SI-AdV (811 and 812), or SG-AdV (SGl and SG2). All 
viral infections occurred at a MOl of 1 and the cultures were harvested on DIV 14 before 
being analysed on a 6% SDS polyacrylamide gel and immunostained with the anti-mRic-
3 antibody (2 Jlg/ ml) in conjugation with the anti-rabbit secondary antibody (1 in 2000 
dilution). This was followed by immunostaining with a monoclonal anti-P-actin antibody 
(1 in 2000 dilution) in combination with an anti-mouse secondary antibody to normalize 
the amounts of protein loaded unto the gel. M represents the molecular weight marker 
used (Precision Plus Protein™ Standards, Bio-Rad). 
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Figure 4.6. Pure neuronal cortical cultures grown in 35 mm dishes at a density of 1500 
cells/ mm2 were infected on DIV 7 with either no virus (C) or SG-AdV (SG). The viral 
infection occurred at a MOl of 1 and the cultures were harvested on DIV 14 before being 
analysed on a 6 % SDS polyacrylamide gel and immunostained with the mouse 
monoclonal anti-GFP antibody (1 in 2000 dilution) (ab1218; Abeam) in conjugation with 
the anti-mouse secondary antibody (1 in 2000 dilution). This was followed by 
immunostaining with a monoclonal anti-~-actin antibody (1 in 2000 dilution) in 
combination with an anti-mouse secondary antibody to normalize the amounts of protein 
loaded unto the gel. M represents the molecular weight marker used. 
171 
C) 
c 
;; 
£ 11 ID 
~ 
u:: 
I 
c 
~ 
0 
... 
ca 
C) 
c 
::I 
ID 
b 
';;!. 
Figure 4.7. DIV 14 pure neuronal cortical cultures grown on glass coverslips were 
infected on DIV 7 with either no virus for the control, SR-AdV, SI-AdV, or S7-AdV. All 
viral infections occurred at a MOl of 1 and the cultures were washed on DIV 14 with 
PBS before being stained with a-Bungarotoxin-FITC. Five digital images were taken of 
each coverslip and submitted to independent blind counting. The average was calculated 
for each coverslip, each average representing a single n-number. Data are expressed as 
percentage of controls; the bars represent the mean ±S.E.M. A non-parametric one-way 
ANOV A statistical analyses was done with n = 6. 
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Figure 4.8. A representation of the cell death caused by the various viral infections of 
pure neuronal cultures infected on DIV 7 for 7 days at either a MOl of 100 (A) or a MOl 
of 1 (B). Cultures were washed on DIV 14 incubated for 24 hours before MTT readings 
were taken. The values represent the mean MTT produced/ absorbance. Data are 
expressed as percentage of controls; the bars represent the mean ±S.E.M from two 
independent culture experiments. A non-parametric one-way ANOVA statistical analyses 
was done with significance indicated by* P < 0.05; ** P < 0.01; *** P < 0.001. n = 12. 
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Figure 4.9. Pure neuronal cultures infected on DlV 7 for 7 days at a MOl of 100 (A) or a 
MOl of 1 (B) were subjected to a 10 minute 1 mM glutamate excitotoxic insult. The 
cultures received three immediate washes with EBS before being incubated for 24 hour 
incubation period before the MTT analyses. The glutamate lethal insult group is 
expressed as a percentage of the control whereas the virally treated group that received a 
lethal insult is expressed as a percentage of the virally treated cells that did not receive 
the glutamate insult. A t-test was used to compare the two resulting groups with the bars 
representing the mean ±S.E.M from two independent culture experiments. Significance 
indicated by *** P < 0.001. n = 12 except for B) SG-AdV+Glu and S7-AdV+Glu where 
the data comes from three independent experiments and n = 18. 
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4.4. Discussion 
The aim of this chapter was to create recombinant adenoviral vectors with which the role 
of alpha 7 nicotinic acetylcholine receptors (a7 nAChRs) in neuroprotection could be 
studied in isolation, without the interference of additional gene regulation. El-deleted 
recombinant adenoviral vectors expressing the mouse a7 nAChR and its function-
dependent chaperone protein's gene, ric3, were created for the expression of these two 
genes in neuronal cells. Despite the observation in Chapter 3 that the mouse brain does 
not express a 25 kDa Ric3 isoform, it was decided to use the truncated mouse sequence 
identified in that chapter as this was the sequence with the highest homology to the hric3 
gene. In addition, great consideration was given to the Ben-Ami eta/. (2005) study in 
which it was shown that the effects of Ric3 on the functional expression and on receptor 
properties are mediated by the two transmembrane domains and that the variable length 
random coil domain or coiled-coil domain of the C-terminal is not required. 
The probability of infecting a single cell with two different adenoviruses is, however, far 
lower than infecting a single cell with only one virus. To ensure that all the cells 
expressing the increased levels of a7 nAChRs have the necessary level of the Ric3 
chaperone protein required for a corresponding increase in functional receptor formation, 
a bicystronic adenoviral construct was also created which expressed both the genes. This 
construct was made possible by the insertion of an internal ribosome entry site (IRES) 
between the two proteins, enabling cells to produce the two proteins from a single mRNA 
transcript. The bicystronic construct is designed to overcome any obstacle of regulation 
associated with the formation of functional a7 nAChRs. The IRES region has been 
shown to function in association with the Synl promoter (Li et a/., 2005) and it has been 
175 
noted that the IRES region provides a ten fold decrease in expression of the second gene 
(ric3) than the first (a7 nAChR) of the construct (AA V Helper-Free System Introduction 
Manual, Stratagene ). The recombinant adenoviruses were created from a composite 
expression cassette containing a neuron-specific 5' human synapsin-1 (Synl) promoter, 
as well as a 3' woodchuck hepatitis virus posttranscriptional regulatory element (WPRE) 
for enhanced expression of the transgenes. A recombinant adenovirus expressing the 
enhanced green fluorescent protein (EGFP) was used as a control in this study. 
Expression of the recombinant adenoviral transgenes were confirmed by exploiting the 
transient non-specific expression of the Synl promoter in HEK 293. Ric3 protein was 
detected in HEK 293 cells infected with SR-AdV and SI-AdV at 25 kDa. An additional 
band was detected in cells infected with SR-AdV in the absence of any a7 nAChR 
protein expression. This protein species of approximately 3 7 kDa is too small to indicate 
a Ric3 dimer but might indicate the interaction of Ric3 with another endogenous protein. 
Co-infection with S7-AdV expressing the a7 nAChR protein leads to the disruption of the 
putative interaction with the unknown protein, providing evidence for an interaction 
between the Ric3 and the a7 nAChR protein. In the study by Kato et al. (2007), it was 
found that the y7 transmembrane AMP A receptor regulatory protein remains associated 
with various proteins upon electrophoretic analysis. The upregulation of Ric3 upon the 
SR-AdV infection of pure neuronal cortical cultures once again led to the formation of 
the 37 kDa protein complex, this time in the presence of the cells' native a7 nAChR 
protein. The reason for this is possibly due to the high over-expression of the Ric3 protein 
with the limited native a7 nAChR protein subunits only able to disrupt a part of Ric3 's 
interaction with yet to be identified protein. It would be interesting to identify the 
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unknown protein by coimmunoprecipitation with the Ric3 protein and proteomic analysis, 
as this would further the current understanding of the function ofRic3. 
Pure neuronal cortical cultures were infected with recombinant adenoviruses expressing 
either a7 nAChR, Ric3 or both these proteins, in an attempt to study the neuroprotective 
effect, if any, that their upregulation might have. Transgene expression and gene 
upregulation in neuronal cells were confirmed using the anti-mRic3 antibody for Ric3 
expression and a-Bungarotoxin-FITC binding for the detection of functional a7 nAChR 
upregulation. A significant increase in Ric3 protein production was detected upon 
infection with the SR-AdV virus but not for the SI-AdV viral infection. The lack of a 
detectable Ric3 protein increase for the SI-AdV infection is probably due to the ric3 gene 
in this construct being under control of the IRES region, leading to a ten times less 
expression of this gene than with the SR-AdV construct. Another possibility is that the 
cultures were infected with a very low number of SI-AdV viral particles due to the 
inaccuracy of the viral titration technique. This is supported by the lack of an increase in 
the formation of functional a7 nAChR, as detected by a-Bungarotoxin-FITC binding. As 
for the S7-AdV infection, a large increase in a-Bungarotoxin-FITC binding was detected, 
although, due to the blind counting and the necessary cultivation of the neurons on glass 
coverslips, the increase was insignificant. The trend was, however, repeated in a 
subsequent repeat of the same experiment (data not shown). 
Culture studies were complicated by the choice of the viral trans gene promoter, requiring 
long infection periods to generate sufficient transgene expression, leading to high cell 
death with increased viral infection. Glover et al. (2002) infected primary hippocampal 
cultures at a maximum MOl of 200 for seven consecutive days while studying the 
177 
fluorescence level generated by the inclusion of the WPRE element in the Syn1-EGFP 
recombinant adenoviral construct. They did not, however, report cellular death associated 
with such a high adenoviral infection for that period of time, as was noted in this study. 
Pi eta/. (2004) infected DIV 12 primary cortical cultures for 24 hours with enough viral 
particles to infect 95 % of the cells. This concentration of virus led to low levels of cell 
death. A subsequent 10-fold decrease in viral particles decreased the attained level of 
transgene expression by 30 % but with no change to virally-induced toxicity being 
observed. The Cytomegalovirus (CMV) promoter is the popular choice for transgene 
neuroprotective studies in vitro as it requires a short incubation period and low viral 
infection numbers for the generation of a sufficient quantity of target protein (Tan et al., 
2003; Pi eta/., 2004; Tsai et al., 2007; Hester et al., 2007). Glover et al. (2002) showed 
that a CMV promoter has approximately 3.5 fold higher expression of the transgene in 
cultured neurons over the same time period as the Synl promoter. The current study 
utilized the Synl promoter due to the use of the recombinant adenoviruses in subsequent 
in vivo experiments (Chapter 5). 
For the neuroprotective studies- statistically speaking- the initial effect of adenoviral-
induced cell death was nullified by expressing the glutamate lethal insult group as a 
percentage of the control, and the virally treated group that received a lethal insult as a 
percentage of the virally treated cells that did not receive the glutamate insult. There 
seem to be an increase in the susceptibility of virally infected cells to a glutamate insult. 
It is reasonable to assume that virally infected cells would be more susceptible to a 
glutamate insult as the cellular survival mechanisms are already strained by the presence 
of the virus and would be able to cope to a lesser extent with the additional glutamate 
excitotoxicity than healthy uninfected cells. This is supported by findings that a reduction 
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in the infective viral particles to cell ratio from 1 00 to 1 attenuates the level of glutamate-
mediated death seen in the adenoviral infected groups. Of interest is tendency for an 
increase in glutamate excitotoxicity subsequent to the upregulation of functional a7 
nAChRs. With a MOl 100 infection approximately 4 % more cells were killed by the 
glutamate insult in the S7-AdV infected group than in any other virally infected group. 
This additional vulnerability increases significantly to approximately 22 % at a MOl of 1. 
The increase in cell death subsequent to a7 nAChR upregulation and glutamate 
excitotoxicity from a high viral infection of a MOl of 100 to a lower viral infection of a 
MOl of 1 is due to more cells surviving subsequent to a lower infection, prior to the 
excitotoxic insult. In Chapter 2 it was observed that contrary to the Chazot et al. (2002) 
study, depolarization with KCl to induce a neuroprotective effect is associated with a 
decrease in a7 nAChRs. The tendency for cells with more functional a7 nAChRs to have 
a higher mortality subsequent to a glutamatergic insult complements the in vitro 
depolarization preconditioning model. A future study that might conclude the issue is to 
use a7 nAChR subunit antisense to down regulate the expression of this receptor 
followed by excitotoxicity studies to see if any neuroprotection is gained (Brussaard, 
1997). Unfortunately this experiment could not be performed due to financial and time 
constraints. 
In conclusion, this chapter discussed the creation and validation of three novel 
recombinant adenoviruses with which it is possible to upregulate a7 nAChR and/ or Ric3 
expression. An investigation was conducted into whether the upregulation of these 
proteins would lead to neuroprotection against an excitotoxic insult. In contradiction to 
the prediction made in the Chazot et al. (2002) study and complementing results from the 
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studies performed in Chapter 2, it was found that the upregulation of functional a7 
nAChRs leads to an increase in excitotoxic susceptibility of the neuronal cells. 
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CHAPTER 5: Overall Discussion and Future Direction 
The overall aims of this project were to investigate the role of a7 nicotinic acetylcholine 
receptors (a7 nAChRs) in depolarisation-induced preconditioning in vitro, and to develop 
novel tools and approaches to study a7 receptors in vivo. The upregulation of this 
receptor subunit is putatively reported to play a role in in vivo cortical spreading 
depression-elicited neuroprotection (Chazot et al., 2002). Addressing this concern 
required the development of a reliable in vitro preconditioning model. Initial 
preconditioning studies with potassium chloride, MK80 1 and nicotine in mixed neuronal 
and glial cell cultures were successful yet unreliable due to the heterogeneity of the 
cultures. Preconditioning in pure neuronal cortical cultures proved to be far more difficult, 
with the successfully attained effect being less pronounced than that seen with the mixed 
neuronal and glial cultures. The pure neuronal cortical cultures were, however, far more 
reliable with the very low variation and high reproducibility leading to relatively low n-
numbers being required to attain high significance. 
Potassium chloride-induced preconditioning in pure neuronal cultures was attained by 
prolonged exposure of the cells to a low concentration of this agent - an effect that 
seemed to positively correlate with cellular density and subsequent increased glutamate 
release. It was confirmed that the induction of neuroprotection in the in vitro model 
follows a similar mechanism to that seen in vivo, with tolerance generation being 
dependent upon cellular glutamate release and NMDA receptor function; blocking of the 
tolerance generation being possible with the selective NMDA receptor antagonist, 
MK801. The role of a7 nAChRs in the KCl-induced neuroprotective effect associated 
with CSD was analysed in vitro, first by blocking any possible upregulation of a7 nAChR 
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mRNA by inhibiting the activation of Ca2+-calmodulin dependent kinase II with KN-62, 
and second by directly blocking any action of a7 nAChR with the receptor-specific 
antagonist, a-bungarotoxin. Both these experiments indicated that the activity of this 
receptor subtype remains essential for the preconditioning mechanism. Quantification of 
a7 nAChRs in vitro with a-Bungarotoxin-FITC showed that, contrary to the findings of 
Chazot et al. (2002) and other various studies in which KCl treatment was shown to 
increase a7 nAChR protein expression, a decrease in the formation of functional 
homomeric a7 nAChRs was found subsequent to chronic KCl-induced preconditioning of 
pure neuronal cortical cultures. 
To further investigate changes in functional a7 nAChR formation associated with 
spreading depression, a study was made of the recently identified obligatory a7 nAChR 
chaperone protein, Ric3. This required the development of a novel antibody for the 
identification of the rodent Ric3 protein. Using this novel tool, evidence was discovered 
for a family of Ric3 related isoforms which are differentially expressed in mouse brain, 
kidney and lung tissue. A common diffuse species (Mr 50-55 kDa) was found in the 
mouse and rat brain, together with a prominent Mr 25,000 species in the rat brain, which 
was expressed at low levels in the adult mouse brain. The larger protein species is likely 
to be a rodent Ric3 isoform- a potential homolog of the major human isoform. Evidence 
was also provided for the robust association of Ric3 with an unidentified protein in 
neuronal and non-neuronal cells. This association was disrupted in the presence of a7 
nAChRs, indicting a tripartite regulatory interaction; the identity of this protein is worthy 
of future study using proteomics or yeast two-hybrid strategies. The Ric3 protein was 
found to be highly expressed in specific subfields and laminae of the mouse hippocampus 
and cerebral cortex, respectively. Notable high expression was also found in the thalamic 
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and hypothalamic paraventricular nuclei, implicating a role in emotional responses to 
stress. In this thesis, the first evidence was provided for the expression of Ric3 in the 
choroid plexus non-neuronal epithelial cells, indicating a distinct role for Ric3 
independent of a7 nAChRs, possibly for the regulation of 5HT3 receptors. Interestingly, 
in vivo spreading depression increased the expression level of Ric3, although no changes 
were detected with the in vitro KCl-preconditioned pure neuronal cortical cultures. It is 
postulated that this is due to the simplicity of the culture system, lacking in brain 
structures (e.g. choroid plexus) and cell types (eg. glia, endothelial cells). 
A human Ric3 antibody would be of great value since there has been a recent increased 
interest in Ric3 expression and receptor regulation during psychiatric disease (Severance 
and Y olken, 2007). These recent early studies have relied on mRNA analysis, however, it 
was observed that Ric3 protein expression does not necessarily correspond to mRNA 
levels. Of importance for future studies is the fact that the amino acid region used for the 
generation of the rodent Ric3 antibody is conserved within the human homolog of the 
protein, and, therefore, highly likely to cross-react with the human homolog. 
The neuroprotective role, if any, played by the isolated increased expression of either a7 
nAChRs, Ric3 or both of these proteins together was studied by the infection of pure 
neuronal cortical cultures with several newly created recombinant adenoviral vectors. 
Infection with the adenoviral constructs did not lead to any significant resultant 
neuroprotection, on the contrary, a tendency for an increase in glutamate excitotoxicity 
was observed subsequent to the upregulation of functional (calcium-permeable) a7 
nAChRs. Taking into account this tendency, the active role played by a7 nAChRs in 
KCI-induced preconditioning, as well as the decrease in the amount of cell surface a7 
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nAChRs subsequent to neuroprotective KCl treatment, it would be of interest to study the 
effect of an artificial decrease in cell surface a7 nAChRs. Such a study would be 
facilitated by the use of an antisense oligonucleotide sequence targeted to the 
translational start site of a7 nAChR mRNA (GCA TCA GCG CCC GGA) (Girod et a/., 
2000). The use of antisense oligonuclotides to induce functional deletion of ligand gated 
ion channels in vitro and in vivo has been well documented (Brussaard, 1997). DIV 7 
pure neuronal cortical culture medium could be supplemented with antisense 
oligonuclotide to a final concentration of 20 J.!M. Controls for the specificity of the 
antisense oligonucleotides would include the use of sense, missense (scrambled) and 
mismatch sequences. On DIV 14, a lethal insult can be elicited, with MTT viability 
assessment the subsequent day. Replenishment of the antisense oligonucleotides may be 
necessary and might also serve to vary the amount of cell surface a7 nAChRs at any 
given time, further elucidating the role played by a7 nAChRs in neuroprotection. 
One of the main objectives of this study was to develop tools and validated protocols to 
study the role that non-pharmacological increases in a7 nAChRs and/ or Ric3 play in 
animal emotional behaviour, subsequent to the anatomical studies reported herein. To 
date, studies have looked at the behavioral effects of a7 nAChRs knockouts and hyper 
excitable mutant a7 nAChRs, but no study has looked at the phenotypic repercussions of 
a7 nAChR upregulation in properly validated animal tests of human anxiety. As stated in 
the introduction and alluded to in the Ric-3 anatomical study, a7 nAChRs may play a role 
in anxiety behaviour. In order to perform such studies, a series of suitable novel AdV 
constructs and behavioural tests were developed. These validated novel adenoviral tools 
and fully validated behavioural tests (Appendix E) are ideal to assess the effects of a7 
and/or Ric3 upregulation upon general activity and anxiety. In fact, the full version of the 
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behavioural test is ideal to assess, in addition, learning and memory behaviours in the 
same animal ("all-in-one test"- first of its kind) (Ennaceur eta!., 2007; Ennaceur et a!., 
2008 ; Michalikova et a!., 2007). 
In conclusion, the antibody and adenoviral vectors created in this project, as well as the 
presented fmdings, will form the basis of further novel investigations into the role of a7 
nAChRs and its chaperone protein Ric3 in neuroprotection as well as behavioural 
phenotypes. As is the case with this research, the end of one project paves the way for the 
beginning of another. 
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APPENDICES 
Appendix A.l. Complete sequence ofpS7-AdV with the a7 nAChR gene highlighted in 
blue 
AATTCATCATCAATAATATACCTTATTTTGGATTGAAGCCAATATGATAATGAGGGGGTGGAGTTTGTGAC 
GTGGCGCGGGGCGTGGGAACGGGGCGGGTGACGTAGTAGTGTGGCGGAAGTGTGATGTTGCAAGTGTGGCG 
GAACACATGTAAGCGACGGATGTGGCAAAAGTGACGTTTTTGGTGTGCGCCGGTGTACACAGGAAGTGACA 
ATTTTCGCGCGGTTTTAGGCGGATGTTGTAGTAAATTTGGGCGTAACCGAGTAAGATTTGGCCATTTTCGC 
GGGAAAACTGAATAAGAGGAAGTGAAATCTGAATAATTTTGTGTTACTCATAGCGCGTAATATTTGTCTAG 
GGCCGCGGGGACTTTGACCGTTTACGTGGAGACTCGCCCAGGTGTTTTTCTCAGGTGTTTTCCGCGTTCCG 
GGTCAAAGTTGGCGTTTTATTATTATAGTCAGTCTAGCTGGTTCCATAGAGCCCACCGCATCCCCAGCATG 
CCTGCTATTGTCTTCCCAATCCTCCCCCTTGCTGTCCTGCCCCACCCCACCCCCCAGAATAGAATGACACC 
TACTCAGACAATGCGATGCAATTTCCTCATTTTATTAGGAAAGGACAGTGGGAGTGGCACCTTCCAGGGTC 
AAGGAAGGCACGGGGGAGGGGCAAACAACAGATGGCTGGCAACTAGAAGGCACAGTCGAGGCTGATCGTAC 
CGAGCTCGAATTCCAGGCGGGGAGGCGGCCCAAAGGGAGATCCGACTCGTCTGAGGGCGAAGGCGAAGACG 
CGGAAGAGGCCGCAGAGCCGGCAGCAGGCCGCGGGAAGGAAGGTCCGCTGGATTGAGGGCCGAAGGGACGT 
AGCAGAAGGACGTCCCGCGCAGAATCCAGGTGGCAACACAGGCGAGCAGCCATGGAAAGGACGTCAGCTTC 
CCCGACAACACCACGGAATTGTCAGTGCCCAACAGCCGAGCCCCTGTCCAGCAGCGGGCAAGGCAGGCGGC 
GATGAGTTCCGCCGTGGCAATAGGGAGGGGGAAAGCGAAAGTCCCGGAAAGGAGCTGACAGGTGGTGGCAA 
TGCCCCAACCAGTGGGGGTTGCGTCAGCAAACACAGTGCACACCACGCCACGTTGCCTGACAACGGGCCAC 
AACTCCTCATAAAGAGACAGCAACCAGGATTTATACAAGGAGGAGAAAATGAAAGCCATACGGGAAGCAAT 
AGCATGATACAAAGGCATTAAAGCAGCGTATCCACATAGCGTAAAAGGAGCAACATAGTTAAGAATACCAG 
TCAATCTTTCACAAATTTTGTAATCCAGAGGTTGATTGTCGACGGATCCTCTAGATGCATGCTCGAGTTAA 
GCAAAGTCTTTGGACACAGCCTCCACAAAGTTTGGGGCTGACATGAGGATGCCGATGGTGCAGATGATGGT 
AAAAACCGAAAAGGCCATGAGGCACAAGCGGTCCACCACACAGGCCGCAAACTTCCACTCACTGCAGATCA 
CCTCACTCTCATCCTGGCAGCGGAAGCGGTTGGCGATGTAGCGGACCTCCTCCAGGATCTTGGCCAGGTCG 
GGGTCCCCATCAGAGGGGTGTGTACCATGCATGAGGTGCTCATCATGTGTTGGGGAGCAGGCCAAACGACC 
ACACACGACCCCAGAGTCTGGAGTTGGGGCACAGTGCATGCCCTCCAGGCCTCGGAAGCCAATGTAGAGCA 
GGTTGCCATTGCTGGTGGGTGGCCCCGCACCTGCGCTCAGCTCCACACTGGCCAGGCTGCAGCGCCGAGGC 
TTGTGCTGACAAGCCGGCCGCACCTTGTCCTCTCCCGGCCTCTTCATGCGCAGAAACCATGCACACCAATT 
CAGAAGAATGATCCTGGTCCACTTAGGCATTTTGCCACCATCAGGGTCATGGTGGTGATATCGCAGCACAA 
TCACTGTCACGACCACTGAGAGGCCCACGATGATCATGGTGCTGGCGAAGTACTGTGCTATCAAGGGCACG 
GAATCAGATGTTGCTGGCATGATCTCAGCCACAAGCAGCATGAAGACAGTCAGAGAAAGTAAGACAGTTAT 
TCCAAGAGAGATTTTCTCTCCAGAGTCTGCAGGCAGCAAGAATACCAGCAAAGCCAGGGCTGAAATGAGCA 
CACAAGGAATGAGCAGGTTGAGGCCATAGTAGAGTGTCCTACGGCGCATGGTTACTGTGTAGGTGACATCT 
GGGTATGGCTCTTTGCAGCATTCATAGAACTTCTCATTCCTTTTGCCAGGGATTCCCATGAGATCCCATTC 
TCCATTGGGGATATAGCTGCTGATATCTGCCTCTTGCATCTGCAGGTCCAAGGACCACCCTCCATAGGACC 
AGGACCCAAACTTCAGTTTGCACTGCTGCACATCAAAAGGGAACCAGCGTACATCGATGTAGCAGGAGCTC 
TTGAATATGCCTGGAGGGAGATACTGGCAATGCCCAGATGCATTCACCAAGACGTTGGTGTGGAATGTGGC 
ATCAAAGCGTTCATCTGCACTGTTATAGAGGAGAATGTCTGGTTTCCAAATCTGGCCATCTGGAAAACGAA 
CATTTTTCACTCCGGGGTACTCAGACATGTTCCACTGCAAATAGTGATCTGTCCAAGACATTTGTAGCCAA 
ATGTTGGTGGTTAAAACTTGGTTCTTCTCATCCACATCCATGATCTGCAGGAGGCTCAGGGAGAAGTACAC 
GGTGAGCGGCTGCGAGTCGTTGGCCACCGGCCTCTCCAGCGGGTTGTAGTTCTTGACCAGCTCCTTGTACA 
GCCTCCTCTGGAACTCGCCTTGCAGGGACACGTGCAGCAGCGCCGCGGCCAGAGCCAGCCAGATGCCTCCC 
CGCCGGCCGCACATGGTACCAAGCTCTAGAGTCGACTGCGCTCTCAGGCACGACACGACTCCTCCGCTGCC 
CACCGCAGACTGAGGCAGCGCTGAGTCGCCGGCGCCGCAGCGCAGATGGTCGCGCCCGTGCCCCCCTATCT 
CGCGCCTCGCGTGGTGCGGTCCGGCTGGGCCGGCGGCGGCGCGGACGCGACCAAGGTGGCCGGGAAGGGGA 
GTTTGCGGGGGACCGGCGAGTGACGTCAGCGCGCCTTCAGTGCTGAGGCGGCGGTGGCGCGCGCCGCCAGG 
CGGGGGCGAAGGCACTGTCCGCGGTGCTGAAGCTGGCAGTGCGCACGCGCCTCGCCGCATCCTGTTTCCCC 
TCCCCCTCTCTGATAGGGGATGCGCAATTTGGGGAATGGGGGTTGGGTGCTTGTCCAGTGGGTCGGGGTCG 
GTCGTCAGGTAGGCACCCCCACCCCGCCTCATCCTGGTCCTAAAACCCACTTGCACTCATACGCAGGGCCC 
TCTGCAGCTGGCGCCATCGATACGCGTATATCTGGCCCGTACATCGCTAGANGATCTGGAAGGTGCTGAGG 
TACGATGAGACCCGCACCAGGTGCAGACCCTGCGAGTGTGGCGGTAAACATATTAGGAACCAGCCTGTGAT 
GCTGGATGTGACCGAGGAGCTGAGGCCCGATCACTTGGTGCTGGCCTGCACCCGCGCTGAGTTTGGCTCTA 
GCGATGAAGATACAGATTGAGGTACTGAAATGTGTGGGCGTGGCTTAAGGGTGGGAAAGAATATATAAGGT 
GGGGGTCTTATGTAGTTTTGTATCTGTTTTGCAGCAGCCGCCGCCGCCATGAGCACCAACTCGTTTGATGG 
AAGCATTGTGAGCTCATATTTGACAACGCGCATGCCCCCATGGGCCGGGGTGCGTCAGAATGTGATGGGCT 
-
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CCAGCATTGATGGTCGCCCCGTCCTGCCCGCAAACTCTACTACCTTGACCTACGAGACCGTGTCTGGAACG 
CCGTTGGAGACTGCAGCCTCCGCCGCCGCTTCAGCCGCTGCAGCCACCGCCCGCGGGATTGTGACTGACTT 
TGCTTTCCTGAGCCCGCTTGCAAGCAGTGCAGCTTCCCGTTCATCCGCCCGCGATGACAAGTTGACGGCTC 
TTTTGGCACAATTGGATTCTTTGACCCGGGAACTTAATGTCGTTTCTCAGCAGCTGTTGGATCTGCGCCAG 
CAGGTTTCTGCCCTGAAGGCTTCCTCCCCTCCCAATGCGGTTTAAAACATAAATAAAAAACCAGACTCTGT 
TTGGATTTGGATCAAGCAAGTGTCTTGCTGTCTTTATTTAGGGGTTTTGCGCGCGCGGTAGGCCCGGGACC 
AGCGGTCTCGGTCGTTGAGGGTCCTGTGTATTTTTTCCAGGACGTGGTAAAGGTGACTCTGGATGTTCAGA 
TACATGGGCATAAGCCCGTCTCTGGGGTGGAGGTAGCACCACTGCAGAGCTTCATGCTGCGGGGTGGTGTT 
GTAGATGATCCAGTCGTAGCAGGAGCGCTGGGCGTGGTGCCTAAAAATGTCTTTCAGTAGCAAGCTGATTG 
CCAGGGGCAGGCCCTTGGTGTAAGTGTTTACAAAGCGGTTAAGCTGGGATGGGTGCATACGTGGGGATATG 
AGATGCATCTTGGACTGTATTTTTAGGTTGGCTATGTTCCCAGCCATATCCCTCCGGGGATTCATGTTGTG 
CAGAACCACCAGCACAGTGTATCCGGTGCACTTGGGAAATTTGTCATGTAGCTTAGAAGGAAATGCGTGGA 
AGAACTTGGAGACGCCCTTGTGACCTCCAAGATTTTCCATGCATTCGTCCATAATGATGGCAATGGGCCCA 
CGGGCGGCGGCCTGGGCGAAGATATTTCTGGGATCACTAACGTCATAGTTGTGTTCCAGGATGAGATCGTC 
ATAGGCCATTTTTACAAAGCGCGGGCGGAGGGTGCCAGACTGCGGTATAATGGTTCCATCCGGCCCAGGGG 
CGTAGTTACCCTCACAGATTTGCATTTCCCACGCTTTGAGTTCAGATGGGGGGATCATGTCTACCTGCGGG 
GCGATGAAGAAAACGGTTTCCGGGGTAGGGGAGATCAGCTGGGAAGAAAGCAGGTTCCTGAGCAGCTGCGA 
CTTACCGCAGCCGGTGGGCCCGTAAATCACACCTATTACCGGGTGCAACTGGTAGTTAAGAGAGCTGCAGC 
TGCCGTCATCCCTGAGCAGGGGGGCCACTTCGTTAAGCATGTCCCTGACTCGCATGTTTTCCCTGACCAAA 
TCCGCCAGAAGGCGCTCGCCGCCCAGCGATAGCAGTTCTTGCAAGGAAGCAAAGTTTTTCAACGGTTTGAG 
ACCGTCCGCCGTAGGCATGCTTTTGAGCGTTTGACCAAGCAGTTCCAGGCGGTCCCACAGCTCGGTCACCT 
GCTCTACGGCATCTCGATCCAGCATATCTCCTCGTTTCGCGGGTTGGGGCGGCTTTCGCTGTACGGCAGTA 
GTCGGTGCTCGTCCAGACGGGCCAGGGTCATGTCTTTCCACGGGCGCAGGGTCCTCGTCAGCGTAGTCTGG 
GTCACGGTGAAGGGGTGCGCTCCGGGCTGCGCGCTGGCCAGGGTGCGCTTGAGGCTGGTCCTGCTGGTGCT 
GAAGCGCTGCCGGTCTTCGCCCTGCGCGTCGGCCAGGTAGCATTTGACCATGGTGTCATAGTCCAGCCCCT 
CCGCGGCGTGGCCCTTGGCGCGCAGCTTGCCCTTGGAGGAGGCGCCGCACGAGGGGCAGTGCAGACTTTTG 
AGGGCGTAGAGCTTGGGCGCGAGAAATACCGATTCCGGGGAGTAGGCATCCGCGCCGCAGGCCCCGCAGAC 
GGTCTCGCATTCCACGAGCCAGGTGAGCTCTGGCCGTTCGGGGTCAAAAACCAGGTTTCCCCCATGCTTTT 
TGATGCGTTTCTTACCTCTGGTTTCCATGAGCCGGTGTCCACGCTCGGTGACGAAAAGGCTGTCCGTGTCC 
CCGTATACAGACTTGAGAGGCCTGTCCTCGACCGATGCCCTTGAGAGCCTTCAACCCAGTCAGCTCCTTCC 
GGTGGGCGCGGGGCATGACTATCGTCGCCGCACTTATGACTGTCTTCTTTATCATGCAACTCGTAGGACAG 
GTGCCGGCAGCGCTCTGGGTCATTTTCGGCGAGGACCGCTTTCGCTGGAGCGCGACGATGATCGGCCTGTC 
GCTTGCGGTATTCGGAATCTTGCACGCCCTCGCTCAAGCCTTCGTCACTGGTCCCGCCACCAAACGTTTCG 
GCGAGAAGCAGGCCATTATCGCCGGCATGGCGGCCGACGCGCTGGGCTACGTCTTGCTGGCGTTCGCGACG 
CGAGGCTGGATGGCCTTCCCCATTATGATTCTTCTCGCTTCCGGCGGCATCGGGATGCCCGCGTTGCAGGC 
CATGCTGTCCAGGCAGGTAGATGACGACCATCAGGGACAGCTTCAAGGATCGCTCGCGGCTCTTACCAGCC 
TAACTTCGATCACTGGACCGCTGATCGTCACGGCGATTTATGCCGCCTCGGCGAGCACATGGAACGGGTTG 
GCATGGATTGTAGGCGCCGCCCTATACCTTGTCTGCCTCCCCGCGTTGCGTCGCGGTGCATGGAGCCGGGC 
CACCTCGACCTGAATGGAAGCCGGCGGCACCTCGCTAACGGATTCACCACTCCAAGAATTGGAGCCAATCA 
ATTCTTGCGGAGAACTGTGAATGCGCAAACCAACCCTTGGCAGAACATATCCATCGCGTCCGCCATCTCCA 
GCAGCCGCACGCGGCGCATCTCGGGCAGCGTTGGGTCCTGGCCACGGGTGCGCATGATCGTGCTCCTGTCG 
TTGAGGACCCGGCTAGGCTGGCGGGGTTGCCTTACTGGTTAGCAGAATGAATCACCGATACGCGAGCGAAC 
GTGAAGCGACTGCTGCTGCAAAACGTCTGCGACCTGAGCAACAACATGAATGGTCTTCGGTTTCCGTGTTT 
CGTAAAGTCTGGAAACGCGGAAGTCAGCGCCCTGCACCATTATGTTCCGGATCTGCATCGCAGGATGCTGC 
TGGCTACCCTGTGGAACACCTACATCTGTATTAACGAAGCGCTGGCATTGACCCTGAGTGATTTTTCTCTG 
GTCCCGCCGCATCCATACCGCCAGTTGTTTACCCTCACAACGTTCCAGTAACCGGGCATGTTCATCATCAG 
TAACCCGTATCGTGAGCATCCTCTCTCGTTTCATCGGTATCATTACCCCCATGAACAGAAATCCCCCTTAC 
ACGGAGGCATCAGTGACCAAACAGGAAAAAACCGCCCTTAACATGGCCCGCTTTATCAGAAGCCAGACATT 
AACGCTTCTGGAGAAACTCAACGAGCTGGACGCGGATGAACAGGCAGACATCTGTGAATCGCTTCACGACC 
ACGCTGATGAGCTTTACCGCAGCTGCCTCGCGCGTTTCGGTGATGACGGTGAAAACCTCTGACACATGCAG 
CTCCCGGAGACGGTCACAGCTTGTCTGTAAGCGGATGCCGGGAGCAGACAAGCCCGTCAGGGCGCGTCAGC 
GGGTGTTGGCGGGTGTCGGGGCGCAGCCATGACCCAGTCACGTAGCGATAGCGGAGTGTATACTGGCTTAA 
CTATGCGGCATCAGAGCAGATTGTACTGAGAGTGCACCATATGCGGTGTGAAATACCGCACAGATGCGTAA 
GGAGAAAATACCGCATCAGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTG 
CGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAA 
GAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATA 
GGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTA 
TAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGG 
ATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTT 
CGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTA 
TCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAA 
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CAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACA 
CTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCT 
TGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAA 
AAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTT 
AAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTT 
AAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTAT 
CTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGG 
AGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCA 
GCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTC 
TATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTG 
CTGCAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGG 
CGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAG 
TAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCG 
TAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGT 
TGCTCTTGCCCGGCGTCAACACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGG 
AAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTC 
GTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAA 
AATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTA 
TTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAA 
TAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTGACGTCTAAGAAACCATTATTATCATGACATTA 
ACCTATAAAAATAGGCGTATCACGAGGCCCTTTCGTCTTCAAG 
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Appendix A.2. CLUSTAL X (1.81) multiple sequence alignment of the a7 nAChR 
transgene ( a7Transg; blue) with its theoretical template. 
Template 
cx7Transg 
Template 
cx7Transg 
Template 
cx7Transg 
Template 
cx7Transg 
Template 
cx7Transg 
Template 
cx7Transg 
Template 
cx7Transg 
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cx7Transg 
Template 
cx7Transg 
Template 
cx7Transg 
Template 
cx7Transg 
Template 
cx7Transg 
Template 
cx7Transg 
AACATAGTTAAGAATACCAGTCAATCTTTCACAAATTTTGTAATCCAGAGGTTGATTGTC 
AACATAGTTAAGAATACCAGTCAATCTTTCACAAATTTTGTAATCCAGAGGTTGATTGTC 
************************************************************ 
GACGGATCCTCTAGATGCATGCTCGAGTTAAGCAAAGTCTTTGGACACAGCCTCCACAAA 
GACGGATCCTCTAGATGCATGCTCGAGTTAAGCAAAGTCTTTGGACACAGCCTCCACAAA 
****************************************************** ****** 
GTTTGGGGCTGACATGAGGATGCCGATGGTGCAGATGATGGTAAAAACCGAAAAGGCCAT 
GTTTGGGGCTGACATGAGGATGCCGATGGTGCAGATGATGGTAAAAACCGAAAAGGCCAT 
************************************************************ 
GAGGCACAAGCGGTCCACCACACAGGCCGCAAACTTCCACTCACTGCAGATCACCTCACT 
GAGGCACAAGCGGTCCACCACACAGGCCGCAAACTTCCACTCACTGCAGATCACCTCACT 
************************************************************ 
CTCATCCTGGCAGCGGAAGCGGTTGGCGATGTAGCGGACCTCCTCCAGGATCTTGGCCAG 
CTCATCCTGGCAGCGGAAGCGGTTGGCGATGTAGCGGACCTCCTCCAGGATCTTGGCCAG 
************************************************************ 
GTCGGGGTCCCCATCAGAGGGGTGTGTACCATGCATGAGGTGCTCATCATGTGTTGGGGA 
GTCGGGGTCCCCATCAGAGGGGTGTGTACCATGCATGAGGTGCTCATCATGTGTTGGGGA 
****************************************************** ****** 
GCAGGCCAAACGACCACACACGACCCCAGAGTCTGGAGTTGGGGCACAGTGCATGCCCTC 
GCAGGCCAAACGACCACACACGACCCCAGAGTCTGGAGTTGGGGCACAGTGCATGCCCTC 
************************************************************ 
CAGGCCTCGGAAGCCAATGTAGAGCAGGTTGCCATTGCTGGTGGGTGGCCCCGCACCTGC 
CAGGCCTCGGAAGCCAATGTAGAGCAGGTTGCCATTGCTGGTGGGTGGCCCCGCACCTGC 
************************************************************ 
GCTCAGCTCCACACTGGCCAGGCTGCAGCGCCGAGGCTTGTGCTGACAAGCCGGCCGCAC 
GCTCAGCTCCACACTGGCCAGGCTGCAGCGCCGAGGCTTGTGCTGACAAGCCGGCCGCAC 
************************************************************ 
CTTGTCCTCTCCCGGCCTCTTCATGCGCAGAAACCATGCACACCAATTCAGAAGAATGAT 
CTTGTCCTCTCCCGGCCTCTTCATGCGCAGAAACCATGCACACCAATTCAGAAGAATGAT 
************************************************************ 
CCTGGTCCACTTAGGCATTTTGCCACCATCAGGGTCATGGTGGTGATATCGCAGCACAAT 
CCTGGTCCACTTAGGCATTTTGCCACCATCAGGGTCATGGTGGTGATATCGCAGCACAAT 
************************************************************ 
CACTGTCACGACCACTGAGAGGCCCACGATGATCATGGTGCTGGCGAAGTACTGTGCTAT 
CACTGTCACGACCACTGAGAGGCCCACGATGATCATGGTGCTGGCGAAGTACTGTGCTAT 
************************************************************ 
CAAGGGCACGGAATCAGATGTTGCTGGCATGATCTCAGCCACAAGCAGCATGAAGACAGT 
CAAGGGCACGGAATCAGATGTTGCTGGCATGATCTCAGCCACAAGCAGCATGAAGACAGT 
************************************************************ 
CAGAGAAAGTAAGACAGTTATTCCAAGAGAGATTTTCTCTCCAGAGTCTGCAGGCAGCAA 
CAGAGAAAGTAAGACAGTTATTCCAAGAGAGATTTTCTCTCCAGAGTCTGCAGGCAGCAA 
************************************************************ 
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Template 
~7Transg 
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~7Transg 
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~7Transg 
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Template 
~7Transg 
Template 
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~7Transg 
Template 
~7Transg 
Template 
~7Transg 
Template 
~7Transg 
Template 
~7Transg 
GAATACCAGCAAAGCCAGGGCTGAAATGAGCACACAAGGAATGAGCAGGTTGAGGCCATA 
GAATACCAGCAAAGCCAGGGCTGAAATGAGCACACAAGGAATGAGCAGGTTGAGGCCATA 
************************************************************ 
GTAGAGTGTCCTACGGCGCATGGTTACTGTGTAGGTGACATCTGGGTATGGCTCTTTGCA 
GTAGAGTGTCCTACGGCGCATGGTTACTGTGTAGGTGACATCTGGGTATGGCTCTTTGCA 
************************************************************ 
GCATTCATAGAACTTCTCATTCCTTTTGCCAGGGATTCCCATGAGATCCCATTCTCCATT 
GCATTCATAGAACTTCTCATTCCTTTTGCCAGGGATTCCCATGAGATCCCATTCTCCATT 
************************************************************ 
GGGGATATAGCTGCTGATATCTGCCTCTTGCATCTGCAGGTCCAAGGACCACCCTCCATA 
GGGGATATAGCTGCTGATATCTGCCTCTTGCATCTGCAGGTCCAAGGACCACCCTCCATA 
************************************************************ 
GGACCAGGACCCAAACTTCAGTTTGCACTGCTGCACATCAAAAGGGAACCAGCGTACATC 
GGACCAGGACCCAAACTTCAGTTTGCACTGCTGCACATCAAAAGGGAACCAGCGTACATC 
************************************************************ 
GATGTAGCAGGAGCTCTTGAATATGCCTGGAGGGAGATACTGGCAATGCCCAGATGCATT 
GATGTAGCAGGAGCTCTTGAATATGCCTGGAGGGAGATACTGGCAATGCCCAGATGCATT 
************************************************************ 
CACCAAGACGTTGGTGTGGAATGTGGCATCAAAGCGTTCATCTGCACTGTTATAGAGGAG 
CACCAAGACGTTGGTGTGGAATGTGGCATCAAAGCGTTCATCTGCACTGTTATAGAGGAG 
************************************************************ 
AATGTCTGGTTTCCAAATCTGGCCATCTGGAAAACGAACATTTTTCACTCCGGGGTACTC 
AATGTCTGGTTTCCAAATCTGGCCATCTGGAAAACGAACATTTTTCACTCCGGGGTACTC 
************************************************************ 
AGACATGTTCCACTGCAAATAGTGATCTGTCCAAGACATTTGTAGCCAAATGTTGGTGGT 
AGACATGTTCCACTGCAAATAGTGATCTGTCCAAGACATTTGTAGCCAAATGTTGGTGGT 
************************************************************ 
TAAAACTTGGTTCTTCTCATCCACATCCATGATCTGCAGGAGGCTCAGGGAGAAGTACAC 
TAAAACTTGGTTCTTCTCATCCACATCCATGATCTGCAGGAGGCTCAGGGAGAAGTACAC 
************************************************************ 
GGTGAGCGGCTGCGAGTCGTTGGCCACCGGCCTCTCCAGCGGGTTGTAGTTCTTGACCAG 
GGTGAGCGGCTGCGAGTCGTTGGCCACCGGCCTCTCCAGCGGGTTGTAGTTCTTGACCAG 
************************************************************ 
CTCCTTGTACAGCCTCCTCTGGAACTCGCCTTGCAGGGACACGTGCAGCAGCGCCGCGGC 
CTCCTTGTACAGCCTCCTCTGGAACTCGCCTTGCAGGGACACGTGCAGCAGCGCCGCGGC 
************************************************************ 
CAGAGCCAGCCAGATGCCTCCCCGCCGGCCGCACATGGTACCAAGCTCTAGAGTCGACTG 
CAGAGCCAGCCAGATGCCTCCCCGCCGGCCGCACATGGTACCAAGCTCTAGAGTCGACTG 
************************************************************ 
CGCTCTCAGGCACGACACGACTCCTCCGCTGCCCACCGCAGACTGAGGCAGCGCTGAGTC 
CGCTCTCAGGCACGACACGACTCCTCCGCTGCCCACCGCAGACTGAGGCAGCGCTGAGTC 
************************************************************ 
GCCGGCGCCGCAGCGCAGATGGTCGCGCCCGTGCCCCCCTATCTCGCGCCTCGCGTGGT 
GCCGGCGCCGCAGCGCAGATGGTCGCGCCCGTGCCCCCCTATCTCGCGCCTCGCGTGGT 
*********************************************************** 
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Appendix B.l. Complete sequence of pSR-AdV with the ric3 gene highlighted in red 
AATTCATCATCAATAATATACCTTATTTTGGATTGAAGCCAATATGATAATGAGGGGGTGGAGTTTGTGAC 
GTGGCGCGGGGCGTGGGAACGGGGCGGGTGACGTAGTAGTGTGGCGGAAGTGTGATGTTGCAAGTGTGGCG 
GAACACATGTAAGCGACGGATGTGGCAAAAGTGACGTTTTTGGTGTGCGCCGGTGTACACAGGAAGTGACA 
ATTTTCGCGCGGTTTTAGGCGGATGTTGTAGTAAATTTGGGCGTAACCGAGTAAGATTTGGCCATTTTCGC 
GGGAAAACTGAATAAGAGGAAGTGAAATCTGAATAATTTTGTGTTACTCATAGCGCGTAATATTTGTCTAG 
GGCCGCGGGGACTTTGACCGTTTACGTGGAGACTCGCCCAGGTGTTTTTCTCAGGTGTTTTCCGCGTTCCG 
GGTCAAAGTTGGCGTTTTATTATTATAGTCAGTCTAGCTGGTTCCATAGAGCCCACCGCATCCCCAGCATG 
CCTGCTATTGTCTTCCCAATCCTCCCCCTTGCTGTCCTGCCCCACCCCACCCCCCAGAATAGAATGACACC 
TACTCAGACAATGCGATGCAATTTCCTCATTTTATTAGGAAAGGACAGTGGGAGTGGCACCTTCCAGGGTC 
AAGGAAGGCACGGGGGAGGGGCAAACAACAGATGGCTGGCAACTAGAAGGCACAGTCGAGGCTGATCGTAC 
CGAGCTCGAATTCCAGGCGGGGAGGCGGCCCAAAGGGAGATCCGACTCGTCTGAGGGCGAAGGCGAAGACG 
CGGAAGAGGCCGCAGAGCCGGCAGCAGGCCGCGGGAAGGAAGGTCCGCTGGATTGAGGGCCGAAGGGACGT 
AGCAGAAGGACGTCCCGCGCAGAATCCAGGTGGCAACACAGGCGAGCAGCCATGGAAAGGACGTCAGCTTC 
CCCGACAACACCACGGAATTGTCAGTGCCCAACAGCCGAGCCCCTGTCCAGCAGCGGGCAAGGCAGGCGGC 
GATGAGTTCCGCCGTGGCAATAGGGAGGGGGAAAGCGAAAGTCCCGGAAAGGAGCTGACAGGTGGTGGCAA 
TGCCCCAACCAGTGGGGGTTGCGTCAGCAAACACAGTGCACACCACGCCACGTTGCCTGACAACGGGCCAC 
AACTCCTCATAAAGAGACAGCAACCAGGATTTATACAAGGAGGAGAAAATGAAAGCCATACGGGAAGCAAT 
AGCATGATACAAAGGCATTAAAGCAGCGTATCCACATAGCGTAAAAGGAGCAACATAGTTAAGAATACCAG 
TCAATCTTTCACAAATTTTGTAATCCAGAGGTTGATTGTCGACGGATCCTCTAGATGCATGCTCGAGCTAA 
CAAGGAAGGGGCATTTTACCTTCCCAGTCCTCCATGTATGGGGCTTCCTCAGCTTCCTTCTCTGGAGATGT 
GTCGATGAACTTGCCTTCTTTCATGACCCTGGTGATTTCTCGGAGCTGATGCAGTAATCGTTTCTCTTGGT 
CAGAAGTCACAGCCTGTGCTCTGCTCTCACCATTAGGTCCAACTCTGTTGATTAATTTTTCCATGGCTTCT 
TCTGTCTCTTTTAGTTTTTCTTGTAGTTGAACAAGCTCAAAGTTGGTAATCTTCCTGTGGGCGTTTCCAGG 
TGGGGCAGTGGAGCAGTTCCGATCCTCTGCAGTTTTCCCCTTTGAAAGCTTAAACAAAATGTACAGTATGT 
ACAAAAAGATCCCAAAGCCATAGATTGGAATGATCTGGCCCATCAGTCCTCTTCCACTACCCCCTCCTCCA 
GCACCTCCACCTGCTCCCTTGGCCTTTGCAAAGGCCTCTGCAAGGTGAGACCTCTGGAAACGAGCCCCTGG 
TGTCTGACCATCTGAGGGTGCCGAGTGGTGATGCATCATAGGTGGAAATCGGTCCAATTTTCCTTCCGGGC 
CCGGCGGCGGCTCCGGTCGCTTCCCGCGAGACAAGAAGGCCTTGGGCAGCAGCAGCGACACGGCCAGGACG 
AGCCCCGAGGCCAGCGCCACTCTCTGCACCGTGGAGTACGCCATACTAGTGGATCCGAGCTCGGTACCAAG 
CTCTAGAGTCGACTGCGCTCTCAGGCACGACACGACTCCTCCGCTGCCCACCGCAGACTGAGGCAGCGCTG 
AGTCGCCGGCGCCGCAGCGCAGATGGTCGCGCCCGTGCCCCCCTATCTCGCGCCTCGCGTGGTGCGGTCCG 
GCTGGGCCGGCGGCGGCGCGGACGCGACCAAGGTGGCCGGGAAGGGGAGTTTGCGGGGGACCGGCGAGTGA 
CGTCAGCGCGCCTTCAGTGCTGAGGCGGCGGTGGCGCGCGCCGCCAGGCGGGGGCGAAGGCACTGTCCGCG 
GTGCTGAAGCTGGCAGTGCGCACGCGCCTCGCCGCATCCTGTTTCCCCTCCCCCTCTCTGATAGGGGATGC 
GCAATTTGGGGAATGGGGGTTGGGTGCTTGTCCAGTGGGTCGGGGTCGGTCGTCAGGTAGGCACCCCCACC 
CCGCCTCATCCTGGTCCTAAAACCCACTTGCACTCATACGCAGGGCCCTCTGCAGCTGGCGCCATCGATAC 
GCGTATATCTGGCCCGTACATCGCTAGANGATCTGGAAGGTGCTGAGGTACGATGAGACCCGCACCAGGTG 
CAGACCCTGCGAGTGTGGCGGTAAACATATTAGGAACCAGCCTGTGATGCTGGATGTGACCGAGGAGCTGA 
GGCCCGATCACTTGGTGCTGGCCTGCACCCGCGCTGAGTTTGGCTCTAGCGATGAAGATACAGATTGAGGT 
ACTGAAATGTGTGGGCGTGGCTTAAGGGTGGGAAAGAATATATAAGGTGGGGGTCTTATGTAGTTTTGTAT 
CTGTTTTGCAGCAGCCGCCGCCGCCATGAGCACCAACTCGTTTGATGGAAGCATTGTGAGCTCATATTTGA 
CAACGCGCATGCCCCCATGGGCCGGGGTGCGTCAGAATGTGATGGGCTCCAGCATTGATGGTCGCCCCGTC 
CTGCCCGCAAACTCTACTACCTTGACCTACGAGACCGTGTCTGGAACGCCGTTGGAGACTGCAGCCTCCGC 
CGCCGCTTCAGCCGCTGCAGCCACCGCCCGCGGGATTGTGACTGACTTTGCTTTCCTGAGCCCGCTTGCAA 
GCAGTGCAGCTTCCCGTTCATCCGCCCGCGATGACAAGTTGACGGCTCTTTTGGCACAATTGGATTCTTTG 
ACCCGGGAACTTAATGTCGTTTCTCAGCAGCTGTTGGATCTGCGCCAGCAGGTTTCTGCCCTGAAGGCTTC 
CTCCCCTCCCAATGCGGTTTAAAACATAAATAAAAAACCAGACTCTGTTTGGATTTGGATCAAGCAAGTGT 
CTTGCTGTCTTTATTTAGGGGTTTTGCGCGCGCGGTAGGCCCGGGACCAGCGGTCTCGGTCGTTGAGGGTC 
CTGTGTATTTTTTCCAGGACGTGGTAAAGGTGACTCTGGATGTTCAGATACATGGGCATAAGCCCGTCTCT 
GGGGTGGAGGTAGCACCACTGCAGAGCTTCATGCTGCGGGGTGGTGTTGTAGATGATCCAGTCGTAGCAGG 
AGCGCTGGGCGTGGTGCCTAAAAATGTCTTTCAGTAGCAAGCTGATTGCCAGGGGCAGGCCCTTGGTGTAA 
GTGTTTACAAAGCGGTTAAGCTGGGATGGGTGCATACGTGGGGATATGAGATGCATCTTGGACTGTATTTT 
TAGGTTGGCTATGTTCCCAGCCATATCCCTCCGGGGATTCATGTTGTGCAGAACCACCAGCACAGTGTATC 
CGGTGCACTTGGGAAATTTGTCATGTAGCTTAGAAGGAAATGCGTGGAAGAACTTGGAGACGCCCTTGTGA 
CCTCCAAGATTTTCCATGCATTCGTCCATAATGATGGCAATGGGCCCACGGGCGGCGGCCTGGGCGAAGAT 
ATTTCTGGGATCACTAACGTCATAGTTGTGTTCCAGGATGAGATCGTCATAGGCCATTTTTACAAAGCGCG 
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GGCGGAGGGTGCCAGACTGCGGTATAATGGTTCCATCCGGCCCAGGGGCGTAGTTACCCTCACAGATTTGC 
ATTTCCCACGCTTTGAGTTCAGATGGGGGGATCATGTCTACCTGCGGGGCGATGAAGAAAACGGTTTCCGG 
GGTAGGGGAGATCAGCTGGGAAGAAAGCAGGTTCCTGAGCAGCTGCGACTTACCGCAGCCGGTGGGCCCGT 
AAATCACACCTATTACCGGGTGCAACTGGTAGTTAAGAGAGCTGCAGCTGCCGTCATCCCTGAGCAGGGGG 
GCCACTTCGTTAAGCATGTCCCTGACTCGCATGTTTTCCCTGACCAAATCCGCCAGAAGGCGCTCGCCGCC 
CAGCGATAGCAGTTCTTGCAAGGAAGCAAAGTTTTTCAACGGTTTGAGACCGTCCGCCGTAGGCATGCTTT 
TGAGCGTTTGACCAAGCAGTTCCAGGCGGTCCCACAGCTCGGTCACCTGCTCTACGGCATCTCGATCCAGC 
ATATCTCCTCGTTTCGCGGGTTGGGGCGGCTTTCGCTGTACGGCAGTAGTCGGTGCTCGTCCAGACGGGCC 
AGGGTCATGTCTTTCCACGGGCGCAGGGTCCTCGTCAGCGTAGTCTGGGTCACGGTGAAGGGGTGCGCTCC 
GGGCTGCGCGCTGGCCAGGGTGCGCTTGAGGCTGGTCCTGCTGGTGCTGAAGCGCTGCCGGTCTTCGCCCT 
GCGCGTCGGCCAGGTAGCATTTGACCATGGTGTCATAGTCCAGCCCCTCCGCGGCGTGGCCCTTGGCGCGC 
AGCTTGCCCTTGGAGGAGGCGCCGCACGAGGGGCAGTGCAGACTTTTGAGGGCGTAGAGCTTGGGCGCGAG 
AAATACCGATTCCGGGGAGTAGGCATCCGCGCCGCAGGCCCCGCAGACGGTCTCGCATTCCACGAGCCAGG 
TGAGCTCTGGCCGTTCGGGGTCAAAAACCAGGTTTCCCCCATGCTTTTTGATGCGTTTCTTACCTCTGGTT 
TCCATGAGCCGGTGTCCACGCTCGGTGACGAAAAGGCTGTCCGTGTCCCCGTATACAGACTTGAGAGGCCT 
GTCCTCGACCGATGCCCTTGAGAGCCTTCAACCCAGTCAGCTCCTTCCGGTGGGCGCGGGGCATGACTATC 
GTCGCCGCACTTATGACTGTCTTCTTTATCATGCAACTCGTAGGACAGGTGCCGGCAGCGCTCTGGGTCAT 
TTTCGGCGAGGACCGCTTTCGCTGGAGCGCGACGATGATCGGCCTGTCGCTTGCGGTATTCGGAATCTTGC 
ACGCCCTCGCTCAAGCCTTCGTCACTGGTCCCGCCACCAAACGTTTCGGCGAGAAGCAGGCCATTATCGCC 
GGCATGGCGGCCGACGCGCTGGGCTACGTCTTGCTGGCGTTCGCGACGCGAGGCTGGATGGCCTTCCCCAT 
TATGATTCTTCTCGCTTCCGGCGGCATCGGGATGCCCGCGTTGCAGGCCATGCTGTCCAGGCAGGTAGATG 
ACGACCATCAGGGACAGCTTCAAGGATCGCTCGCGGCTCTTACCAGCCTAACTTCGATCACTGGACCGCTG 
ATCGTCACGGCGATTTATGCCGCCTCGGCGAGCACATGGAACGGGTTGGCATGGATTGTAGGCGCCGCCCT 
ATACCTTGTCTGCCTCCCCGCGTTGCGTCGCGGTGCATGGAGCCGGGCCACCTCGACCTGAATGGAAGCCG 
GCGGCACCTCGCTAACGGATTCACCACTCCAAGAATTGGAGCCAATCAATTCTTGCGGAGAACTGTGAATG 
CGCAAACCAACCCTTGGCAGAACATATCCATCGCGTCCGCCATCTCCAGCAGCCGCACGCGGCGCATCTCG 
GGCAGCGTTGGGTCCTGGCCACGGGTGCGCATGATCGTGCTCCTGTCGTTGAGGACCCGGCTAGGCTGGCG 
GGGTTGCCTTACTGGTTAGCAGAATGAATCACCGATACGCGAGCGAACGTGAAGCGACTGCTGCTGCAAAA 
CGTCTGCGACCTGAGCAACAACATGAATGGTCTTCGGTTTCCGTGTTTCGTAAAGTCTGGAAACGCGGAAG 
TCAGCGCCCTGCACCATTATGTTCCGGATCTGCATCGCAGGATGCTGCTGGCTACCCTGTGGAACACCTAC 
ATCTGTATTAACGAAGCGCTGGCATTGACCCTGAGTGATTTTTCTCTGGTCCCGCCGCATCCATACCGCCA 
GTTGTTTACCCTCACAACGTTCCAGTAACCGGGCATGTTCATCATCAGTAACCCGTATCGTGAGCATCCTC 
TCTCGTTTCATCGGTATCATTACCCCCATGAACAGAAATCCCCCTTACACGGAGGCATCAGTGACCAAACA 
GGAAAAAACCGCCCTTAACATGGCCCGCTTTATCAGAAGCCAGACATTAACGCTTCTGGAGAAACTCAACG 
AGCTGGACGCGGATGAACAGGCAGACATCTGTGAATCGCTTCACGACCACGCTGATGAGCTTTACCGCAGC 
TGCCTCGCGCGTTTCGGTGATGACGGTGAAAACCTCTGACACATGCAGCTCCCGGAGACGGTCACAGCTTG 
TCTGTAAGCGGATGCCGGGAGCAGACAAGCCCGTCAGGGCGCGTCAGCGGGTGTTGGCGGGTGTCGGGGCG 
CAGCCATGACCCAGTCACGTAGCGATAGCGGAGTGTATACTGGCTTAACTATGCGGCATCAGAGCAGATTG 
TACTGAGAGTGCACCATATGCGGTGTGAAATACCGCACAGATGCGTAAGGAGAAAATACCGCATCAGGCGC 
TCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTC 
AAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGC 
AAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCAT 
CACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCC 
TGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTT 
CGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAG 
CTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTC 
CAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATG 
TAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATC 
TGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGC 
TGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTT 
TGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTA 
TCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGA 
GTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTT 
CATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGT 
GCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAG 
GGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTA 
GAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTGCAGGCATCGTGGTGTCACGC 
TCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTT 
GTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCAC 
TCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGT 
GAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAACACG 
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GGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAAC 
TCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCA 
TCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAG 
GGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTATT 
GTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCC 
CGAAAAGTGCCACCTGACGTCTAAGAAACCATTATTATCATGACATTAACCTATAAAAATAGGCGTATCAC 
GAGGCCCTTTCGTCTTCAAG 
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Appendix B.2. CLUSTAL X (1.81) multiple sequence alignment of the ric3 transgene 
(ric Trans; red) with its theoretical template. 
Template 
ricTrans 
Template 
ricTrans 
Template 
ricTrans 
Template 
ricTrans 
Template 
ricTrans 
Template 
ricTrans 
Template 
ricTrans 
Template 
ricTrans 
Template 
ricTrans 
Template 
ricTrans 
Template 
ricTrans 
Template 
ricTrans 
Template 
ricTrans 
Template 
ricTrans 
AACATAGTTAAGAATACCAGTCAATCTTTCACAAATTTTGTAATCCAGAGGTTGATTGTC 
AACATAGTTAAGAATACCAGTCAATCTTTCACAAATTTTGTAATCCAGAGGTTGATTGTC 
************************************************************ 
GACGGATCCTCTAGATGCATGCTCGAGCTAACAAGGAAGGGGCATTTTACCTTCCCAGTC 
GACGGATCCTCTAGATGCATGCTCGAGCTAACAAGGAAGGGGCATTTTACCTTCCCAGTC 
************************************************************ 
CTCCATGTATGGGGCTTCCTCAGCTTCCTTCTCTGGAGATGTGTCGATGAACTTGCCTTC 
CTCCATGTATGGGGCTTCCTCAGCTTCCTTCTCTGGAGATGTGTCGATGAACTTGCCTTC 
************************************************************ 
TTTCATGACCCTGGTGATTTCTCGGAGCTGATGCAGTAATCGTTTCTCTTGGTCAGAAGT 
TTTCATGACCCTGGTGATTTCTCGGAGCTGATGCAGTAATCGTTTCTCTTGGTCAGAAGT 
************************************************************ 
CACAGCCTGTGCTCTGCTCTCACCATTAGGTCCAACTCTGTTGATTAATTTTTCCATGGC 
CACAGCCTGTGCTCTGCTCTCACCATTAGGTCCAACTCTGTTGATTAATTTTTCCATGGC 
************************************************************ 
TTCTTCTGTCTCTTTTAGTTTTTCTTGTAGTTGAACAAGCTCAAAGTTGGTAATCTTCCT 
TTCTTCTGTCTCTTTTAGTTTTTCTTGTAGTTGAACAAGCTCAAAGTTGGTAATCTTCCT 
************************************************************ 
GTGGGCGTTTCCAGGTGGGGCAGTGGAGCAGTTCCGATCCTCTGCAGTTTTCCCCTTTGA 
GTGGGCGTTTCCAGGTGGGGCAGTGGAGCAGTTCCGATCCTCTGCAGTTTTCCCCTTTGA 
************************************************************ 
AAGCTTAAACAAAATGTACAGTATGTACAAAAAGATCCCAAAGCCATAGATTGGAATGAT 
AAGCTTAAACAAAATGTACAGTATGTACAAAAAGATCCCAAAGCCATAGATTGGAATGAT 
************************************************************ 
CTGGCCCATCAGTCCTCTTCCACTACCCCCTCCTCCAGCACCTCCACCTGCTCCCTTGGC 
CTGGCCCATCAGTCCTCTTCCACTACCCCCTCCTCCAGCACCTCCACCTGCTCCCTTGGC 
************************************************************ 
CTTTGCAAAGGCCTCTGCAAGGTGAGACCTCTGGAAACGAGCCCCTGGTGTCTGACCATC 
CTTTGCAAAGGCCTCTGCAAGGTGAGACCTCTGGAAACGAGCCCCTGGTGTCTGACCATC 
************************************************************ 
TGAGGGTGCCGAGTGGTGATGCATCATAGGTGGAAATCGGTCCAATTTTCCTTCCGGGCC 
TGAGGGTGCCGAGTGGTGATGCATCATAGGTGGAAATCGGTCCAATTTTCCTTCCGGGCC 
************************************************************ 
CGGCGGCGGCTCCGGTCGCTTCCCGCGAGACAAGAAGGCCTTGGGCAGCAGCAGCGACAC 
CGGCGGCGGCTCCGGTCGCTTCCCGCGAGACAAGAAGGCCTTGGGCAGCAGCAGCGACAC 
************************************************************ 
GGCCAGGACGAGCCCCGAGGCCAGCGCCACTCTCTGCACCGTGGAGTACGCCATACTAGT 
GGCCAGGACGAGCCCCGAGGCCAGCGCCACTCTCTGCACCGTGGAGTACGCCATACTAGT 
************************************************************ 
GGATCCGAGCTCGGTACCAAGCTCTAGAGTCGACTGCGCTCTCAGGCACGACACGACTCC 
GGATCCGAGCTCGGTACCAAGCTCTAGAGTCGACTGCGCTCTCAGGCACGACACGACTCC 
************************************************************ 
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Appendix C.l. Complete sequence ofpSI-AdV with the a7 nAChR gene highlighted in 
blue, the ric3 gene in red and the IRES region in green. 
AATTCATCATCAATAATATACCTTATTTTGGATTGAAGCCAATATGATAATGAGGGGGTGGAGTTTGTGAC 
GTGGCGCGGGGCGTGGGAACGGGGCGGGTGACGTAGTAGTGTGGCGGAAGTGTGATGTTGCAAGTGTGGCG 
GAACACATGTAAGCGACGGATGTGGCAAAAGTGACGTTTTTGGTGTGCGCCGGTGTACACAGGAAGTGACA 
ATTTTCGCGCGGTTTTAGGCGGATGTTGTAGTAAATTTGGGCGTAACCGAGTAAGATTTGGCCATTTTCGC 
GGGAAAACTGAATAAGAGGAAGTGAAATCTGAATAATTTTGTGTTACTCATAGCGCGTAATATTTGTCTAG 
GGCCGCGGGGACTTTGACCGTTTACGTGGAGACTCGCCCAGGTGTTTTTCTCAGGTGTTTTCCGCGTTCCG 
GGTCAAAGTTGGCGTTTTATTATTATAGTCAGTCTAGCTGGTTCCATAGAGCCCACCGCATCCCCAGCATG 
CCTGCTATTGTCTTCCCAATCCTCCCCCTTGCTGTCCTGCCCCACCCCACCCCCCAGAATAGAATGACACC 
TACTCAGACAATGCGATGCAATTTCCTCATTTTATTAGGAAAGGACAGTGGGAGTGGCACCTTCCAGGGTC 
AAGGAAGGCACGGGGGAGGGGCAAACAACAGATGGCTGGCAACTAGAAGGCACAGTCGAGGCTGATCGTAC 
CGAGCTCGAATTCCAGGCGGGGAGGCGGCCCAAAGGGAGATCCGACTCGTCTGAGGGCGAAGGCGAAGACG 
CGGAAGAGGCCGCAGAGCCGGCAGCAGGCCGCGGGAAGGAAGGTCCGCTGGATTGAGGGCCGAAGGGACGT 
AGCAGAAGGACGTCCCGCGCAGAATCCAGGTGGCAACACAGGCGAGCAGCCATGGAAAGGACGTCAGCTTC 
CCCGACAACACCACGGAATTGTCAGTGCCCAACAGCCGAGCCCCTGTCCAGCAGCGGGCAAGGCAGGCGGC 
GATGAGTTCCGCCGTGGCAATAGGGAGGGGGAAAGCGAAAGTCCCGGAAAGGAGCTGACAGGTGGTGGCAA 
TGCCCCAACCAGTGGGGGTTGCGTCAGCAAACACAGTGCACACCACGCCACGTTGCCTGACAACGGGCCAC 
AACTCCTCATAAAGAGACAGCAACCAGGATTTATACAAGGAGGAGAAAATGAAAGCCATACGGGAAGCAAT 
AGCATGATACAAAGGCATTAAAGCAGCGTATCCACATAGCGTAAAAGGAGCAACATAGTTAAGAATACCAG 
TCAATCTTTCACAAATTTTGTAATCCAGAGGTTGATTGTCGACGGATCCCTAACAAGGAAGGGGCATTTTA 
CCTTCCCAGTCCTCCATGTATGGGGCTTCCTCAGCTTCCTTCTCTGGAGATGTGTCGATGAACTTGCCTTC 
TTTCATGACCCTGGTGATTTCTCGGAGCTGATGCAGTAATCGTTTCTCTTGGTCAGAAGTCACAGCCTGTG 
CTCTGCTCTCACCATTAGGTCCAACTCTGTTGATTAATTTTTCCATGGCTTCTTCTGTCTCTTTTAGTTTT 
TCTTGTAGTTGAACAAGCTCAAAGTTGGTAATCTTCCTGTGGGCGTTTCCAGGTGGGGCAGTGGAGCAGTT 
CCGATCCTCTGCAGTTTTCCCCTTTGAAAGCTTAAACAAAATGTACAGTATGTACAAAAAGATCCCAAAGC 
CATAGATTGGAATGATCTGGCCCATCAGTCCTCTTCCACTACCCCCTCCTCCAGCACCTCCACCTGCTCCC 
TTGGCCTTTGCAAAGGCCTCTGCAAGGTGAGACCTCTGGAAACGAGCCCCTGGTGTCTGACCATCTGAGGG 
TGCCGAGTGGTGATGCATCATAGGTGGAAATCGGTCCAATTTTCCTTCCGGGCCCGGCGGCGGCTCCGGTC 
GCTTCCCGCGAGACAAGAAGGCCTTGGGCAGCAGCAGCGACACGGCCAGGACGAGCCCCGAGGCCAGCGCC 
ACTCTCTGCACCGTGGAGTACGCCATGAATTCGGTTGTGGCCATTATCATCGTGTTTTTCAAAGGAAAACC 
ACGTCCCCGTGGTTCGGGGGGCCTAGACGTTTTTTAACCTCGACTAAACACATGTAAAGCATGTGCACCGA 
GGCCCCAGATCAGATCCCATACAATGGGGTACCTTCTGGGCATCCTTCAGCCCCTTGTTGAATACGCTTGA 
GGAGAGCCATTTGACTCTTTCCACAACTATCCAACTCACAACGTGGCACTGGGGTTGTGCCGCCTTTGCAG 
GTGTATCTTATACACGTGGCTTTTGGCCGCAGAGGCACCTGTCGCCAGGTGGGGGGTTCCGCTGCCTGCAA 
AGGGTCGCTACAGACGTTGTTTGTCTTCAAGAAGCTTCCAGAGGAACTGCTTCCTTCACGACATTCAACAG 
ACCTTGCATTCCTTTGGCGAGAGGGGAAAGACCCCTAGGAATGCTCGTCAAGAAGACAGGGCCAGGTTTCC 
GGGCCCTCACATTGCCAAAAGACGGCAATATGGTGGAAAATAACATATAGACAAACGCACACCGGCCTTAT 
TCCAAGCGGCTTCGGCCAGTAACGTTAGGGGGGGGGGAGGGAGAGGGGCTCGAGTTAAGCAAAGTCTTTGG 
ACACAGCCTCCACAAAGTTTGGGGCTGACATGAGGATGCCGATGGTGCAGATGATGGTAAAAACCGAAAAG 
GCCATGAGGCACAAGCGGTCCACCACACAGGCCGCAAACTTCCACTCACTGCAGATCACCTCACTCTCATC 
CTGGCAGCGGAAGCGGTTGGCGATGTAGCGGACCTCCTCCAGGATCTTGGCCAGGTCGGGGTCCCCATCAG 
AGGGGTGTGTACCATGCATGAGGTGCTCATCATGTGTTGGGGAGCAGGCCAAACGACCACACACGACCCCA 
GAGTCTGGAGTTGGGGCACAGTGCATGCCCTCCAGGCCTCGGAAGCCAATGTAGAGCAGGTTGCCATTGCT 
GGTGGGTGGCCCCGCACCTGCGCTCAGCTCCACACTGGCCAGGCTGCAGCGCCGAGGCTTGTGCTGACAAG 
CCGGCCGCACCTTGTCCTCTCCCGGCCTCTTCATGCGCAGAAACCATGCACACCAATTCAGAAGAATGATC 
CTGGTCCACTTAGGCATTTTGCCACCATCAGGGTCATGGTGGTGATATCGCAGCACAATCACTGTCACGAC 
CACTGAGAGGCCCACGATGATCATGGTGCTGGCGAAGTACTGTGCTATCAAGGGCACGGAATCAGATGTTG 
CTGGCATGATCTCAGCCACAAGCAGCATGAAGACAGTCAGAGAAAGTAAGACAGTTATTCCAAGAGAGATT 
TTCTCTCCAGAGTCTGCAGGCAGCAAGAATACCAGCAAAGCCAGGGCTGAAATGAGCACACAAGGAATGAG 
CAGGTTGAGGCCATAGTAGAGTGTCCTACGGCGCATGGTTACTGTGTAGGTGACATCTGGGTATGGCTCTT 
TGCAGCATTCATAGAACTTCTCATTCCTTTTGCCAGGGATTCCCATGAGATCCCATTCTCCATTGGGGATA 
TAGCTGCTGATATCTGCCTCTTGCATCTGCAGGTCCAAGGACCACCCTCCATAGGACCAGGACCCAAACTT 
CAGTTTGCACTGCTGCACATCAAAAGGGAACCAGCGTACATCGATGTAGCAGGAGCTCTTGAATATGCCTG 
GAGGGAGATACTGGCAATGCCCAGATGCATTCACCAAGACGTTGGTGTGGAATGTGGCATCAAAGCGTTCA 
TCTGCACTGTTATAGAGGAGAATGTCTGGTTTCCAAATCTGGCCATCTGGAAAACGAACATTTTTCACTCC 
GGGGTACTCAGACATGTTCCACTGCAAATAGTGATCTGTCCAAGACATTTGTAGCCAAATGTTGGTGGTTA 
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AAACTTGGTTCTTCTCATCCACATCCATGATCTGCAGGAGGCTCAGGGAGAAGTACACGGTGAGCGGCTGC 
GAGTCGTTGGCCACCGGCCTCTCCAGCGGGTTGTAGTTCTTGACCAGCTCCTTGTACAGCCTCCTCTGGAA 
CTCGCCTTGCAGGGACACGTGCAGCAGCGCCGCGGCCAGAGCCAGCCAGATGCCTCCCCGCCGGCCGCACA 
TGGTACCAAGCTCTAGAGTCGACTGCGCTCTCAGGCACGACACGACTCCTCCGCTGCCCACCGCAGACTGA 
GGCAGCGCTGAGTCGCCGGCGCCGCAGCGCAGATGGTCGCGCCCGTGCCCCCCTATCTCGCGCCTCGCGTG 
GTGCGGTCCGGCTGGGCCGGCGGCGGCGCGGACGCGACCAAGGTGGCCGGGAAGGGGAGTTTGCGGGGGAC 
CGGCGAGTGACGTCAGCGCGCCTTCAGTGCTGAGGCGGCGGTGGCGCGCGCCGCCAGGCGGGGGCGAAGGC 
ACTGTCCGCGGTGCTGAAGCTGGCAGTGCGCACGCGCCTCGCCGCATCCTGTTTCCCCTCCCCCTCTCTGA 
TAGGGGATGCGCAATTTGGGGAATGGGGGTTGGGTGCTTGTCCAGTGGGTCGGGGTCGGTCGTCAGGTAGG 
CACCCCCACCCCGCCTCATCCTGGTCCTAAAACCCACTTGCACTCATACGCAGGGCCCTCTGCAGCTGGCG 
CCATCGATACGCGTATATCTGGCCCGTACATCGCTAGANGATCTGGAAGGTGCTGAGGTACGATGAGACCC 
GCACCAGGTGCAGACCCTGCGAGTGTGGCGGTAAACATATTAGGAACCAGCCTGTGATGCTGGATGTGACC 
GAGGAGCTGAGGCCCGATCACTTGGTGCTGGCCTGCACCCGCGCTGAGTTTGGCTCTAGCGATGAAGATAC 
AGATTGAGGTACTGAAATGTGTGGGCGTGGCTTAAGGGTGGGAAAGAATATATAAGGTGGGGGTCTTATGT 
AGTTTTGTATCTGTTTTGCAGCAGCCGCCGCCGCCATGAGCACCAACTCGTTTGATGGAAGCATTGTGAGC 
TCATATTTGACAACGCGCATGCCCCCATGGGCCGGGGTGCGTCAGAATGTGATGGGCTCCAGCATTGATGG 
TCGCCCCGTCCTGCCCGCAAACTCTACTACCTTGACCTACGAGACCGTGTCTGGAACGCCGTTGGAGACTG 
CAGCCTCCGCCGCCGCTTCAGCCGCTGCAGCCACCGCCCGCGGGATTGTGACTGACTTTGCTTTCCTGAGC 
CCGCTTGCAAGCAGTGCAGCTTCCCGTTCATCCGCCCGCGATGACAAGTTGACGGCTCTTTTGGCACAATT 
GGATTCTTTGACCCGGGAACTTAATGTCGTTTCTCAGCAGCTGTTGGATCTGCGCCAGCAGGTTTCTGCCC 
TGAAGGCTTCCTCCCCTCCCAATGCGGTTTAAAACATAAATAAAAAACCAGACTCTGTTTGGATTTGGATC 
AAGCAAGTGTCTTGCTGTCTTTATTTAGGGGTTTTGCGCGCGCGGTAGGCCCGGGACCAGCGGTCTCGGTC 
GTTGAGGGTCCTGTGTATTTTTTCCAGGACGTGGTAAAGGTGACTCTGGATGTTCAGATACATGGGCATAA 
GCCCGTCTCTGGGGTGGAGGTAGCACCACTGCAGAGCTTCATGCTGCGGGGTGGTGTTGTAGATGATCCAG 
TCGTAGCAGGAGCGCTGGGCGTGGTGCCTAAAAATGTCTTTCAGTAGCAAGCTGATTGCCAGGGGCAGGCC 
CTTGGTGTAAGTGTTTACAAAGCGGTTAAGCTGGGATGGGTGCATACGTGGGGATATGAGATGCATCTTGG 
ACTGTATTTTTAGGTTGGCTATGTTCCCAGCCATATCCCTCCGGGGATTCATGTTGTGCAGAACCACCAGC 
ACAGTGTATCCGGTGCACTTGGGAAATTTGTCATGTAGCTTAGAAGGAAATGCGTGGAAGAACTTGGAGAC 
GCCCTTGTGACCTCCAAGATTTTCCATGCATTCGTCCATAATGATGGCAATGGGCCCACGGGCGGCGGCCT 
GGGCGAAGATATTTCTGGGATCACTAACGTCATAGTTGTGTTCCAGGATGAGATCGTCATAGGCCATTTTT 
ACAAAGCGCGGGCGGAGGGTGCCAGACTGCGGTATAATGGTTCCATCCGGCCCAGGGGCGTAGTTACCCTC 
ACAGATTTGCATTTCCCACGCTTTGAGTTCAGATGGGGGGATCATGTCTACCTGCGGGGCGATGAAGAAAA 
CGGTTTCCGGGGTAGGGGAGATCAGCTGGGAAGAAAGCAGGTTCCTGAGCAGCTGCGACTTACCGCAGCCG 
GTGGGCCCGTAAATCACACCTATTACCGGGTGCAACTGGTAGTTAAGAGAGCTGCAGCTGCCGTCATCCCT 
GAGCAGGGGGGCCACTTCGTTAAGCATGTCCCTGACTCGCATGTTTTCCCTGACCAAATCCGCCAGAAGGC 
GCTCGCCGCCCAGCGATAGCAGTTCTTGCAAGGAAGCAAAGTTTTTCAACGGTTTGAGACCGTCCGCCGTA 
GGCATGCTTTTGAGCGTTTGACCAAGCAGTTCCAGGCGGTCCCACAGCTCGGTCACCTGCTCTACGGCATC 
TCGATCCAGCATATCTCCTCGTTTCGCGGGTTGGGGCGGCTTTCGCTGTACGGCAGTAGTCGGTGCTCGTC 
CAGACGGGCCAGGGTCATGTCTTTCCACGGGCGCAGGGTCCTCGTCAGCGTAGTCTGGGTCACGGTGAAGG 
GGTGCGCTCCGGGCTGCGCGCTGGCCAGGGTGCGCTTGAGGCTGGTCCTGCTGGTGCTGAAGCGCTGCCGG 
TCTTCGCCCTGCGCGTCGGCCAGGTAGCATTTGACCATGGTGTCATAGTCCAGCCCCTCCGCGGCGTGGCC 
CTTGGCGCGCAGCTTGCCCTTGGAGGAGGCGCCGCACGAGGGGCAGTGCAGACTTTTGAGGGCGTAGAGCT 
TGGGCGCGAGAAATACCGATTCCGGGGAGTAGGCATCCGCGCCGCAGGCCCCGCAGACGGTCTCGCATTCC 
ACGAGCCAGGTGAGCTCTGGCCGTTCGGGGTCAAAAACCAGGTTTCCCCCATGCTTTTTGATGCGTTTCTT 
ACCTCTGGTTTCCATGAGCCGGTGTCCACGCTCGGTGACGAAAAGGCTGTCCGTGTCCCCGTATACAGACT 
TGAGAGGCCTGTCCTCGACCGATGCCCTTGAGAGCCTTCAACCCAGTCAGCTCCTTCCGGTGGGCGCGGGG 
CATGACTATCGTCGCCGCACTTATGACTGTCTTCTTTATCATGCAACTCGTAGGACAGGTGCCGGCAGCGC 
TCTGGGTCATTTTCGGCGAGGACCGCTTTCGCTGGAGCGCGACGATGATCGGCCTGTCGCTTGCGGTATTC 
GGAATCTTGCACGCCCTCGCTCAAGCCTTCGTCACTGGTCCCGCCACCAAACGTTTCGGCGAGAAGCAGGC 
CATTATCGCCGGCATGGCGGCCGACGCGCTGGGCTACGTCTTGCTGGCGTTCGCGACGCGAGGCTGGATGG 
CCTTCCCCATTATGATTCTTCTCGCTTCCGGCGGCATCGGGATGCCCGCGTTGCAGGCCATGCTGTCCAGG 
CAGGTAGATGACGACCATCAGGGACAGCTTCAAGGATCGCTCGCGGCTCTTACCAGCCTAACTTCGATCAC 
TGGACCGCTGATCGTCACGGCGATTTATGCCGCCTCGGCGAGCACATGGAACGGGTTGGCATGGATTGTAG 
GCGCCGCCCTATACCTTGTCTGCCTCCCCGCGTTGCGTCGCGGTGCATGGAGCCGGGCCACCTCGACCTGA 
ATGGAAGCCGGCGGCACCTCGCTAACGGATTCACCACTCCAAGAATTGGAGCCAATCAATTCTTGCGGAGA 
ACTGTGAATGCGCAAACCAACCCTTGGCAGAACATATCCATCGCGTCCGCCATCTCCAGCAGCCGCACGCG 
GCGCATCTCGGGCAGCGTTGGGTCCTGGCCACGGGTGCGCATGATCGTGCTCCTGTCGTTGAGGACCCGGC 
TAGGCTGGCGGGGTTGCCTTACTGGTTAGCAGAATGAATCACCGATACGCGAGCGAACGTGAAGCGACTGC 
TGCTGCAAAACGTCTGCGACCTGAGCAACAACATGAATGGTCTTCGGTTTCCGTGTTTCGTAAAGTCTGGA 
AACGCGGAAGTCAGCGCCCTGCACCATTATGTTCCGGATCTGCATCGCAGGATGCTGCTGGCTACCCTGTG 
GAACACCTACATCTGTATTAACGAAGCGCTGGCATTGACCCTGAGTGATTTTTCTCTGGTCCCGCCGCATC 
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CATACCGCCAGTTGTTTACCCTCACAACGTTCCAGTAACCGGGCATGTTCATCATCAGTAACCCGTATCGT 
GAGCATCCTCTCTCGTTTCATCGGTATCATTACCCCCATGAACAGAAATCCCCCTTACACGGAGGCATCAG 
TGACCAAACAGGAAAAAACCGCCCTTAACATGGCCCGCTTTATCAGAAGCCAGACATTAACGCTTCTGGAG 
AAACTCAACGAGCTGGACGCGGATGAACAGGCAGACATCTGTGAATCGCTTCACGACCACGCTGATGAGCT 
TTACCGCAGCTGCCTCGCGCGTTTCGGTGATGACGGTGAAAACCTCTGACACATGCAGCTCCCGGAGACGG 
TCACAGCTTGTCTGTAAGCGGATGCCGGGAGCAGACAAGCCCGTCAGGGCGCGTCAGCGGGTGTTGGCGGG 
TGTCGGGGCGCAGCCATGACCCAGTCACGTAGCGATAGCGGAGTGTATACTGGCTTAACTATGCGGCATCA 
GAGCAGATTGTACTGAGAGTGCACCATATGCGGTGTGAAATACCGCACAGATGCGTAAGGAGAAAATACCG 
CATCAGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTAT 
CAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCA 
AAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCC 
TGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGG 
CGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCC 
TTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGT 
TCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATC 
GTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGA 
GCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGT 
ATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAAC 
AAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAA 
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGT 
CATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAA 
GTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGT 
CTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATC 
TGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGC 
CAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGC 
CGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTGCAGGCATCGT 
GGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGAT 
CCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCA 
GTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTC 
TGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGG 
CGTCAACACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCG 
GGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTG 
ATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAA 
AGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTAT 
CAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCG 
CACATTTCCCCGAAAAGTGCCACCTGACGTCTAAGAAACCATTATTATCATGACATTAACCTATAAAAATA 
GGCGTATCACGAGGCCCTTTCGTCTTCAAG 
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Appendix C.2. CLUST AL X (1 .81) multiple sequence alignment of the a7 nAChR gene 
(blue), IRES region (green) and ric3 (red) transgenes (7IRTrans) with its theoretical 
template. 
Template 
7IRTra ns 
Template 
7IRTrans 
Template 
7IRTrans 
Template 
7IRTrans 
Template 
7IRTrans 
Template 
7IRTrans 
Template 
7IRTrans 
Template 
7IRTrans 
Template 
7IRTrans 
Template 
7IRTrans 
Template 
7IRTrans 
Template 
7IRTrans 
Template 
7IRTrans 
AACATAGTTAAGAATACCAGTCAATCTTTCACAAATTTTGTAATCCAGAGGTTGATTGTC 
AACATAGTTAAGAATACCAGTCAATCTTTCACAAATTTTGTAATCCAGAGGTTGATTGTC 
************************************************************ 
GACGGATCCCTAACAAGGAAGGGGCATTTTACCTTCCCAGTCCTCCATGTATGGGGCTTC 
GACGGATCCCTAACAAGGAAGGGGCATTTTACCTTCCCAGTCCTCCATGTATGGGGCTTC 
************************************************************ 
CTCAGCTTCCTTCTCTGGAGATGTGTCGATGAACTTGCCTTCTTTCATGACCCTGGTGAT 
CTCAGCTTCCTTCTCTGGAGATGTGTCGATGAACTTGCCTTCTTTCATGACCCTGGTGAT 
************************************************************ 
TTCTCGGAGCTGATGCAGTAATCGTTTCTCTTGGTCAGAAGTCACAGCCTGTGCTCTGCT 
TTCTCGGAGCTGATGCAGTAATCGTTTCTCTTGGTCAGAAGTCACAGCCTGTGCTCTGCT 
************************************************************ 
CTCACCATTAGGTCCAACTCTGTTGATTAATTTTTCCATGGCTTCTTCTGTCTCTTTTAG 
CTCACCATTAGGTCCAACTCTGTTGATTAATTTTTCCATGGCTTCTTCTGTCTCTTTTAG 
************************************************************ 
TTTTTCTTGTAGTTGAACAAGCTCAAAGTTGGTAATCTTCCTGTGGGCGTTTCCAGGTGG 
TTTTTCTTGTAGTTGAACAAGCTCAAAGTTGGTAATCTTCCTGTGGGCGTTTCCAGGTGG 
************************************************************ 
GGCAGTGGAGCAGTTCCGATCCTCTGCAGTTTTCCCCTTTGAAAGCTTAAACAAAATGTA 
GGCAGTGGAGCAGTTCCGATCCTCTGCAGTTTTCCCCTTTGAAAGCTTAAACAAAATGTA 
************************************************************ 
CAGTATGTACAAAAAGATCCCAAAGCCATAGATTGGAATGATCTGGCCCATCAGTCCTCT 
CAGTATGTACAAAAAGATCCCAAAGCCATAGATTGGAATGATCTGGCCCATCAGTCCTCT 
************************************************************ 
TCCACTACCCCCTCCTCCAGCACCTCCACCTGCTCCCTTGGCCTTTGCAAAGGCCTCTGC 
TCCACTACCCCCTCCTCCAGCACCTCCACCTGCTCCCTTGGCCTTTGCAAAGGCCTCTGC 
************************************************************ 
AAGGTGAGACCTCTGGAAACGAGCCCCTGGTGTCTGACCATCTGAGGGTGCCGAGTGGTG 
AAGGTGAGACCTCTGGAAACGAGCCCCTGGTGTCTGACCATCTGAGGGTGCCGAGTGGTG 
************************************************************ 
ATGCATCATAGGTGGAAATCGGTCCAATTTTCCTTCCGGGCCCGGCGGCGGCTCCGGTCG 
ATGCATCATAGGTGGAAATCGGTCCAATTTTCCTTCCGGGCCCGGCGGCGGCTCCGGTCG 
************************************************************ 
CTTCCCGCGAGACAAGAAGGCCTTGGGCAGCAGCAGCGACACGGCCAGGACGAGCCCCGA 
CTTCCCGCGAGACAAGAAGGCCTTGGGCAGCAGCAGCGACACGGCCAGGACGAGCCCCGA 
************************************************************ 
GGCCAGCGCCACTCTCTGCACCGTGGAGTACGCCATGAATTCGGTTGTGGCCATTATCAT 
GGCCAGCGCCACTCTCTGCACCGTGGAGTACGCCATGAATTCGGTTGTGGCCATTATCAT 
************************************************************ 
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Template 
7IRTrans 
Template 
7IRTrans 
Template 
7IRTrans 
Template 
7IRTrans 
Template 
7IRTrans 
Template 
7IRTrans 
Template 
7IRTrans 
Template 
7IRTrans 
Template 
7IRTrans 
Template 
7IRTrans 
Template 
7IRTrans 
Template 
7IRTrans 
Template 
7IRTrans 
Template 
7IRTrans 
Template 
7IRTrans 
Template 
CGTGTTTTTCAAAGGAAAACCACGTCCCCGTGGTTCGGGGGGCCTAGACGTTTTTTAACC 
CGTGTTTTTCAAAGGAAAACCACGTCCCCGTGGTTCGGGGGGCCTAGACGTTTTTTAACC 
************************************************************ 
TCGACTAAACACATGTAAAGCATGTGCACCGAGGCCCCAGATCAGATCCCATACAATGGG 
TCGACTAAACACATGTAAAGCATGTGCACCGAGGCCCCAGATCAGATCCCATACAATGGG 
************************************************************ 
GTACCTTCTGGGCATCCTTCAGCCCCTTGTTGAATACGCTTGAGGAGAGCCATTTGACTC 
GTACCTTCTGGGCATCCTTCAGCCCCTTGTTGAATACGCTTGAGGAGAGCCATTTGACTC 
************************************************************ 
TTTCCACAACTATCCAACTCACAACGTGGCACTGGGGTTGTGCCGCCTTTGCAGGTGTAT 
TTTCCACAACTATCCAACTCACAACGTGGCACTGGGGTTGTGCCGCCTTTGCAGGTGTAT 
************************************************************ 
CTTATACACGTGGCTTTTGGCCGCAGAGGCACCTGTCGCCAGGTGGGGGGTTCCGCTGCC 
CTTATACACGTGGCTTTTGGCCGCAGAGGCACCTGTCGCCAGGTGGGGGGTTCCGCTGCC 
************************************************************ 
TGCAAAGGGTCGCTACAGACGTTGTTTGTCTTCAAGAAGCTTCCAGAGGAACTGCTTCCT 
TGCAAAGGGTCGCTACAGACGTTGTTTGTCTTCAAGAAGCTTCCAGAGGAACTGCTTCCT 
************************************************************ 
TCACGACATTCAACAGACCTTGCATTCCTTTGGCGAGAGGGGAAAGACCCCTAGGAATGC 
TCACGACATTCAACAGACCTTGCATTCCTTTGGCGAGAGGGGAAAGACCCCTAGGAATGC 
************************************************************ 
TCGTCAAGAAGACAGGGCCAGGTTTCCGGGCCCTCACATTGCCAAAAGACGGCAATATGG 
TCGTCAAGAAGACAGGGCCAGGTTTCCGGGCCCTCACATTGCCAAAAGACGGCAATATGG 
************************************************************ 
TGGAAAATAACATATAGACAAACGCACACCGGCCTTATTCCAAGCGGCTTCGGCCAGTAA 
TGGAAAATAACATATAGACAAACGCACACCGGCCTTATTCCAAGCGGCTTCGGCCAGTAA 
************************************************************ 
CGTTAGGGGGGGGGGAGGGAGAGGGGCTCGAGTTAAGCAAAGTCTTTGGACACAGCCTCC 
CGTTAGGGGGGGGGGAGGGAGAGGGGCTCGAGTTAAGCAAAGTCTTTGGACACAGCCTCC 
************************************************************ 
ACAAAGTTTGGGGCTGACATGAGGATGCCGATGGTGCAGATGATGGTAAAAACCGAAAAG 
ACAAAGTTTGGGGCTGACATGAGGATGCCGATGGTGCAGATGATGGTAAAAACCGAAAAG 
************************************************************ 
GCCATGAGGCACAAGCGGTCCACCACACAGGCCGCAAACTTCCACTCACTGCAGATCACC 
GCCATGAGGCACAAGCGGTCCACCACACAGGCCGCAAACTTCCACTCACTGCAGATCACC 
************************************************************ 
TCACTCTCATCCTGGCAGCGGAAGCGGTTGGCGATGTAGCGGACCTCCTCCAGGATCTTG 
TCACTCTCATCCTGGCAGCGGAAGCGGTTGGCGATGTAGCGGACCTCCTCCAGGATCTTG 
************************************************************ 
GCCAGGTCGGGGTCCCCATCAGAGGGGTGTGTACCATGCATGAGGTGCTCATCATGTGTT 
GCCAGGTCGGGGTCCCCATCAGAGGGGTGTGTACCATGCATGAGGTGCTCATCATGTGTT 
************************************************************ 
GGGGAGCAGGCCAAACGACCACACACGACCCCAGAGTCTGGAGTTGGGGCACAGTGCATG 
GGGGAGCAGGCCAAACGACCACACACGACCCCAGAGTCTGGAGTTGGGGCACAGTGCATG 
************************************************************ 
CCCTCCAGGCCTCGGAAGCCAATGTAGAGCAGGTTGCCATTGCTGGTGGGTGGCCCCGCA 
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CCCTCCAGGCCTCGGAAGCCAATGTAGAGCAGGTTGCCATTGCTGGTGGGTGGCCCCGCA 
************************************************************ 
CCTGCGCTCAGCTCCACACTGGCCAGGCTGCAGCGCCGAGGCTTGTGCTGACAAGCCGGC 
CCTGCGCTCAGCTCCACACTGGCCAGGCTGCAGCGCCGAGGCTTGTGCTGACAAGCCGGC 
************************************************************ 
CGCACCTTGTCCTCTCCCGGCCTCTTCATGCGCAGAAACCATGCACACCAATTCAGAAGA 
CGCACCTTGTCCTCTCCCGGCCTCTTCATGCGCAGAAACCATGCACACCAATTCAGAAGA 
************************************************************ 
ATGATCCTGGTCCACTTAGGCATTTTGCCACCATCAGGGTCATGGTGGTGATATCGCAGC 
ATGATCCTGGTCCACTTAGGCATTTTGCCACCATCAGGGTCATGGTGGTGATATCGCAGC 
************************************************************ 
ACAATCACTGTCACGACCACTGAGAGGCCCACGATGATCATGGTGCTGGCGAAGTACTGT 
ACAATCACTGTCACGACCACTGAGAGGCCCACGATGATCATGGTGCTGGCGAAGTACTGT 
************************************************************ 
GCTATCAAGGGCACGGAATCAGATGTTGCTGGCATGATCTCAGCCACAAGCAGCATGAAG 
GCTATCAAGGGCACGGAATCAGATGTTGCTGGCATGATCTCAGCCACAAGCAGCATGAAG 
************************************************************ 
ACAGTCAGAGAAAGTAAGACAGTTATTCCAAGAGAGATTTTCTCTCCAGAGTCTGCAGGC 
ACAGTCAGAGAAAGTAAGACAGTTATTCCAAGAGAGATTTTCTCTCCAGAGTCTGCAGGC 
************************************************************ 
AGCAAGAATACCAGCAAAGCCAGGGCTGAAATGAGCACACAAGGAATGAGCAGGTTGAGG 
AGCAAGAATACCAGCAAAGCCAGGGCTGAAATGAGCACACAAGGAATGAGCAGGTTGAGG 
************************************************************ 
CCATAGTAGAGTGTCCTACGGCGCATGGTTACTGTGTAGGTGACATCTGGGTATGGCTCT 
CCATAGTAGAGTGTCCTACGGCGCATGGTTACTGTGTAGGTGACATCTGGGTATGGCTCT 
************************************************************ 
TTGCAGCATTCATAGAACTTCTCATTCCTTTTGCCAGGGATTCCCATGAGATCCCATTCT 
TTGCAGCATTCATAGAACTTCTCATTCCTTTTGCCAGGGATTCCCATGAGATCCCATTCT 
************************************************************ 
CCATTGGGGATATAGCTGCTGATATCTGCCTCTTGCATCTGCAGGTCCAAGGACCACCCT 
CCATTGGGGATATAGCTGCTGATATCTGCCTCTTGCATCTGCAGGTCCAAGGACCACCCT 
************************************************************ 
CCATAGGACCAGGACCCAAACTTCAGTTTGCACTGCTGCACATCAAAAGGGAACCAGCGT 
CCATAGGACCAGGACCCAAACTTCAGTTTGCACTGCTGCACATCAAAAGGGAACCAGCGT 
************************************************************ 
ACATCGATGTAGCAGGAGCTCTTGAATATGCCTGGAGGGAGATACTGGCAATGCCCAGAT 
ACATCGATGTAGCAGGAGCTCTTGAATATGCCTGGAGGGAGATACTGGCAATGCCCAGAT 
************************************************************ 
GCATTCACCAAGACGTTGGTGTGGAATGTGGCATCAAAGCGTTCATCTGCACTGTTATAG 
GCATTCACCAAGACGTTGGTGTGGAATGTGGCATCAAAGCGTTCATCTGCACTGTTATAG 
************************************************************ 
AGGAGAATGTCTGGTTTCCAAATCTGGCCATCTGGAAAACGAACATTTTTCACTCCGGGG 
AGGAGAATGTCTGGTTTCCAAATCTGGCCATCTGGAAAACGAACATTTTTCACTCCGGGG 
************************************************************ 
TACTCAGACATGTTCCACTGCAAATAGTGATCTGTCCAAGACATTTGTAGCCAAATGTTG 
TACTCAGACATGTTCCACTGCAAATAGTGATCTGTCCAAGACATTTGTAGCCAAATGTTG 
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************************************************************ 
GTGGTTAAAACTTGGTTCTTCTCATCCACATCCATGATCTGCAGGAGGCTCAGGGAGAAG 
GTGGTTAAAACTTGGTTCTTCTCATCCACATCCATGATCTGCAGGAGGCTCAGGGAGAAG 
************************************************************ 
TACACGGTGAGCGGCTGCGAGTCGTTGGCCACCGGCCTCTCCAGCGGGTTGTAGTTCTTG 
TACACGGTGAGCGGCTGCGAGTCGTTGGCCACCGGCCTCTCCAGCGGGTTGTAGTTCTTG 
************************************************************ 
ACCAGCTCCTTGTACAGCCTCCTCTGGAACTCGCCTTGCAGGGACACGTGCAGCAGCGCC 
ACCAGCTCCTTGTACAGCCTCCTCTGGAACTCGCCTTGCAGGGACACGTGCAGCAGCGCC 
************************************************************ 
GCGGCCAGAGCCAGCCAGATGCCTCCCCGCCGGCCGCACATGGTACCAAGCTCTAGAGTC 
GCGGCCAGAGCCAGCCAGATGCCTCCCCGCCGGCCGCACATGGTACCAAGCTCTAGAGTC 
************************************************************ 
GACTGCGCTCTCAGGCACGACACGACTCCTCCGCTGCCCACCGCAGACTGAGGCAGCGCT 
GACTGCGCTCTCAGGCACGACACGACTCCTCCGCTGCCCACCGCAGACTGAGGCAGCGCT 
************************************************************ 
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AATTCATCATCAATAATATACCTTATTTTGGATTGAAGCCAATATGATAATGAGGGGGTGGAGTTTGTGAC 
GTGGCGCGGGGCGTGGGAACGGGGCGGGTGACGTAGTAGTGTGGCGGAAGTGTGATGTTGCAAGTGTGGCG 
GAACACATGTAAGCGACGGATGTGGCAAAAGTGACGTTTTTGGTGTGCGCCGGTGTACACAGGAAGTGACA 
ATTTTCGCGCGGTTTTAGGCGGATGTTGTAGTAAATTTGGGCGTAACCGAGTAAGATTTGGCCATTTTCGC 
GGGAAAACTGAATAAGAGGAAGTGAAATCTGAATAATTTTGTGTTACTCATAGCGCGTAATATTTGTCTAG 
GGCCGCGGGGACTTTGACCGTTTACGTGGAGACTCGCCCAGGTGTTTTTCTCAGGTGTTTTCCGCGTTCCG 
GGTCAAAGTTGGCGTTTTATTATTATAGTCAGTCTAGCTGGTTCCATAGAGCCCACCGCATCCCCAGCATG 
CCTGCTATTGTCTTCCCAATCCTCCCCCTTGCTGTCCTGCCCCACCCCACCCCCCAGAATAGAATGACACC 
TACTCAGACAATGCGATGCAATTTCCTCATTTTATTAGGAAAGGACAGTGGGAGTGGCACCTTCCAGGGTC 
AAGGAAGGCACGGGGGAGGGGCAAACAACAGATGGCTGGCAACTAGAAGGCACAGTCGAGGCTGATCGTAC 
CGAGCTCGAATTCCAGGCGGGGAGGCGGCCCAAAGGGAGATCCGACTCGTCTGAGGGCGAAGGCGAAGACG 
CGGAAGAGGCCGCAGAGCCGGCAGCAGGCCGCGGGAAGGAAGGTCCGCTGGATTGAGGGCCGAAGGGACGT 
AGCAGAAGGACGTCCCGCGCAGAATCCAGGTGGCAACACAGGCGAGCAGCCATGGAAAGGACGTCAGCTTC 
CCCGACAACACCACGGAATTGTCAGTGCCCAACAGCCGAGCCCCTGTCCAGCAGCGGGCAAGGCAGGCGGC 
GATGAGTTCCGCCGTGGCAATAGGGAGGGGGAAAGCGAAAGTCCCGGAAAGGAGCTGACAGGTGGTGGCAA 
TGCCCCAACCAGTGGGGGTTGCGTCAGCAAACACAGTGCACACCACGCCACGTTGCCTGACAACGGGCCAC 
AACTCCTCATAAAGAGACAGCAACCAGGATTTATACAAGGAGGAGAAAATGAAAGCCATACGGGAAGCAAT 
AGCATGATACAAAGGCATTAAAGCAGCGTATCCACATAGCGTAAAAGGAGCAACATAGTTAAGAATACCAG 
TCAATCTTTCACAAATTTTGTAATCCAGAGGTTGATTGTCGACGGATCCTCTAGATGCATGCTCGAGCGGC 
CGCTTTACTTGTACAGCTCGTCCATGCCGAGAGTGATCCCGGCGGCGGTCACGAACTCCAGCAGGACCATG 
TGATCGCGCTTCTCGTTGGGGTCTTTGCTCAGGGCGGACTGGGTGCTCAGGTAGTGGTTGTCGGGCAGCAG 
CACGGGGCCGTCGCCGATGGGGGTGTTCTGCTGGTAGTGGTCGGCGAGCTGCACGCTGCCGTCCTCGATGT 
TGTGGCGGATCTTGAAGTTCACCTTGATGCCGTTCTTCTGCTTGTCGGCCATGATATAGACGTTGTGGCTG 
TTGTAGTTGTACTCCAGCTTGTGCCCCAGGATGTTGCCGTCCTCCTTGAAGTCGATGCCCTTCAGCTCGAT 
GCGGTTCACCAGGGTGTCGCCCTCGAACTTCACCTCGGCGCGGGTCTTGTAGTTGCCGTCGTCCTTGAAGA 
AGATGGTGCGCTCCTGGACGTAGCCTTCGGGCATGGCGGACTTGAAGAAGTCGTGCTGCTTCATGTGGTCG 
GGGTAGCGGCTGAAGCACTGCACGCCGTAGGTCAGGGTGGTCACGAGGGTGGGCCAGGGCACGGGCAGCTT 
GCCGGTGGTGCAGATGAACTTCAGGGTCAGCTTGCCGTAGGTGGCATCGCCCTCGCCCTCGCCGGACACGC 
TGAACTTGTGGCCGTTTACGTCGCCGTCCAGCTCGACCAGGATGGGCACCACCCCGGTGAACAGCTCCTCG 
CCCTTGCTCACCATGGTGGCGACCGGTGGATCCCGGGCCCGCGGTACCAAGCTCTAGAGTCGACTGCGCTC 
TCAGGCACGACACGACTCCTCCGCTGCCCACCGCAGACTGAGGCAGCGCTGAGTCGCCGGCGCCGCAGCGC 
AGATGGTCGCGCCCGTGCCCCCCTATCTCGCGCCTCGCGTGGTGCGGTCCGGCTGGGCCGGCGGCGGCGCG 
GACGCGACCAAGGTGGCCGGGAAGGGGAGTTTGCGGGGGACCGGCGAGTGACGTCAGCGCGCCTTCAGTGC 
TGAGGCGGCGGTGGCGCGCGCCGCCAGGCGGGGGCGAAGGCACTGTCCGCGGTGCTGAAGCTGGCAGTGCG 
CACGCGCCTCGCCGCATCCTGTTTCCCCTCCCCCTCTCTGATAGGGGATGCGCAATTTGGGGAATGGGGGT 
TGGGTGCTTGTCCAGTGGGTCGGGGTCGGTCGTCAGGTAGGCACCCCCACCCCGCCTCATCCTGGTCCTAA 
AACCCACTTGCACTCATACGCAGGGCCCTCTGCAGCTGGCGCCATCGATACGCGTATATCTGGCCCGTACA 
TCGCTAGANGATCTGGAAGGTGCTGAGGTACGATGAGACCCGCACCAGGTGCAGACCCTGCGAGTGTGGCG 
GTAAACATATTAGGAACCAGCCTGTGATGCTGGATGTGACCGAGGAGCTGAGGCCCGATCACTTGGTGCTG 
GCCTGCACCCGCGCTGAGTTTGGCTCTAGCGATGAAGATACAGATTGAGGTACTGAAATGTGTGGGCGTGG 
CTTAAGGGTGGGAAAGAATATATAAGGTGGGGGTCTTATGTAGTTTTGTATCTGTTTTGCAGCAGCCGCCG 
CCGCCATGAGCACCAACTCGTTTGATGGAAGCATTGTGAGCTCATATTTGACAACGCGCATGCCCCCATGG 
GCCGGGGTGCGTCAGAATGTGATGGGCTCCAGCATTGATGGTCGCCCCGTCCTGCCCGCAAACTCTACTAC 
CTTGACCTACGAGACCGTGTCTGGAACGCCGTTGGAGACTGCAGCCTCCGCCGCCGCTTCAGCCGCTGCAG 
CCACCGCCCGCGGGATTGTGACTGACTTTGCTTTCCTGAGCCCGCTTGCAAGCAGTGCAGCTTCCCGTTCA 
TCCGCCCGCGATGACAAGTTGACGGCTCTTTTGGCACAATTGGATTCTTTGACCCGGGAACTTAATGTCGT 
TTCTCAGCAGCTGTTGGATCTGCGCCAGCAGGTTTCTGCCCTGAAGGCTTCCTCCCCTCCCAATGCGGTTT 
AAAACATAAATAAAAAACCAGACTCTGTTTGGATTTGGATCAAGCAAGTGTCTTGCTGTCTTTATTTAGGG 
GTTTTGCGCGCGCGGTAGGCCCGGGACCAGCGGTCTCGGTCGTTGAGGGTCCTGTGTATTTTTTCCAGGAC 
GTGGTAAAGGTGACTCTGGATGTTCAGATACATGGGCATAAGCCCGTCTCTGGGGTGGAGGTAGCACCACT 
GCAGAGCTTCATGCTGCGGGGTGGTGTTGTAGATGATCCAGTCGTAGCAGGAGCGCTGGGCGTGGTGCCTA 
AAAATGTCTTTCAGTAGCAAGCTGATTGCCAGGGGCAGGCCCTTGGTGTAAGTGTTTACAAAGCGGTTAAG 
CTGGGATGGGTGCATACGTGGGGATATGAGATGCATCTTGGACTGTATTTTTAGGTTGGCTATGTTCCCAG 
CCATATCCCTCCGGGGATTCATGTTGTGCAGAACCACCAGCACAGTGTATCCGGTGCACTTGGGAAATTTG 
TCATGTAGCTTAGAAGGAAATGCGTGGAAGAACTTGGAGACGCCCTTGTGACCTCCAAGATTTTCCATGCA 
TTCGTCCATAATGATGGCAATGGGCCCACGGGCGGCGGCCTGGGCGAAGATATTTCTGGGATCACTAACGT 
CATAGTTGTGTTCCAGGATGAGATCGTCATAGGCCATTTTTACAAAGCGCGGGCGGAGGGTGCCAGACTGC 
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GGTATAATGGTTCCATCCGGCCCAGGGGCGTAGTTACCCTCACAGATTTGCATTTCCCACGCTTTGAGTTC 
AGATGGGGGGATCATGTCTACCTGCGGGGCGATGAAGAAAACGGTTTCCGGGGTAGGGGAGATCAGCTGGG 
AAGAAAGCAGGTTCCTGAGCAGCTGCGACTTACCGCAGCCGGTGGGCCCGTAAATCACACCTATTACCGGG 
TGCAACTGGTAGTTAAGAGAGCTGCAGCTGCCGTCATCCCTGAGCAGGGGGGCCACTTCGTTAAGCATGTC 
CCTGACTCGCATGTTTTCCCTGACCAAATCCGCCAGAAGGCGCTCGCCGCCCAGCGATAGCAGTTCTTGCA 
AGGAAGCAAAGTTTTTCAACGGTTTGAGACCGTCCGCCGTAGGCATGCTTTTGAGCGTTTGACCAAGCAGT 
TCCAGGCGGTCCCACAGCTCGGTCACCTGCTCTACGGCATCTCGATCCAGCATATCTCCTCGTTTCGCGGG 
TTGGGGCGGCTTTCGCTGTACGGCAGTAGTCGGTGCTCGTCCAGACGGGCCAGGGTCATGTCTTTCCACGG 
GCGCAGGGTCCTCGTCAGCGTAGTCTGGGTCACGGTGAAGGGGTGCGCTCCGGGCTGCGCGCTGGCCAGGG 
TGCGCTTGAGGCTGGTCCTGCTGGTGCTGAAGCGCTGCCGGTCTTCGCCCTGCGCGTCGGCCAGGTAGCAT 
TTGACCATGGTGTCATAGTCCAGCCCCTCCGCGGCGTGGCCCTTGGCGCGCAGCTTGCCCTTGGAGGAGGC 
GCCGCACGAGGGGCAGTGCAGACTTTTGAGGGCGTAGAGCTTGGGCGCGAGAAATACCGATTCCGGGGAGT 
AGGCATCCGCGCCGCAGGCCCCGCAGACGGTCTCGCATTCCACGAGCCAGGTGAGCTCTGGCCGTTCGGGG 
TCAAAAACCAGGTTTCCCCCATGCTTTTTGATGCGTTTCTTACCTCTGGTTTCCATGAGCCGGTGTCCACG 
CTCGGTGACGAAAAGGCTGTCCGTGTCCCCGTATACAGACTTGAGAGGCCTGTCCTCGACCGATGCCCTTG 
AGAGCCTTCAACCCAGTCAGCTCCTTCCGGTGGGCGCGGGGCATGACTATCGTCGCCGCACTTATGACTGT 
CTTCTTTATCATGCAACTCGTAGGACAGGTGCCGGCAGCGCTCTGGGTCATTTTCGGCGAGGACCGCTTTC 
GCTGGAGCGCGACGATGATCGGCCTGTCGCTTGCGGTATTCGGAATCTTGCACGCCCTCGCTCAAGCCTTC 
GTCACTGGTCCCGCCACCAAACGTTTCGGCGAGAAGCAGGCCATTATCGCCGGCATGGCGGCCGACGCGCT 
GGGCTACGTCTTGCTGGCGTTCGCGACGCGAGGCTGGATGGCCTTCCCCATTATGATTCTTCTCGCTTCCG 
GCGGCATCGGGATGCCCGCGTTGCAGGCCATGCTGTCCAGGCAGGTAGATGACGACCATCAGGGACAGCTT 
CAAGGATCGCTCGCGGCTCTTACCAGCCTAACTTCGATCACTGGACCGCTGATCGTCACGGCGATTTATGC 
CGCCTCGGCGAGCACATGGAACGGGTTGGCATGGATTGTAGGCGCCGCCCTATACCTTGTCTGCCTCCCCG 
CGTTGCGTCGCGGTGCATGGAGCCGGGCCACCTCGACCTGAATGGAAGCCGGCGGCACCTCGCTAACGGAT 
TCACCACTCCAAGAATTGGAGCCAATCAATTCTTGCGGAGAACTGTGAATGCGCAAACCAACCCTTGGCAG 
AACATATCCATCGCGTCCGCCATCTCCAGCAGCCGCACGCGGCGCATCTCGGGCAGCGTTGGGTCCTGGCC 
ACGGGTGCGCATGATCGTGCTCCTGTCGTTGAGGACCCGGCTAGGCTGGCGGGGTTGCCTTACTGGTTAGC 
AGAATGAATCACCGATACGCGAGCGAACGTGAAGCGACTGCTGCTGCAAAACGTCTGCGACCTGAGCAACA 
ACATGAATGGTCTTCGGTTTCCGTGTTTCGTAAAGTCTGGAAACGCGGAAGTCAGCGCCCTGCACCATTAT 
GTTCCGGATCTGCATCGCAGGATGCTGCTGGCTACCCTGTGGAACACCTACATCTGTATTAACGAAGCGCT 
GGCATTGACCCTGAGTGATTTTTCTCTGGTCCCGCCGCATCCATACCGCCAGTTGTTTACCCTCACAACGT 
TCCAGTAACCGGGCATGTTCATCATCAGTAACCCGTATCGTGAGCATCCTCTCTCGTTTCATCGGTATCAT 
TACCCCCATGAACAGAAATCCCCCTTACACGGAGGCATCAGTGACCAAACAGGAAAAAACCGCCCTTAACA 
TGGCCCGCTTTATCAGAAGCCAGACATTAACGCTTCTGGAGAAACTCAACGAGCTGGACGCGGATGAACAG 
GCAGACATCTGTGAATCGCTTCACGACCACGCTGATGAGCTTTACCGCAGCTGCCTCGCGCGTTTCGGTGA 
TGACGGTGAAAACCTCTGACACATGCAGCTCCCGGAGACGGTCACAGCTTGTCTGTAAGCGGATGCCGGGA 
GCAGACAAGCCCGTCAGGGCGCGTCAGCGGGTGTTGGCGGGTGTCGGGGCGCAGCCATGACCCAGTCACGT 
AGCGATAGCGGAGTGTATACTGGCTTAACTATGCGGCATCAGAGCAGATTGTACTGAGAGTGCACCATATG 
CGGTGTGAAATACCGCACAGATGCGTAAGGAGAAAATACCGCATCAGGCGCTCTTCCGCTTCCTCGCTCAC 
TGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTAT 
CCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAA 
AAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAG 
TCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCT 
CTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCT 
CATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACC 
CCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACT 
TATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTC 
TTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGT 
TACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTG 
TTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCT 
GACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTA 
GATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTT 
ACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTC 
CCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGA 
CCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTC 
CTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTT 
AATAGTTTGCGCAACGTTGTTGCCATTGCTGCAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTC 
ATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCT 
CCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTG 
CATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATT 
CTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAACACGGGATAATACCGCGCCACATA 
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GCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTG 
TTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGT 
TTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAA 
TACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATA 
TTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTGACGT 
CTAAGAAACCATTATTATCATGACATTAACCTATAAAAATAGGCGTATCACGAGGCCCTTTCGTCTTCAAG 
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The present report describes the emotional responses of different strains of mice to exposure to a novel open space model of anxiety using a 3D 
spatial navigation task. The 3D maze is modification of the radial maze with flexible arms that can be raised above or lowered below the horizontal 
level of a central platform. To access the arms animals need to cross a bridge linking the arms to the central platform. In this model, mice are 
exposed to novelty in an unfamiliar open space setting with no safe alternative. Fear from novelty is compounded with the need to explore. The 
drive to escape and the drive to approach are intermingled making this open space model radically different from the current models of anxiety 
which provide animals with the choice between safe and anxiogenic spaces. 
In a series of experiments, we examined the behaviour of different groups of mice from C57, C3H, CD I and Balb/c strains. In the first experiment, 
different groups of C57 mice were tested in one of the three arms configurations. In the second experiment, C57 mice were compared to C3H mice. 
In the third experiment, C57 mice were compared to COl and Balb/c mice in the raised arm configuration over three successive sessions. In the 
fourth experiment, we examined the behaviour of C57 mice in the lowered arm configuration with an open and an enclosed central. In the final 
experiment, we examined the difference between C57 and C3H mice of both genders. 
Using several spatia-temporal parameters of the transition responses between central platform, bridges and arms, we have been able to show 
consistent results demonstrating significant differences between C57 and C3H mice, and between Balb/c and both C57 and CD I mice. C3H appear 
more anxious than C57 mice, and Balb/c mice seem more anxious than C57 and COl mice. We also observed significant differences between 
sexes in C3H mice but not in C57 mice. C3H male mice appear more anxious than C3H female mice and than both C57 male and female mice. 
In the lowered arm configuration with an enclosed central platform, C57 mice took longer time to make a first entry to an arm, made more visits 
to bridges before first entry to an arm and required longer time between re-entries to arms, spent longer time on the central platform and shorter 
time on arms compared to mice in the other arm configurations. They also made frequent entries to the centre and bridges compared to mice in the 
lowered arm with an open central platform. 
These results demonstrate not only the sensitivity of the parameters of the test but also the consistencies and concordances of the results which 
make this 3D maze a valuable new tool in the study of the underlying neural mechanisms of anxiety responses in addition to learning and memory, 
and in assessing the effects of potential anxiolytic drugs. In this report we examine methodological issues related to the design of animal behavioural 
paradigms and question the value and the construct validity of the current models of human anxiety. 
© 2006 Elsevier B.V. All rights reserved. 
Keywords: Neophobia; Habituation; Tolerance; Benwdiazepines; GABAA; Amygdala; Hippocampus; Sex; Rats 
1. Introduction 
In everyday life, humans are faced with challenges that are 
often anxiogenic such as sitting for exams, interviews, sport 
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competitions and public oral communications. Some spatial set-
tings also have been proved to be anxiogenic, such as unfamiliar 
enclosed or large spaces and elevated surfaces. While most sub-
jects would feel the need to face challenges and overcome their 
anxiety and fear, some may be more fearful and attempt to avoid 
the challenge or escape. Fear is an emotional response which can 
be induced by exposure to novelty and can be expressed through 
escape, avoidance or anxiety responses. Escape and avoidance 
10 A. Ennaceur et al. I Behavioural Brain Research 174 (2006) 9-38 
responses should not be confused with anxiety responses. In 
the former, the subject is not and/or does not feel compelled to 
confront the threatening stimuli and there is a safe alternative to 
choose from while in the latter, the subject is and/or feels obliged 
to confront real or a potential threat either immediately or in the 
near future and there is no obvious safe alternative option to 
escape to Gray and McNaughton wrote that there is "a distinc-
tion between pure fear and anxiety. In pure fear, defence is simple 
and requires only escape or active avoidance controlled by the 
fight/flight/freeze system. In anxiety, defence is more compli-
cated and fear is compounded with a tendency to approach the 
source of potential threat-producing an approach-avoidance 
conflict" [ 106]. 
Fear is a common feature and an indissociable component of 
escape, avoidance and anxiety. What makes escape and avoid-
ance distinct from anxiety is that in the latter, fear is compounded 
with the need to approach the source of threat. This means that 
the drive to escape or avoid and the drive to explore are intermin-
gled. They are expressed simultaneously, in combination; they 
are not separate. 
A wide range of behavioural tests have been developed to 
assess anxiety [27 ,40,59,57 ,74, 104,115,116,152,167 ,258,265], 
they are all based on two alternative choices and are claimed to 
induce an approach-avoidance conflict in animals. This conflict 
is seen to be induced by the presence of open spaces alongside 
enclosed or protected spaces in the elevated T-maze, plus-maze 
and zero-maze and, in the light-dark box and the open-field 
[28,51,73,137,180,170,265]. It seems to us that this assump-
tion is based on the juxtaposition of the physical static state 
of contrasting elements present in the outside world (open ver-
sus enclosed, light versus dark and white versus black) to a 
dynamic state of mind of animals which would mirror this con-
trast through approach and avoidance responses. It is not clear 
how animals that are mostly escaping to protected spaces or 
mostly avoiding open spaces can be described as expressing 
the drive or need to explore anxiogenic spaces. Furthermore, it 
is not clear whether animals experience anxiety when engag-
ing in an open space, when retracting in an enclosed space 
or when moving anywhere in the apparatus. The use of these 
two-choice models does not discriminate between fear induc-
ing escape or avoidance responses from fear resulting in anxiety 
responses. In fact, reports in the literature seem to suggest that 
escape and avoidance responses reflect some forms of anxi-
ety and are used indiscriminately [17 ,33,36,35,46,49,51 ,56, 76, 
103,129,160,187,203,212,215,219,221,229,166]. In our view, 
this association of escape and avoidance responses of open 
spaces to an anxious state is possible when a subject feels that 
it will or may be forced to confront the source of threat in the 
near future. This prospective emotional response has yet to be 
explored in animals. 
This confusion between escape, avoidance and anxiety 
responses is further exacerbated by another confusion currently 
rife amongst many scientists between animal models of human 
behaviour and animal models of human psychopathologies 
or neurological disorders [6,25,33,37,38,69,70,93,130,152, 
180, 195,264]. This confusion arises from the perceived need 
for animal behaviourists to mimic largely questionable clinical 
assessments of psychological and neurological pathologies 
[18, 138,158, 197,217,218,274,262]. The current models of anx-
iety are expected to produce symptoms and determine the aeti-
ology of these symptoms in normal animals that are challenged 
with anxiolytic as well as anxiogenic compounds [6,38,45,52, 
62,78,97, 116,117,128,130,132,133,136,152,157,162,184,189, 
195,214,216,220,254]. The pharmacological validity of the 
current anxiety tests imply that the purpose of a behavioural 
test is to provide symptoms for benzodiazepines and SSRI to 
act upon. Apparently, without benzodiazepines and SSRls there 
would be no valid test of anxiety. 
This confusion between escape, avoidance and anxiety 
responses and between animal models of human behaviour and 
animal models of human psychopathologies or neurological dis-
orders account for the inconsistent and contradictory results 
observed with the current models of anxiety. Because of this 
confusion, it is not surprising that various physiological and 
pharmacological data have been accumulated supporting a wide 
range of theories which are unfortunately based on divergent 
results. It is not clear up to now what the elevated T-maze, 
plus-maze, the open-field, the light-dark box are really mea-
suring. Which behavioural measurement is supposed to reflect 
or measure anxiety without being confused with other forms of 
behaviour, affective state and cognitive processes? [84]. 
The entries in open arms, in a lit box or in the centre 
of the field may induce anxiety but they do not represent 
the natural behaviour expressed by animals when exposed to 
these experimental settings. The spontaneous responses of ani-
mals in these settings are avoidance or escape. Most of these 
tests rely mainly on the use of anxiolytic drugs obtained from 
clinical studies to increase the number of entries and dura-
tion of entries in open spaces [41,47,49,51 ,58,69,103, 107,116, 
172,190,195,212,244,24 7 ,257]. Amphetamine also increases 
the number of entries in the open spaces of these experimen-
tal settings [67,264]. However, because of its known stimulant 
effects it sparked a debate over the value of open-arm entries and 
it was, thus, denied any potential anxiolytic properties [67,69]. 
Is the definition of benzodiazepines any less problematical than 
amphetamine in terms of their well known cognitive effects? 
Moreover, there have been no objections raised to the introduc-
tion of SSRI as if anxiety is just another variant of depression 
[9,80,94,111' 169,175,177,178, 185,226,224,228,275]. 
Studies based on the current models of anxiety are con-
strained by the limitation of clinical methods that is imposed 
on them. Clinical studies are biased by their reliance on verbal 
communication. The tests used for the assessment of anxiety and 
affective states are based on questionnaires and the scoring of 
patients' answers [101,231,232,243,272]. It is unclear whether 
results obtained from clinical studies concerning mental states 
and functions are always accurate and reliable [13,43,71, 
158,217,218,252,262]. The positive effect of drugs can be the 
result of expectancy as patients are told for ethical reasons 
about the possible outcomes of a treatment [99,230,239,241]. 
Furthehnore, when dealing with human feelings and perception, 
it is inevitable that words lead to some misinterpretation and 
confusion; they are and remain subjective measures [3, 114 ]. Fol-
lowing administration of benzodiazepines, a subject may seem 
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relieved or report being relieved from anxiety but numerous evi-
dence shows that perception and cognitive processes are altered 
by these drugs [21 ,44,64,95, 151 ,188, 198,230,236,238,268]. 
Patients under the influence of these drugs are not encoding 
and processing normally the information from the outside 
world and might feel detached from it. Therefore, these 
compounds may be not anxiolytic after all . Clinical evidence is 
not compelling [12,14,19, 178,235,236,158, 169,268,267,275] . 
Furthermore "anxiolytics" and "antidepressants" seem to 
be interchangeable in both clinical and laboratory settings 
[6,8,39,41 ,80,86,92, 117,176,207,228,233,236,94,169,175,226, 
263] . It is our view that the lack of verbal communication 
between human and animals in scientific research is a bless-
ing. Behaviour, cognition and emotion are now subjects of 
laboratory studies in diverse fields of science and have been 
largely removed from the psychologists' monopoly. Scientists 
from different disciplines ranging from physics, mathematics, 
computer modelling, chemistry, molecular biology and genetics 
are currently involved in the study of behaviour, cognition and 
emotion. With these numerous inputs from most of the fields of 
science, animal studies should lead the way to the understanding 
of human behaviour, the underlying mechanisms and drug 
discoveries. They do not need to trail behind clinical research 
to support and confirm its findings as is currently the case. 
Animal behavioural studies have yet to reveal any drug with 
potential therapeutic action on depression and anxiety disorders 
[119,200,201 ,227] . We do not wish to provide further ammu-
nition for those who devalue the importance of animal studies 
[ 194,20 I] but we feel it is time for an unbiased, objective critical 
evaluation of the methods and techniques used in behavioural 
neuroscience. The current anxiolytic compounds did not arise 
from drug discovery through laboratory experiments but are 
the result of fortuitous clinical observations and assessments 
of the effects of drugs that were not specifically designed for 
anxiety [77, 119,200,227] . Chlorpromazine was the result of 
Laborit fortuitous clinical observations. It was considered as a 
pre-anaesthetic sedative in 1930 until Laborit in 1950 observed 
its mood-altering side effects on patients. He reported that it 
has a calming effect which led to the drug being prescribed 
as a major antipsychotic drug [72,147,148]. Chlorpromazine 
which was preceded earlier by anti-histaminergic drugs, widely 
used in the clinic as CNS depressants at that time, Jed chemists 
and clinicians to the discovery of the tricyclic antidepressants 
(imipramine) and benzodiazepines (Chlordiazepoxide and 
Diazepam) [ 146,161 ,237 ,245,246, 120,200]. Animal studies 
did not play a major role and animal neuroscientists were since 
being tunnelled by clinicians to follow their lead. When a drug 
is attributed anxiolytic properties by clinicians, behavioural 
neuroscientists are all forcefully tuned to these properties. Drug 
discovery is initiated and conducted by clinicians. Laboratory 
neuroscientists are left to a secondary role to account and justify 
the purpose of a "pharmaceutical" compound. They seem 
constrained within a "clinically" restricted view of pre-defined 
action properties of a drug and resigned to accommodate any 
findings within this view. They try to confirm the existence of 
these properties and when these properties are not revealed, 
they barely think to question the clinical methods that led to 
these drugs. It would be more appropriate and advantageous 
that animal neuroscientists pursue their investigation of a 
compound independent from clinical influences. However, this 
mission cannot be achieved without a thorough methodological 
validation of animal models of human behaviour. 
In order to study anxiety responses as distinct from escape 
and avoidance responses it is necessary to expose or subject ani-
mals to a situation where they would be tempted to explore but 
cannot escape or avoid. We should view anxiety as one of many 
forms of emotional responses [ 16,179, 182,222] that might be 
experienced by animals during a test and which can evolve to 
maladaptive responses. We propose the use of a 3D maze as an 
open space model of anxiety. It is an open space as there are 
no walls around the central platform and the arms, and animals 
cannot feel protected from potential threat. Animals are intro-
duced to the central platform and are left to explore the spatial 
settings. They would naturally attempt to explore and adventure 
in different areas of the maze in search for an escape route. 
The 3D maze is a modification of the classic eight-arm radial 
with arms divided in two segments. The first segment attached 
to the central platform constitutes a bridge to a flat, a raised or 
a lowered arm which provides the possibility to run the maze 
in three spatial configurations (Fig. I). Animals have to cross a 
~ Flattened arms 
d 
nRaised arms 
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Fig. I. Schematic representation of the 30 maze. (a) Central platform, (b) ramp for access to arms of the maze, (c) horizontal arm, and (d) panel for displaying visual 
stimuli. 
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bridge to reach an arm. A panel is attached to the end of each 
arm with a display of a distinctive stimulus that can be used as 
spatial navigation cue. The maze is surrounded with a curtain 
preventing animals to use external cues. This maze can offer an 
open space model of anxiety as animals exposed for the first 
time to a novel and unfamiliar spatial setting are compelled to 
explore while at the same time may experience fear without an 
alternative to avoid or escape. Animals that are placed in the 
central platform for a session of 10-12min would spend some 
time exploring the central platform and would attempt to explore 
the bridges and arms. 
Anxiety can be measured by the number of entries to bridges, 
arms and re-entries to central platform as well as by latencies 
to and duration in these areas of the maze. In anxious animals, 
the number of entries to bridges or re-entries to central plat-
form is always higher than the number of entries to arms on 
the first sessions of exposure to the test. In non-anxious animals 
and/or with repeated exposures to the test the number of entries 
to bridges would reduce to equal the number of entries to arms. 
When less anxious, an animal would engage in a bridge and 
continue up to the arm linked to that bridge whereas animal that 
is anxious would make many hesitations before adventuring in 
an arm. These hesitations are reflected by number of entries to 
bridges. 
Our test is based on the spontaneous exploratory activity 
of animals and relies on the measure of crossing responses 
from/to defined areas of the maze-the central platform, bridges 
and arms. Our analysis of behaviour is therefore based on 
spatia-temporal parameters which seem unwelcome by some 
scientists and which are progressively overshadowed by etho-
logical measurements [10,45,47,53,62, 112,125,127,135,136, 
206,209,213,225,264,223]. These ethological parameters have 
been introduced recently after repeated failure and frus-
tration reported with the current models of anxiety where 
results were often inconsistent and sometimes contradictory 
[24,33,41,69,91,122,172,204,208,260]. They are in fact a global 
term attributed to independent measures of a variety of responses 
from animals. They cannot be compared to spatia-temporal 
parameters which are a set of measures of the same behavioural 
response. The current use of ethological parameters involves the 
recording of several variables that are mostly based on subjective 
appreciations and are subject to non unequivocal interpreta-
tions [47,48,109,122,152,205,209,260,271,84]. In addition, the 
results of these ethological parameters seem insufficient and 
need to be cross-examined in a battery of behavioural tests 
[7,42,60,256]. 
The motive for such unnecessary complexity seems to be a 
lack of confidence in the primary purpose of the behavioural 
paradigms that were originally promoted as models of anxi-
ety. The philosophy behind the recording of several variables -
each variable may have several associated parameters - is that 
any of these variables may produce something significant that 
may cross-link with results from other studies. This strategy 
is justified by File [90] who wrote that in a free exploratory 
paradigm "the experimenter has little control over the animal's 
responses in a test of exploration, it is therefore important that 
as many different behaviours as possible should be recorded". 
This strategy is unscientific as the experimenter should define 
the precise conditions under which a behavioural test takes place 
and delimits beforehand the variables to assess and/or manipu-
late. In most current studies of anxiety, a behavioural test in a 
laboratory experiment involves too many independent variables 
which remain undefined and there is almost unlimited number 
of dependent variables that could be measured. 
Partisans of ethological validity claims that "unknown 
behavioural characteristics occurring in genetically modified 
animals" can be detected with ethological parameters [ 4 7, 180]. 
It is puzzling how any behavioural test can be designed to assess 
undefined behavioural responses that genetic manipulation may 
'create'. This claim justifies the eclectic strategy adopted by cur-
rent scientists to resolve methodological issues that arose from 
the poor construct validity of their animal models of human 
behaviour. When dealing with "unknown behavioural charac-
teristics" following physiological, pharmacological or genetic 
manipulations, the use of a battery of tests becomes justified 
and standardization becomes the main issue that would promote 
the debates over contradictions and inconsistencies of results 
[255,270] and distracts attention from the core problem which 
is the construct validity of the behavioural tests. 
Construct validity is defined as the extent to which a test 
measures a theoretical construct such as learning, memory, emo-
tion, attention in animal models of human behaviour or such as 
amnesia, anxiety, depression in animal models of human psycho 
or neuropathology. It is concerned with the relationship of the 
measures of the underlying attributes it is attempting to assess. 
Construct validity includes a wider range of types of validity 
among which content validity, concurrent validity, convergent 
and discriminant validity [4,61,96,118,149,192]. 
In the current behavioural neuroscience studies, a novel 
behavioural test is often challenged with pharmacological, phys-
iological or genetic manipulations in order to establish its 'con-
struct' validity while very often these manipulations themselves 
remains still to be validated. This led to inconsistencies and 
controversies in anxiety studies and some confusion between 
methodological issues which concern animal models of human 
behaviour from those concerning animal models of human psy-
cho or neuropathologies (see Section 4). 
In the present report, we describe a series of experiments 
which covers several aspects of the construct validity of our 
novel animal model of human anxiety. We examined the 
behaviour of a range of commonly used experimental mice 
strains including C57, C3H, CD1 and Balb/c strains in the 
3D maze. We are opposed to pharmacological validation of a 
novel animal behavioural test of anxiety as we consider that a 
behavioural test should be able to stand alone and reveal the func-
tional properties of any test compound (perceived anxiolytic or 
unknown). A difference between strains of mice is more appro-
priate for the examination of the sensitivity and the reliability 
of the measures of a behavioural test. In the first experiment, 
different groups of C57 mice were tested each in one of the 
three spatial arm configurations of the maze. The purpose of 
this experiment is to examine whether these maze configurations 
would produce comparable emotional responses in animals. In 
the second experiment, C57 mice were compared to C3H mice. 
A. Ennaceur et al. I Behavioural Brain Research 174 (2006) 9-38 13 
This experiment would try to confirm the pattern of responses 
observed in C57 mice in experiment 1. In addition, in low-
ered arm configuration the bridges were lined with wire mesh 
to examine whether motor activity would be improved in mice 
when walking up or down a bridge and if it contributes to anxiety 
responses. In the third experiment, C57 mice were compared to 
CD 1 and Balblc mice in the raised arm configuration over three 
successive sessions. In our laboratory, the 3D maze is used to 
test memory in mice and rats. We introduce animals directly 
to a working memory paradigm without the usual habituation 
procedure. The first sessions of exposure to the 3D maze pro-
vide an opportunity to examine animal emotional responses at 
an early stage of learning and memory processes. In the fourth 
experiment, a group of C57 were tested in lowered arm configu-
ration with an enclosed central platform and compared to other 
groups tested in other arm configurations with an open central 
platform. The purpose of this experiment is to demonstrate that 
the presence of an enclosed space encourages escape/avoidance 
responses and that the open space models do not involve such 
responses. In the final experiment, we examined the difference 
between C57 and C3H mice of both sexes. This experiment was 
run on a mixed spatial configuration of the arms which is another 
option that is offered by the test, but unfortunately there were 
only eight arms. It would have been more appropriate with an 
equal number of raised, lowered and flat arms. 
The video and data analysis of all experiments were per-
formed at later stage after all experiments were finished. There-
fore the design of each experiment was based on some assump-
tions made from gross observations which were revealed some-
times incorrect such as the selection in experiment 4 of C57 mice 
which were the least anxious strain. 
2. General methods 
2.1. Animals 
The animal weight was 20--25 g at the time of their arrival. The colony room 
was held under a 12 h light/12 h dark cycle (light 07:00--19:00 hat 180 lx) and at 
23 ± 1 oc. In order to avoid unequal1ight exposure, the upper shelf was occupied 
with empty plastic cages filled with sawdust. Mice were housed in a group of five 
to six mice per cage. Individual mice could be identified by their cage number 
and their ear tags. Mice were allowed to acclimatize for a month before the start 
of the experiment. All mice had ad libitum access to food and water. During their 
stay in respective housing conditions, they were removed twice a week from their 
cages for cleaning the cages and renewing their food and water supply. Animal 
treatment and husbandry were in accordance with approved use of animals in 
scientific procedures regulated by the Animals (Scientific Procedures) Act 1986, 
UK. 
2.2. Apparatus 
It consists of eight arms radiating from a central platform (Fig. I). Each 
arm (51 em x 11.2 em) is made from two segments, extended from an octagonal 
shaped central hub (30 em in diameter) and can be manipulated independently. 
The first segment of an arm ( 15.2 em x 11.2 em) directly attached to the central 
platform can be tilted (max. 90°) and constitutes a bridge that allow access to the 
second segment (35 em x 11.2 em) of the arm which is presented horiwntally 
either at the same, below or above the level of a central platform. Sidewalls, about 
I em high, extended the length of each arm that is raised 60 em from the ground. 
Tn order to change the configurations of the maze, the central platform is raised 
or lowered by 15 em. The bridge forms a slope which is inclined by about 60°. 
The maze is placed in a sound attenuated room with a masking noise of 70 db 
above the human thresholds. The end of each arm is extended with panels of 
identical size (20.2 em x 11.2 em). These panels are used for holding intra-maze 
cues made of distinctive pattern drawings designed on plastic adhesive material 
and attached to a PVC board (18 em x 11.2cm). A small cup (2.5 em wide) was 
placed at the end of each arm. The maze is made from grey PVC (5 mm thick). 
The maze is totally surrounded with a heavy beige-light coloured curtain. A 
camera is centred 200 em above the central platform. The ambient light at the 
surface of the central platform was 180 lx. 
2.3. Tools and recording measures 
During the test, mice were observed on a screen monitor connected to a video 
camera suspended above the test arena. The video record of the experiment is 
run on a computer screen monitor through a capture card. The live scene is 
shown alongside a console window (EventLog) that simulates the arena of the 
box apparatus. The experimenterneeds only to press either pre-defined keyboard 
keys whenever a mouse approaches an object or moves the mouse key on pre-
defined areas of the screen. Since the experiment is videotaped, the experimenter 
can review the tape and check the accuracy of the recording at any time. In the 
present experiment, the recording was performed from a video tape played on 
a VCR. The EventLog program is written in C++ and can be used for many 
purposes as it requires only visual definition of the layouts of the test apparatus 
and, the experimenter has only to press the appropriate related key whenever a 
mouse approaches a predefined area. EventLog provides a record in sequential 
order of the start and end of each approach, the duration of each approach, and 
the list of key codes of the predefined area of the test that have been activated. The 
data record of each mouse can be saved on a text document and, can be exported 
to any spreadsheet for data analysis. From these records, it is possible to generate 
a variety of measures such as frequency, latencies between approaches and the 
sequence order of responses (see section below). 
2.3.1. Measurements and statistical analysis 
Several measurements were considered: 
(1) Number of bridge and arm entries. An entry to an arm or a bridge is 
recorded whenever a mouse crosses with all four paws the line that delimits 
these areas. The same bridge and the same arm can be visited several times 
within a session. 
(2) Number of bridge entries before first arm visit. An entry to a bridge is 
recorded whenever a mouse crosses with all four paws the line that delimits 
this area. The same bridge can be visited several times. A mouse that did 
not enter an arm receives the highest score registered from any mice +I. 
(3) Latency of first entry to a bridge. The time spent by a mouse in the central 
platform before it enters for the first time in one of the bridges with all 
four paws. A mouse that did not enter a bridge receives the highest score 
which is 10--12 min. 
( 4) Latency of first entry to an arm. The time spent by a mouse in the central 
platform and bridges before it enters for the first time in one of the arms 
with all four paws. A mouse that did not enter an arm receives the highest 
score which is 10--12 min. 
(5) Latency of first entry in the eighth arm. The time spent by a mouse before 
entering the last remaining non-visited arm. This should not be confused 
with eighth choices. Some mice may have visited only a few arms and up 
to seven arms in a session and may have made many repeated entries to 
these same arms in a session that lasted I 0--12 min, their latency score is 
10-12min. 
(6) Total duration and average duration of bridge entries. The time is recorded 
from the entry of a mouse with all four paws in a bridge until it exits to the 
central platform or to an arm. The average duration is based on the total 
duration of entries to bridge divided by number of entries to bridges. 
(7) Total duration and average duration of arm entries. The time is recorded 
from the entry of a mouse with all four paws in an arm until it exits to the 
bridge. The average duration is based on the total duration of arm entries 
divided by number of entries to arms. 
(8) Total duration and average duration of centre re-entries. The time is 
recorded from the entry of a mouse with all four paws in the central plat-
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form until it exits to a bridge. The average duration is based on the total 
duration of entries to the centre divided by number of entries to the centre. 
(9) Average number of entries to centre between arm visits. A mouse can 
return many times to the centre by visiting the bridges without engaging 
in an arm. This measure will examine the average number of entries of the 
centre between consecutive visits to arms. 
( 10) Total latencies and average latency between exits from and entries to arms. 
The time is recorded when a mouse exits from an arm with all four paws 
until its next re-entry to an arm (the same or another arm). The average 
latency is based on the total latencies between exit and entries to arms 
divided by the number of entries to the centre. A mouse that did not enter 
an arm receives the highest score which is 10 or 12 min. 
(II ) Number of unique arm visits. ln an eight arms radial maze, there can be 
only eight unique visits maximum in a session. Any arm can be visited 
more than once within a session that lasted I 0 or 12 min and the total 
number of visits can be higher than eight but some arms may receive no 
visit. This measure will indicate how many arms were left unvisited and 
avoided. 
(12) Session duration. When animals are left in the maze until eight choices 
were made or 10-12 min elapsed the latency of first entry in the eighth 
arm do not apply and is replaced here by the measure of the time it took 
for animals to make eight choices in a session. A choice can be any visit 
or repeated visit to an arm. 
Differences among group means for each of the above measurements 
were tested for significance with one-way ANOVA in the first two experi-
ments. Two-way ANOVA was performed in the third experiment with strains 
as variables and sessions as repeated measures. This was foUowed up with 
Newman-Keuls post hoc comparisons. We also performed correlation analy-
ses to examine the relations between the different measurements in the three 
arm maze configurations. Statistics were calculated using the statistical pack-
age Statistica for Wrndows (Version 5.5). Results were considered significant 
when p::; 0.05. When p::; 0. 10, it was reported and rounded up to the nearest 
value. 
2.4. Experiment 1: reaction to novelty and open spaces in C57 
mice 
Different groups of C57 mice were examined in the 3D maze. Each group 
was tested in a unique session in one arm configuration only. These mice 
were exposed for the first time to the apparatus and were not previously 
food deprived. The purpose of this experiment is to examine the behavioural 
responses of animals to open spaces and novelty in the different configurations 
of the maze. It is possible that emotional responses would be best observed 
in one configuration than another and would justify its selection in future 
experiments. 
2.4. I. Subjects 
Thirty C57 male mice supplied by Charles River Laboratories (Kent, UK) 
were used in the present study. 
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2.4.2. Testing procedures 
Mice were tested in a unique session in one of the three arm maze configu-
rations. The bridges were not covered with wire mesh grid. The order of testing 
was randomly alternated between batches of five mice from the same cage; each 
batch of mice being randomly selected for testing in one of the three arm maze 
configurations. We used three groups of mice (n = 10 each). Each group was 
exposed to one configuration of the maze only, either raised, flat or lowered 
arms. A mouse is removed from its cage, put in a small bucket in which it is 
weighted and then poured gently in the centre platform of the maze. It is left in 
the maze until 12 min elapsed. 
2.4.3. Results 
2.4.3.1. Number of bridge entries (Fig. 2 (left)). One-way ANOVA revealed 
significant differences between groups (F2.21 = !3.05,p < 0.0001). Post hoc com-
parisons show that the number of entries to bridges is significantly low in 
lowered arm configurations compared to flattened (p<0.0003) and raised arm 
(p < 0.0005) configurations. 
2.4.3.2. Number of arm entries. One-way AN OVA revealed no significant dif-
ferences between groups (F2,27 = 1.30, p > 0.1 0) for the number of entries to 
arms in each arm configurations. 
2.4.3.3. Number of bridge entries before first arm visit (Fig. 2 (right)). One-way 
AN OVA revealed significant differences between groups (F2.21 =4.73,p <0.02). 
Post hoc comparisons show that the number of entries to bridges is significanlly 
high in flat arm configuration compared to lowered (p < 0.02) and raised arm 
(p < 0.02) configurations. 
2.4.3.4. Latency of first entry to a bridge (Fig. 3 (left)). One-way ANOVA 
revealed significant differences between groups (F2.21 = 3.91 ,p < 0.03). Post hoc 
comparisons show that the latency of the first entry to a bridge is significanlly 
low in flat arm configuration compared to lowered (p < 0.03) and raised arm 
(p < 0.05) configurations. 
2.4.3.5. Latency of first entry to an arm (Fig. 3 (right)). One-way ANOVA 
revealed no significant differences between groups (F2.21 = 2.90, p S. 0.07). The 
latency of first entry to an arm in raised arms appears lower than in flat and 
lowered arms. 
2.4.3.6. Latency of first entry to the eighth arm. One-way ANOVA revealed no 
significant differences between groups (F 2.21 = 1.81 , p > 0.1 0) for the latency to 
visit the eighth arm of the maze. 
2.4.3.7. Average number of entries to centre between arm visits. One-way 
ANOVA revealed no significant differences between groups (F2,27 = 0.89, 
p > 0.1 0) for the number of entries to the centre between arm visits. 
2.4.3.8. Total duration and average duration of bridge entries. One-way 
AN OVA revealed no significant differences between groups (F2.21 = 1.74, 
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Fig. 2. Number of entries to bridges (left) and number of entries to bridges before first visit to an arm (right) in each maze configuration. See text above for statistic 
results. 
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Fig. 3. Latency of first entry to a bridge (left) and latency of first entry to an arm (right) in each maze configuration. See text above for statistic results. 
p > 0.1 0) for the total duration of entries to bridges. However, there were signifi-
cant differences between groups on the average duration of entries (Fz;n = 3.50, 
p < 0.04). Fig. 4 (left) shows that mice in lowered arms spent significantly more 
time on bridges than mice in raised (p < 0.05) and flattened arms (p < 0.04). 
2.4.3.9. Total duration and average duration of ann entries. One-way AN OVA 
revealed no significant differences between groups for the total duration 
(Fz,z7 =0.13, p>O.lO) and average duration (Fz,z7=2.06, p>O.lO) of entries 
to arms. 
2.4.3.10. Total duration and average duration of centre re-entries. One-way 
AN OVA revealed no significant differences between groups (Fz,27 = 1.08, 
p >O.lO) for the total duration of entries to the centre in each arm configura-
tion. However, there were significant differences between groups on the average 
duration of entries (F2,21 = 15 .18, p < 0.000 I). Fig. 4 (right) shows that mice in 
lowered arms spent significantly more time on the central platform than mice in 
raised {p<0.0002) and flattened arms {p<0.0002). 
2.4.3.1 1. Total latencies and average latency between exits from and entries 
to anns. One-way ANOVA revealed no significant differences between groups 
for the total latencies (F2,21 = 1.89, p >0. 10) and average latency (F2,27 =0.68, 
p > 0.1 0) between exits and entries to arms. 
2.4.3.12. Number of unique ann visits. One-way ANOVA revealed no signifi-
cant differences between groups for the number of unique visits to the arms of 
the maze (F2,27 = 0.99, p > 0.1 0). 
2.4.4. Summary 
C57 mice in the maze configuration with raised arms spent less time in the 
central platform compared to mice in lowered arm configuration. They took 
longer time to enter a bridge for the first time compared to flat arm configuration 
and less time to enter an arm for the first time compared to mice in fiat and 
lowered arm configurations. They also made large number of visits to bridges 
compared to mice in lowered arm configuration and required fewer bridge entries 
before first arm visit compared to mice in flat arm configuration. 
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C57 in the maze configuration with flat arms spent less time in the central 
platform compared to mice in lowered arm configuration. They took less time to 
enter a bridge for the first time compared to raised and lowered arm configura-
tions but required more time to enter an arm for the first time compared to raised 
arm configuration. They also made large number of visits to bridges compared 
to mice in lowered arm configuration and required high number of bridge entries 
to first arm visit compared to mice in raised and lowered arm configuration. 
C57 in the maze configuration with lowered arms spent more time in the 
central platform compared to mice in raised and flat arm configurations. They 
took less time to enter a bridge for the first time compared to flat arm configura-
tion and more time to enter an arm for the first time compared to mice in raised 
arm configuration. They also made a few number of visits to bridges compared 
to mice in raised and flat arm configurations and required fewer bridge entries 
before first arm visit compared to mice in flat arm configuration. 
There were no differences between groups in the number of entries to arms 
and the time spent in the arms, in the latency to enter the eighth arm, in the 
average number of entries to the centre between arm visits, in the latencies 
between re-entries to arms as well as in the number of unique visits to arms. 
The examination of the different measurements suggests that raised arm 
configuration provides the most consistent results and this is supported by the 
correlation analysis (Table I). 
2.5. Experiment 2: reaction to novelty and open spaces in C57 
and CJH mice 
In the previous experiment, C57 mice made several visits to bridges and 
arms but these seem less important in the lowered arm configurations than in 
the raised one but some measures were not significant which might be due to a 
ceiling performance level in this strain of mice. There are indeed results in the 
literature suggesting that C57 mice are less emotional than other strains of mice 
in the T-maze, open-field and light-dark box. These results, however, are not 
supported by all studies. In this second experiment, we used C57 mice to confirm 
our results from experiment I and to compare and contrast their behaviour to 
C3H strain in the three configurations of the maze. In addition, we thought that 
a wire mesh grid on the floor of the bridges may help mice to climb up and 
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Fig. 4. Average time spent in the bridges (left) and in the central platform (right) in each maze configuration. See text above for statistic results. 
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return back to the central platform more easily. Animals in several experiments 
seemed not having any problems walking up and down the bridges except that 
we observed consistently that in lowered ann configuration mice made less visits 
to arms. Both in raised and lowered maze configurations the bridges between 
the central platform and the arms have comparable slopes. In this experiment 
we would examine whether motor activity would be improved when walking 
up or down a bridge and if it contributes to our measures of anxiety responses. 
Therefore we examined a separate group of animals from each strain of mice on 
lowered ann configuration with the bridges covered with wire mesh in addition 
to other groups tested separately in the three configurations of the maze without 
a wire mesh on the bridges. 
2.5.1. Subjects 
Twenty C57 and 24 C3H male mice supplied by Charles River Laboratories 
(Kent, UK) were used in the present study. 
2.5.2. Testing procedures 
Different groups of C57 and C3H mice were examined in the 30 maze. Each 
group was tested in a unique session in one of the three ann configurations of 
the maze without wire mesh grid on the floors of the bridges. In addition to these 
· groups, one group of C57 mice and one group of C3H mice were included in 
the experiment and were tested in lowered maze configuration with a wire mesh 
Table 1 
grid covering the floor of the bridges. All mice were exposed for the first time 
to the apparatus and were tested in a unique session in one of these four ann 
configurations of the maze. They were not previously food deprived. There were 
five C57 and six C3H mice in each test configuration. They were released by 
hand on the central platform and were left in the maze until 12 min elapsed. 
2.5.3. Results 
2.5.3.1. Number of bridge entries (Fig. 5 (left)). One-way ANOVA revealed 
significant differences between groups <F7.36 =8.10, p<O.OOOl). In C57, the 
number of bridge entries is comparable between the different arm configurations. 
In C3H mice, the number of entries in the bridges is significantly high in flattened 
arms compared to raised arms (p<0.04), to lowered arms (p<0.008) and to 
lowered arms with wire mesh (p<0.04). 
There are also significant differences between C57 and C3H mice on all ann 
configurations except flattened arms. C57 mice, compared to C3H, made more 
entries in the bridges of raised arms (p < 0.002), lowered arms (p < 0.001) and 
lowered arms with wire mesh (p<0.04). 
2.5.3.2. Number of arm entries (Fig. 5 (right)). One-way ANOVA revealed 
significant differences between groups CF7.36 = 13.92, p<O.OOOl). In C57, the 
number of arms entries is comparable between the different arm configurations. 
In C3H mice, the number of entries in the arms is significantly high in flattened 
Correlations between the different measurements of the behaviour of mice in lowered (A), flat (B), raised (C) arms configurations, and of the behaviour of all animals 
(pooled data) independent of ann configurations (D). •significant correlations at p::;0.05 (n= 16, r?:0.50 for A, B, C and n=48, r?:0.29 for D). !significant 
correlations at p ::; 0.10 (n = 16, r?: 0.42 and r::; 0.50 for A, B, C and n = 48, r?: 0.24 and r ::; 0.29 for D). Greyed areas highlight the common significant correlations 
observed in the three arm configurations of the maze 
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3 -0.29 
4 -0.16 
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Table I (Continued) 
(C) 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
2 0.16 
3 
-0.18 0.38 
4 
-0.30 0.58* 0.64* 
5 0.07 0.41 0.54* -0.01 
6 
-0.10 -0.45t -0.51* -0.05 -0.97* 
7 
·0.01 -0.35 -0.54* -0.11 -0.92* 0.97* 
8 0.09 0.47t 0.43t 0.00 0.96* -0.96* -0.93* 
9 0.10 0.47t 0.45t 0.02 0.96* -0.97* -0.94* 1.00* 
10 0.17 0.00 0 .19 -0.48t 0.81 * -0.75* -0.71* 0.75* 0.75* 
11 
-0.25 0.53* 0.84* 0.74* 0.46t -0.45t -0.44t 0.39 0.41 -0.05 
12 
-0.34 0.02 0 .38 0.64* -0.43t 0.44t 0.41 -0.55* -0.53* -0.67* 0.53* 
13 
-0.02 0.42f 0.44t 0.70* -0.10 0.05 -0.04 -0.01 0.00 -0.37 0.38 0.24 
14 
-0.07 -0.23 -0.24 0.29 -0.91 * 0.88* 0.81* -0.89* -0.88* -0.85* -0.22 0 .54* 0.45t 
15 0.17 -0.60* -0.90* -0.76* -0.53* 0.54* 0.57* -0.50* -0.53* -0.07 -0.91 * -0.32 -0.63* 0.21 
16 
-0.01 -0.43t -0.73* -0.20 -0.90* 0 .88* 0.88* -0.88* -0.89* -0.71* -0.58* 0.28 -0.24 0.70* 0.74* 
17 
-0.05 0.04 0.26 0.54* -0.34 0.34 0.27 -0.31 -0.32 -0.62* 0.27 0.46t 0.53* 0.54* -0.26 0.21 
(0) 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
2 
-0.05 
3 0.10 0.52* 
4 0.03 0.43* 0.55* 
5 0.01 0.40* 0.48* -0.10 
6 
-0.16 -0.35* -0.44* 0.14 -0.88* 
7 
-0.21 -0.08 -0.42* -0.04 -0.74* 0.88* 
8 0.04 0.41* 0.64* 0.37* 0.71* -0.60* -0.58* 
9 0.08 0.45* 0.67* 0.35* 0.78* -0.69* -0.66* 0.99* 
10 0.09 -0.03 0.18 ·0.35* 0.79* -0.71 * ·0.62* 0.55* 0.59* 
11 0.08 0.45* 0.74* 0.38* 0.45* -0.38* ·0.35* 0.46* o.5o* 0.05 
12 0.05 0.13 0.21 0.07 -0.09 0.03 0 .02 -0.39* -0.32* -0 .36* 0.58* 
13 
-0.07 0 .11 0.17 0.31* -0 .27t 0.35* 0.26t 0.03 -0.03 -0.35* 0.16 0 .22 
14 
-006 -0.21 -0.39* -009 -0.62* 0.49* 0.42* -0.65* -0.66* -0.54* -0.29* 0.38* 0.64* 
15 
-0.17 -0.43* -0.64* ·0.40* -0.54* 0.52* 0.50* -0.64* -0.68* -0.27t -0.47* 0.16 0.42* 0.82* 
16 
-0.12 ·0.27t -0.57* ·0.24 f -0.61* 0.47* 0.45* -0.72* -0.73* -0.50* ·0.40* 0.31* 0.41 * 0.93* 0.89* 
17 0.00 0.22 0.16 0.27 t -0 .25t 0.15 0.14 -0.17 -0. 16 -0.49* 0.18 0.33* 0.24t 0.29t 0.01 0.22 
I: latency of entry to fi rst bridge; 2: latency of entry to fi rst ann; 3: total latencies between exit from and return to arms; 4: average latency between exit from and 
return to arms; 5: average number of entries to centre between visits to arms; 6: number of bridge entries before visit to first ann; 7: number of entries to centre; 8: 
number of entries to bridges; 9: number of entries to arms; I 0: number of repeated visited to arms; II : duration in centre; 12: average duration in centre; 13: duration 
in bridges; 14: average duration in bridges; 15: duration in arms; 16: average duration in arms; 17: latency of first entry to the eighth ann. 
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Fig. 5. Number of entries to bridges (left) and to arms (right) in each maze configuration. See text above for statistic results. 
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Fig. 6. Latency of first entry to a bridge (top-left) and an arm (top-right) and latency of first entry to the last non-visited arm in each maze configuration. See text 
above for statistic results. 
arms compared to raised arms (p < 0.05), to lowered arms (p < 0.004) but not to 
lowered arms with wire mesh (p<O.lO). 
There are also significant differences between C57 and C3H mice on all arm 
configurations. C57 mice, compared to C3H, made more entries in raised arms 
(p<O.OOOl), flattened arms (p<O.Ol), lowered arms (p<0.0002) and lowered 
arms with wire mesh (p<0.003). 
2.5.3.3. Number of bridge entries before first arm visit. One-way ANOVA 
revealed no significant differences between groups (F7,J6 = 0.90, p > 0.1 0) for 
the number of entries to bridges before first visit to an arm. 
2.5.3.4. Latency of first entry to a bridge (Fig. 6 (top-left)). One-way AN OVA 
revealed significant differences between groups (F7,36 = 16.95, p<0.0001). In 
C57, the latency of first entry to a bridge is comparable between the different 
arm configurations. In C3H mice, the latency of first entry to a bridge is signifi-
cantly low in flattened arms compared to raised arms (p < 0.0007) and to lowered 
arms (p<O.OOOl). It is also significantly low in lowered arms with wire mesh 
compared to raised arms (p < 0.00 I) and lowered arms (p < 0.0002). 
There are also significant differences between C57 and C3H mice on raised 
and lowered arm configurations. C57 mice, compared to C3H, took less time to 
enter for the first time a bridge in the raised (p < 0.0002), and lowered (p < 0.000 I) 
arm configurations. 
2.5.3.5. Latency of first entry to an arm (Fig. 6 (top-right)). One-way AN OVA 
revealed significant differences between groups (F7,36 = 12.47, p<O.OOOI). In 
C57, the latency of first entry to a bridge is comparable between the different arm 
configurations. In C3H mice, the latency of first entry to an arm is significantly 
low in flattened arms compared to raised arms (p < 0.02) and to lowered arms 
(p<O.OI). It is also significantly low in lowered arms with wire mesh compared 
to raised arms (p < 0.02) and lowered arms (p < 0.008). 
There are also significant differences between C57 and C3H mice on the 
different arm configurations. C57 mice, compared to C3H, took less time to enter 
an arm for the first time in raised arms (p < 0.0002), flattened arms (p < 0.05), 
lowered arms (p<O.OOOI) and lowered arms with wire mesh (p<0.03). 
2.5.3.6. Latency of first entry to the eighth arm (Fig. 6 (bottom)). One-
way ANOVA revealed significant differences between groups (F7,36 = 8.04, 
p < 0.000 I). In C57, the number of bridge entries before entry to the eighth 
arm is significantly high in lowered arm with wire mesh compared to raised 
(p < 0.01 ), to flattened (p < 0.008) and lowered (p < 0.02) arm configurations. In 
C3H, the latency is comparable between the different arm configurations. 
There are also significant differences between C57 and C3H mice on all arm 
configurations except for lowered arms with wire mesh. C57 mice, compared 
to C3H, took less time to visit the eighth arm in the raised (p < 0.001 ), flattened 
(p <0.009), 1owered (p<0.004) arm configurations. 
2.5.3. 7. Average number of entries to centre between arm visits. One-way 
ANOVA revealed no significant differences between groups (F7,36 =0.64, 
p > 0.1 0) for the number of entries to the centre between arm visits. 
2.5.3.8. Total duration and average duration of bridge entries. One-way 
ANOVA revealed significant differences between groups for the total duration 
(F7,36 =4.61 , p<0.0009) and the average duration (F7,36 =3.45, p<0.006) of 
entries to bridges. 
In C57, the total duration (Fig. 7, top-left) and average duration of entries 
to the bridges (Fig. 7, top-right) is comparable between the different arm con-
figurations. In C3H mice, the total duration and average duration of entries to 
the bridges is significantly low in raised and lowered arms compared to lowered 
arms with wire mesh (p < 0.02). 
There are also significant differences between C57 and C3H mice on the low-
ered arm configurations. The total duration of visits to bridges of lowered arms 
was significantly high in C57 mice compared to C3H (p < 0.02) and the average 
duration of visits to bridges of lowered arm with wire mesh was significantly 
low in C57 compared to C3H. 
2.5.3.9. Total duration and average duration of arm entries. One-way 
ANOVA revealed significant differences between groups for the total duration 
(F7,36 = 7.9l ,p< 0.0001) but not for the average duration (F7,36 = 1.18, p>O.IO) 
of entries to arms. 
A. Ennaceur eta/. I Behavioural Brain Research 174 (2006) 9-38 19 
Time spent In bridges 
400 
350 
300 
i 250 
.!!. 
Cll 200 
E 
i= 150 
100 
50 
0 
Raised Flattened Lowered Low+Meshwire 
Ann configurations 
80 
70 
50 
i so 
Ill 
-; 40 
E 
;:: 30 
20 
Average time spent In bridges 
10 
o+---~~~~~~~ 
Raised Flattened Lowered Low+Meshwire 
Arm configurations 
Time spent in arms 
450 
400 
350 
u 300 
Cll 
.!. 250 
Cll E 200 
;:: 150 
100 
50 
0 
fiCs7l 
~ 
Raised Flattened Lowered Low+Meshwire 
Arm configurations 
Fig. 7. Total duration (top-left) and average duration (top-right) of entries to bridges and total duration of entries to arms (bottom) in each maze configuration. See 
text above for statistic results. 
In C57, the total duration of entries to arms is comparable between the 
different arm configurations. In C3H mice, the total duration of entries to arms 
is significantly low in lowered arms compared to flattened arms (p<0.02). It 
was not significant between raised and lowered arms (p < 0.09). 
There are also significant differences between C57 and C3H mice on all 
arm configurations except for the flattened arms (Fig. 7, bottom). C57 mice, 
compared to C3H mice, spent more time on raised arms (p<O.Ol ), on lowered 
arms (p<0.003) and lowered arms with wire mesh (p<0.04). 
2.5.3. 10. Total duration and average duration of centre re-entries. One-way 
AN OVA revealed significant differences between groups for the total duration 
(F7,36 = 18.37,p < 0.0001 ) and the average duration <F7,36 = 8.60, p<O.OOOl) of 
entries to the central platform. 
In C57, the total duration of entries to the central platform is comparable 
between the different arm configurations. Tn C3H mice, the total duration and 
average duration of entries to the central platform is significantly low in flat-
Time spent In the central platform 
Raised Flattened Lowered Low+Meshwlre 
Ann configurations 
tened and lowered arms with wire mesh compared to raised and lowered arms 
(p<0.0004). 
There are also significant differences between C57 and C3H mice on raised 
and lowered arm configurations. The total time (Fig. 8, left) and average time 
(Fig. 8, right) spent on the platform is significantly low in C57 mice compared 
to C3H on raised arms (p<0.003) and on lowered arms (p<0.0004). 
2.5.3.11. Total latencies and average latency between exits from and entries 
to arms. One-way AN OVA revealed significant differences between groups for 
the total latencies (F 7,36 = 3.07, p <0.01) and the average latency (F7,36 = 5.47, 
p < 0.0002) between entries to arms. 
In both C57 and C3H mice, the total latencies (Fig. 9, left) and the average 
latency (Fig. 9, right) between entries to arms is comparable between the different 
arm configurations. 
The total latencies was significantly high C3H on raised arms compared to 
C57 on flattened (p<0.04) and lowered arms (p<0.05). The average latency 
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Fig. 8. Total duration (left) and average duration (right) of entries to the central platform in each maze configuration. See text above for statistic results. 
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between entries to arms, however, revealed that C3H mice took significantly 
much longer time to return to arms than C57 mice on raised (p < 0.007) and 
lowered arms (p<O.OI). 
2.5.3.12. Number of unique arm visits. One-way ANOVA revealed signif-
icant differences between groups for the number of unique visits to arms 
{F7,36= 15.49,p<0.0001). 
In C57, the number of unique visits to arms is comparable between the 
different ann configurations. In C3H mice, the number of unique visits to arms 
is significantly high in tlattened compared to raised (p < 0.05) and lowered arms 
(p<0.02). 
There are also significant differences between C57 and C3H mice on all ann 
configurations (Fig. 10). The number of unique visits to arms is significantly 
high in C57 mice compared to C3H on raised arms (p<O.OOOl), flattened arms 
(p<0.007), lowered arms (p<O.OOOl) and on lowered arms with wire mesh 
(p<0.002). 
2.5.4. Summary 
2.5.4.1. Difference between arm configurations within C57 and C3H mice. In 
C57 mice, there were no differences between the measurements on the different 
configurations of the test except for the latency of the first unique visit to the 
eighth ann. C57 took longer time to enter the eighth ann. 
C3H mice, in the flat ann configuration compared the raised and lowered 
ann configurations spent less time in the central platform, took less time to enter 
the first bridge and the first ann; they made more entries to bridge and arms and 
more unique visits to arms. 
C3H mice in lowered ann+ wire mesh configuration compared to raised an 
lowered ann configuration spent less time in the central platform and more time 
on the bridges; they took less lime to the enter the first bridge and the first ann. 
2.5.4.2. Difference between C57 and C3H on each arm configuration. C3H 
mice compared to C57 mice, in the raised lowered ann configurations, spent 
more time in the central platform and less time in the arms, made fewer visits to 
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Fig. 10. Number of unique visits to arms (right) in each maze configuration. See 
text above for statistic results. 
bridges and arms, took longer time to enter the first bridge and the first ann. They 
also required longer latencies between ann entries and visited a few number of 
unique arms. 
C3H mice compared to C57 mice, in the flat ann configuration, made a few 
number of arm visits, took longer time to visit a bridge and an arm for the first 
time, and made a few number of unique ann visits. 
C3H mice compared to C57 mice, in the lowered+wire mesh ann config-
uration, made a few number of visits to arms and bridges, took longer time to 
enter an ann of the first time, spent more lime on bridges and less lime on arms, 
and made a few number of unique ann visits. 
2.5.4.3. Effects of the wire mesh grid. The introduction of a wire mesh grid on 
the floor of the bridge had no significant effects on any parameter of the test 
in C57 mice except on the latency of entry to eighth ann (p< 0.02). However, 
in C3H, it reduced significantly the total time (p < 0.0002) and average time 
(p < 0.0003) spent in the central platform. It also reduced significantly the latency 
of first entry to a bridge (p < 0.0002) and to an ann (p < 0.008) of the maze and 
increased significantly the total time (p < 0.002) and average time (p < 0.02) 
spent in the bridges. 
The number of entries to arms, the latency to first entry to bridge and arms 
and both total duration and average duration of entries to arms in the lowered 
ann configuration with wire mesh are comparable to those observed in the flat 
ann configuration. 
2.6. Experiment 3: reaction to novelty and open spaces in food 
deprived C57, CDJ and Balb/c mice over three successive sessions 
In a previous study, we demonstrated how to take advantage of the habituation 
phase of an object recognition test to assess anxiety [83]. We suggest here that 
it is possible to assess anxiety responses in animals during the first phase of a 
learning and memory tests without any changes to the testing conditions. Indeed 
in our laboratory, we are able to introduce rats and mice directly to a spatial 
maze and train rats for a maximum of 12-16 sessions without the introduction 
of pre-training or shaping. Animals reach a high performance level in much 
shorter period of time than if they had undergone habituation or pre-training. ln 
this study, we present only results from the first three sessions. A group of C57, 
CD I and Balblc mice were examined in the raised ann configuration of the 3D 
maze. Each group was tested in three successive sessions, one session a day. In 
the present study, animals were food deprived. 
2.6.1. Subjects 
Thirty male mice (Balb/c, C57 and CD! , n = 10 each) supplied by Charles 
River Laboratories (Kent, UK) were used in the present study. 
2.6.2. Testing procedures 
Mice were tested in a unique session in the elevated ann maze configuration. 
The floors of the bridges were covered with wire mesh grid. The cups at the end 
of each ann contained one reward pellet (20 mg P.J. Noyes Company Inc., UK). 
One hour after the completion of the session animals had a free access to 5 g of 
biscuits. 
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The order of testing was randomly alternated between batches of five mice 
from the same cage and between cages from different strains of mice. A mouse 
is removed from its cage, put in a small bucket in which it is weighted and 
then poured gently in the centre platform of the maze. Unlike in the previous 
experiments, mice were left in the maze until eight choices were made or 
I 0 min elapsed. 
2.6.3. Results 
2.6.3.1. Number of bridge entries (Fig. ll, top-left). There are a sig-
nificant effect between groups (Fz.z? =5.28, p<O.OI), between sessions 
(Fz.54 = 57.64, p < 0.0001) and significant interactions between groups and ses-
sions CF4.54 = 13.81, p<O.OOOI). 
CD I made fewer visits to bridges than Balb/c (p < 0.05) and C57 (p < 0.009). 
The number of entries to bridges decreased significantly from session to session 
(p<0.003). 
Post hoc comparisons revealed that CD I visited more bridges than Balb/c 
(p<0.04) and less than C57 (p<0.03) and in the first session, and they visited 
a few number of bridges in session 2 compared to C57 (p < 0.0008) and Balb/c 
(p<O.OOl) and in session 3 compared to Balb/c only (p<0.004). C57 mice 
visited more bridges than Balb/c in session I (p < 0.0006) and fewer bridges in 
session 3 (p < 0.008). 
2.6.3.2. Number of arm entries (Fig. 11, top-right). There are a signifi-
cant differences between groups (F2.21 =30.77, p<O.OOOI), between sessions 
(Fz,54 =20.57, p<O.OOOI) but no significant interactions between groups and 
sessions <F4.54 = 1.67, p > 0.10). 
C57 and CD I made more visits to arms than Balb/c (p < 0.000 I). The number 
of arm entries increased significantly from session to session (p < 0.005). 
Post hoc comparisons revealed that C57 and CDI visited more arms than 
Balb/c in each of the three sessions of the test (p <0.001). C57 mice visited also 
more arms than CDI in the second session (p < 0.04). 
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2.6.3.3. Numberofbridgeentriesbeforejirstarm visit(Fig.1 1, bottom). There 
are significant differences between groups (Fz.z? = 23.96, p < 0.0001 ), between 
sessions (F2,54 = 31.24, p < 0.0001) and significant interactions between groups 
and sessions (F 4,54 = 4.24, p < 0.005). 
C57 and CD I made a few number of visits to bridges before first entry 
to an arm than Balb/c (p < 0.0002). The number of entries to bridges before 
first visit to an arm decreased significantly from session to session (p < 
0.002). 
Post hoc comparisons revealed that CD 1 and C57 visited a few number of 
bridges than Balb/c in sessions 2 and 3 (p < 0.0004). The difference between 
CD 1 and C57 in session 1 did not reach significance (p < 0.09). 
2.6.3.4. Latency of first entry to a bridge. There are a no significant differences 
between groups (Fz.27 = 1.91, p> 0.10), but significant differences between ses-
sions (F2,54 = 7.63,p < 0.001) and no significant interactions between groups and 
sessions (F4,54 =0.77,p>0.10). The latency of first entry to a bridge decreased 
significantly from session to session (p < 0.01). 
2.6.3.5. Latency of first entry to an arm (Fig. 12, left). There are signifi-
cant differences between groups (F2.21 =33.51, p<0.0001), between sessions 
(Fz,54 = 19.17, p<0.0001) but no significant interactions between groups and 
sessions <F4.54 = 1.06, p> 0.10). 
C57 and CD1 took less time to visit an arm for the first time than Balb/c 
(p<O.OOOI). The difference between C57 and CD! did not reach significance 
(p < 0.08). The latency of first entry to an arm decreased significantly from 
session to session (p<O.OI). 
Post hoc comparisons revealed that C57 and CDI mice took significantly 
less time to visit an arm for the first time than Balb/c (p < 0.02) in the sec-
ond (p < 0.002) and third (p < 0.0001) sessions. C57 but not CD 1 took less 
time to visit an arm for the first time than Balb/c (p < 0.02) in the first 
session. 
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Fig. 11. Number of bridge entries (left), arms entries (right) and number of bridge entries before first visit to an arm (bottom) in each maze configuration. See text 
above for statistic results. 
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2.6.3.6. Average number of entries to centre between arm visits (Fig. 12, right). 
There are significant differences between groups (F2.21 =29.22, p<O.OOOI), 
between sessions (Fz.54 =39.67, p<O.OOOI) but no significant interactions 
between groups and sessions (F4,54 = 1.16, p >0.10). 
C57 and CD I returned to visit an arm after fewer visits to the centre than 
Balb/c (p < 0.000 I). The number of entries to the central platform between arm 
visits decreased significantly from session to session (p < 0.007). 
Post hoc comparisons revealed that C57 and CD 1 mice returned to visit an 
arm after fewer visits to the centre than Balb/c in each of the three sessions 
(p < 0.0002). 
2.6.3. 7. Total duration and average duration of bridge entries (Fig. 13, left). 
There are significant differences between groups (respectively, F2.21 = 19.34, 
p<O.OOOI and F2.21 = 12.04, p<O.OOOI) and between sessions (respectively, 
Fz.54 =43.92, p<O.OOOI and Fz,54 =9.19, p<0.0004). There are, however, sig-
nificant interactions between groups and sessions on the average duration of 
bridge entries (F4,54 = 3.35, p < 0.02) but not for the total duration (F4,s4 = 2.80, 
p<0.07). 
The total time and average time spent on the bridges was lower in C57 
and CD! than in Balb/c (p<0.0002). The total time on the bridges decreased 
significantly from session to session (p<O.OOOI). 
Post hoc comparisons revealed that the total duration time spent on the 
bridges was significantly low in CD I compared to Balb/c in session I (p < 0.05) 
and in both C57 and CD I compared to Balb/c in sessions 2 (p < 0.02) and 
3 (p<O.OOOI). The average duration, however, was significantly low in both 
C57 and CD! in sessions I (p<O.OOI) and 3 (p<0.0006) but not in session 2 
(p>O.IO). 
400 
350 
300 
i 250 
"' ; 200 
E j:: 150 
100 
50 
Total duration of visits to the bridges 
-Balbc 
--C57 
- -o- -CD1 
0+----------.----------.----------. 
s1 s2 
Sessions 
s3 
2.6.3.8. Total duration and average duration of arm entries (Fig. 14). The 
total duration revealed significant differences between groups (F2.21 = 21.38, 
p<O.OOOl) and between sessions (F2,54 = 13.57, p<O.OOOI) but no significant 
interactions (F4,54 = 2.23, p < 0.08). The average duration, however, was not sig-
nificant between groups (F2.21 = 3.01, p < 0.07), between sessions (Fz,54 = 7 .33, 
p <0.002) and no significant interactions (F4,54 = 2.37, p< 0.06). 
The total time spent on arms was higher in C57 and CD! than in 
Balb/c (p < 0.0001) and it increased significantly from session to session (p 
<0.01). 
Post hoc comparisons revealed that the total and average time duration spent 
on arms was significantly high in C57 and CD! compared to Balb/c in sessions 
1 (p < 0.04) and 2 (p < 0.04). The total time alone was significantly high in CD I 
compared to Balb/c (p<O.Ol) in session 3. 
2.6.3.9. Total duration and average duration of centre re-entries (Fig. 15). 
The total and average duration revealed significant differences between groups 
(respectively, F2.21 = 17.52, p<O.OOOI and F2.21 =5.31, p<O.OI) and between 
sessions (respectively, F2,54 = 16.24, p < 0.0001 and F2.54 = 5.28, p < 0.008). The 
interactions between groups and sessions was significant for the total duration 
(F4,54 = 3.24, p< 0.02) but not for the average duration (F4.54 = 1.94, p> 0.10) 
of centre entries. 
The total time spent on the central platform was lower in C57 and CD I than 
inBalb/c (p<0.002) and it is alsolowerinC57 compared to CDI (p<0.03). The 
average time spent on the central platform, however, is low in C57 compared to 
Balb/c (p<0.02) and CDl (p<O.Ol). The total time decreased significantly in 
session 3 compared to sessions I and 2 (p<O.OOOI). 
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Fig. 13. Total duration of entries (left) and average duration of entries to bridges (right) in each maze configuration. See text above for statistic results. 
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Post hoc comparisons revealed that the total time spent on the central plat-
form was significantly low in C57 compared to Balb/c in session 2 (p<O.Ol), 
and in C57 and CD I compared to Balb/c in session 3 (p < 0.0002). 
The average duration spent on arms was significantly low in C57 compared 
to Balb/c in session I {p<0.006) and in C57 and CD! compared to Balb/c in 
session 3 (p < 0.02). 
2.6.3.10. Total latencies and average latency between exits from and entries 
to arms (Fig. 16 ). The total and average latencies revealed significant differ-
ences between groups (respectively, F2.27 = 33.72, p < 0.0001 and F2.27 = 29.10, 
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p<O.OOO!) and between sessions (respectively, Fz.s4 =21.97, p<O.OOO! and 
Fz,s4= 17.91, p<O.OOOI). The interactions between groups and sessions was 
not significant for the total latencies CF4,54 = 1.54, p>O.!O) and the average 
latencies (F4,54 = 2.03, p = 0.10). 
The total and average latencies in C57 and CD! were lower than in 
Balb/c {p<O.OOOl). They also decreased significantly from session to session 
(p<O.OOOI). 
Post hoc comparisons revealed that the total and average latencies between 
exits and entries to arms were significantly low in C57 and CD! compared to 
Balb/c in sessions I {p<0.004) and 2 (p<O.Ol). 
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Fig. 16. Total latencies (left) and average latencies between arm visits (right) in each maze configuration. See text above for statistic results. 
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2.6.3.11. Number of unique visits (Fig. 17, top-right). There are signifi-
cant differences between groups CF2,27 =30.17, p<O.OOOI), between sessions 
(F2,54 =21.79, p<O.OOOI) but no significant interactions between groups and 
sessions (F4,54 = 2.09, p = 0.09). 
C57 and CD! made more unique visits to arms than Balb/c (p<O.OOOI). The 
number of unique visits to arms increased significantly from session to session 
(p<0.005). 
Post hoc comparisons revealed that C57 and CD! made more unique visits 
to arms than Balb/c in sessions 2 (p < 0.004) and 3 (p < 0.001 ). In addition, C57 
made more unique visits to arms than Balb/c in session 1 (p < 0.003) and more 
than CD! in session 2 (p<0.05). 
2.6.3.12. Session duration (Fig. 17, bottom). There are significant differences 
between groups (Fz.z?=22.57, p<O.OOOl), between sessions (F2,54 =44.06, 
p<O.OOOl) and significant interactions between groups and sessions 
CF4.s4 = 9.37, p < 0.0001). 
C57 and CD 1 too less time to perform eight choices in the maze than Balb/c 
(p<O.OOO!) and the duration of the test decreased significantly from session to 
session (p < 0.008). 
Post hoc comparisons revealed no significant differences between groups 
in session I (p > 0. 10). In session 2 CD 1 spent less time in the maze than 
Balb/c (p < 0.04) and in session 3 both CD 1 and C57 spent less time than Balb/c 
(p<O.OOO!). 
2.6.4. Summary 
In comparisons to Balb/c, CD I and C57 visited more arms, spent more time 
on the arms, less time on the bridges and less time on the central platform. They 
were fast to visit the first arm and required less number of entries to bridges 
before visit to first arm. They also made fewer re-entries to the central platform 
between consecutive entries to arms and shorter latencies between re-entries to 
arms. They visited most of the eight arms of the maze at least once and were 
quicker to make eight arm choices. The only differences between CD 1 and C57 
are that CD 1 made fewer entries to bridges and spent longer time in the central 
platform than C57. 
After repeated exposure to the maze, the number of entries to bridges and to 
the central platform decreased significantly while the number of arms entries as 
well as the number of unique visits to arms increased. In addition, the latency of 
first entry to a bridge and to an arm, the total latencies between entries to arms, 
the number of entries to bridges before first visit to an arm, the total time on the 
bridges and the total time to perform eight choices decreased significantly while 
the total time on arms increased from session to session. 
2. 7. Experiment 4: reaction to novelty in presence and absence of 
a protected space in C57 and Balb/c mice 
Most current behavioural models of anxiety provide a choice between an 
anxiogenic and a safe alternative. It has been suggested that this situation involves 
a conflict between the drive to escape or avoid and the drive to explore. In 
our view these models involve escape or avoidance and the assumption that 
animals "need" or "want" to explore is very speculative. Results from a series 
of experiments [84] comparing the behavioural reactions of rats to novelty in an 
open space and an enclosed space suggest that the two testing conditions do not 
involve the same construct. In an enclosed space rats avoid entry to the central 
area of a box and spend most of their time against walls and in comers while 
in a comparable space without walls, animals have to avoid every part of the 
platform and therefore need to explore in order to find an escape route. The need 
to explore and the need to escape are more evident in the open space than in 
the enclosed space. Fear inducing escape or avoidance need to be discriminated 
from fear inducing anxiety. 
In the present experiment, we examined the behaviour of C57 mice in the 
lowered arm configuration with an enclosed central platform. We expected mice 
to prefer the enclosed space and avoid entry to bridges and arms of the maze. 
Mice behaviour in this configuration was compared to that of other groups of 
mice exposed to different arm configurations of the maze with an open central 
platform. 
2.7.1. Subjects 
Thirty C57 mice supplied by Charles River Laboratories (Kent, UK) were 
used in the present study. 
2. 7.2. Testing procedures 
A cylinder (20 em high) with small openings (5 em x 5 em) leading to each 
bridge of the maze was used to provide an enclosed central platform. The diam-
eter of the cylinder was exactly the same as the diameter of the central platform 
(30 em). Mice were tested in a unique session in different arm configurations 
of the maze. One group (n = 6) was tested in an enclosed central platform with 
lowered arms. All other groups (n = 6 each) were tested with open central plat-
form either in lowered, raised or flat arm configuration. A fourth group (n = 6) 
was tested in a mixed arm configuration with three raised arms, three lowered 
arms and two flat arms. Mice were released by hand in the centre platform of the 
maze. They were left in the maze until 12 min elapsed. The floors of the bridges 
were not covered with wire mesh grid. 
2. 7.3. Results 
2. 7.3.1. Number of bridges, arms and central platform entries. There are 
significant differences between groups for the number of bridges entries 
(F4,25 =2.92, p <0.04, Fig. 18left) and central platform entries in CF4,25 = 2.69, 
p < 0.05, Fig. 18 right) but not for the number of arm entries CF4,25 = 2.08, 
p > 0.10). Mice in the lowered arms with an enclosed central platform made 
more entries in the bridges and in the central platform than mice in the enclosed 
arm with an open central platform (p < 0.04). However, they were not signifi-
cantly different from the other groups (p> 0.10). Mice in the lowered arms with 
an open central platform made less bridge and central platform entries com-
pared to mice in raised arms (p<0.03) but they were not significantly different 
from those in flat arms for the number of bridge entries (p < 0.07) and they were 
not significantly different from those in mixed arms for the number of central 
platform entries (p<O.lO). 
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Fig. 18. Number of entries to bridges (left) and to the centre (right) in each maze configuration. See text above for statistic result. Lowered.£: lowered arms with 
enclosed central platform. 
2. 7.3.2. Number of bridge entries before first arm visit (Fig. /9, top-left). There 
are significant differences between groups for the number of bridges entries 
before the first visit to an arm of the maze <F4.25 =4.4l , p<0.008). Mice tested 
in lowered arms with an enclosed central platform required more bridge entries 
before first visit to an arm of the maze compared to all other groups (p < 0.02). 
2.7.3.3. Latency of first entry to a bridge. One-way ANOVA revealed no sig-
nificant differences between groups (F4,25 = 1.09, p > 0.10). 
2. 7.3.4. Latency of first entry to an arm (Fig. 19, top-right). One-way AN OVA 
revealed significant differences between groups (F4,25 = 2.94, p < 0.04). Mice in 
the lowered arm with an enclosed central platform took significantly longer time 
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to visit for the first time an arm of the maze compared to all other groups of mice 
(p<0.05). 
2. 7.3.5. Latency of first entry in the eighth arm. One-way AN OVA revealed no 
significant differences between groups <F4.25 = 0.33, p > 0.1 0). 
2. 7.3.6. Total latencies and average latency between exits from and entrU!s 
to arms (Fig. 19, bottom). One-way ANOVA revealed significant differences 
between groups on the total latencies (F4,25 = 7 .28, p < 0.0005) but not on average 
between entries in the arms (F4,25 = 1.48,p> 0.10). Mice in the lowered arm with 
an enclosed central platform took significantly longer time to return to an arm of 
the maze compared to all other groups of mice (p < 0.02). Mice in the lowered 
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Fig. 19. Number of entries to bridges before first visit to an arm (top-left), latency of first entry to an arm (top-right) and latency between entries to arms (bottom) 
in each maze configuration. See text above for statistic results. 
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Fig. 20. Total duration of entries in bridges (top-left), in arms (top-right) and in the central platform (bottom) in each maze configuration. See text above for statistic 
results . 
arm with an open central platform took less time to return to an arm of the maze 
compared to mice on flat arms (p < 0.05) and raised arm (p = 0.07) configurations. 
2.7.3.7. Total duration and average duration of bridge entries (Fig. 20, top-
left). One-way A NOVA revealed significant differences between groups on the 
duration CF4,25 = 8.82, p < 0.0001) and average duration of entries in the bridges 
(F4,25 =5.07, p<0.0004). 
The total duration and average duration of visits to the bridges shows that 
mice in the flat arms spent significantly longer time than mice in the bridges of 
lowered arms with (p < 0.0007) and without (p < 0.0004) enclosed central plat-
form and compared to mice in raised (p < 0.0009) and mixed arm configurations 
(p<0.0004). 
2. 7.3.8. Total duration and average duration of arm entries (Fig. 20, top-right). 
One-way AN OVA revealed significant differences between groups on the total 
duration (F4,25 = 13.63, p<O.OOOI) but not on average duration of entries in 
the arms (F4,25 = 0.82, p > 0.10). Mice in the enclosed central platform spent 
significantly less time on the arms of the maze than the other groups of mice 
(p<0.04). Mice in the flat arm configurations spent significantly more time in 
the arms of the maze compared to all other groups (p < 0.005). 
2. 7.3.9. Total duration and average duration of centre re-entries (Fig. 20, bot-
tom). One-way AN OVA revealed significanl differences between groups on the 
total duration (F4.25 =8.82, p<O.OOOI ) and average duration of entries in the 
central platform CF4,25 =5.07, p<0.0004). Mice in the lowered arms with an 
enclosed central platform spent significantly more time in the centre than any 
other group of mice (p<O.Ol). Mice in the lowered arms with an open central 
platform spent less time than mice in flat and raised arms but the difference was 
not significant (p < 0.09). 
2.7.3.10. Average number of entries to centre between arm visits. One-way 
ANOVA revealed no significant differences between groups on the average 
number of entries to the central platform between visits to arms CF4,25 = 1.66, 
p>O.lO). 
2.7.3.11 . Number of unique visits. One-way AN OVA revealed no significant 
differences between groups on the number of unique visits to arms CF4.25 = 1.48, 
p>0.10). 
2. 7.4. Summary 
In the lowered arm configuration with an enclosed central platform, C57 mice 
took longer time to make a first entry to an arm, made more visits to bridges 
before first entry to an arm and required longer time between re-entries to arms, 
spent longer time on the central platform and shorter time on arms compared 
to mice in the lowered arm with an open central platform and compared to 
mice in the other arm configurations. They also made frequent entries to the 
centre and bridges compared to mice in the lowered arm with an open central 
platform. This experiment demonstrates the significant difference between the 
behaviour of mice in an open space as compared to an enclosed space which is 
supported by our previous results in different experimental designs [84]. Each 
experiment described in this report was designed without any a priori knowledge 
of the outcome of each one. The video analysis took place at the end of all set 
of experiments described in this report. C57 revealed less emotionally reactive 
than any other strains of mice and therefore their selection for the purpose of this 
experiment appears inappropriate. However, the experiment provides evidence 
that the presence of an enclosed space reduces the exploratory activity of mice 
and delays the exploration of the arms of the maze. In our view, an enclosed space 
involves avoidance and escape responses. We expect that an enclosed space will 
discourage animals to explore open spaces as they provide safety; this effect 
would have been more obvious with Balb/c and C3H mice. 
2.8. Experiment 5: strain and gender differences in mixed arm 
configurations of the maze 
In this experiment mice were tested in a single session in mixed arm config-
urations. Three arms were raised, three arms were lowered and, unfortunately 
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there are only eight arms, two arms were left flat. A group of C57 was compared 
to C3H mice. This experiment would confirm the differences between these two 
strains of mice and examine gender differences within strains. 
2.8.1. Subjects 
Eleven C57 mice (six females and five males) and 12 C3H mice (six males 
and six females) supplied by Charles River Laboratories (Kent, UK) were used 
in the present study. 
2.8.2. Testing procedures 
Mice were tested in a unique session in a mixed arm maze configuration 
with three raised arms, three lowered arms and two flat arms. The floors of the 
bridges were not covered with wire mesh grid. Mice were released by hand in 
the centre platform of the maze. They were left in the maze until I 0 min elapsed. 
We recorded only entries to arms. At that time we did not have the means to 
record entries to bridges. Therefore, it is not possible to provide the frequency 
of entries to and the time spent on the bridges and central platform. An entry to 
an arm is recorded when a mouse leaves a bridge with all four paws and an exit 
is recorded when all four paws leave an arm. 
2.8.3. Results 
2.8.3.1. Latency of first visit to arms (Fig. 21, left). There are significant 
differences between groups (F3.19 = 6.17, p < 0.004). C3H male mice were sig-
nificantly different from C3H female mice (p < 0.007) and from both C57 male 
(p<0.006) and female mice (0.01). 
2.8.3.2. Frequency of visits to arms (Fig. 21, right). There are significant differ-
ences between groups (F3.19 = 19.80, p<O.OOOJ). C3H male and females mice 
visited less arms than C57 male and females mice (p < 0.0004). 
2.8.3.3. Duration of visits to arms (Fig. 22, top-left). There are significant dif-
ferences between groups (F3,19 = 13.26, p < 0.0001). C3H males spent Jess time 
in the arms than C3H female (p<0.003) and both C57 male and female mice 
(p < 0.0003). C3H female mice spent Jess time than C57 female mice, but this 
is not significant (p = 0.09). 
2.8.3.4. Average duration of visits to anns (Fig. 22, top-right). There are sig-
nificant differences between groups (F3,!9 =4.09,p<0.02). C3H females spent 
longer time in the arms than both C57 male (p < 0.03) and female (p < 0.05) 
mice while C3H male mice spent longer time than C57 male mice (p<0.05). 
The difference between these results based on average duration and the results 
above based on total duration is that the number of arms visited by C3H is sig-
nificantly very low compared to that of C57 mice (mean = 4.7 ± 1.30 for females 
and 2.7 ± 0.8 for males). 
2.8.3.5. Latencies between visits to arms (Fig. 22, bottom-left). There are sig-
nificant differences between groups (F3.I9 = 3.40, p < 0.04). C3H male mice took 
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longer time to re-enter in the arms of the maze compared toC3H and C57 female 
mice (p < 0.05). 
2.8.3.6. Average latency between visits to anns (Fig. 22, bottom-right). There 
are significant differences between groups (F3.19 = 5.34, p < 0.008). C3H male 
mice took longer time to re-enter in the arms of the maze compared to C3H 
female mice (p<0.03) and to both C57 male and female mice (p<O.OI). 
2.8.4. Summary 
The main significant results of this study are from C3H males which seem 
more anxious than C3H female and C57 mice. C3H males took longer time to 
visit an arm for the first time and to return to arms. They made a very few visils 
to arms. Though their total duration of visits to arms was shorter than that of 
the other groups (C3H females and C57 male and female mice), their average 
duration per visit was longer than that of C57 male and female mice which is 
accounted for by their low number of entries to arms. 
2.9. Correlations analysis 
In the above experiments, we described a wide range of measurements that 
we selected for assessing the reactions of animals to novelty in different arm maze 
configurations. Most of these measurements revealed sensitivity to differences 
between test conditions, strains and genders. They also showed consistency 
between experiments. Correlation analyses were performed to examine whether 
the different measurements of the tests measure the same construct. 
Experiments I and 4 contain comparable groups of mice tested in three arm 
maze configurations. The groups from the same test conditions were comparable 
(p > 0.10) and they were therefore combined to provide a large sample (n = 16) 
for correlation analysis. 
As shown in Table lA-C (separate arm configurations) and Table lD (com-
bined arm configurations), most parameters of the tests were correlated signif-
icantly to each other (bold, p ~ 0.05) while a few remained below significance 
(italics, p ~ 0.1 0) except for the measure of latency of first entry to a bridge 
which did not correlate with other measurements (p > 0.1 0) in any of the three 
arm configurations of the maze. The average duration of visits to the central 
platform and the latency of first entry to the eighth arm did not correlate with 
any latency measurements and they did not correlate with the average number 
of entries to centre between visits to arms and number of bridge entries before 
first visit an arm. 
3. Discussion 
A wide range of behavioural tests have been introduced for 
the study of anxiety in rats and mice. Most of these tests offer 
the choice between open spaces and enclosed spaces. Because of 
the presence of these contrasting physical entities, it is claimed 
that these tests induce a conflict between the drive to explore 
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Fig. 21. Latency of first visit to an arm (left) and frequency of visits to arms. F: females; M: males. 
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there are only eight arms, two arms were left flat. A group of C57 was compared 
to C3H mice. This experiment would confirm the differences between these two 
strains of mice and examine gender differences within strains. 
2.8.1. Subjects 
Eleven C57 mice (six females and five males) and 12 C3H mice (six males 
and six females) supplied by Charles River Laboratories (Kent, UK) were used 
in the present study. 
2.8.2. Testing procedures 
Mice were tested in a unique session in a mixed arm maze configuration 
with three raised arms, three lowered arms and two flat arms. The floors of the 
bridges were not covered with wire mesh grid. Mice were released by hand in 
the centre platform of the maze. They were left in the maze until! 0 min elapsed. 
We recorded only entries to arms. At that time we did not have the means to 
record entries to bridges. Therefore, it is not possible to provide the frequency 
of entries to and the time spent on the bridges and central platform. An entry to 
an arm is recorded when a mouse leaves a bridge with all four paws and an exit 
is recorded when all four paws leave an arm. 
2.8.3. Results 
2.8.3.1. Latency of first visit to arms (Fig. 21, left). There are significant 
differences between groups <F3,l9 =6.17, p<0.004). C3H male mice were sig-
nificantly different from C3H female mice (p < 0.007) and from both C57 male 
(p<0.006) and female mice (0.01). 
2.8.3.2. Frequency of visits to arms (Fig. 21, right). There are significant differ-
ences between groups (F3,19= 19.80, p<0.0001). C3H male and females mice 
visited less arms than C57 male and females mice (p < 0.0004 ). 
2.8.3.3. Duration of visits to arms (Fig. 22, top-left). There are significant dif-
ferences between groups <F3.l9 = 13.26,p<0.0001 ). C3H males spent less time 
in the arms than C3H female (p<0.003) and both C57 male and female mice 
(p < 0.0003). C3H female mice spent less time than C57 female mice, but this 
is not significant (p = 0.09). 
2.8.3.4. Average duration of visits to anns (Fig. 22, top-right). There are sig-
nificant differences between groups (F3,l9 = 4.09, p < 0.02). C3H females spent 
longer time in the arms than both C57 male (p<0.03) and female (p<0.05) 
mice while C3H male mice spent longer time than C57 male mice (p<0.05). 
The difference between these results based on average duration and the results 
above based on total duration is that the number of arms visited by C3H is sig-
nificantly very low compared to that of C57 mice (mean = 4.7 ± 1.30 for females 
and 2.7 ± 0.8 for males). 
2.8.3.5. Latencies between visits to arms (Fig. 22, bottom-left). There are sig-
nificant differences between groups (F3, l9 = 3.40, p <0.04). C3H male mice took 
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longer time to re-enter in the arms of the maze compared to C3H and C57 female 
mice (p<0.05). 
2.8.3.6. Average latency between visits to anns (Fig. 22, bottom-right). There 
are significant differences between groups (F3,l9 =5.34, p<0.008). C3H male 
mice took longer time to re-enter in the arms of the maze compared to C3H 
female mice (p<0.03) and to both C57 male and female mice (p<O.Ol ). 
2.8.4. Summary 
The main significant results of this study are from C3H males which seem 
more anxious than C3H female and C57 mice. C3H males took longer time to 
visit an arm for the first time and to return to arms. They made a very few visits 
to arms. Though their total duration of visits to arms was shorter than that of 
the other groups (C3H females and C57 male and female mice), their average 
duration per visit was longer than that of C57 male and female mice which is 
accounted for by their low number of entries to arms. 
2.9. Correlations analysis 
In the above experiments, we described a wide range of measurements that 
we selected for assessing the reactions of animals to novelty in different arm maze 
configurations. Most of these measurements revealed sensitivity to differences 
between test conditions, strains and genders. They also showed consistency 
between experiments. Correlation analyses were performed to examine whether 
the different measurements of the tests measure the same construct. 
Experiments I and 4 contain comparable groups of mice tested in three arm 
maze configurations. The groups from the same test conditions were comparable 
(p > 0.1 0) and they were therefore combined to provide a large sample (n = 16) 
for correlation analysis. 
As shown in Table lA-C (separate arm configurations) and Table lD (com-
bined arm configurations), most parameters of the tests were correlated signif-
icantly to each other (bold, p:::;: 0.05) while a few remained below significance 
(italics, p:::;: 0.10) except for the measure of latency of first entry to a bridge 
which did not correlate with other measurements (p > 0.10) in any of the three 
arm configurations of the maze. The average duration of visits to the central 
platform and the latency of first entry to the eighth arm did not correlate with 
any latency measurements and they did not correlate with the average number 
of entries to centre between visits to arms and number of bridge entries before 
first visit an arm. 
3. Discussion 
A wide range of behavioural tests have been introduced for 
the study of anxiety in rats and mice. Most of these tests offer 
the choice between open spaces and enclosed spaces. Because of 
the presence of these contrasting physical entities, it is claimed 
that these tests induce a conflict between the drive to explore 
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Fig. 21. Latency of first visit to an arm (left) and frequency of visits to arms. F: females; M: males. 
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and the drive to escape or avoid. This claim makes an assump-
tion about animals' intentions and needs to explore the source 
of threat. The spontaneous and natural response of animals is 
to escape to enclosed spaces and avoid novel unfamiliar open 
spaces and objects. In order to induce and measure anxiety, 
animals need to be challenged with stimuli that they have to 
explore and cannot escape or avoid. This seems to us an obvi-
ous way to bring about a conflict in animals. There are numerous 
situations where we may feel anxious such as in exams,job inter-
views, public oral communications, and sport competitions. We 
can also avoid or escape these challenging events by staying 
at home or with friends. It is possible, however, for anxiety to 
be expressed before exposure to an anxiogenic environment or 
after escape or avoidance. In this case, escape or avoidance did 
not terminate the manifestation of fear but it becomes rather 
associated with the need to approach the source of threat-not 
facing a challenge and worrying about consequences. This form 
of anxiety is not currently accessible to testing in animals as 
it involves episodic memory through recollection of stressful 
events. 
The present studies provide an open space model of anxiety 
based on exploratory activity of mice in a 30 maze which is a 
spatial navigation apparatus that was recently introduced by our 
lab for testing working memory from different view perspectives 
! I 7 ~ 1. Animals can be exposed to the apparatus for a unique 
session or directly introduced to a memory test without the usual 
habituation phase. The unique session as well as the first three 
sessions of the memory test could reflect emotional responses of 
animal to novelty in an open space. These emotional responses 
would subside over time with animals' progression in learning 
about the conditions and requirements of the test. 
In this novel model, animals are introduced to the central plat-
form of the test apparatus and are left free to explore. Because it 
is an unfamiliar open space animals may feel unsafe in the cen-
tral platform and would need to explore the maze in order to find 
an escape route. Some mice may be more anxious than others 
and would avoid entering the bridges, while others may adven-
ture no further than the bridges whereas other mice may visit a 
few arms. These apparent differences in maze exploration would 
reflect different degrees of emotional responses in animals. In 
addition, the test provides a wide range of measurements of the 
transition responses between the different parts ofthe maze, such 
as latencies, duration and number of entries to bridges and arms 
which can be useful in the analysis and interpretations of the 
results. 
In the first experiment, different groups of C57 mice were 
each exposed to one of the three arm configurations of the maze. 
Contrary to our expectations, this strain of mice explored the dif-
ferent areas of the maze and did not hesitate to visit the arms 
in each maze configuration. Significant differences between the 
three maze configurations were observed on a limited number 
of measurements which seem to indicate a preference for raised 
arms. Results from the second experiment demonstrate signif-
icant differences between maze configurations in C3H mice 
but not in C57 mice. C3H mice displayed a very low level of 
exploratory activity in the maze and showed a preference for 
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of the one-trial phenomenon are mostly based on speculative 
interpretations; they are not based on experimental evidence 
in which the internal validity of the test was challenged. It is 
very likely that open-arm exploration would be increased by an 
introduction of novelty in these arms. Behavioural experiments 
assessing the internal validity of a behavioural test are very 
scarce; a few examples can be found in Ennaceur and Aggleton 
[81], Miller and Murphy [164] and in Klebaur and Bardo [141] 
reports. The one-trial phenomenon provides further evidence in 
support of our view that the current two-choice models involve 
fear inducing escape or avoidance responses and that the drive 
to explore the source of potential threat which is assumed by 
many scientists to be the source of conflict inducing anxiety 
becomes less evident on the second exposure to the test. In the 
3D maze, most arms remain unexplored after the first session of 
the test in Balb/c and C3H mice, and even the least emotional 
mice such as C57 and CDI mice would have visited only a 
few arms (unique visits). Therefore repeated exposures do not 
prevent mice from attempting to adventure in unexplored and 
unprotected areas of the maze. In the present experiment, mice 
were food deprived but we have now data (not shown here) 
confirming the present results with non food-deprived C57 and 
Balb/c mice. 
The final experiment confirms, furthermore, the difference 
between C3H and C57 mice. In addition, it demonstrates that 
male C3H mice are more anxious than C3H female mice. C3H 
males took longer time to visit an arm for the first time and to 
return to arms. They made a very few number of visits to arms 
and spent a very short amount of time in the arms of the maze. 
There are no differences between genders in C57 mice. These 
differences between strains and between genders reveal the sen-
sitivity and consistencies of the different measures that we have 
selected for assessing anxiety. The reduced anxiety in female 
C3H mice in this study and in different strains of mice and rats in 
other studies [2,83,84, 105,193, 196,259,273] contrasts with the 
prevalence of anxiety and depression in human females [186]. 
While the ecological context of both species may account for 
this difference, sex differences in human studies refers mainly to 
clinical subjects [186] and it is possible that clinical diagnostics 
do not discriminate clearly between anxiety and other emotional 
disorders. However, sex differences in animal studies are mostly 
contradictory [34,42,55 ,89, 131 ,98,154,269 ,240,259]. In order 
to compare to sex differences data reported in clinical studies, 
there is a need to perform experiments in animals expressing 
anxiety induced by anxiogenic compounds, or by physiological 
or genetic manipulations. 
The results of the present studies suggest that C57 mice are 
less anxious than C3H and Balb/c mice when exposed to the 3D 
maze. Unfortunately, it is not possible to draw direct compar-
isons between Balb/c and C3H as they were not tested in the 
same experiment, though our observations and the current data 
suggest that the former are less anxious than the latter. Numer-
ous studies from our laboratory confirm the differences between 
these strains of mice in the 3D maze with C57 mice being less 
anxious than Balb/c and C3H while Balb/c are less anxious than 
C3H (data not shown). The consistencies of our results with 
these strains of mice in the 3D maze contrasts significantly with 
the inconsistencies of the results reported in the literature for the 
same strains of mice. In some reports, Balb/c mice seem more 
anxious than C57 while in other reports it is completely the 
opposite [11 ,23,48,79, 108,144,150,181,202,251 ,271]. Whether 
these inconsistencies and contradictions arise from the use 
of the same test or from comparable tests aimed at anxiety, 
they clearly raise some doubts about the construct validity of 
these tests: are they measuring the same construct? In many 
reports the difference observed between different behavioural 
tests designed for anxiety and lack of correlations between these 
tests is too easily accounted for by a simplistic view that the 
tests are tapping into different states or forms of anxiety disor-
ders [5,11,26,33, 109,113, 144,253]. The discriminant validity of 
these tests is left unchallenged, that these tests are not measur-
ing other constructs such as fear inducing escape or avoidance 
responses rather than fear inducing anxiety. 
Numerous methodological concerns have been raised fol-
lowing the accumulation, over two decades, of inconsistent 
and contradictory results with the current models of anxiety. 
Unfortunately, the focus of most critical reviews was limited 
to sensitivity, predictive validity and reliability of the measures 
of the tests [22,36,69, 116,122,130,132,133,142,163, 199]. There 
are no direct references to the construct validity of the respec-
tive behavioural tests. It seems that any test is assumed to be a 
valid model of anxiety whenever it demonstrates sensitivity to 
benzodiazepines or to newer subtype-selective GABAA recep-
tor compounds [36, 103,108,160,167,172,183,189,190,195,203, 
212,219,225,248]. In fact, the current theory of anxiety [35, 159] 
is almost exclusively based on the sensitivity of a wide range 
of behavioural responses to anxiolytic compounds which were 
provided by clinical studies. The validity of a behavioural 
test is considered a correlation between a set of symptoms 
and the predicted effects of a neurochemical, physiological or 
genetic manipulations. The learning and cognitive hypothesis 
of anxiety [16,20,65,66, 75,145,139,140,153,156,165,168,261] 
is rarely mentioned in this context, which is surpris-
ing considering the well documented effects on cogni-
tion induced by benzodiazepines and GABAA agonist com-
pounds [21,15,44,53,54,100,171, 174,221,236,238,268]. GABA 
is widely distributed and utilized throughout the CNS and it is 
involved in major behavioural and cognitive functions. There is 
no experimental evidence excluding a primary action of these 
compounds on cognition rather than anxiety. 
A behavioural test is developed to provide objective assess-
ments of a specific behaviour, emotion or cognitive function it 
is designed to measure. This means that a particular behaviour, 
emotion or cognitive response is translated to parameters of 
a variable to be quantified and then analyzed within the def-
inition attributed beforehand to the significance of a specific 
behaviour, emotion or cognitive function. A wide range of 
parameters are therefore made available in the development 
of a test such as frequency, number of correct or incorrect 
responses, duration and distance of crossings or transitions. 
These parameters are challenged for content validity, discrim-
inant validity and internal consistency to support the construct 
validity of the test [4,61 ,96, 118,149, 192]. Unfortunately, in cur-
rent anxiety studies, scientists attempt to deal ambitiously with 
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would reveal the presence or absence of activation in these brain 
structures. 
A behavioural test can also provide the means to manipulate 
the variable that it is concerned with and modify its expression 
and therefore its consequence on the brain. For instance, the 
emotional responses of animals in the 3D maze can be manip-
ulated through separate or combined use of anxiolytics com-
pounds and the introduction of stressors such as increased light 
intensity, sounds and predator odours. These manipulations are 
not meant to contribute to the construct validity of a behavioural 
test; they are not part of the test. They are external variables that 
are introduced to the test to examine their effects on behaviour 
within the established settings of the test-a norm or a standard 
of reference. A behavioural test has to be validated behaviourally 
before any of these manipulations can be performed. Any claim 
of validity of a behavioural test through pharmacological, phys-
iological or genetic manipulations is inappropriate and illog-
ical. These manipulations can be associated with the validity 
of animal models of human psychopathology and neurological 
disorders and not to animal models of human behaviour. 
In the 3D maze, we do not induce symptoms but provide the 
conditions under which these symptoms might be expressed and 
appreciated. C57 mice seem less anxious and visited all arms of 
the maze while Balb/c and C3H appears more anxious as they 
were more hesitant and reluctant to visit the bridges and arms 
of the maze. Therefore, C57 as well as C3H and Balb/c can be 
used to screen for anxiolytic and anxiogenic compounds. For 
instance, administration of anxiolytic drugs would be expected 
to modify the behaviour of C3H and Balb/c to align to that of C57 
mice while an anxiolytic effect on the behaviour of C57 mice 
would increase the number of bridge entries to equal the num-
ber of entries to arms while reducing latencies between entries 
to arms and bridges without reducing the number of entries to 
bridges. An anxiogenic compound would reduce the number of 
entries to arms and may increase the number of entries to bridges. 
It should not decrease the number of entries to bridges as such 
an effect can be assumed to be non-specific. Repeated entries to 
bridges with less or no entries to arms would reflect an increase 
in the number of hesitations of animals to engage in the arms of 
the maze which can be considered an expression of an anxiety 
state. 
When assessing the validity of our test, we included a vari-
ety of parameters of measurements for the crossing responses 
made by mice in the different areas of the maze. We tried to 
cover all relevant dimensions of the measured variable to achieve 
content validity and challenge the internal consistency of the 
parameters of the test. Most of these parameters provided con-
cordant results within each experiment and consistent results 
between experiments. The correlation analyses confirmed fur-
thermore the strong association between the different parameters 
of the test which were used to assess anxiety responses in ani-
mals. An interesting feature of our behavioural model is the 
very low variability between individuals that is demonstrated 
in most of the parameters used to assess anxiety despite the 
test being based on spontaneous exploratory activity. The issue 
of inter-individual variability has been a subject of attention and 
debates [45,69,255,270]. Most scientists view that the main pur-
pose of standardization is to minimize variability and to facilitate 
the reproduction of the results, however Wiirbel [270] seems to 
object to standardization, raising concerns about experiments 
turning into case studies due to loss of inter-individual variabil-
ity and consequently resulting in a loss of external validity. This 
view is supported by Calatayud et al. [45] who consider that 
"inter-individual variability ... should be seen as the essence of 
behaviour" and propose "to maximise inter-individual variabil-
ity". These critical comments are ill founded; they contradict the 
basic fundamental principles of a test that is to provide reliable 
measures of behaviour. An increase in inter-individual variabil-
ity would prevent reliability and consistency between results. 
If a test promotes inter-individual differences then predictabil-
ity becomes impossible. In fact an increase in inter-individual 
variability would result inevitability in step-by-step selection of 
cases that fit with the expectations of the experimenter. This 
is illustrated by an increased number of studies who failed to 
provide consistent results and now resort to arbitrary sub-group 
selection within a specific strain of mice and rats. These studies 
are expected to reveal pathological cases that are highly unlikely 
to be produced by a behavioural test in normal animals. Large 
inter-individual variability would question the validity of the 
measurements of a behavioural test. For instance, the latency 
of first entry to a bridge in the 3D maze produces larger inter-
individual variability than other measurements and this accounts 
for the poor correlation of this measure with the remaining 
measures of emotional responses of mice (see Table 1 ). This 
inter-individual variability is often observed with the measure 
of latency of first entry to the centre in the open-field or to the 
lit compartment in the light-dark box [83, 116]. It is mainly due 
to the difficulty in controlling and standardizing the release of 
animals in the apparatus. It can be reduced when animals are 
poured from a bucket onto the central platform instead of being 
released by hand but this still may not be sufficient to produce 
consistent results. 
The 3D maze was used in the present studies as an open 
space model of anxiety in support of a previous report in which 
we suggested that the current models of anxiety involve separate 
open spaces and enclosed spaces and therefore would involve 
fear-inducing escape or avoidance rather than anxiety per se. 
In experiment 4 we tried to demonstrate that the presence of 
an enclosed space would encourage animals to remain in an 
enclosed central platform and would avoid entries to bridges 
and arms. Unfortunately, C57 mice were inappropriate for this 
demonstration as they were shown to be the least fearful strain of 
mice. Balb/c and C3H would have been much more appropriate 
for this purpose. However, the experiment still demonstrates that 
the presence of an enclosed space affects the behaviour of mice. 
C57 mice took longer time to make a first entry to an arm, made 
more visits to bridges before first entry to an arm and required 
longer time between re-entries to arms, spent longer time on 
the central platform and shorter time on arms compared to mice 
tested in an open central platform. They also made frequent re-
entries to the centre and bridges compared to mice in the lowered 
arm with an open central platform. These results suggest that the 
presence of an enclosed space alongside an open space promotes 
avoidance responses. 
A. Ennaceur eta/. I Behavioural Brain Research 174 (2006) 9--38 33 
In conclusion, the present report provides the first model 
of unconditioned behaviour which involves a conflict between 
exploration and fear inherent to the nature of the test. It demon-
strates that animals released in an unenclosed central platform 
display clear differential anxiety responses dependent on sex 
and strains, providing an important new model for future inves-
tigation of the underlying neural systems involved in anxiety 
and screening for anxiolytic therapeutics. Through this report, 
we attempted to challenge the current models of anxiety that 
are used in animal studies and to trigger a wide ranging debate 
regarding basic methodological issues in clinical and laboratory 
studies, focusing on the construct validity of the techniques used 
to assess affective states. 
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Abstract 
Fifty percent of CD-1 mice from both sex die by the end of 2 years. The survival rate is higher in females than in males. This high mortality 
rate is associated to the high susceptibility of this strain of mice to some immuno-pathologies and the high incidence of systemic amyloidosis. 
It is therefore possible that premature cognitive deficits can be observed in CD-1 mice. In the present study, we describe a novel method for 
assessing emotional responses and memory performance of young (4 months) and middle-aged (12 months) CD-I mice of both sexes in a 3D 
spatial navigation task. Animals are introduced to the maze without preliminary habituation and trained in a working memory test. As expected 
CD-1 mice have a low number of entries to arms on their first exposure to the maze which confirm our previous report on the anxious trait of this 
strain compared to C57/BL6 mice. The measure of arm/bridge ratio suggests that anxiety induced by exposure to the maze persists much longer 
in middle-aged male mice compared to middle-aged female mice and compared to both young male and female mice. The measure of memory 
revealed that young female mice made significantly less arm repeats and more unique arm visits before first arm repeat than middle-aged female 
and male mice. There are also significant differences between young female and young male mice with the former committing fewer errors than 
the latter. 
© 2007 Elsevier B.V. All rights reserved. 
Keywords: Aging; Alzheimer's; Amyloid; Amnesia; Hippocampus; Amygdala; Benzodiazepines; Strains; Rats 
1. Introduction 
In the present study we examined whether emotional 
responses to novelty and open spaces and the acquisition of a 
working memory spatial navigation task are affected by age in 
CD-I strain of mice. We examined both male and female CD-I 
mice from 4 and 12 months of age in a 3D maze which is a 
modification of the eight arm radial maze. In this maze, animals 
need to cross a bridge to reach an arm which can be presented 
horizontally raised above or lowered below the level of a cen-
tral platform. The arms can also be presented at the same level 
of the central platform as in the standard version of a radial 
maze. There are no enclosures surrounding the central platform, 
* Animals used in the study were handled in accordance with approved use of 
animals in scientific procedures regulated by the Animals (Scientific Procedures) 
Act 1986, UK. 
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bridges or arms. In our laboratory, animals are introduced to the 
maze without prior habituation. They can be assessed for their 
emotional responses to novelty and open spaces in a single or 
a few sessions without food deprivation [1,2]. They can also 
be food-deprived and tested in a working memory paradigm in 
12-16 sessions and the first few sessions are assessed for emo-
tional responses [3]. In our view, the first sessions of exposure 
to the test are likely to trigger emotional responses induced by 
novelty and unfamiliarity to the open space of the maze that 
would subside over time after repeated exposures while learning 
takes place and consolidates. Learning and memory processes 
are involved from the first encounter of a novel or a familiar 
environment however anxiety would be predominant in the first 
phase of the test and it is unlikely to persist after several expo-
sures. The acquisition of a working memory task is evident at 
some later stage of the training period; it is not in place on 
the first sessions as animals need to learn the rule of the task. 
Therefore, it is possible to assess emotional responses and work-
ing memory performance within the same experimental settings 
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and testing conditions. The introduction of animals to a learning 
and memory test without preliminary habituation can be useful 
in understanding the difference between strains and the conse-
quence of a drug treatment on performance. Based on the current 
study and previous one, we have shown that different strains 
of mice require different number of exposures to habituate to 
the experimental settings. Furthermore, a drug treatment may 
extend the period of time required to habituate for some strains 
of mice. Therefore, in many published studies anxiety may still 
be present within the initial stages of the acquisition of a learn-
ing or a memory task which could influence the interpretation 
of drug effects. 
A large number of CD-I mice have been shown to display 
tumors, skin lesions and abscesses and die earlier than observed 
in other strains of mice [4-7] . A high incidence of systemic 
amyloidosis in CD-I mice was reported [8,86] . Amyloidosis 
was observed in 50% of CD-I mice of both sexes, beginning 
at 8 months in males and I2 months in females [8]. It was 
found to be higher than in other strains of mice and as one 
of the major factors contributory to death in aging CD-I mice 
[9,94] . Numerous studies suggest that more than 50% of CD-
I mice from both sex die by the end of 2 years. The survival 
rate was higher in females than in males [4,5,7,10,11]. It is 
therefore possible that this strain of mice also develops pre-
mature cognitive deficits and would be useful as a model of 
aging and for screening for drug and therapeutic manipulations. 
A recent study from our laboratory demonstrates that middle-
aged CD-I female mice (12 months) made significantly more 
errors than young CD-I female mice (3 months) in a 3D maze 
[3] . 
Very few studies have considered other parameters than the 
number of errors (or correct choices) in the radial maze. This is 
very unfortunate as performance of animals can be accounted for 
by other parameters than the number of repeated arm choices. 
The records and data analysis of several spatio-temporal param-
eters of a behavioral task contribute to its content validity 
and are very helpful in the interpretation of animal behavior 
[I ,12] . In the present experiment, we recorded not only the 
number of visits to bridges and arms of the maze but also 
the latencies to bridges and arm entries, and duration of vis-
its. Some parameters are related to anxiety responses while 
others are related to learning and memory. Measures of anx-
iety do not preclude an involvement of learning and memory 
processes. Therefore some measures are shared between mea-
sures of anxiety and memory while others are more specific to 
either one. Correlation analysis between the different parame-
ters of our spatial navigation task is performed to demonstrate 
the concordances and consistencies of the results obtained in 
this experiment. 
2. Methods 
2.1. Animals 
Thirty-three mice from CD-I mice slrains were obtained from our breeding 
colony. They were 8 young females (FY, 4 months), 10 middle-aged females 
(FA, 12 months), 8 young males (MY, 4 months) and 7 middle-aged males 
(MA, 12 months). The average animal weight was 42.32 ± 2.52 gat the start of 
Fig. I . 3D maze with a raised arm configuration. Note the narrowing of the 
entries to and exits from the bridges to prevent mice relying entirely on sequential 
arm choices. 
the experiment. The colony room was held under a 12 h light/12 h dark cycle 
(light 07:00-19:00 hat 180 lx) and at 23 ± I °C. In order to avoid unequal light 
exposure, the upper shelf was occupied with empty plastic cages filled with saw-
dust. Mice were housed in a group of five mice per cage. Individual mice could 
be identified by their cage number and their ear tags. All mice had ad libitum 
access to food and water. During their stay in respective housing conditions, 
they were removed twice a week from their cages for cleaning the cages and 
renewing their food and water supply. Animals were food-deprived 24 h before 
the testing began; their body weights were subsequently adjusted and main-
tained to 85% of their normal free-feeding weights throughout the test. Animal 
lrealrnent and husbandry were in accordance with approved use of animals in 
scientific procedures regulated by the Animals (Scientific Procedures) Act 1986, 
UK. 
2.2. Apparatus 
The maze is made from grey PVC (5 mm thick). It consists of eight arms 
radiating from a cenlral platform (Fig. 1). Each arm (51 em x 11.2cm) is made 
from two segments, extended from an octagonal shaped cenlral hub (30 em in 
diameter) and can be manipulated independently. The first segment of an arm 
(15.2cm x 11.2 em) directly attached to the cenlral platform was tilted to form 
a 60° slope and constitutes a bridge that allows access to the second segment 
(35 em x 11 .2 em) of the arm which is presented horizontally either at the same 
(flat arm configuration), below (lowered arm configuration) or above (raised arm 
configuration) the level of a cenlral platform. In order to change the configura-
tions of the maze, the cenlral platform can be raised or lowered. Each enlry to a 
bridge is narrowed with a short wiremesh wall (8 em x 4 em) either on the left 
or on the right side. The narrowing of the entries to and exits from the bridges 
are designed to prevent mice relying entirely on sequential arm choices. The 
end of each arm is extended with panels of identical size (20.2 em x 11 .2 em). 
These panels are used for holding intra-maze cues made of distinctive pattern 
drawings designed on plastic adhesive material and attached to a PVC board 
( 18 em x 11 .2 em). Sidewalls, about I em high, extended the length of each arm. 
There are no enclosures surrounding the cenlral platform, bridges or arms. The 
maze is totally surrounded with a heavy beige-light colored curtain. A camera 
is cenlred 180 em above the central platform. The ambient light at the surface 
of the cenlral platform is 180 lx. 
2.3. Testing procedures 
Naive food-deprived mice were inlroduced to the maze to acquire a spatial 
working memory task. They had no previous experience or habituation to the 
maze. They are placed in the central platform and let free to explore the maze 
until eight arm choices are made or I 0 min elapsed. One food pellet is available 
314 A. Ennaceur et al. I Behavioural Brain Research 187 (2008) 312-326 
at the end of each arm. A first visit to an arm is a recorded as unique visit (correct 
choice) and any subsequent visit is considered as a repeated choice or incorrect 
choice. A mouse can make up to seven repeated visits to the same arm. Animals 
are tested one session a day on 16 consecutive days. 
2.4. Tools and recording measures 
During the test, mice were observed on a screen monitor connected to a video 
camera suspended above the test arena. The video record of the experiment is 
run on a computer screen monitor through a capture card. The experiment is also 
video taped, the experimenter can review the VCR tape and check the accuracy 
of the recording at any time. An in-house computer program is used to record the 
frequency of entries as well as the duration and latencies of entries of pre-defined 
areas of the maze. 
2.5. Measurements and statistical analysis 
Several measurements were considered. A session last until eight choices 
are made or 10 min elapsed. An entry to an arm or a bridge is recorded whenever 
a mouse crosses with all four paws the line that delimits these areas. 
( 1) Number of bridge and arm entries: An entry onto a bridge is recorded only 
once if a mouse enters a bridge and continues to an arm. A return from an 
arm to a bridge within the same visit is not recorded. 
(2) Ann/bridge ratio: Number of arm entries divided by the number of bridges 
entries. A ratio close to I describes an animal that continued to an arm each 
time it visited a bridge. A ratio close to 0 describes an animal that made 
numerous visits to bridges before engaging onto an arm. In the former, the 
animal showed no hesitations or fewer hesitations to engage fully onto an 
arm whereas in the latter the animal demonstrated more hesitations before 
adventuring onto an arm. 
(3) Average number of entries onto bridges between arm visits: This mea-
sure examines the average number of entries onto the bridges between 
successive visits to arms. 
( 4) Number of bridge entries before first arm visit: The total number of bridge 
entries is recorded for those animals that did not visit any arm. 
(5) Number of bridge entries before first repeated arm visit: A repeated entry 
onto an arm is considered as an incorrect choice or an error (see Number 
of repeated visits to arms). In the first few sessions some animals visit no 
arms or a fewer number of arms (made less than eight choices). One bridge 
entry is recorded for animals that did not visit any arm (a penalty). The 
total number of bridge entries is recorded for those animals that made less 
than eight arm choices. 
(6) Number of arm entries before first repeated arm visit: An arm that is visited 
only once during a session is considered as a unique entry onto that arm 
(see Number of repeated visits to arms). A mouse that did not visit any 
arm will be recorded as having made zero unique visits before first repeat. 
A mouse that has made less than eight choices with no repeat will be 
recorded as having made his first repeated choice after his last arm visit. 
(7) Number of repeated visits to arms: This measure refers to incorrect choices 
or errors. An arm that is visited only once during a session is considered 
as a unique entry onto that arm (a correct choice). A session last until eight 
choices are made or I 0 min elapsed. Each entry onto an arm is considered 
as one choice. An animal can make up to eight visits to the same arm. The 
first visit is considered a unique visit or a correct choice and subsequent 
visits are considered repeated choice or incorrect choices. In the first few 
sessions a mouse may visit a few arms or may not visit any arm. In this 
case, a mouse that did not visit any arm will receive a penalty of eight 
repeated visits. For a mouse that has made less than eight choices, the 
number of the remaining arm choices is added to their actual number of 
repeated arm visits. For example, a mouse that has made five choices 
and two repeat visits to arms will be recorded having made three unique 
visits and five repeated visited (the actual 2 repeats+ the remaining arm 
choices 3). A mouse that has made five choices and zero repeats visits to 
arms will be recorded having made five unique visits and three repeated 
visited. 
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Fig. 2. In the second block of four sessions, young males (MY) and both young 
(FY) and middle-aged (FA) females compared to middle-aged males (MA), 
p<0.02. 
(8) Number of sessions and unique arm visits to criterion: A criterion is set 
to a total of five repeated choices maximum obtained in five consecutive 
sessions. 
(9) Latency of first entry onto a bridge: The time spent by a mouse in the 
central platform before it enters for the first time onto one of the bridges 
with all four paws. A mouse that did not enter onto a bridge receives the 
highest score which is I 0 min. 
( 1 0) Latency of first entry onto an arm: The time spent by a mouse in the central 
platform and bridges before it enters for the first time onto an arm. A mouse 
that did not enter onto any arm receives the highest score which is 10 min. 
(11) Latency of first repeated visit onto an arm: The time spent by a mouse in 
a session before it makes a first repeat visit onto an arm. A mouse that did 
not enter onto any arm receives the lowest score which is 0 min. 
(12) Total latencies between exits from and entries onto arms: The time is 
recorded when a mouse exits from an arm with all four paws until its next 
re-entry onto an arm (the same or another arm). A mouse that did not enter 
onto an arm receives the highest score which is 10 min. 
(13) Total duration of centre re-entries: The time is recorded from the entry 
of a mouse with all four paws onto the central platform until it exits to a 
bridge. 
(14) Total duration of bridge entries: The time is recorded from the entry of a 
mouse with all four paws onto a bridge until it exits to the central platform 
or onto an arm. If a mouse enters onto a bridge and continues to an arm, 
then the time on an arm is subtracted from the time spent on a bridge. 
( 15) Total duration of arm entries: The time is recorded from the entry of a 
mouse with all four paws onto an arm until it exits onto the bridge. 
( 16) Session duration: Animals are removed from the maze at the end of a ses-
sion when 10 min elapsed or when animals return onto the central platform 
after eight choices were made. A choice can be any visit or repeated visit 
to an arm. It is highly recommended that animals are not removed from an 
arm but left to return to the central platform. Our experiments with a radial 
maze and a T-maze show that removing animals from the arms delay the 
acquisition of the test and can lead to some animals not learning the test. 
Differences among group means for each of the above measurements were 
tested for significance with one-way ANOVA repeated measures. This was 
followed up with Newman-Keuls post hoc comparisons. Statistics were calcu-
lated using the statistical package Statistica for Windows (version 5.5). Results 
were considered significant when p ~ 0.05. When p ~ 0. I 0, it was reported and 
rounded up to the nearest value. 
3. Results 
(1) Number of bridge and arm entries (Fig. 2): One-way 
AN OVA repeated measures reveals significant differences 
between groups (F3,29 = 3.44, p::;:: 0.03) on the number 
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Fig. 3. FY and FA compared to MY and MA (p < 0.03) in each sessions' block. 
of bridge entries. Middle-aged males made more bridge 
entries than young (p < 0.01) and middle-aged (p < 0.05) 
females. They also made more entries to bridges than 
young males but these were not significant (p < 0.08). 
There are also significant differences between sessions 
(F3,87 = 81.02, p < 0.0001) but no significant interaction 
between groups and sessions (p > 0.1 0) on the number of 
bridge visits. The number of bridge entries were signif-
icantly high in the first block of four sessions compared 
to the other three sessions' blocks (p < 0.0001) and they 
were significantly low in the last block of four sessions 
compared to the second (p < 0.008) and third (p < 0.05) 
sessions' block. Post hoc analysis shows that young males 
and both young and middle-aged females made less entries 
to bridges than middle-aged males (p < 0.02) in the second 
sessions' block. 
The number of entries to arms shows significant dif-
ferences between sessions (p<O.OOOl) but not between 
groups (p > 0.1 0) and there are no significant interactions 
between groups and sessions (p > 0.10). 
(2) Arm/bridge ratio (Fig. 4): There are significant differ-
ences between groups (F3,29 = 3.30, p < 0.03), differences 
between sessions (F3,87 = 142.54, p < 0.0001) and signifi-
cant interactions (F9,87 = 3.24, p < 0.002). The arm/bridge 
ratio is significantly low in the first session block compared 
to all other sessions' blocks (p < 0.0001) and in the second 
block compared to the third block (p = 0.003) and the third 
block compared to the fourth block (p < 0.03). 
Post hoc analysis shows that in the second and third 
session blocks middle-aged males had a lower arm/bridge 
ratio compared to middle-aged females (p < 0.002 and 
<0.05), young females (p < 0.001 and <0.03, respectively) 
and young males (p < 0.002 and <0.05). 
(3) Average number of bridge entries between ann vis-
its (Fig. 3): There are significant differences between 
groups (F3,29 = 13.08, p _:::: 0.0001). Young and middle-
aged females made significantly fewer entries on bridges 
between arm visits than young and middle-aged males 
(p < 0.0007). 
There are also significant differences between session 
blocks (F3,87 = 29. 78, p _:::: 0.0001) but no significant inter-
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Fig. 4. In the second and third blocks of four sessions, MA compared to FA 
(p < 0.002 and <0.05, respectively), FY (p < 0.001 and <0.03, respectively) and 
MY (p<0.002 and <0.05, respectively). 
actions between groups and sessions' blocks (F9 ,87 = 1. 76, 
p _:::: 0.09). The average number of entries on bridges was 
significantly high in the first sessions' blocks compared to 
the other sessions' blocks (p<0.0001). 
Post hoc analysis shows significant differences between 
groups in each sessions' block (p < 0.01). Young and 
middle-aged females made less number of bridge entries 
than young and middle-aged males (p < 0.03). 
(4) Number of bridge entries before first ann visit 
(Fig. 5): There are significant differences between groups 
(F3,29=3.27, p<0.04). Young and middle-aged females 
entered a fewer bridges than middle-aged males (p < 0.02 
and <0.05, respectively). There are no significant differ-
ences between young females and middle-aged females 
(p > 0.1 0) and between young male and middle-aged males 
(p=0.06). 
There are also significant differences between sessions 
(F3,87 = 3.27, p < 0.0001) but no significant interac-
tions between groups and session blocks (F9,87 = 0.84, 
p > 0.1 0). The number of bridge visits is high in the first 
sessions' block compared to the other sessions' blocks 
(p<0.0001). 
Number of bridges before first arm entry 
14 
1/) 12 -.-MA 
· ·k ·MY 
-B-FA 
···0···FY 
Q) 
·c 
~ 10 
Q) 
0> 8 "0 
:g 
0 6 
a; 
.0 4 E 
::> 
z 
2 
0 
s1-s4 s5-s8 s9-s 12 
Blocks of 4 sessions 
s13-s16 
Fig. 5. In the third block of four sessions, FY and FA compared to MA (p < 0.009 
and <0.02, respectively). MY compared to MA (p < 0.009). 
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FY compared to MY in the second (p = 0.06), third (p < 0.1 0) and last (p < 0.002) 
sessions' blocks. FY compared to FA in the first (p=0.06) and last (p<0.002) 
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Post hoc analysis shows that middle-aged males made 
more number of bridge visits compared to young males 
(p < 0.009) and compared to both young (p < 0.009) and 
middle-aged females (p < 0.02) in the third sessions' block. 
They also made more number of bridge visits compared to 
young females in the second sessions' block but this was 
not significant (p < 0.06). 
(5) Number of bridge entries before first arm repeat: There are 
significant differences between sessions (F3,87 = 36.89, 
p < 0.0001) but no significant differences between groups 
(F3,29 = 0.55, p > 0.10) and no significant interactions 
(F9,87 = 0.82, p > 0.10). The number of bridge entries is 
significantly high in the first session block compared to 
the other blocks (p < 0.0001). 
(6) Number of repeated visits to arms (Fig. 6): One-way 
ANOVA repeated measures revealed significant differ-
ences between groups (F3,29 = 4.72, p ~ 0.008). Young 
female mice made significantly a fewer errors com-
pared to young male mice (p < 0.01) and to both 
middle-aged male (p < 0.007) and female (p < 0.05) 
mice. 
There are also significant differences between sessions 
(F3,87 = 56.47,p < 0.0001) but there is no significant inter-
action between groups and sessions (p > 0.1 0). The number 
of errors in the first block of four sessions is significantly 
higher than any other session (p < 0.0001 ). 
Post hoc analysis shows that the number of repeated vis-
its to arms is significantly low in young females compared 
to middle-aged males (p < 0.02) in the last three sessions' 
blocks. It is also low in young females compared to young 
males but this is significant only in the last (p < 0.002) but 
not in the second (p = 0.06) and third (p < 0.1 0) sessions' 
blocks. Young female made less repeated visits to arms 
than middle-aged females in the first (p = 0.06) and last 
(p < 0.002) sessions' blocks. 
(7) Number of arm entries before first arm repeat (Fig. 7): 
One-way AN OVA reveals significant differences between 
groups on errors (F3,29 = 5.43, p < 0.004 ), between 
sessions (F3,87 = 45.50, p < 0.0001) and significant inter-
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Fig. 7. FY compared to FA in the second (p<0.05) and fourth (p<0.0008) 
sessions' blocks. FY compared to MA in the last three blocks of four sessions 
(p < 0.006). FA compared to MY in the third sessions' block (p < 0.04). 
actions between groups and sessions (F9,87 = 45.50, 
p<0.0008). 
The group differences are between young female 
and middle-aged female (p < 0.03) and between young 
female and both young (p < 0.01) and middle-aged males 
(p = 0.002). Young females made more arm entries before 
making their first arm repeat. The session differences are 
between the first block of four sessions and the remaining 
other blocks (p < 0.0001) and between the second and the 
last (p < 0.04) sessions' blocks. The second sessions' block 
is not significantly different from the third sessions' block 
(p<O.lO). 
Post hoc analysis shows significant differences between 
groups on the second to the third blocks of four sessions 
(p < 0.01) but not on the first block (p > 0.10). The number 
of arm visits before first arm repeat is significantly high 
in young female compared to middle-aged female in the 
second (p < 0.05) and fourth (p < 0.0008) sessions' blocks. 
It is also significantly high in young females compared to 
middle-aged males in the last three blocks of four sessions 
(p < 0.006) and in middle-aged females compared to young 
males in the third sessions' block (p < 0.04 ). 
(8) Number of arm repeats (Fig. 8) and sessions to cri-
terion (Fig. 9): One-way ANOVA reveals significant 
differences between groups on the number of arm 
repeats (F3,29 = 6.59, p < 0.002) and sessions to criterion 
(F3,29=5.50, p<0.004). Post hoc comparisons shows 
that young females made a few arm repeats to criterion 
and a few number of sessions to criterion compared to 
middle-aged females (p < 0.04 ), and to both young and 
middle-aged males (p < 0.02). Female middle-aged made 
less number of arm repeats than male middle-aged but this 
is not significant (p < 0.09). 
(9) Latency of first entry to a bridge: There are significant dif-
ferences between sessions (F3,87 = 5.81, p ~ 0.001), but 
no significant differences between groups (p > 0.1 0) and no 
significant interactions between groups and session blocks 
(p > 0.10). The latency of first entry to a bridge is signifi-
cantly high in the first session block compared to the other 
blocks (p < 0.02). 
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(10) Latency of first entry to an arm: There are significant dif-
ferences between sessions (F3,87 = 90.68,p ::=:: 0.0001), but 
no significant differences between groups (p > 0.1 0) and no 
significant interactions between groups and session blocks 
(p > 0.1 0). The latency of first entry to an arm is signifi-
cantly high in the first session block compared to the other 
blocks (p < 0.0001 ). 
( 1 1) Latency of first repeated visit to an arm (Fig. 1 0): There are 
significant differences between sessions (F3,87 = 44.92, 
p ::=:: 0.0001) and significant interactions between groups 
and session blocks (F9,87 = 1 .98, p ::=:: 0.05) but no signifi-
cant differences between groups (F3,29 = 2.39, p ::=:: 0.09). 
The latency of first repeated visit to an arm is significantly 
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Fig. 10. FY compared to FA in the second sessions' block (p < 0.03) and to MA 
in the third sessions' block (p = 0.05). FY compared to MY (p <0.01) in the last 
sessions' block. MY compared to MAin the third sessions' block (p<0.04) and 
compared to both MA (p <0.02) and FA (p<0.01) in the last sessions ' block. 
high in the first block of four sessions compared to the other 
blocks (p<O.OOOl) and in the second block compared to 
third (p<0.04) and fourth (p<O.OOl) blocks. There is no 
significant difference between the third and fourth blocks 
(p=O.IO). 
Post hoc analysis shows that the latency of first repeated 
visit to an arm is shorter in young females compared to 
middle-aged females in the second block of four sessions 
(p<0.03) and to middle-aged males in the third sessions' 
block (p = 0.05). It is, however, longer in the last ses-
sions' block in young females compared to young males 
(p < 0.01). The latency of first repeated visit to an armis sig-
nificantly shorter in young males compared to middle-aged 
males in the third sessions' block (p < 0.04) and com-
pared to both middle-aged males (p < 0.02) and females 
(p < 0.01) in the last sessions' block. 
(12) Total latencies between exits from and entries to arms 
(Fig. II ): There are significant differences between groups 
(F3,29 = 4.19, p ::=:: O.oi ). Middle-aged males spent signif-
icantly longer time between entries to arms than young 
males (p < 0.005) and middle-aged females (p < 0.01 ). 
There are also significant differences between session 
blocks (F3,87 = 195.05, p ::=:: 0.0001) and significant inter-
actions between groups and session blocks (F9,87 = 3.51 , 
p ::=:: 0.0009). The latency of re-entry to arms is significantly 
high in the first session block compared to the other blocks 
(p < 0.0001) and in the second session block compared to 
the third (p<0.01) offourth session block (p<0.05). 
Post hoc analysis shows that the latencies between arms 
were significantly low in young females compared to 
young males (p < 0.04) in the first session block and com-
pared to middle-aged males in the second (p < 0.002) and 
318 A. Ennaceur eta/. I Behavioural Brain Research 187 (2008) 312-326 
450 
400 
350 
r..i 300 
a> 250 
.e 
a> 200 E 
i= 150 
100 
50 
0 
Latencies between re-entries to arms 
s1-s4 s5-s8 s9-s 12 
Blocks of 4 sessions 
s13-s16 
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block (p<O.Ol). 
third (p < 0.01) session blocks. Young females spent sig-
nificantly less time than middle-aged females in the second 
block (p < 0.04) and young males spent significantly less 
time than middle-aged males in the third session block 
(p<0.01). 
(13) Total duration of centre re-entries (Fig. 12): There 
are significant differences between groups (F3,29 = 3.36, 
p < 0.03). Young females spent significantly less time on 
the central platform compared to middle-aged female 
(p < 0.03) but not significant compared to young (p = 0.1 0) 
and middle-aged (p < 0.07) males. 
There are also significant differences between sessions 
(F3,87= 159.61, p<O.OOOl) and significant interactions 
between groups and sessions' blocks (F9,87 = 3.86, 
p < 0.0004). The time spent on the central platform is sig-
nificantly high in the first sessions' block compared to 
the other sessions' blocks (p < 0.0001) and in the second 
sessions' block compared to the third (p < 0.02) of fourth 
(p < 0.003) sessions' blocks. 
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Fig. 13. MA compared to MY (p<0.04) and to both FY (p<O.Ol) and FA 
(p < 0.03) in the second and third sessions' blocks. 
Post hoc analysis show that young females spent less 
time on the central platform compared to young males and 
middle-aged females in the first sessions' block (p < 0.03) 
and compared to both middle-aged males and middle-
aged females in the second sessions' block (p<0.04). In 
the third sessions' block middle-aged males spent signif-
icantly more time on the central platform compared to 
young males and young females (p < 0.03) and compared 
to middle-aged females (p < 0.05). 
( 14) Total duration of bridge entries (Fig. 13): There are signifi-
cant differences between groups (F3,29 = 4.78, p < 0.008). 
The time spent on the bridges is significantly high in 
middle-aged males compared to middle-aged females 
(p < 0.02), and compared to both young males (p < 0.04) 
and young females (p < 0.003 ). 
There are also significant differences between sessions 
(F3,87= 118.21, p<O.OOOl) but no significant interac-
tions between groups and sessions' blocks (F9,87 = 1.86, 
p < 0.07). The time spent on the bridges is high in the first 
sessions' block and decreases significantly between each 
subsequent sessions' block (p < 0.005). 
Post hoc analysis shows that the above differences 
between groups are observed in the second and third ses-
sions' blocks. Middle-aged males spent longer time on the 
bridges compared to young males (p < 0.04) and to both 
young (p < 0.01) and middle-aged (p < 0.03) females. 
(15) Total duration of arm entries (Fig. 14): There are signif-
icant differences between groups (F3,29 = 2.86, p < 0.05), 
between sessions' blocks (F3,87 = 2.99,p < 0.04) and sig-
nificant interactions between groups and sessions' blocks 
(F9,87 = 2.74, p < 0.007). 
The overall analysis shows that the time spent on the 
arms is significantly high in middle-aged females com-
pared to young males (p < 0.05). The time spent on the 
arms is significantly high in the second sessions' block 
compared to the last sessions' block (p < 0.04). It is low in 
the first sessions' block compared to the second sessions' 
block but is not significant (p = 0.06). 
Post hoc analysis shows the difference between middle-
aged females and young males on the second and last 
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Fig. 14. FA compared to MY in the second and last sessions' blocks (p<0.03). 
FA compared to MAin the second sessions' block (p<0.06) and compared to 
MY in the third sessions' block (p<0.09). MA compared to MY in the third 
sessions' block (p < 0.09). 
sessions' blocks (p < 0.03 ). Middle-aged females spent 
more time on the arms compared to middle-aged males 
in the second sessions' block (p<0.06) and compared to 
young males in the third sessions' block (p < 0.09) but this 
is not significant. Middle-aged males spent also longer time 
on the arms compared to young males in the third sessions' 
block but this is not significant (p < 0.09). 
(16) Total duration of unique visits to arms: There are 
no significant differences between groups (F3,29 = 2. 70, 
p = 0.06) and no significant differences between sessions' 
blocks (F3,87 = 2.23, p = 0.09) but significant interac-
tions between groups and sessions' blocks (F9,87 = 2.38, 
p<0.01). 
(17) Total duration of repeated visits to arms: There are 
no significant differences between groups (F3,29 = 1.85, 
p > 0.10) but significant differences between sessions' 
blocks (F3,87 = 3.73, p < 0.01) and no significant interac-
tions between groups and sessions' blocks (F9,87 = 1.85, 
p<0.01). 
(18) Session duration (Fig. 15): There are significant differ-
ences between groups (F3,29=5.75, p<0.003). Young 
males and females made significantly less time to per-
form eight choices in the maze than middle-aged males 
and middle-aged females (p < 0.03). 
There are also significant differences between sessions' 
blocks (F3,87= 160.57, p<O.OOOI) and significant inter-
actions between groups and sessions' blocks (F9,87 = 5.12, 
p<O.OOOl). The time spent on the maze is high in the first 
sessions' block and decreases significantly between each 
subsequent sessions' block (p < 0.008). 
Post hoc analysis shows that young females finished 
the test faster than middle-aged males and middle-aged 
females in the first sessions' block (p < 0.07) and this 
is significant in the second sessions' block (p < 0.002). 
Young females are also significantly faster than young 
males in the first (p < 0.02) and fourth (p < 0.03) sessions' 
blocks and than middle-aged males in the third sessions' 
block (p < 0.02). Young males were faster than middle-
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(p<0.03) sessions' blocks. MY compared to FA in the second (p<O.Ol) and 
fourth (p=0.002) sessions' blocks. 
aged males in the second (p = 0.007), third (p < 0.01) and 
fourth (p < 0.03) sessions' blocks. They were also faster 
than middle-aged females in the second (p<O.Ol) and 
fourth (p = 0.002) sessions' blocks. 
3.1. Correlation analyses 
Table lA describes the correlations between all parame-
ters of the tests for the total number of 16 sessions. It shows 
that the memory indices (number of arm repeats, number of 
unique arm visits before first arm repeats, number arm repeats 
to criterion and sessions to criterion) are strongly correlated 
to each other (r=0.58, p<0.0004 to r=0.92, p<0.0001). 
Number of arm visits before first arm repeat correlates nega-
tively with number of arm repeats (r= -0.85, p <0.0001), with 
arm repeats to criterion (r= -0.84, p<0.0001) and sessions 
to criterion (r= -0.79, p<O.OOOI), with duration in bridges 
(r= -0.42, p < 0.02), with number of bridges before first arm 
visit (r= -0.38, p<0.03), with number of bridges (r= -0.36, 
p <0.04) and with central platform entries (r= -0.36,p< 0.04). 
Number of arm repeats correlates positively with number of arm 
repeat to criterion (r= 0.91, p < 0.0001) and sessions to criterion 
(r= 0.58, p < 0.0004), latency to first entry on an arm (r= 0.56, 
p < 0.0008), number of bridge before first arm visit (r= 0.50, 
p<0.003) and it correlates negatively with number of bridges 
before first arm repeat (r= -0.34, p < 0.05) and number of arm 
visits (r= -0.54, p < 0.001). Number of arm repeats to criterion 
correlates negatively with number of arms before first arm repeat 
(r= -0.84, p<O.OOOl) and it correlates positively with number 
of arm repeats (r= 0.91, p < 0.0001), number of sessions to cri-
terion (r= 0.76, p < 0.0001), number of bridge visits (r= 0.41, 
p < 0.02), latency to first arm visit (r= 0.36, p < 0.04), and num-
ber of bridge before first arm visit (r=0.44, p<O.OI). Number 
of sessions to criterion correlates negative! y with number of arm 
before first arm repeat (r= -0.79, p< 0.0001) and it correlates 
positively with number of arm repeats (r = 0.59, p < 0.0003), 
with number of arm repeats to criterion (r=0.76, p<O.OOOI). 
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Table lA-C 
Correlations between the different measures of the test based on the average values of 16 sessions (A), first block of 4 sessions (B) and last block of 4 
sessions (C). 
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There are no correlations between the memory indices and ses-
sion duration, latency to first entry on a bridge, latency to first 
arm repeat. 
Table IB and C shows the correlations between the different 
parameters of the test on the first and last blocks of four ses-
sions. It demonstrates that there are no significant correlations 
between measures of anxiety and measures of memory in the 
last session block (p>O.IO). The number of arm entries before 
first arm repeat and the number of arm repeats are significantly 
correlated to each other in both session blocks (respectively, 
r = -0.72 and -0.87, p < 0.000 I). They do not correlate to any 
other parameters in the last session block except that number 
of arm entries before first arm repeat correlates with latency 
of first repeated arm entry (r=0.42, p<0.02) and that number 
of arm repeats correlates with time spent on repeated arm vis-
its (r= 0.37, p < 0.04); both parameters correlate with number of 
bridge entries before first repeated arm visit (r= 0.74 and -0.63, 
p<O.OOI). 
41. Discussion 
The present study examined the behavior of young and 
middle-aged CD-I mice of both sexes in a raised arm con-
figuration of a 3D maze. Mice were introduced to a working 
memory test without prior habituation to the apparatus and the 
testing environment. This testing procedure provides a chance 
to examine the emotional responses to novelty and open spaces 
on first exposure to the test in addition to learning and memory 
performance which continues throughout the successive testing 
sessions. 
Examination of the first sessions of exposure to novelty in 
the 3D maze revealed that young females spent significantly 
less time on the central platform compared to young males and 
they spent less time between arm visits compared to young 
males and middle-aged females. They also finish the test ses-
sion faster than middle-aged females and than both young and 
middle-aged males. There is however no significant differences 
between groups on the number of entries to arms. CD-1 mice did 
not make all eight arm choices on the first sessions (average from 
all animals on the first block of four sessions 5.71 ± 0.29). The 
low number of entries to arms suggests that CD-I mice express 
some anxiety responses in the 3D maze which confirms pre-
vious studies from our laboratory where CD-I were compared 
to C57/BL6 and Balb/c mice [I ,2]. We demonstrated consis-
tently that CD-1 male mice are more anxious than C57/BL6 
mice and less anxious than Balb/c mice in a 12 min exposure 
to the 3D maze. CD-I mice make a very few number of arm 
visits on their first exposure to the maze and required more 
than two sessions to make eight or more arm visits in a ses-
sion compared to C57/BL6 mice which visit more arms on a 
first exposure to the maze and make eight or more arm visits 
on a second exposure. CD-I mice however are less anxious than 
Balb/c mice which make a very few or no visit onto arms on their 
first exposure to the maze and require several sessions to make 
eight arm visits. In the present study, it is not possible to rely 
on the number of arm entries to assess anxiety as it is limited to 
a maximum of eight arm visits which are achieved by all CD-I 
mice on the fourth session and maintained through the remain-
ing test sessions. Instead, the index arm/bridge ratio is used to 
assess the difference in anxiety between sex and age groups. 
Analysis of the arm/bridge ratio confirms the lack of significant 
effect between groups on the first four sessions but revealed 
significant differences between groups on the second and third 
sessions blocks. There were no significant differences between 
groups on the last session block. The arm/bridge ratio was sig-
nificantly low in middle-aged males compared to middle-aged 
female mice and compared to both young male and female mice. 
This index arm/bridge ratio may reflect a prolonged anxiety in 
middle-aged males that subsided after three sessions' blocks. 
It cannot be accounted for by hesitation responses associated 
to cognitive processes as the arm/bridge ratio did not correlate 
with measures of learning and memory (number of arm before 
first arm repeat, number of arm repeats, errors and sessions to 
criterion, see Table lA). This lack of correlations was observed 
in each of the last three sessions' blocks (only the last session 
block shown in Table I C). Furthermore, in middle-aged male 
mice the latency of first entry onto a unique arm, the latency 
of first repeated arm visit, the number of arm repeats, number 
of arm visits before first arm repeat, number of errors and ses-
sion to criterion were comparable to that of middle-aged female 
mice. Further experiments are required to confirm the presence 
of anxiety in middle-aged male CD-I mice after repeated expo-
sure to a behavioral test. CD-I middle-aged male mice need to 
be compared to a strain of mice of the same age that expresses 
lower anxiety trait. 
Examination of the behavior of CD-I mice during the acqui-
sition and memory performance of the spatial navigation task 
shows that both young males and young females required sig-
nificantly less time to perform eight arm choices in the maze than 
middle-aged males and middle-aged females. However, only 
young females were able to make more correct arm choices. 
They made significantly fewer arm repeats, more unique arm 
entries before making first arm repeat, fewer arm repeats to 
criterion and fewer number of sessions to criterion compared 
to young male mice and to both middle-aged male and female 
mice. The main difference between young females and middle-
aged females, in addition to session duration and the memory 
indices, is the time spent on the central platform which was 
shorter in young females compared to middle-aged females. The 
main difference between young males and middle-aged males, 
in addition to session duration and arm/bridge ratio, is the time 
spent on the bridges and latencies between re-entries to arms 
which were shorter in young males compared to middle-aged 
males. The main difference between young females and young 
males, in addition to memory indices, is the number of re-entries 
to the centre which were significantly lower in females than in 
males. The main difference between middle-aged females and 
middle-aged males is the arm/bridge ratio, the number of entries 
to bridges, duration of entries to bridges, number of bridges 
before first arm visit and number of entries to the central platform 
which were significantly lower in females than in males. 
The central platform and the bridges are the two places were 
a decision can be made about the choice of an arm. A high num-
ber of entries to bridges reflect the hesitations or reluctance of 
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mice to engage onto an arm while a lengthy duration on the cen-
tral platform may reflect the hesitation and reluctance of mice to 
engage onto the bridges. Our results suggest that females made 
their decision on the central platform while for males the deci-
sion were made on the bridges. This hypothesis is supported by 
the fact that female mice made a fewer bridge entries, entered 
a fewer bridges before first arm visit and spent less time on the 
bridges than middle-aged males. They also made significantly 
a fewer returns to the central platform between arm visits than 
young males and middle-aged males. This means that most of the 
time female mice enter the bridges and continue to arms while 
males move back and forth between the central platform and 
bridges before adventuring onto an arm-younger males being 
faster than middle-aged males. Hesitations of rats at a choice 
point before committing to a choice were originally described 
as vicarious trials-and-errors (VTEs) by Tolman [13,14] and 
Muenzinger [82]. These are discrete responses that are not easy 
to record manually and time consuming if examined over 12-16 
sessions. Bimonte and Denenberg [ 15] proposed to record a VTE 
when the tip of a rat's snout did not cross a line that was set 
approximately II em into the 27.9 em of arm length and that 
the rat "was clearly oriented toward the end of an arm, and was 
accompanied by a distinct stop in motion". Under this crite-
rion, female rats were reported to demonstrate more VTEs than 
male rats which conflict with our observations. There is how-
ever some differences between the two experimental settings in 
addition to the species differences. The total length of an arm 
(including the bridge) in the 3D maze is 51 em, the width is 
11.2 em and the diameter of the central platform is 30 em while 
in Bimonte and Denenberg's radial maze the length of an arm 
is 38.9cm, the width 12.7 em and the diameter of the central 
platform is 48.3. The length of a bridge of the 3D maze con-
stitutes only 30% (15 em) of the total length of an arm while in 
Bimonte and Denenberg's radial maze the VTE zone constitutes 
39% (11 em). Considering the size of a rat, there is a very short 
distance left to reach the end of an arm (28 em) while in the 3D 
maze mice have still 2/3 (35 em) left to cover. In addition, in a 
very large central platform with wide separation between arms, 
animals are likely to follow sequential choices which would 
reduce the amount of VTEs (see below). In our view, hesitations 
or VTEs take place on the central platform at the point of entry 
to an arm and also on the first third part of an arm-this third 
should be long enough to contain at least the full length of an 
animal. 
There are only a few studies devoted to age-related mem-
ory performance in CD-1 mice. In a recent study, a premature 
deficit in the acquisition of a working memory test in a 3D 
maze was observed in middle-aged (12 months) female CD-
I mice in comparison to young (3 months) female CD-1 mice 
[3] which confirms our present findings. In another study [10], 
13 weeks old male and female CD-1 mice were tested every 2 
weeks over 65 weeks in aT-maze spontaneous exploration task. 
Performance decreased with age in both male and female mice 
but females performed better and showed a greater exploratory 
activity than males. Exploration time was longer in young and 
old males than in young and adult females. In recent study 
[85], adult (5 months) vs. middle-aged (13 months) CD-1 male 
mice were examined in a water maze. The authors report that 
middle-aged mice show deficit in the acquisition of the test as 
they displayed longer latencies to find the platform location 
than adults, showed longer cumulative distance from both the 
acquisition quadrant and platform location area than adults, and 
tended to spend more time in the outer area. They also report 
no age differences in swimming path or swimming speed. Simi-
lar deficits were reported in C57BL/6Nia mice at age 10 months 
[93], 15 months [99], 22 months [16] and 24-26 months [93,17]. 
A deficit in the water maze is also observed in aged C57BL/6J 
mice (18-20 months old) [18,100, 101] but middle-aged (10-12 
months old) mice were comparable to 3-4 months old mice [ 18]. 
These results from the water maze are difficult to compare with 
the 3D maze or the standard radial maze which involve choices 
between various alternatives and are based on food reward and 
not an aversive reinforcer. In addition, in the standard radial 
maze and the 3D maze, memory performance is inferred from 
the type of choices made by animals during a session whereas 
in the water maze they are inferred from latencies, duration 
and distance which can be confounded with alteration in motor 
activity. In the 3D maze, the radial maze and the T-maze, a 
choice of an arm is a specific response made by animals that 
can be measured independent of the latency and duration of its 
occurrence and independent of the length or the surface of the 
maze covered for its occurrence. The latency of entry to an arm, 
distance traveled to an arm and time spent on an arm can be 
used to account for memory performance (parametres explica-
tives) but do not measure or provide valid measures of memory; 
they cannot be used as memory indices (parametres indicatives); 
they are very often contaminated by confounding factors. In our 
experiment, the memory parameters of the test (number of arm 
repeats, number of unique arm visits before first arm repeats, 
number arm repeats to criterion and sessions to criterion) are 
strongly correlated to each other (r = 0.58, p < 0.0004 to r = 0.91, 
p < 0.0001). They all revealed consistently that young female 
mice performed better than young males and than both middle-
aged male and female mice. These parameters do not correlate 
with latency between entries to arms, time spent on the arms or 
the central platform, time spent on unique arm visits, latency 
to first arm repeat, latency to first entry to bridge and sessions' 
duration (p > 0.1 0). Only the latency to first arm visit correlates 
significantly with number of arm repeats (r= 0.56, p < 0.0008) 
and with number arm repeats to criterion (r = 0.36, p < 0.04 ), 
and time spent on the bridges correlates significantly with num-
ber of arm visits before first repeat (r = 0.42, p < 0.02) and with 
arm repeats to criterion (r=0.41, p<0.02). However, latency 
to first arm visit revealed no significant differences between 
groups while time spent on the bridges show significant dif-
ferences between middle-aged males compared to middle-aged 
females and compared to both young male and female mice. 
The results from the latency of first arm visit and time spent 
on bridges are not consistent with the results observed with the 
memory indices. Measures of latencies, duration and distance 
are not specific indices of memory function. They are likely 
to reflect a physical or physiological state of animals as well 
as the exploratory strategy or pattern of responses adopted by 
animals. 
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There are numerous reports on sex differences in cogni-
tive processes and these are becoming increasingly inconsistent 
and conflicting both in humans and animals ([15,19-34,91]. 
However, these inconsistencies and contradictions need to be 
carefully analyzed as one needs to consider the nature of 
the behavioral test and the parameters of the test that have 
been affected, the age of the subjects, and in animals the 
strains differences and estrus cycle. Sex differences in spa-
tial learning and memory tasks have been reported for humans 
and animals, with males often performing better than females 
[20,31,34-48]. There are other studies which demonstrate the 
opposite [10,15,19,22,29,49] or no sex differences [15,91]. 
Sex differences in age-related cognitive decline have been 
reported for humans and animals but here too the results 
are inconsistent and conflicting. In some studies, a rapid 
age-related decline was reported in females than in males 
[ 17,37 ,50,51-55,84,96,98] while other studies suggest the oppo-
site, a rapid decline in males than in females [43,56-61]. No sex 
difference is also reported in other studies [34,35,37,62-64]. 
It has been reported that motor activity in animals [65-68] and 
motor and psychomotor skills in humans [69,70] decline with 
age. Therefore it is possible that in our experiment aged mice 
have impaired motor activity which is reflected by a longer time 
to perform the test and this may account for their poor mem-
ory performance. However, if this were so, this argument would 
also apply to young males which also did not perform well in 
the test. In addition, the latency of first entry to an arm was 
comparable between all groups in all sessions. In our experi-
ments, all mice of different strains and ages are able to climb 
the bridges to reach the raised arms. In fact, mice seem to pre-
fer climbing, and the raised arm configuration appears more 
attractive to mice than the flat or lowered arm configurations. 
In addition, the bridge floors are covered with wiremesh to pro-
vide mice with further grip on the floor though our experiments 
demonstrate that mice can climb the bridges tilted by 60° without 
wire mesh. 
The design and the physical characteristics of a test apparatus 
can contribute to or interfere with learning and memory perfor-
mance in animals which are encouraged to adopt behavioral 
choice patterns or responses strategies [71-77]. For instance, 
with narrow arms that are about 12cm wide, some aged rats are 
too large to be able to tum back when at the end of an arm and are 
forced to withdraw rear-first to the central platform facing once 
again the same arm which may constrain their subsequent choice 
to one of the two adjacent arms. In contrast, young rats will return 
head-first from an arm to the central platform facing all remain-
ing arms. In addition, wide angles between adjacent arms can 
lead animals to learn movement sequences which result, through 
habit, in a smooth body movement swerving from one arm to the 
next. In our maze, the width of the bridges and arms is sufficient 
for three mice to run comfortably side by side. The exits from 
the bridges to the central platform are narrowed on either side of 
the bridge entries in a semi-random arrangement to prevent mice 
following a sequential strategy. At any time, an animal can miss 
the next one or two adjacent arms as it cannot rely on automatic 
body movement, and would be forced to rely on its memory of 
the previous visited arms. 
In human studies, cognitive functions have been reported to 
decline with age, these include episodic memory [97], work-
ing memory [83] and spatial memory [92,78,79]). Aging has 
been reported to affect information processing speed in human 
[90,95] and animals [88]. Older subjects were found to require 
more time to solve a 3D spatial navigation task and to acquire 
spatial information in a novel environment compared to younger 
adults [69,70,89]). The speed with which animals and humans 
perform a cognitive task is not an indicator of memory per-
formance. Latencies between arm entries and session durations 
do not correlate with any of the measures of memory perfor-
mance in the 3D maze. Making a fast decision or choice does 
not guarantee an accurate or a correct response, and taking 
longer time to make a decision or a choice can be equivalent 
to increasing a memory retention interval leading to confusion 
between choices. However, it is also possible that perform-
ing a memory task at a slower more considered pace can 
benefit performance in the aged subject as shown with non-
thermal near infra-red light treatment in female middle-aged 
mice [3]. 
CD-1 mice demonstrate a high incidence of spontaneous neo-
plastic and non-neoplastic lesions [4,5,8,80] and record a high 
mortality rate at about 24 months of age (32.6% and 28.6% at 
83 weeks of age and 66.4% and 63.3% at 109 weeks of age 
for male and females, respectively [4]). Amyloidosis is consid-
ered one of the major factors that contribute to death in aging 
CD-1 mice [9,94 }. Amyloid deposits represent frequent histolog-
ical findings in CD-I strains of mice [87} but their observation 
was limited to peripheral organs; there are no reports on his-
tological brain tissues. It is possible that the premature deficit 
in the acquisition of a working memory task observed female 
mice in this and a previous experiment in the 3D maze [3} can 
be due to a high level of circulating amyloid or possibly to a 
natural occurrence of amyloidosis in the brain of CD-1 mice. 
This issue is currently investigated in our laboratory. The poor 
performance of young male CD-1 mice which compare to that 
of middle-aged male CD-1 mice in the acquisition of a spa-
tial working memory task is supported by an early study from 
Mizumori et al. [81] in the validation of the radial maze for mice. 
Mizumori et al. [81} report that 3 months old male CD-1 mice 
were unable to acquire a working memory task in a continu-
ous choice procedure. Our results and those of Mizumori et al. 
[81 J suggest that male CD-1 mice present cognitive deficit very 
early in life and that this deficit is delayed in female. Exam-
ination of working memory performance in a radial maze of 
younger male CD-1 mice of 1 month and up to 3 months of 
age is required to investigate whether male CD-1 mice would 
perform a working memory task better than 4-months old CD-1 
rats. A study comparing middle-aged female CD-1 mice with 
other strains of mice is also needed to corroborate our find-
ing of the premature cognitive deficit observed at 12 months of 
age. 
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Abstract 
The effects of diazepam and chlordiazepoxide were assessed in a 3D maze which is a modification of an 8-arm radial maze. Each arm of the 
maze is attached to a bridge radiating from a central platform. Animals exposed for the first time to the maze do not venture beyond the line that 
separate a bridge from an arm. The prime criteria set for an anxiolytic effect is whether mice would increase the frequency of entries onto arms 
and increase arm/bridge entries ratio. C57 mice readily cross the line on first exposure and make more than 8 arm visits onto arms on second 
exposure, while other strains (CD-1 and Balb/c) hold back and rarely cross the line on first exposure and require more sessions to make more than 
8 arm entries. An anxiolytic drug is expected to encourage intermediate (CD-1) and high (Balb/c) anxiety mice to adventure onto the arms of the 
maze and make more visits to the arms to comparable levels seen with low anxiety c57 mice. In the present report, administration of different 
doses of diazepam (0.625, 1.25, 2.5 and 5 mg kg-1 i.p.) and chlordiazepoxide (5, 10 and 15 mg kg- 1 i.p.) did not reduce anxiety in animals, with 
the lowest dose of diazepam increasing motor activity in Balb/c and increasing anxiety in c57 mice while the highest doses of both diazepam 
(2.5 and 5 mg kg- 1 i.p.) and chlordiazepoxide ( 15 mg kg- 1 i.p.) induced mild sedation. Our results raise some concerns about the methodological 
foundations in the current assessment of anxiety and anxiolytic compounds both in animal and human studies. 
© 2007 Elsevier B.V. All rights reserved. 
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1. Introduction 
Benzodiazepines (BZDs) are the first-line drugs for the treat-
ment of anxiety disorders, acting at the GABAA receptors 
which remain primary targets for novel anxiolytic compounds. 
They are held up as the prototypical anxiolytic agent despite 
major central and peripheral side effects which undermine their 
use and conflict with their therapeutic purposes. The appar-
ent calming effect of BZDs reported in the clinic through 
interviews and questionnaires may actually result from a combi-
nation of mild sedation, cognitive dampening and/or peripheral 
myorelaxation. BZDs are indeed prescribed to induce anxi-
olysis but also sleep and anesthesia. They are also amnesic, 
and are routinely used in a perioperative setting for this 
purpose, to ensure that patients forget their experience in 
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surgery [58,63,88,91,121,129]. Furthermore, long-term BZD 
use induces tolerance and dependence. Numerous basic research 
studies have been devoted, for more than half a century, to follow 
up the clinical findings of the perceived anxiolytic effects ofben-
zodiazepines. Vast amounts of resources are currently invested 
in animal studies, mainly rats and mice and, in the develop-
ment of new GABAA compounds without the side effects of 
benzodiazepines. 
Current animal tests for anxiety have proved unreliable for 
the development of new anxiolytic drugs. They lack construct 
validity which is sine qua none to any other validity issue, 
producing often very inconsistent and contradictory results 
[3,16,73,109,139, see 138]. These tests are mostly based on a 
choice between two options, aversive and non-aversive stim-
uli. Animals are free to avoid an aversive stimulus; this is not an 
option in an anxiety state. In anxiety "fear is compounded with a 
tendency to approach the source of potential threat-producing 
an approach-avoidance conflict" [ 45]. In the current two-choice 
paradigms, BZDs did not demonstrate consistently an increase in 
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Emotional responses and memory performance of middle-aged 
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Abstract 
Non-thermal near infra-red (IR) has been shown to have many beneficial photobiological effects on a range of cell types, including 
neurons. In the present study, a pretreatment with a daily 6 min exposure to IR1072 for 10 days yielded a number of significant behav-
ioral effects on middle-aged female CD-1 mice (12-months) tested in a 3D-maze. Middle-aged mice show significant deficits in a working 
memory test and IR treatment reversed this deficit. Interestingly, theIR treated middle-aged group despite making less memory errors 
than sham middle-aged group spent longer time in different parts of the maze than both the young group (4-months) and sham-middle-
aged group (12-months). Young mice appeared more anxious than middle-aged mice in the first sessions of the test. Exposure to IR 
appeared to have no significant effects upon exploratory activity or anxiety responses. However, it elicited significant effects on working 
memory, with theIR middle-aged mice being more considerate in their decision making, which results in an overall improved cognitive 
performance which is comparable to that of young CD-I mice. The present study describes a novel method for assessing emotional 
responses and memory performance in a 3D spatial navigation task and demonstrates the validity of our new ali-in-one test and its sen-
sitivity to ageing and non-invasive beneficia!IR treatment. 
© 2007 Elsevier Inc. All rights reserved. 
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1. Introduction 
Sunlight is the most important and universal source of 
non-ionising radiation essential for life on Earth. Non-
thermal near infra-red (IR) (700-2000 nm) light has high 
penetrability of biological tissues, with low degrees of light 
scatter, and has been shown to have a wide range of ther-
apeutic benefits, for example, in the treatment of musculo-
skeletal disorders (Ceylan, Hizmetli, & Silig, 2003}, healing 
indolent wounds (Karu, 2003; Vinck, Cagnie, Cambier, & 
Cornelissen, 2001; Whelan et al., 2003) and reducing pain 
(Honmura, Ishii, Yanase, Obata, & Haruki, 1993). IR 
improved recovery from ischemic injury of the heart 
(Kawasuji et al., 2000}, prevents the development of oral 
mucositis in pediatric bone marrow transplant patients 
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(Whelan et al., 2002), and attenuates the developmental 
toxicity of dioxin in chicken embryos (Yeager et al. , 
2005). It can also generate significant biological effects 
including cellular proliferation, collagen synthesis, and 
the release of growth factors from cells (Conlan, Rapley, 
& Cobb, 1996; Karu, 1999; Leung, Lo, Siu, & So, 
2002). 
A growing number of reports have shown effects of IR 
on the nervous system. Low power laser irradiation has 
been shown also to improve retinal function and attenuate 
degeneration of injured optic nerves induced by methanol-
derived formic acid in rat models (Eells et a!., 2003) and has 
also been shown to alter gene expression in retinal neurons 
(Eells et al., 2004) and olfactory ensheathing cells in vitro 
(Byrnes, Wu, Waynant, Ilev, & Anders, 2005). Further-
more, effects upon neurotransmission has been described, 
modulating cerebral blood flow and changes in energy 
metabolism, including selective rises in A TP levels (Moe-
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